Sentence,class,file
J Virol 2012; 86:3975-84; PMID:22278228; http://dx.doi.org/10.1128/JVI.06828-1130.,Non-OADS,/arxiv_data1/oa_pdf/c5/fd/khvi-11-05-988554.PMC4514375.pdf
Vaccine 2008; 26:2930-4;PMID:18440103; http://dx.doi.org/10.1016/j.vaccine.,Non-OADS,/arxiv_data1/oa_pdf/c5/fd/khvi-11-05-988554.PMC4514375.pdf
Vaccine 2007;25:1464-9; PMID:17187906; http://dx.doi.org/ 10.1016/j.vaccine.2006.10.033 32.,Non-OADS,/arxiv_data1/oa_pdf/c5/fd/khvi-11-05-988554.PMC4514375.pdf
ClinVaccine Immunol 2007; 14:978-83; PMID:17596426; http://dx.doi.org/10.1128/CVI.00033-0734.,Non-OADS,/arxiv_data1/oa_pdf/c5/fd/khvi-11-05-988554.PMC4514375.pdf
Scand J Immunol 2005; 62:36-44;PMID:16092921; http://dx.doi.org/10.1111/j.1365- 3083.2005.01633.x 35.,Non-OADS,/arxiv_data1/oa_pdf/c5/fd/khvi-11-05-988554.PMC4514375.pdf
Virus Res 2004; 103:91-5; PMID:15163495; http://dx.doi.org/10.1016/j.virusres.2004.02.019 36.,OADS,/arxiv_data1/oa_pdf/c5/fd/khvi-11-05-988554.PMC4514375.pdf
Lancet 2006; 367:1657-64;PMID:16714186; http://dx.doi.org/10.1016/S0140- 6736(06)68656-X www.tandfonline.com 1243 Human Vaccines & Immunotherapeutics,Non-OADS,/arxiv_data1/oa_pdf/c5/fd/khvi-11-05-988554.PMC4514375.pdf
"© Katherine M Atkinson, Robin Ducharme, Jacqueline Westeinde, Sarah E Wilson, Shelley L Deeks, Dante Pascali, and Kumanan Wilson *Correspondence to: Kumanan Wilson; Email: kwilson@ohri.caSubmitted: 09/24/2014; Revised: 12/10/2014; Accepted: 12/20/2014 http://dx.doi.org/10.1080/21645515.2015.1009807 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/57/aa/khvi-11-04-1009807.PMC4514377.pdf
Hum Vaccin Immunother 2013; 9:1802–11; PMID:23807361; http://dx.doi.org/10.4161/hv.25031 2.,Non-OADS,/arxiv_data1/oa_pdf/57/aa/khvi-11-04-1009807.PMC4514377.pdf
Am J Public Health 2012; 102:e15-e21; PMID:22390457; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/57/aa/khvi-11-04-1009807.PMC4514377.pdf
Patient Educ Couns 2011; 85:119-21; PMID:20832970; http://dx.doi.org/10.1016/j.pec.2010.08.007 4.,Non-OADS,/arxiv_data1/oa_pdf/57/aa/khvi-11-04-1009807.PMC4514377.pdf
"Am J Public Health 2014; 104(S1):27-e12; PMID:24354839,http://dx.doi.org/10.2105/AJPH.2013.301620 5.",Non-OADS,/arxiv_data1/oa_pdf/57/aa/khvi-11-04-1009807.PMC4514377.pdf
Pediatrics 2011; 128:e1100-5; PMID:22007019; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/57/aa/khvi-11-04-1009807.PMC4514377.pdf
Retrieved from http://www.immunize.ca/en/app.aspx 8.,Non-OADS,/arxiv_data1/oa_pdf/57/aa/khvi-11-04-1009807.PMC4514377.pdf
J Clin Epidemiol2005; 58:1081-8; PMID:16223649; http://dx.doi.org/ 10.1016/j.jclinepi.2005.09.002 9.,OADS,/arxiv_data1/oa_pdf/57/aa/khvi-11-04-1009807.PMC4514377.pdf
Hum Vaccin Immunother2013; 9:1782-9; PMID:23900266; http://dx.doi.org/ 10.4161/hv.25959 11.,Non-OADS,/arxiv_data1/oa_pdf/57/aa/khvi-11-04-1009807.PMC4514377.pdf
Vaccine2012; 30:3778-89; PMID:22172504; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/57/aa/khvi-11-04-1009807.PMC4514377.pdf
Hum Vaccin Immunother 2013; 9:1752-4; PMID:23974831; http://dx.doi.org/10.4161/ hv.26217 15.,Non-OADS,/arxiv_data1/oa_pdf/57/aa/khvi-11-04-1009807.PMC4514377.pdf
Hum Vaccin Immunother 2013;9:1755-62; PMID:23744504; http://dx.doi.org/ 10.4161/hv.25085 16.,Non-OADS,/arxiv_data1/oa_pdf/57/aa/khvi-11-04-1009807.PMC4514377.pdf
BMC Med Inform Decis Mak 2013; 13:88; PMID:23938040;http://dx.doi.org/10.1186/1472-6947-13-88 18.,Non-OADS,/arxiv_data1/oa_pdf/57/aa/khvi-11-04-1009807.PMC4514377.pdf
2014;46:440-4; PMID:25220777; http://dx.doi.org/ 10.1016/j.jneb.2014.04.291 20.,OADS,/arxiv_data1/oa_pdf/57/aa/khvi-11-04-1009807.PMC4514377.pdf
J Med Internet Res 2014; 16:e135; PMID:24860070; http://dx.doi.org/10.2196/jmir.3421 21.,Non-OADS,/arxiv_data1/oa_pdf/57/aa/khvi-11-04-1009807.PMC4514377.pdf
Paper 118. http://digitalcommons.georgefox.edu/psyd/118.,Non-OADS,/arxiv_data1/oa_pdf/57/aa/khvi-11-04-1009807.PMC4514377.pdf
Gait Posture 2012; 36:163-5; PMID:22421189; http://dx.doi.org/10.1016/j.gaitpost.2012.02.006 27.,OADS,/arxiv_data1/oa_pdf/57/aa/khvi-11-04-1009807.PMC4514377.pdf
http://www4.hrsdc.gc.ca/.3ndic.1t.4r@-eng.jsp?iid=75 31.,Non-OADS,/arxiv_data1/oa_pdf/57/aa/khvi-11-04-1009807.PMC4514377.pdf
Jama 2007; 298:2482-4; PMID:18056901; http://dx.doi.org/10.1001/jama.298.,OADS,/arxiv_data1/oa_pdf/57/aa/khvi-11-04-1009807.PMC4514377.pdf
N Engl J Med 2011; 364:97-9; PMID:21226573; http://dx.doi.org/10.1056/NEJMp 1010594 35.,Non-OADS,/arxiv_data1/oa_pdf/57/aa/khvi-11-04-1009807.PMC4514377.pdf
Dermatol Clin 2009; 27:133-6; PMID:19254656; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/57/aa/khvi-11-04-1009807.PMC4514377.pdf
Retrieved from https://www.ottawahospital.on.ca/wps/portal/ Base/TheHospital/OurModelofCare/ProfessionalTeam/Nursing/NursingUnitProﬁles/BirthingUnit 38.,Non-OADS,/arxiv_data1/oa_pdf/57/aa/khvi-11-04-1009807.PMC4514377.pdf
"Thi rdly, other toxins belonged to © Junhong Wang, Shan Gao, Wenwen Xin, Lin Kang, Na Xu, Tao Zhang, Wensen Liu, and Jinglin Wang *Correspondence to: Wensen Liu; Email: liuws85952@163.com; Jinglin Wang; Email: wjl0801@vip.163.comSubmitted: 10/10/2014; Revised: 12/01/2014; Accepted: 12/11/2014 http://dx.doi.org/10.1080/21645515.2015.1008879 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4f/ec/khvi-11-06-1008879.PMC4514378.pdf
A recombinant mutant abrin A chain expressed in Escher- ichia coli can be used as an effective vaccine candidate.Hum Vaccin 2011; 7:838-44; PMID:21817853; http://dx.doi.org/10.4161/hv.7.8.16258 2.,Non-OADS,/arxiv_data1/oa_pdf/4f/ec/khvi-11-06-1008879.PMC4514378.pdf
Clin Vaccine Immunol 2008;15:737-43; PMID:18353919; http://dx.doi.org/ 10.1128/CVI.00254-07 3.,Non-OADS,/arxiv_data1/oa_pdf/4f/ec/khvi-11-06-1008879.PMC4514378.pdf
Toxicon 2013; 69:131-42; PMID:23339855; http://dx.doi.org/10.1016/j.toxicon.,OADS,/arxiv_data1/oa_pdf/4f/ec/khvi-11-06-1008879.PMC4514378.pdf
Vaccine 2002; 20:1681-91; PMID:11858879; http://dx.doi.org/10.1016/S0264-410X(01)00484-4 5.,Non-OADS,/arxiv_data1/oa_pdf/4f/ec/khvi-11-06-1008879.PMC4514378.pdf
Hum Exp Toxicol 1995; 14:155-64; PMID:7779439; http://dx.doi.org/10.1177/096032719501400201 6.,Non-OADS,/arxiv_data1/oa_pdf/4f/ec/khvi-11-06-1008879.PMC4514378.pdf
PLoS One 2012; 7:e45595; PMID:23049820; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4f/ec/khvi-11-06-1008879.PMC4514378.pdf
HumVaccin Immunother 2014; 10:2648-55; PMID: 25483485; http://dx.doi.org/10.4161/hv.29645 8.,Non-OADS,/arxiv_data1/oa_pdf/4f/ec/khvi-11-06-1008879.PMC4514378.pdf
JImmunol Methods 1996; 197:69-83; PMID:8890895; http://dx.doi.org/10.1016/0022-1759(96)00127-5 9.,Non-OADS,/arxiv_data1/oa_pdf/4f/ec/khvi-11-06-1008879.PMC4514378.pdf
Br J Haematol 2011; 154:471-6; PMID:21732928; http://dx.doi.org/10.1111/j.1365- 2141.2011.08762.x 12.,Non-OADS,/arxiv_data1/oa_pdf/4f/ec/khvi-11-06-1008879.PMC4514378.pdf
Acta Crystallogr D Biol Crystallogr 2011; 67:826-30; PMID:21904036; http://dx.doi.org/ 10.1107/S0907444911026771 13.,OADS,/arxiv_data1/oa_pdf/4f/ec/khvi-11-06-1008879.PMC4514378.pdf
Toxicol Sci 2012; 126:72-83; PMID:21987460; http://dx.doi.org/10.1093/toxsci/ kfr274 14.,Non-OADS,/arxiv_data1/oa_pdf/4f/ec/khvi-11-06-1008879.PMC4514378.pdf
Clin Vaccine Immunol 2012; 19:1697-9;PMID:22914366; http://dx.doi.org/10.1128/ CVI.00381-12 15.,Non-OADS,/arxiv_data1/oa_pdf/4f/ec/khvi-11-06-1008879.PMC4514378.pdf
Hum Vaccin Immunother 2013; 9:744-52; PMID:23563512; http://dx.doi.org/10.4161/hv.22998 16.,Non-OADS,/arxiv_data1/oa_pdf/4f/ec/khvi-11-06-1008879.PMC4514378.pdf
Clin Vaccine Immunol 2013; 20:789-94; PMID:23515013; http://dx.doi.org/ 10.1128/CVI.00098-13 17.,Non-OADS,/arxiv_data1/oa_pdf/4f/ec/khvi-11-06-1008879.PMC4514378.pdf
Infect Immun2006; 74:3463-70; PMID:16714577; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/4f/ec/khvi-11-06-1008879.PMC4514378.pdf
Infect Immun 2006; 74:3455-62; PMID:16714576; http://dx.doi.org/10.1128/IAI.,Non-OADS,/arxiv_data1/oa_pdf/4f/ec/khvi-11-06-1008879.PMC4514378.pdf
Vaccine 2011; 29:7925-35;PMID:21872634; http://dx.doi.org/10.1016/j.vaccine.,Non-OADS,/arxiv_data1/oa_pdf/4f/ec/khvi-11-06-1008879.PMC4514378.pdf
Adv Drug Deliv Rev 2005; 57:1424-39; PMID:15935880; http://dx.doi.org/10.1016/j.addr.,OADS,/arxiv_data1/oa_pdf/4f/ec/khvi-11-06-1008879.PMC4514378.pdf
Vaccine 2005; 23:4775-84; PMID:15961194; http://dx.doi.org/10.1016/j.vaccine.2005.04.037 24.,Non-OADS,/arxiv_data1/oa_pdf/4f/ec/khvi-11-06-1008879.PMC4514378.pdf
Toxins (Basel) 2011; 3:1163-84; PMID:22069761; http://dx.doi.org/10.3390/toxins3091163 25.,Non-OADS,/arxiv_data1/oa_pdf/4f/ec/khvi-11-06-1008879.PMC4514378.pdf
Vaccine 2003; 21:997-1005; PMID:12547614; http://dx.doi.org/10.1016/S0264- 410X(02)00551-0 26.,Non-OADS,/arxiv_data1/oa_pdf/4f/ec/khvi-11-06-1008879.PMC4514378.pdf
Int J Mol Sci 2013; 14:12401-10; PMID:23765218; http://dx.doi.org/10.3390/ijms140612401 www.tandfonline.com 1367 Human Vaccines & Immunotherapeutics,Non-OADS,/arxiv_data1/oa_pdf/4f/ec/khvi-11-06-1008879.PMC4514378.pdf
"However, it is well known that immunogenic and evolu-tionary differences exist between mice and humans, and © Sano ﬁPasteur *Correspondence to: Roger H Brookes; Email: Roger.Brookes@sano ﬁpasteur.com Submitted: 11/04/2014; Revised: 01/27/2015; Accepted: 02/22/2015 http://dx.doi.org/10.1080/21645515.2015.1023970 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/54/94/khvi-11-06-1023970.PMC4514381.pdf
Vaccine 2011; 29:2100-9; PMID:21256189; http://dx.doi.org/10.1016/j.vaccine.2010.12.135 2.,Non-OADS,/arxiv_data1/oa_pdf/54/94/khvi-11-06-1023970.PMC4514381.pdf
Sci Transl Med 2010; 2:53-74; PMID:20944089; http://dx.doi.org/10.1126/ scitranslmed.3001094 3.,Non-OADS,/arxiv_data1/oa_pdf/54/94/khvi-11-06-1023970.PMC4514381.pdf
J Clin Invest 2012; 122:303-14; PMID:22133873; http://dx.doi.org/10.1172/JCI46252 4.,Non-OADS,/arxiv_data1/oa_pdf/54/94/khvi-11-06-1023970.PMC4514381.pdf
Am J Respir Crit Care Med 2013; 188:492-502; PMID:23306546; http://dx.doi.org/10.1164/rccm.201208-1385OC 5.,Non-OADS,/arxiv_data1/oa_pdf/54/94/khvi-11-06-1023970.PMC4514381.pdf
PLoS One 2012; 7: e39909; PMID:22768165; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/54/94/khvi-11-06-1023970.PMC4514381.pdf
Vaccine 2011; 29:426-36;PMID:21093498; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/54/94/khvi-11-06-1023970.PMC4514381.pdf
PLoSOne 2013; 8: e55264; PMID:23405128; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/54/94/khvi-11-06-1023970.PMC4514381.pdf
Vaccine 2010; 28:1084-93; PMID:19896449; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/54/94/khvi-11-06-1023970.PMC4514381.pdf
PMID:15879133; http://dx.doi.org/10.4049/ jimmunol.174.10.6332 10.,Non-OADS,/arxiv_data1/oa_pdf/54/94/khvi-11-06-1023970.PMC4514381.pdf
Eur J Immunol 2008; 38:1247-56; PMID:18412160; http://dx.doi.org/10.1002/ eji.200737889 11.,Non-OADS,/arxiv_data1/oa_pdf/54/94/khvi-11-06-1023970.PMC4514381.pdf
PLoS One 2008; 3:e3683; PMID:18997860; http://dx.doi.org/ 10.1371/journal.pone.0003683 12.,Non-OADS,/arxiv_data1/oa_pdf/54/94/khvi-11-06-1023970.PMC4514381.pdf
PLoS One 2009; 4: e5930; PMID:19529771; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/54/94/khvi-11-06-1023970.PMC4514381.pdf
Vaccine 2010; 28:3571-81; PMID:20226890; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/54/94/khvi-11-06-1023970.PMC4514381.pdf
Hum Vac- cines Immunother 2014; 10:0-1; PMID:24401565;http://dx.doi.org/10.4161/hv.27657 15.,Non-OADS,/arxiv_data1/oa_pdf/54/94/khvi-11-06-1023970.PMC4514381.pdf
Immunity 2010; 33:441-50;PMID:21029956; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/54/94/khvi-11-06-1023970.PMC4514381.pdf
Immunol Rev 2011; 239:178-96;PMID:21198672; http://dx.doi.org/10.1111/j.1600- 065X.2010.00978.x 17.,Non-OADS,/arxiv_data1/oa_pdf/54/94/khvi-11-06-1023970.PMC4514381.pdf
J Immunol 2009; 183:6186-97; PMID:19864596; http://dx.doi.org/ 10.4049/jimmunol.090147418.,Non-OADS,/arxiv_data1/oa_pdf/54/94/khvi-11-06-1023970.PMC4514381.pdf
J Control Release 2014; 190: 563-79; PMID:24998942; http://dx.doi.org/10.1016/j.jconrel.2014.06.027 19.,OADS,/arxiv_data1/oa_pdf/54/94/khvi-11-06-1023970.PMC4514381.pdf
Mol Pharmaceutics 2014; 11:1772-84; PMID:24738485; http://dx.doi.org/10.1021/ mp400597z 20.,Non-OADS,/arxiv_data1/oa_pdf/54/94/khvi-11-06-1023970.PMC4514381.pdf
J Immunol 2014; 193:3704-16;PMID:25165152; http://dx.doi.org/10.4049/ jimmunol.1401018 21.,Non-OADS,/arxiv_data1/oa_pdf/54/94/khvi-11-06-1023970.PMC4514381.pdf
J Immunol 2012; 188:4828-37; PMID:22504654; http://dx.doi.org/10.4049/ jimmunol.1103183 www.tandfonline.com 1455 Human Vaccines & Immunotherapeutics,Non-OADS,/arxiv_data1/oa_pdf/54/94/khvi-11-06-1023970.PMC4514381.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b7/94/ndt-11-1749.PMC4514382.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2015:11 1749–1765Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1749OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S8460 2Disconnection of the hippocampus and amygdala  associated with lesion load in relapsing–remitting  multiple sclerosis: a structural and functional  connectivity study Fuqing Zhou1,2,* Ying Zhuang3,* lingling Wang4 Yue Zhang5 lin Wu1,2 Xianjun Zeng1,2 honghan gong1,2 1Department of radiology, The  First affiliated hospital, Nanchang  University, 2Jiangxi Province Medical   imaging research institute,   3Department of Oncology, The second  hospital of Nanchang, Nanchang,   Jiangxi Province, 4Department of  geriatrics, The Fifth affiliated hospital  of sun Yat-sen University, Zhuhai,   guangdong Province, 5Department  of radiology, The affiliated hospital  of Jiangxi University of Traditional  chinese Medicine, Nanchang, Jiangxi  Province, People’s republic of china *These authors contributed equally  to this workBackground and purpose:  Little is known about the functional and structural connectivity  (FC and SC) of the hippocampus and amygdala, which are two important structures involved in  cognitive processes, or their involvement in relapsing–remitting multiple sclerosis (RRMS).",Non-OADS,/arxiv_data1/oa_pdf/b7/94/ndt-11-1749.PMC4514382.pdf
"Evidence for hippocampal6 or amygdala demyelination7  in MS has been reported in recent histopathological studies.6–8 Advanced magnetic correspondence: Fuqing Zhou;   honghan gong Department of radiology, The First  Affiliated Hospital, Nanchang University,  17 Yongwaizhen street, Nanchang 330006,  Jiangxi Province, People’s  republic  of china Tel +86 791 8869 5132;   +86 791 8869 2582 email fq.chou@yahoo.co m;   honghan_gong@sina.co mJournal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2015 Volume: 11 Running head verso: Zhou et al Running head recto: Disconnection of the hippocampus and amygdala in MS DOI: http://dx.doi.org/10.2147/NDT.S84602",Non-OADS,/arxiv_data1/oa_pdf/b7/94/ndt-11-1749.PMC4514382.pdf
Available  from: http://www.restfmri.net.,Non-OADS,/arxiv_data1/oa_pdf/b7/94/ndt-11-1749.PMC4514382.pdf
Available from: http://fsl.fmrib.ox.ac.uk/fsl/fslwiki/FDT.,Non-OADS,/arxiv_data1/oa_pdf/b7/94/ndt-11-1749.PMC4514382.pdf
Available  from: http://www.fil.ion.ucl.ac.uk/spm/.,Non-OADS,/arxiv_data1/oa_pdf/b7/94/ndt-11-1749.PMC4514382.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/b7/94/ndt-11-1749.PMC4514382.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/b7/94/ndt-11-1749.PMC4514382.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e8/f7/jmdh-8-323.PMC4514383.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pJournal of Multidisciplinary Healthcare 2015:8 323–334Journal of Multidisciplinary Healthcare Dove press submit your manuscript | www.dovepress.co m Dove press  323Original researcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/JMDH.S8024 2The eXtraordinarY Kids clinic: an  interdisciplinary model of care for children and  adolescents with sex chromosome aneuploidy nicole Tartaglia1,2 susan Howell1,2 rebecca Wilson2 Jennifer Janusz1,2 richard Boada1,2 sydney Martin2 Jacqueline B Frazier2 Michelle Pfeiffer2 Karen regan2 sarah Mcswegin2 Philip Zeitler1,2 1Department of Pediatrics, University  of colorado school of Medicine,   2child Development Unit, children’s  Hospital colorado, aurora, cO, Usa correspondence: nicole Tartaglia   child Development Unit, children’s  Hospital colorado,  anschutz Medical  campus, 1 3123 east  19th avenue, B140,  aurora, cO  80045, Usa   Tel +1 720 777 8087   Fax +1 720 777 7868   email n icole.tartaglia@childrenscolorado.",Non-OADS,/arxiv_data1/oa_pdf/e8/f7/jmdh-8-323.PMC4514383.pdf
"Journal of Multidisciplinary Healthcare Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-multidisciplinary-healthcare-journa lThe Journal of Multidisciplinary Healthcare is an international, peer- reviewed open-access journal that aims to represent and publish research  in healthcare areas delivered by practitioners of different disciplines.",Non-OADS,/arxiv_data1/oa_pdf/e8/f7/jmdh-8-323.PMC4514383.pdf
Visit http://www.dove - press.com/testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/e8/f7/jmdh-8-323.PMC4514383.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ca/d3/ijn-10-4605.PMC4514384.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 4605–4620International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  4605OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S8235 4Preparation and tumor cell model based  biobehavioral evaluation of the nanocarrier  system using partially reduced graphene oxide  functionalized by surfactant Yimin Wang1 Kunping liu1,2 Zewei luo1 Yixiang Duan1 1research center of analytical  Instrumentation, Key laboratory  of Bio-resource and eco-environment,   Ministry of education, college of life  science, sichuan University, 2Faculty  of Biotechnology Industry, chengdu  University, chengdu, People’s republic  of chinaBackground:  Currently, surfactant-functionalized nanomaterials are tending toward  development of novel tumor-targeted drug carriers to overcome multidrug resistance in cancer  therapy.",Non-OADS,/arxiv_data1/oa_pdf/ca/d3/ijn-10-4605.PMC4514384.pdf
"Keywords:  biocompatibility, cytotoxicity, drug delivery, controlled release, fluorescence  colocalization, epirubicin Introduction An effective chemotherapeutic drug should specifically and highly accumulate in tumor  tissues and target the tumor cells,1,2 since drugs in the family of anthracyclines, includ - ing doxorubicin (DOX), daunorubicin (DNR), idarubicin (IDA), and epirubicin (EPI),  can only operate in the nucleus of tumor cells through the following mechanisms: 1)  by inhibiting the DNA synthesis; 2) by inhibiting topoisomerase II and inducing cell correspondence: Yixiang Duan research center of analytical  Instrumentation, college of life science,  sichuan University, 29 Wangjiang road,  chengdu 610064, People’s republic  of china Tel +86 28 8541 8180 Fax +86 28 8541 8180 email yduan@scu.edu.c n Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Wang et al Running head recto: Biobehavioral evaluation of partially reduced graphene oxide DOI: http://dx.doi.org/10.2147/IJN.S82354",Non-OADS,/arxiv_data1/oa_pdf/ca/d3/ijn-10-4605.PMC4514384.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/ca/d3/ijn-10-4605.PMC4514384.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ca/d3/ijn-10-4605.PMC4514384.pdf
"ﬁ http://dx.doi.org/10.1080/21645515.2015.1051404 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/), which permits unrestrictednon-commercial use, distribution, and reproductionin any medium, provided the original work is prop- erly cited.",Non-OADS,/arxiv_data1/oa_pdf/91/25/khvi-11-06-1051404.PMC4514387.pdf
" Editor's CornEr www.landesbioscience.com Human Vaccines & i mmunotherapeutics 1Human Vaccines & i mmunotherapeutics 11:1, 1–2; January 2015; © 2015 Landes BioscienceEditor's CornEr  Editor's CornEr *Correspondence to: Ronald Ellis; Email: rellis@landesbioscience.com Submitted: 10/10/2014; Accepted: 10/10/2014http://dx.doi.org/10.4161/hv.36803Letter from the Editor ronald Ellis1,* and Eva M r iedmann2 1senior Vice President r &d and Chief t echnology o fficer; n asVax, Ltd.; n ess Ziona, i srael; 2Acquisitions Editor; Landes Bioscience; Vienna, AustriaEditor's CornEr Dear Reader, We want to take this opportunity to wish you all a happy, healthy and prosperous new year!",Non-OADS,/arxiv_data1/oa_pdf/58/00/khvi-11-01-984099.PMC4514389.pdf
"7 © Carolyn Sanford, Joanne M Langley, Scott A Halperin, and Mitchell Zelman *Correspondence to: Joanne M Langley; Email: joanne.langley@dal.caSubmitted: 10/29/2014; Revised: 12/19/2014; Accepted: 01/01/2015 http://dx.doi.org/10.1080/21645515.2015.1012028 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f4/40/khvi-11-04-1012028.PMC4514393.pdf
Expert Rev Vaccines 2010; 9(4):395-407;PMID:20370550; http://dx.doi.org/10.1586/erv.10.17 2.,Non-OADS,/arxiv_data1/oa_pdf/f4/40/khvi-11-04-1012028.PMC4514393.pdf
24 January 2014: Available from:http://publications.gc.ca/collections/collection_2014/ aspc-phac/HP40-95-2014-eng.pdf.,Non-OADS,/arxiv_data1/oa_pdf/f4/40/khvi-11-04-1012028.PMC4514393.pdf
BMC Public Health 2014; 14(1):908;PMID:25182067; http://dx.doi.org/10.1186/1471- 2458-14-908 8.,Non-OADS,/arxiv_data1/oa_pdf/f4/40/khvi-11-04-1012028.PMC4514393.pdf
Available from: http://www.gov.pe.ca/photos/original/dhw_rcp_ rpt2011.pdf.9.,Non-OADS,/arxiv_data1/oa_pdf/f4/40/khvi-11-04-1012028.PMC4514393.pdf
Clini Infect Dis 2013; 56(4):548-51; PMID:23271788; http://dx.doi.org/10.1093/cid/cis939 10.,Non-OADS,/arxiv_data1/oa_pdf/f4/40/khvi-11-04-1012028.PMC4514393.pdf
BMC infectious diseases 2012; 12:306;PMID:23153184; http://dx.doi.org/10.1186/1471- 2334-12-306 11.,Non-OADS,/arxiv_data1/oa_pdf/f4/40/khvi-11-04-1012028.PMC4514393.pdf
Vac- cine 2010; 28 Suppl 1:A58-63; PMID:20412999; http://dx.doi.org/10.1016/j.vaccine.2010.02.035 13.,Non-OADS,/arxiv_data1/oa_pdf/f4/40/khvi-11-04-1012028.PMC4514393.pdf
Expert Rev Vaccines 2014; 13(3):365-76; PMID:24392657; http://dx.doi.org/10.1586/14760584.2014.877846 16.,Non-OADS,/arxiv_data1/oa_pdf/f4/40/khvi-11-04-1012028.PMC4514393.pdf
Available from: http://www12.statcan.gc.ca/ census-recensement/index-eng.cfm.,OADS,/arxiv_data1/oa_pdf/f4/40/khvi-11-04-1012028.PMC4514393.pdf
Available from: http://www.gsk.,Non-OADS,/arxiv_data1/oa_pdf/f4/40/khvi-11-04-1012028.PMC4514393.pdf
Pediatr Infect Dis J 2010; 29(9):879-82; PMID:20467353; http://dx.doi.org/10.1097/INF.,OADS,/arxiv_data1/oa_pdf/f4/40/khvi-11-04-1012028.PMC4514393.pdf
Vaccine 2004; 22(5-6):569-74;PMID:14741146; http://dx.doi.org/10.1016/j.vaccine.,Non-OADS,/arxiv_data1/oa_pdf/f4/40/khvi-11-04-1012028.PMC4514393.pdf
"In the United States, P. aeruginosa is the second most common pathogen causing acute healthcare-associated pneumonia in the critically ill, elderly and immunocompromised, while worldwide  *Correspondence to: Allan W Cripps; Email: allan.cripps@griffith.edu.au Submitted: 06/30/2014; Accepted: 08/07/2014; Published Online: 08/05/2014http://dx.doi.org/10.4161/hv.34296Vaccination against respiratory Pseudomonas  aeruginosa  infection Keith Grimwood1,2,3, Jennelle M Kyd4, Suzzanne J Owen2,5, Helen M Massa2,5, and Allan w Cripps1,2,* 1School of Medicine; Griffith University; Gold Coast, Queensland Australia; 2Griffith Health Institute; Griffith University; Gold Coast, Queensland Australia; 3Departments of  Paediatrics and Infectious Diseases; Gold Coast University Hospital; Gold Coast, Queensland Australia; 4Swinburne University of Technology; Hawthorn, Victoria Australia;  5School of Medical Science; Griffith University; Gold Coast, Queensland Australia Keywords:  P. aeruginosa , vaccine, oral immunisation, mucosal immunity, cystic fibrosis, chronic obstructive pulmonary disease,  bronchiectasis Abbreviations: Ad, amidase; AHL, acyl homoserine lactones; BHL, butyryl L-homoserine lactone; BSA, bovine serum albumin;  CF, cystic fibrosis; CFU, colony forming units; COPD, chronic obstructive pulmonary disease; HKPa, heat killed P. aeruginosa;  IFA, incomplete Freund’s adjuvant; IT, intra-tracheal; KatA, catalase A; LPS, lipopolysaccharide; nCFB, non-cystic fibrosis  bronchiectasis; NTHi, non-typeable Haemophilus influenzae;  OdDHL, N -3-(oxododecanoyl)-L-homoserine lactone; OprF-I,  Recombinant outer membrane fusion protein I of P. aeruginosa; PBS, phosphate buffered saline; QSSM, quorum sensing signalling  molecules Respiratory infections caused by Pseudomonas aeruginosa   are a major clinical problem globally, particularly for patients  with chronic pulmonary disorders, such as those with cystic fibrosis (CF), non-CF bronchiectasis (nCFB) and severe chronic obstructive pulmonary disease (COPD).",Non-OADS,/arxiv_data1/oa_pdf/7b/21/khvi-11-01-984103.PMC4514401.pdf
Front Microbiol 2011; 2:150 ;  PMID:21808635 ; http://dx.doi.org/10.3389/ fmicb.2011.00150 3.,OADS,/arxiv_data1/oa_pdf/7b/21/khvi-11-01-984103.PMC4514401.pdf
Curr Opin Pulm Med 2013; 19:251-8;  PMID:23449384 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/7b/21/khvi-11-01-984103.PMC4514401.pdf
Ann Am Thorac Soc 2014; 11:303-9; PMID:24423399 ; http://dx.doi.org/10.1513/ AnnalsATS.201310-350OC 7.,Non-OADS,/arxiv_data1/oa_pdf/7b/21/khvi-11-01-984103.PMC4514401.pdf
Pathog Dis 2013; 67:159-73; PMID:23620179 ;  http://dx.doi.org/10.1111/2049-632X.12033 8.,Non-OADS,/arxiv_data1/oa_pdf/7b/21/khvi-11-01-984103.PMC4514401.pdf
Infect Control Hosp Epidemiol 2013; 34:1-14; PMID:23221186 ; http://dx.doi.org/10.1086/668770 10.,Non-OADS,/arxiv_data1/oa_pdf/7b/21/khvi-11-01-984103.PMC4514401.pdf
JAMA 2009; 302:2323-9; PMID:19952319 ; http://dx.doi.org/10.1001/ jama.2009.1754 11.,Non-OADS,/arxiv_data1/oa_pdf/7b/21/khvi-11-01-984103.PMC4514401.pdf
Chest 2011; 139:1172-85; PMID:21540216 ; http://dx.doi.org/10.1378/ chest.10-0167 12.,Non-OADS,/arxiv_data1/oa_pdf/7b/21/khvi-11-01-984103.PMC4514401.pdf
Am J Respir Crit Care Med 2014; 189:812-24; PMID:24467627 ; http://dx.doi.org/10.1164/ rccm.201312-2142OC 13.,Non-OADS,/arxiv_data1/oa_pdf/7b/21/khvi-11-01-984103.PMC4514401.pdf
Crit Care Med 1997; 25:1862-7;  PMID:9366771 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/7b/21/khvi-11-01-984103.PMC4514401.pdf
Infection 2010; 38:25-32;  PMID:20012908 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/7b/21/khvi-11-01-984103.PMC4514401.pdf
Ann Am Thorac Soc 2014; 11:63-72; PMID:24261460 ; http://dx.doi.org/10.1513/ AnnalsATS.201309-303OC 16.,Non-OADS,/arxiv_data1/oa_pdf/7b/21/khvi-11-01-984103.PMC4514401.pdf
Eur Respir J 2014; 43:125-33; PMID:23598952 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/7b/21/khvi-11-01-984103.PMC4514401.pdf
Ann Am Thorac Soc 2014; 11:404-6; PMID:24673696 ; http://dx.doi.org/10.1513/ AnnalsATS.201311-405PS 20.,Non-OADS,/arxiv_data1/oa_pdf/7b/21/khvi-11-01-984103.PMC4514401.pdf
Respirology 2010; 15:1037-56;  PMID:20723140 ;  http://dx.doi.org/10.1111/j.1440-1843.2010.01819.x 21.,Non-OADS,/arxiv_data1/oa_pdf/7b/21/khvi-11-01-984103.PMC4514401.pdf
Eur Respir J 2012; 40:1014-23;  PMID:22743672 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/7b/21/khvi-11-01-984103.PMC4514401.pdf
Future Microbiol 2014; 9:457-63;  PMID:24810345 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/7b/21/khvi-11-01-984103.PMC4514401.pdf
Nat Med 2012; 18:509-19; PMID:22481418 ; http://dx.doi.org/10.1038/ nm.2715 25.,Non-OADS,/arxiv_data1/oa_pdf/7b/21/khvi-11-01-984103.PMC4514401.pdf
Microbes Infect 2011; 13:1133-45; PMID:21839853 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/7b/21/khvi-11-01-984103.PMC4514401.pdf
Environ Microbiol 2011; 13:1682-9; PMID:21429065 ;  http://dx.doi.org/10.1111/j.1462-2920.2011.02459.x 29.,Non-OADS,/arxiv_data1/oa_pdf/7b/21/khvi-11-01-984103.PMC4514401.pdf
Nat Rev Microbiol 2012; 10:841-51; PMID:23147702 ; http://dx.doi.org/10.1038/ nrmicro2907 30.,Non-OADS,/arxiv_data1/oa_pdf/7b/21/khvi-11-01-984103.PMC4514401.pdf
Vaccine 2008;  26:1011-24;  PMID:18242792 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/7b/21/khvi-11-01-984103.PMC4514401.pdf
Expert Opin Biol Ther 2005; 5:967-82;  PMID:16018741 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/7b/21/khvi-11-01-984103.PMC4514401.pdf
FEMS Immunol Med Microbiol 2003; 37:155-60; PMID:12832119 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/7b/21/khvi-11-01-984103.PMC4514401.pdf
Am J Respir Crit Care Med 2012; 186:420-7;  PMID:22723292 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/7b/21/khvi-11-01-984103.PMC4514401.pdf
Infect Immun 2008; 76:1223-9; PMID:18086812 ; http://dx.doi.org/10.1128/ IAI.01356-07 39.,Non-OADS,/arxiv_data1/oa_pdf/7b/21/khvi-11-01-984103.PMC4514401.pdf
Infect Immun 2005; 73:4399-403;  PMID:15972537 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/7b/21/khvi-11-01-984103.PMC4514401.pdf
Vaccine 2000; 19:348-57; PMID:10930690 ; http://dx.doi.org/10.1016/ S0264-410X(00)00146-8 41.,Non-OADS,/arxiv_data1/oa_pdf/7b/21/khvi-11-01-984103.PMC4514401.pdf
Mol Microbiol 1999; 34:1082-93; PMID:10594832 ;  http://dx.doi.org/10.1046/j.1365-2958.1999.01672.x43.,OADS,/arxiv_data1/oa_pdf/7b/21/khvi-11-01-984103.PMC4514401.pdf
J Biol Chem 2007; 282:19598-605; PMID:17442671 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/7b/21/khvi-11-01-984103.PMC4514401.pdf
J Cyst Fibros 2011; 10:357-65; PMID:21664196 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/7b/21/khvi-11-01-984103.PMC4514401.pdf
Ann Am Thorac Soc 2014; 11:425-34;  PMID:24673698 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/7b/21/khvi-11-01-984103.PMC4514401.pdf
Am J Respir Crit Care Med 2012; 186:657-65; PMID:22744718 ;  http://dx.doi.org/10.1164/rccm.201203-0487OC 50.,Non-OADS,/arxiv_data1/oa_pdf/7b/21/khvi-11-01-984103.PMC4514401.pdf
Nature 2002; 416:740-3; PMID :11961556 ; http://dx.doi.org/10.1038/416740a 51.,OADS,/arxiv_data1/oa_pdf/7b/21/khvi-11-01-984103.PMC4514401.pdf
Curr Drug Targets 2011; 12:521-30;  PMID:21194403 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/7b/21/khvi-11-01-984103.PMC4514401.pdf
Int J Med Microbiol 2006; 296:73-81; PMID:16476569 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/7b/21/khvi-11-01-984103.PMC4514401.pdf
Infect Immun 2000; 68:4331-4; PMID:10858254 ; http://dx.doi.org/10.1128/ IAI.68.7.4331-4334.200054.,Non-OADS,/arxiv_data1/oa_pdf/7b/21/khvi-11-01-984103.PMC4514401.pdf
PLoS One 2013; 8:e60973; PMID:23593362 ;  http://dx.doi.org/10.1371/journal.pone.0060973 56.,Non-OADS,/arxiv_data1/oa_pdf/7b/21/khvi-11-01-984103.PMC4514401.pdf
Int J Med Microbiol 2006; 296:149-61;  PMID:16503194 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/7b/21/khvi-11-01-984103.PMC4514401.pdf
J Am Chem Soc 2006; 128:2802-3; PMID:16506750 ; http://dx.doi.org/10.1021/ ja0578698 58.,OADS,/arxiv_data1/oa_pdf/7b/21/khvi-11-01-984103.PMC4514401.pdf
J Med Microbiol 2006; 55:1381-7; PMID:17005787 ; http://dx.doi.org/10.1099/ jmm.0.46658-0 59.,Non-OADS,/arxiv_data1/oa_pdf/7b/21/khvi-11-01-984103.PMC4514401.pdf
Infect Immun 2006; 74:968-74;  PMID:16428742 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/7b/21/khvi-11-01-984103.PMC4514401.pdf
"© Satoshi Iwata, Naohisa Kawamura, Haruo Kuroki, Yasunobu Tokoeda, Mitsunobu Miyazu, Asayuki Iwai, Tomohiro Oishi, Tomohide Sato, Akari Suyama, Na ncy Fran ¸cois, Fakrudeen Sha ﬁ, Javier Ruiz-Gui ~naz/C18u, and Dorota Borys *Correspondence to: Satoshi Iwata; Email: siwata@a8.keio.jpSubmitted: 06/05/2014; Revised: 11/18/2014; Accepted: 12/07/2014 http://dx.doi.org/10.1080/21645515.2015.1012019 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5b/8a/khvi-11-04-1012019.PMC4514407.pdf
Lancet 2009; 374:893-902; PMID:19748398; http://dx.doi.org/10.1016/S0140- 6736(09)61204-6 2.,Non-OADS,/arxiv_data1/oa_pdf/5b/8a/khvi-11-04-1012019.PMC4514407.pdf
J Infect Chemother 2011; 17:799-802; PMID:21701961; http://dx.doi.org/10.1007/s10156-011-0264-8 3.,Non-OADS,/arxiv_data1/oa_pdf/5b/8a/khvi-11-04-1012019.PMC4514407.pdf
Pediatr Infect Dis J 2013; 32:1394-6; PMID:23804122; http://dx.doi.org/10.1097/INF.0b013e3182a14971 4.,OADS,/arxiv_data1/oa_pdf/5b/8a/khvi-11-04-1012019.PMC4514407.pdf
Epidemiol Infect 2010; 138:61-8; PMID:19538821; http://dx.doi.org/10.1017/ S0950268809990239 5.,Non-OADS,/arxiv_data1/oa_pdf/5b/8a/khvi-11-04-1012019.PMC4514407.pdf
J Infect Chemother 2011; 17:334-40;PMID:21161561; http://dx.doi.org/10.1007/s10156- 010-0180-3 6.,Non-OADS,/arxiv_data1/oa_pdf/5b/8a/khvi-11-04-1012019.PMC4514407.pdf
J Antimicrob Chemother 2005; 56:756-60; PMID:16131518;http://dx.doi.org/10.1093/jac/dki302 8.,Non-OADS,/arxiv_data1/oa_pdf/5b/8a/khvi-11-04-1012019.PMC4514407.pdf
J Clin Microbiol 2008; 46:3808-10; PMID:18832131; http://dx.doi.org/10.1128/JCM.01782-08 10.,Non-OADS,/arxiv_data1/oa_pdf/5b/8a/khvi-11-04-1012019.PMC4514407.pdf
PLoS One 2013; 8:e68711;PMID:23844235; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/5b/8a/khvi-11-04-1012019.PMC4514407.pdf
Expert Rev Vaccines 2009; 8:1479- 500; PMID:19863240; http://dx.doi.org/10.1586/ erv.09.113 15.,Non-OADS,/arxiv_data1/oa_pdf/5b/8a/khvi-11-04-1012019.PMC4514407.pdf
Lancet 2006; 367:740-8; PMID:16517274; http://dx.doi.org/10.1016/S0140-6736(06)68304-9 16.,OADS,/arxiv_data1/oa_pdf/5b/8a/khvi-11-04-1012019.PMC4514407.pdf
Available from: http://www.jpeds.or.jp/uploads/ﬁles/sai sin_1106273.pdf.,Non-OADS,/arxiv_data1/oa_pdf/5b/8a/khvi-11-04-1012019.PMC4514407.pdf
Available at: https://surv.esr.cri.nz/surveillance/ IPD.php.,OADS,/arxiv_data1/oa_pdf/5b/8a/khvi-11-04-1012019.PMC4514407.pdf
Pediatr Infect Dis J 2009; 28:S97-S108;PMID:19325452; http://dx.doi.org/10.1097/ INF.0b013e318199f61b 49.,Non-OADS,/arxiv_data1/oa_pdf/5b/8a/khvi-11-04-1012019.PMC4514407.pdf
Pediatr Infect Dis J 2009; 28:S109-18; PMID:19325447; http://dx.doi.org/10.1097/ INF.0b013e318199f62d 51.,OADS,/arxiv_data1/oa_pdf/5b/8a/khvi-11-04-1012019.PMC4514407.pdf
Jpn J Infect Dis 2013; 66:235-7; PMID:23698486; http://dx.doi.org/ 10.7883/yoken.66.235 52.,Non-OADS,/arxiv_data1/oa_pdf/5b/8a/khvi-11-04-1012019.PMC4514407.pdf
Acta Paediatr Jpn 1995; 37:562-74; PMID:8533580; http://dx.doi.org/10.1111/j.1442- 200X.1995.tb03378.x 53.,Non-OADS,/arxiv_data1/oa_pdf/5b/8a/khvi-11-04-1012019.PMC4514407.pdf
Clin Vaccine Immunol 2006; 13:356-60; PMID:16522777; http://dx.doi.org/10.1128/ CVI.13.3.356-360.2006 55.,Non-OADS,/arxiv_data1/oa_pdf/5b/8a/khvi-11-04-1012019.PMC4514407.pdf
Clin Vaccine Immunol 2010; 17:134-42; PMID:19889940; http://dx.doi.org/10.1128/ CVI.00289-09 56.,Non-OADS,/arxiv_data1/oa_pdf/5b/8a/khvi-11-04-1012019.PMC4514407.pdf
Vaccine 2007; 25:2518-27; PMID:17034907; http://dx.doi.org/ 10.1016/j.vaccine.2006.09.029 www.taylorandfrancis.com 837 Human Vaccines & Immunotherapeutics,Non-OADS,/arxiv_data1/oa_pdf/5b/8a/khvi-11-04-1012019.PMC4514407.pdf
"In addition, rotavirusvaccine is recommended at 2 and 4 months of age, varicella at © Kevin L Schwartz, Karen Tu, Laura Wing, Michael A Campitelli, Natasha S Crowcroft, Shelley L Deeks, Sarah E Wilson, Kumanan Wilson, Ian Gemmill, and J effrey C Kwong*Correspondence to: Jeffrey C Kwong; Email: jeff.kwong@utoronto.caSubmitted: 01/13/2015; Revised: 04/02/2015; Accepted: 04/16/2015 http://dx.doi.org/10.1080/21645515.2015.1043499 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/19/76/khvi-11-07-1043499.PMC4514409.pdf
Available from: http://www.cpha.ca/en/programs/history/achievements.aspx.,Non-OADS,/arxiv_data1/oa_pdf/19/76/khvi-11-07-1043499.PMC4514409.pdf
Vaccine 2012; 30:6115-20; PMID: 22709951; http://dx.doi.org/10.1016/j.vaccine.,Non-OADS,/arxiv_data1/oa_pdf/19/76/khvi-11-07-1043499.PMC4514409.pdf
Pediatrics 1997; 99:765-73; PMID:9164767; http://dx.doi.org/10.1542/peds.99.6.765 4.,Non-OADS,/arxiv_data1/oa_pdf/19/76/khvi-11-07-1043499.PMC4514409.pdf
Avail- able from: http://www.statcan.gc.ca/tables-tableaux/ sum-som/l01/cst01/demo02a-eng.htm.,OADS,/arxiv_data1/oa_pdf/19/76/khvi-11-07-1043499.PMC4514409.pdf
Available from: http://www.health.gov.on.ca/en/public/programs/immuniza tion/docs/schedule.pdf.,Non-OADS,/arxiv_data1/oa_pdf/19/76/khvi-11-07-1043499.PMC4514409.pdf
Canad Med Associat J 2013; 185:E393-E4; PMID:23649422; http://dx.doi.org/10.1503/cmaj.,OADS,/arxiv_data1/oa_pdf/19/76/khvi-11-07-1043499.PMC4514409.pdf
Pediatr Infect DisJ 2009; 28:582-7; PMID:19561423; http://dx.doi.org/ 10.1097/INF.0b013e318197fac1 11.,Non-OADS,/arxiv_data1/oa_pdf/19/76/khvi-11-07-1043499.PMC4514409.pdf
Vaccine 2008; 26:6462-5; PMID:18573297; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/19/76/khvi-11-07-1043499.PMC4514409.pdf
Implement Sci 2013; 8:142; PMID:24341511; http://dx.doi.org/ 10.1186/1748-5908-8-142 13.,OADS,/arxiv_data1/oa_pdf/19/76/khvi-11-07-1043499.PMC4514409.pdf
Can J Cardiol 2010; 26:e225-8;PMID:20847968; http://dx.doi.org/10.1016/S0828- 282X(10)70412-8 15.,Non-OADS,/arxiv_data1/oa_pdf/19/76/khvi-11-07-1043499.PMC4514409.pdf
Can J Cardiol 2013; 29:1388-94; PMID:24075778; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/19/76/khvi-11-07-1043499.PMC4514409.pdf
Epilepsia 2014; 55:335-43; PMID:24417710;http://dx.doi.org/10.1111/epi.12506 17.,Non-OADS,/arxiv_data1/oa_pdf/19/76/khvi-11-07-1043499.PMC4514409.pdf
[accessed 2014 December 11]; Available from: https://http://www.ontariomd.ca/portal/server.pt/community/emr_ funding/emr_enhanced_use_program/.,Non-OADS,/arxiv_data1/oa_pdf/19/76/khvi-11-07-1043499.PMC4514409.pdf
Pediatrics 2012; 129:e1421– 30; PMID:22585770; http://dx.doi.org/10.1542/peds.2011-2441 21.,Non-OADS,/arxiv_data1/oa_pdf/19/76/khvi-11-07-1043499.PMC4514409.pdf
Pediatrics 2006; 117:595-602; PMID:16510636; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/19/76/khvi-11-07-1043499.PMC4514409.pdf
"Although a © Kyoko Kondo, Kanzo Suzuki, Masakazu Washio, Satoko Ohfuji, Wakaba Fukushima, Akiko Maeda, Yoshio Hirota, and the Pneumonia in Elderly People Study Group*Correspondence to: Kyoko Kondo; Email: kyou@med.osaka-cu.ac.jpSubmitted: 08/22/2014; Revised: 12/26/2014; Accepted: 01/24/2015 http://dx.doi.org/10.1080/21645515.2015.1016668 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/39/8b/khvi-11-05-1016668.PMC4514410.pdf
Vaccine 2011; 29:7773–8; PMID:21821084; http://dx.doi.org/10.1016/j.vaccine.2011.07.112 3.,Non-OADS,/arxiv_data1/oa_pdf/39/8b/khvi-11-05-1016668.PMC4514410.pdf
Ann Intern Med 1994; 121:947–52; PMID:7978721;http://dx.doi.org/10.7326/0003-4819-121-12- 199412150-00008 4.,Non-OADS,/arxiv_data1/oa_pdf/39/8b/khvi-11-05-1016668.PMC4514410.pdf
N Engl J Med 2007; 357:1373–81; PMID:17914038; http://dx.doi.org/10.1056/NEJMoa 070844 5.,OADS,/arxiv_data1/oa_pdf/39/8b/khvi-11-05-1016668.PMC4514410.pdf
Arch Intern Med 1998; 158:1769– 76; PMID:9738606; http://dx.doi.org/10.1001/ archinte.158.16.1769 6.,Non-OADS,/arxiv_data1/oa_pdf/39/8b/khvi-11-05-1016668.PMC4514410.pdf
Vaccine 2010; 28:7267–72; PMID:20832494;http://dx.doi.org/10.1016/j.vaccine.2010.08.088 7.,Non-OADS,/arxiv_data1/oa_pdf/39/8b/khvi-11-05-1016668.PMC4514410.pdf
PLoS One 2013; 8:e66125;PMID:23840413; http://dx.doi.org/10.1371/journal.,OADS,/arxiv_data1/oa_pdf/39/8b/khvi-11-05-1016668.PMC4514410.pdf
Lancet 2008; 372:398–405; PMID:18675690; http://dx.doi.org/10.1016/S0140-6736(08)61160-5 9.,OADS,/arxiv_data1/oa_pdf/39/8b/khvi-11-05-1016668.PMC4514410.pdf
Int J Epidemiol 2006; 35:345–52; PMID: 16368724; http://dx.doi.org/10.1093/ije/dyi275 11.,OADS,/arxiv_data1/oa_pdf/39/8b/khvi-11-05-1016668.PMC4514410.pdf
Thorax 2013; 68:1057–65; PMID:24130229; http://dx.doi.org/10.1136/ thoraxjnl-2013-204282 12.,Non-OADS,/arxiv_data1/oa_pdf/39/8b/khvi-11-05-1016668.PMC4514410.pdf
BMJ 2010;340:c1004;PMID:20211953;http://dx.doi.org/10.1136/ bmj.c1004 14.,Non-OADS,/arxiv_data1/oa_pdf/39/8b/khvi-11-05-1016668.PMC4514410.pdf
Vaccine 2008; 26:6466–9; PMID:18582520; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/39/8b/khvi-11-05-1016668.PMC4514410.pdf
J Infect Dis 2011; 203:1301–8; PMID:21459817; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/39/8b/khvi-11-05-1016668.PMC4514410.pdf
Vaccine 2010; 28:7063–9; PMID:20723631; http://dx.doi.org/ 10.1016/j.vaccine.2010.08.010 www.tandfonline.com 1093 Human Vaccines & Immunotherapeutics,Non-OADS,/arxiv_data1/oa_pdf/39/8b/khvi-11-05-1016668.PMC4514410.pdf
"Participants were © Helen Petousis-Harris, Catherine Jackson, Joanna Stewart, Gregor Coster, Nikki Turner, Felicity Goodyear-Smith, and Diana Lennon *Correspondence to: Helen Petousis-Harris; Email: h.petousis-harris@auckland.ac.nzSubmitted: 10/07/2014; Revised: 01/18/2015; Accepted: 01/28/2015 http://dx.doi.org/10.1080/21645515.2015.1016670 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1e/ce/khvi-11-07-1016670.PMC4514414.pdf
Sex Transm Infect 2008; 84:227-32; PMID:18256106; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1e/ce/khvi-11-07-1016670.PMC4514414.pdf
Pediatr Infect Dis J 2005; 24:953-61; PMID:16282928; http://dx.doi.org/10.1097/01.inf.0000183853.16113.a6 5.,OADS,/arxiv_data1/oa_pdf/1e/ce/khvi-11-07-1016670.PMC4514414.pdf
Pediatr Infect Dis J 2001; 20:S57-62; PMID:11704725; http://dx.doi.org/10.1097/00006454-200111001-00009 7.,OADS,/arxiv_data1/oa_pdf/1e/ce/khvi-11-07-1016670.PMC4514414.pdf
Hum Vaccine 2008; 4:67-73; PMID: 17881890; http://dx.doi.org/10.4161/hv.4.1.47478.,Non-OADS,/arxiv_data1/oa_pdf/1e/ce/khvi-11-07-1016670.PMC4514414.pdf
Clin Vaccine Immunol 2007; 14:1393-9; PMID:17898183; http://dx.doi.org/ 10.1128/CVI.00167-07 10.,Non-OADS,/arxiv_data1/oa_pdf/1e/ce/khvi-11-07-1016670.PMC4514414.pdf
Vaccine 2006; 24:1395-400;PMID:16242221; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/1e/ce/khvi-11-07-1016670.PMC4514414.pdf
Pediatr Infect Dis J 2007; 26:345-50; PMID:17414400; http://dx.doi.org/10.1097/01.inf.0000258697.05341.2c 12.,OADS,/arxiv_data1/oa_pdf/1e/ce/khvi-11-07-1016670.PMC4514414.pdf
Arch Dis Child 2009; 94:745-51;PMID:18838420; http://dx.doi.org/10.1136/ adc.2007.132571 13.,Non-OADS,/arxiv_data1/oa_pdf/1e/ce/khvi-11-07-1016670.PMC4514414.pdf
Pain Med 2012; 13:522-40;PMID:22390201; http://dx.doi.org/10.1111/j.1526- 4637.2012.01336.x 14.,Non-OADS,/arxiv_data1/oa_pdf/1e/ce/khvi-11-07-1016670.PMC4514414.pdf
Pediatr Infect Dis J 2009; 28:521-8; PMID:19436236; http://dx.doi.org/ 10.1097/INF.0b013e318199d2fc 17.,OADS,/arxiv_data1/oa_pdf/1e/ce/khvi-11-07-1016670.PMC4514414.pdf
Vaccine 2005; 23:2191-6; PMID:15755593; http://dx.doi.org/10.1016/j.vaccine.2005.01.063 18.,Non-OADS,/arxiv_data1/oa_pdf/1e/ce/khvi-11-07-1016670.PMC4514414.pdf
Clin Infect Dis 2010; 51:1127-37; PMID:20954968; http://dx.doi.org/10.1086/656741 www.tandfonline.com 1877 Human Vaccines & Immunotherapeutics,Non-OADS,/arxiv_data1/oa_pdf/1e/ce/khvi-11-07-1016670.PMC4514414.pdf
"8 Speciﬁcally, there are several mutations in the H7N9 virus associ-ated with adaptation to human; for example, the HA protein has the Q226L mutation which could enhance viral binding to mam- malian receptors in the human upper airway while the E627K © Changgui Li, Kangwei Xu, Anwar Hashem, Ming Shao, Shuzhen Liu, Yong Zou, Qiang Gao, Yongchao Zhang, Liyong Yuan, Miao Xu, Xuguang Li, and Junzhi Wang*Correspondence to: Junzhi Wang; Email: wangjz@nifdc.org.cnSubmitted: 12/15/2014; Revised: 03/01/2015; Accepted: 03/16/2015 http://dx.doi.org/10.1080/21645515.2015.1032490 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7c/fa/khvi-11-06-1032490.PMC4514420.pdf
Emerg Infect Dis 2004; 10:2196-9; PMID:15663860; http://dx.doi.org/10.3201/eid1012.040961 3.,Non-OADS,/arxiv_data1/oa_pdf/7c/fa/khvi-11-06-1032490.PMC4514420.pdf
Emerg Infect Dis 2009; 15:859-65; PMID:19523282; http://dx.doi.org/ 10.3201/eid1506.090072 5.,Non-OADS,/arxiv_data1/oa_pdf/7c/fa/khvi-11-06-1032490.PMC4514420.pdf
Proc Natl Acad Sci U S A 2004; 101:1356-61; PMID:14745020; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/7c/fa/khvi-11-06-1032490.PMC4514420.pdf
Microbes Infect 2013; 15:432-9; PMID:23628410; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/7c/fa/khvi-11-06-1032490.PMC4514420.pdf
Nat Commun 2013; 4:2854; PMID:24326875; http://dx.doi.org/10.1038/ ncomms3854 12.,OADS,/arxiv_data1/oa_pdf/7c/fa/khvi-11-06-1032490.PMC4514420.pdf
J Biol Stand 1977; 5:237-47; PMID:408355; http://dx.doi.org/10.1016/S0092- 1157(77)80008-5 13. WHO.,OADS,/arxiv_data1/oa_pdf/7c/fa/khvi-11-06-1032490.PMC4514420.pdf
Biologicals 2010; 38:284-9; PMID:20074976; http://dx.doi.org/ 10.1016/j.biologicals.2009.12.004 15.,OADS,/arxiv_data1/oa_pdf/7c/fa/khvi-11-06-1032490.PMC4514420.pdf
Vaccine 2008; 26:6550-4; PMID:18840494; http://dx.doi.org/ 10.1016/j.vaccine.2008.09.050 16.,Non-OADS,/arxiv_data1/oa_pdf/7c/fa/khvi-11-06-1032490.PMC4514420.pdf
Vaccine 2010; 28:2442-9; PMID:20074687; http://dx.doi.org/10.1016/j.vaccine.2009.12.079 17.,Non-OADS,/arxiv_data1/oa_pdf/7c/fa/khvi-11-06-1032490.PMC4514420.pdf
Anal Chem 2007; 79:3164- 72; PMID:21704111; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/7c/fa/khvi-11-06-1032490.PMC4514420.pdf
Vaccine 2012; 30:4762-70;PMID:22643214; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/7c/fa/khvi-11-06-1032490.PMC4514420.pdf
Vaccine 2008; 26:6068-76; PMID:19007587; http://dx.doi.org/10.1016/j.vaccine.2008.09.015 21.,Non-OADS,/arxiv_data1/oa_pdf/7c/fa/khvi-11-06-1032490.PMC4514420.pdf
"Nat Protoc 2010; 5:14-9; PMID:20010723; http://dx.doi.org/10.1038/ nprot.2009.200 2 2 .H a r d yS ,E i c h e l b e r g e rM ,G r i f ﬁ t h sE ,W e i rJ P , Wood D, Alfonso C. Confronting the next pan- demic–workshop on lessons learned from potency testing of pandemic (H1N1) 2009 inﬂuenza vac- cines and considerations for future potency tests,Ottawa, Canada, July 27–29, 2010.",Non-OADS,/arxiv_data1/oa_pdf/7c/fa/khvi-11-06-1032490.PMC4514420.pdf
"Inﬂuenza Other Respir Viruses 2011; 5:438-42; PMID:21668676; http://dx.doi.org/10.1111/j.1750-2659.2011.00250.x 2 3 .E l m g r e nL ,L iX ,W i l s o nC ,B a l lR ,W a n gJ , Cichutek K, Pﬂeiderer M, Kato A, Cavaleri M, Southern J, et al.",Non-OADS,/arxiv_data1/oa_pdf/7c/fa/khvi-11-06-1032490.PMC4514420.pdf
N Engl J Med 2010; 363:2416-23; PMID:21158658; http://dx.doi.org/ 10.1056/NEJMoa1006736 25.,OADS,/arxiv_data1/oa_pdf/7c/fa/khvi-11-06-1032490.PMC4514420.pdf
Rev Infect Dis 1983; 5(4):723-36; PMID:6353529; http://dx.doi.org/10.1093/clinids/5.4.723 26.,Non-OADS,/arxiv_data1/oa_pdf/7c/fa/khvi-11-06-1032490.PMC4514420.pdf
PLoS One 2013; 8(2):e55428; PMID:23424631; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/7c/fa/khvi-11-06-1032490.PMC4514420.pdf
J Biol Stand 1974; 2:249-58; PMID:4459394; http://dx.doi.org/10.1016/0092-1157(74)90033-X 29.,OADS,/arxiv_data1/oa_pdf/7c/fa/khvi-11-06-1032490.PMC4514420.pdf
"ForKeywords: antiangiogenic cancer vaccine, cell heterogeneity, cell proteomic foot-printing, cell surface antigens, cell surface proﬁling, microvascular endothelial cells, universal cancer vaccine, vaccine design Abbreviations: HMEC, human microvas- cular endothelial cells; UCV, universalcancer vaccine; CTA, cytotoxicity assay;CPF, cell proteomic footprinting; CTL,cytotoxic T lymphocytes; SANTAVAC,Set of All Natural Target Antigens forVaccination Against Cancer © Petr G Lokhov and Elena E Balashova *Correspondence to: Petr G Lokhov; Email:lokhovpg@rambler.ru Submitted: 09/11/2014Revised: 10/30/2014 Accepted: 11/17/2014 http://dx.doi.org/10.1080/21645515.2015.1011022 This is an Open Access article distributed under theterms of the Creative Commons Attribution-Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/), which permits unrestrictednon-commercial use, distribution, and reproductionin any medium, provided the original work is prop- erly cited.",Non-OADS,/arxiv_data1/oa_pdf/54/a7/khvi-11-03-1011022.PMC4514425.pdf
Nat Rev Cancer 2006; 6:204-16; PMID:16498443; http://dx.doi.org/10.1038/nrc18152.,Non-OADS,/arxiv_data1/oa_pdf/54/a7/khvi-11-03-1011022.PMC4514425.pdf
J Natl Cancer Inst 2012; 104:599-613; PMID:22395641; http://dx.doi.org/ 10.1093/jnci/djs033 3.,Non-OADS,/arxiv_data1/oa_pdf/54/a7/khvi-11-03-1011022.PMC4514425.pdf
Nature 1997; 390:404-7; PMID:9389480; http://dx.doi.org/ 10.1038/37126 4.,Non-OADS,/arxiv_data1/oa_pdf/54/a7/khvi-11-03-1011022.PMC4514425.pdf
N Engl J Med 1971; 285:1182-6; PMID:4938153; http://dx.doi.org/10.1056/NEJM197108122850711 6.,OADS,/arxiv_data1/oa_pdf/54/a7/khvi-11-03-1011022.PMC4514425.pdf
J Natl Cancer Inst 1990; 82:4-6;PMID:1688381; http://dx.doi.org/10.1093/jnci/82.1.4 7.,Non-OADS,/arxiv_data1/oa_pdf/54/a7/khvi-11-03-1011022.PMC4514425.pdf
Nature 2000; 407:249-57; PMID:11001068; http://dx.doi.org/10.1038/35025220 9.,OADS,/arxiv_data1/oa_pdf/54/a7/khvi-11-03-1011022.PMC4514425.pdf
Int Rev Immunol 2006; 25:297-319; PMID:17169778; http://dx.doi.org/10.1080/ 08830180600992472 10.,Non-OADS,/arxiv_data1/oa_pdf/54/a7/khvi-11-03-1011022.PMC4514425.pdf
Nat Med 2000; 6:1160-6; PMID:11017149;http://dx.doi.org/10.1038/80506 13.,Non-OADS,/arxiv_data1/oa_pdf/54/a7/khvi-11-03-1011022.PMC4514425.pdf
Cancer Immu- nol Immunother 2004; 53:955-62; PMID:15449042;http://dx.doi.org/10.1007/s00262-004-0529-5 14.,Non-OADS,/arxiv_data1/oa_pdf/54/a7/khvi-11-03-1011022.PMC4514425.pdf
Cancer Sci 2004; 95:85-90; PMID:14720332; http://dx.doi.org/10.1111/j.1349- 7006.2004.tb03175.x 15.,Non-OADS,/arxiv_data1/oa_pdf/54/a7/khvi-11-03-1011022.PMC4514425.pdf
Clin Cancer Res 2006; 12:5834-40; PMID:17020991; http://dx.doi.org/ 10.1158/1078-0432.CCR-06-1105 16.,Non-OADS,/arxiv_data1/oa_pdf/54/a7/khvi-11-03-1011022.PMC4514425.pdf
J Exp Med 2000; 191:795-804; PMID:10704461; http://dx.doi.org/10.1084/jem.191.5.79519.,Non-OADS,/arxiv_data1/oa_pdf/54/a7/khvi-11-03-1011022.PMC4514425.pdf
Nat Rev Immunol 2003; 3:630-41;PMID:12974478; http://dx.doi.org/10.1038/nri1150 24.,Non-OADS,/arxiv_data1/oa_pdf/54/a7/khvi-11-03-1011022.PMC4514425.pdf
Circ Res 2007; 100:158-73; PMID:17272818; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/54/a7/khvi-11-03-1011022.PMC4514425.pdf
Circ Res 2007;100:174-90; PMID:17272819; http://dx.doi.org/ 10.1161/01.RES.0000255690.03436.ae 28.,OADS,/arxiv_data1/oa_pdf/54/a7/khvi-11-03-1011022.PMC4514425.pdf
Science 2000; 289:1197-202;PMID:10947988; http://dx.doi.org/10.1126/ science.289.5482.1197 29.,Non-OADS,/arxiv_data1/oa_pdf/54/a7/khvi-11-03-1011022.PMC4514425.pdf
J Cell Sci 2003; 116:1013-22; PMID:12584245; http://dx.doi.org/10.1242/jcs.00281 30.,OADS,/arxiv_data1/oa_pdf/54/a7/khvi-11-03-1011022.PMC4514425.pdf
Am J Pathol 2008; 172:1381-90;PMID:18403594; http://dx.doi.org/10.2353/ ajpath.2008.070988 31.,Non-OADS,/arxiv_data1/oa_pdf/54/a7/khvi-11-03-1011022.PMC4514425.pdf
Cancer Res 2006; 66:10770-7;PMID:17108113; http://dx.doi.org/10.1158/0008- 5472.CAN-06-1609 32.,Non-OADS,/arxiv_data1/oa_pdf/54/a7/khvi-11-03-1011022.PMC4514425.pdf
75; PMID:16505122; http://dx.doi.org/10.1158/1535- 7163.MCT-05-0417 33.,Non-OADS,/arxiv_data1/oa_pdf/54/a7/khvi-11-03-1011022.PMC4514425.pdf
In Vitro Cell Dev Biol Anim 2002; 38:273-81; PMID:12418924; http://dx.doi.org/10.1290/1071- 2690(2002)038 <0273:IAMCOB >2.0.CO;2 35.,Non-OADS,/arxiv_data1/oa_pdf/54/a7/khvi-11-03-1011022.PMC4514425.pdf
Hum Vaccin Immunother 2013; 9:198-209;PMID:23442592; http://dx.doi.org/10.4161/hv.22828 38.,Non-OADS,/arxiv_data1/oa_pdf/54/a7/khvi-11-03-1011022.PMC4514425.pdf
J Cancer Sci Ther 2010; 2:126-131; http://dx.doi.org/10.4172/1948-5956.1000037 39.,Non-OADS,/arxiv_data1/oa_pdf/54/a7/khvi-11-03-1011022.PMC4514425.pdf
Hum Vaccin Immunother 2013; 9:1549-52; PMID:23571178; http://dx.doi.org/ 10.4161/hv.24300 40.,Non-OADS,/arxiv_data1/oa_pdf/54/a7/khvi-11-03-1011022.PMC4514425.pdf
J Cancer 2010; 1:230-41; PMID:21151581; http://dx.doi.org/10.7150/jca.1.230 41.,Non-OADS,/arxiv_data1/oa_pdf/54/a7/khvi-11-03-1011022.PMC4514425.pdf
Rapid Commun Mass Spectrom 2009; 23:680-2; PMID:19184978; http://dx.doi.org/ 10.1002/rcm.3928 42.,OADS,/arxiv_data1/oa_pdf/54/a7/khvi-11-03-1011022.PMC4514425.pdf
Clin Cancer Res 2009; 15:5323-37; PMID:19723653; http://dx.doi.org/ 10.1158/1078-0432.CCR-09-0737 45.,Non-OADS,/arxiv_data1/oa_pdf/54/a7/khvi-11-03-1011022.PMC4514425.pdf
Expert Rev Vaccines 2009; 8:1657-61; PMID:19943761; http://dx.doi.org/10.1586/erv.09.134 46.,Non-OADS,/arxiv_data1/oa_pdf/54/a7/khvi-11-03-1011022.PMC4514425.pdf
J Carci- nog Mutagen 2010; 1:103; http://dx.doi.org/10.4172/2157-2518.1000103 47.,Non-OADS,/arxiv_data1/oa_pdf/54/a7/khvi-11-03-1011022.PMC4514425.pdf
Mol Cell Proteomics 2012; 11: M111.014480-M111.014480; PMID:22074704;http://dx.doi.org/10.1074/mcp.M111.01448048.,OADS,/arxiv_data1/oa_pdf/54/a7/khvi-11-03-1011022.PMC4514425.pdf
Differentia- tion 1987; 36:57-70; PMID:2451631; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/54/a7/khvi-11-03-1011022.PMC4514425.pdf
Eur J Cell Biol 2003; 82:163-73; PMID:12751902; http://dx.doi.org/10.1078/0171-9335-00306 50.,Non-OADS,/arxiv_data1/oa_pdf/54/a7/khvi-11-03-1011022.PMC4514425.pdf
J Cell Physiol 1991; 146:8-17; PMID:1990021; http://dx.doi.org/10.1002/jcp.1041460103 51.,Non-OADS,/arxiv_data1/oa_pdf/54/a7/khvi-11-03-1011022.PMC4514425.pdf
Int J Biochem Cell Biol 2001; 33:325-35; PMID:11312103; http://dx.doi.org/10.1016/S1357- 2725(01)00020-6 52.,OADS,/arxiv_data1/oa_pdf/54/a7/khvi-11-03-1011022.PMC4514425.pdf
J Invest Dermatol 1992; 98:79-85; PMID:1370233; http://dx.doi.org/10.1111/1523- 1747.ep12495643 55.,Non-OADS,/arxiv_data1/oa_pdf/54/a7/khvi-11-03-1011022.PMC4514425.pdf
Oncology 1976; 33:17-23;PMID:185564; http://dx.doi.org/10.1159/000225095 58.,Non-OADS,/arxiv_data1/oa_pdf/54/a7/khvi-11-03-1011022.PMC4514425.pdf
Exp Cell Res 1958;14:80-3; PMID:13512305; http://dx.doi.org/10.1016/ 0014-4827(58)90214-3 60.,OADS,/arxiv_data1/oa_pdf/54/a7/khvi-11-03-1011022.PMC4514425.pdf
Exp Cell Res 1969; 54:293-301;PMID:4975920; http://dx.doi.org/10.1016/0014-4827 (69)90205-5 61.,OADS,/arxiv_data1/oa_pdf/54/a7/khvi-11-03-1011022.PMC4514425.pdf
J Cell Physiol 1966; 68:85-90; PMID:5967192; http://dx.doi.org/10.1002/ jcp.1040680112 62.,Non-OADS,/arxiv_data1/oa_pdf/54/a7/khvi-11-03-1011022.PMC4514425.pdf
Exp Cell Res 1965; 40:186-8; PMID:5891332; http://dx.doi.org/10.1016/0014-4827 (65)90312-5 66.,OADS,/arxiv_data1/oa_pdf/54/a7/khvi-11-03-1011022.PMC4514425.pdf
J Cell Physiol 1967; 69:199-207; PMID:6033950; http://dx.doi.org/10.1002/jcp.1040690210 67.,Non-OADS,/arxiv_data1/oa_pdf/54/a7/khvi-11-03-1011022.PMC4514425.pdf
Biochemistry1970; 9:4567-76; PMID:4319754; http://dx.doi.org/ 10.1021/bi00825a016 70.,Non-OADS,/arxiv_data1/oa_pdf/54/a7/khvi-11-03-1011022.PMC4514425.pdf
J Biol Chem 2003; 278:7607-16; PMID:12493773; http://dx.doi.org/10.1074/jbc.M210455200 72.,OADS,/arxiv_data1/oa_pdf/54/a7/khvi-11-03-1011022.PMC4514425.pdf
Proteomics 2003; 3:1947-54; PMID:14625857;http://dx.doi.org/10.1002/pmic.200300563 73.,OADS,/arxiv_data1/oa_pdf/54/a7/khvi-11-03-1011022.PMC4514425.pdf
Nat Biotechnol 2006; 24:191-7; http://dx.doi.org/10.1038/nbt1179 74.,OADS,/arxiv_data1/oa_pdf/54/a7/khvi-11-03-1011022.PMC4514425.pdf
J ProteomeRes 2009; 8:3078-90; PMID:19341246; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/54/a7/khvi-11-03-1011022.PMC4514425.pdf
Biotechnol Lett 1989; 11:531-536; http://dx.doi.org/10.1007/BF01040030 79.,Non-OADS,/arxiv_data1/oa_pdf/54/a7/khvi-11-03-1011022.PMC4514425.pdf
Bio- technol Lett 1987; 9:831-6; http://dx.doi.org/10.1007/ BF01026191 80.,Non-OADS,/arxiv_data1/oa_pdf/54/a7/khvi-11-03-1011022.PMC4514425.pdf
Expert Opin Investig Drugs 2009; 18:687- 94; PMID:19388882; http://dx.doi.org/10.1517/ 13543780902897631 82.,Non-OADS,/arxiv_data1/oa_pdf/54/a7/khvi-11-03-1011022.PMC4514425.pdf
Expert Rev Vaccines 2010; 9:1007-16; PMID:20822343; http://dx.doi.org/10.1586/erv.10.92 83.,Non-OADS,/arxiv_data1/oa_pdf/54/a7/khvi-11-03-1011022.PMC4514425.pdf
J Mam- mary Gland Biol Neoplasia 2001; 6:339-53;PMID:11547902; http://dx.doi.org/10.1023/ A:1011379725811 85.,Non-OADS,/arxiv_data1/oa_pdf/54/a7/khvi-11-03-1011022.PMC4514425.pdf
Cancer Biol Ther 2007; 6:481-6;PMID:18027437; http://dx.doi.org/10.4161/ cbt.6.4.4201 86.,Non-OADS,/arxiv_data1/oa_pdf/54/a7/khvi-11-03-1011022.PMC4514425.pdf
A heteroge- neous in vitro three dimensional model of tumour- stroma interactions regulating sprouting angiogenesis.PLoS One 2012; 7; PMID:22363483; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/54/a7/khvi-11-03-1011022.PMC4514425.pdf
"The possible pneumococcal infec- tion group had either lobar/focal or unilateral consolidation onchest radiograph and <15£10 9WBC/l (or /C2115£109WBC/ liter with <60% neutrophils) and /C218 mg/l CRP or patchy or widespread, bilateral consolidation on chest radiograph and /C2115 £109WBC/l (with /C2160% neutrophils) or /C218 mg/l CRP.2 Introduction Streptococcus pneumoniae is an important cause of bacterial pneumonia, meningitis, and sepsis in children in developed and © Yi-Chien Ho, Pei-Lun Lee, Yu-Chiao Wang, Shiou-Chien Chen, and Kow-Tong Chen *Correspondence to: Kow-Tong Chen; Email: kowton@ms81.hinet.net; ktchen@mail.ncku.edu.twSubmitted: 10/21/2014; Revised: 02/10/2015; Accepted: 02/21/2015 http://dx.doi.org/10.1080/21645515.2015.1023969 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ec/a2/khvi-11-05-1023969.PMC4514427.pdf
Clin Infect Dis 2009; 49(2):205-12; PMID:19508165; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ec/a2/khvi-11-05-1023969.PMC4514427.pdf
Changes in frequency and pathogens causing acute otitis media in 1995-2003.Pediatr Infect Dis J 2004; 23(9):824-8; PMID:15361720; http://dx.doi.org/10.1097/01.,Non-OADS,/arxiv_data1/oa_pdf/ec/a2/khvi-11-05-1023969.PMC4514427.pdf
Expert Rev Vaccines 2005; 4 (6):843-53[Review]; PMID:16372880; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ec/a2/khvi-11-05-1023969.PMC4514427.pdf
J Clin Microbiol 2003; 41 (7):3064-9; PMID:12843045; http://dx.doi.org/10.1128/JCM.41.7.3064-3069.2003 7.,Non-OADS,/arxiv_data1/oa_pdf/ec/a2/khvi-11-05-1023969.PMC4514427.pdf
Vac- cine 2012; 30(28):4267-75; PMID:22521287; http://dx.doi.org/10.1016/j.vaccine.2012.04.028 12.,Non-OADS,/arxiv_data1/oa_pdf/ec/a2/khvi-11-05-1023969.PMC4514427.pdf
Vaccine 2011; 29(38):6686-94;PMID:21745516; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/ec/a2/khvi-11-05-1023969.PMC4514427.pdf
Pharmacoeco- nomics 2001; 19:609-21; PMID:11456210; http://dx.doi.org/10.2165/00019053-200119060-00001 17.,Non-OADS,/arxiv_data1/oa_pdf/ec/a2/khvi-11-05-1023969.PMC4514427.pdf
J Med Microbiol 2006; 55(Pt 8):1109-14; PMID:16849732; http://dx.doi.org/10.1099/jmm.0.46530-0 18.,Non-OADS,/arxiv_data1/oa_pdf/ec/a2/khvi-11-05-1023969.PMC4514427.pdf
"Lucero MG, Dulalia VE, Nillos LT, Williams G, Parre ~no RA, Nohynek H, Riley ID, Makela H. Pneu- mococcal conjugate vaccines for preventing vaccine- type invasive pneumococcal disease and X-ray deﬁned pneumonia in children less than two years of age.Cochrane Database Syst Rev 2009; (4):CD004977; PMID:19821336; http://dx.doi.org/10.1002/ 14651858.CD004977.pub2 19.",Non-OADS,/arxiv_data1/oa_pdf/ec/a2/khvi-11-05-1023969.PMC4514427.pdf
Cochrane Database Syst Rev 2009; (2):CD001480; PMID:19370566; http://dx.doi.org/10.1002/14651858.CD001480.pub3 20.,OADS,/arxiv_data1/oa_pdf/ec/a2/khvi-11-05-1023969.PMC4514427.pdf
J Infect Dis 2005; 92:s44-8; PMID:16088804; http://dx.doi.org/10.1086/431495 22.,OADS,/arxiv_data1/oa_pdf/ec/a2/khvi-11-05-1023969.PMC4514427.pdf
Accessed on 15 August 2014 by http://www.nhi.gov.tw/00english/e_index.htm 23.,Non-OADS,/arxiv_data1/oa_pdf/ec/a2/khvi-11-05-1023969.PMC4514427.pdf
Vaccine2013; 31:2762-71; PMID:23588088; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ec/a2/khvi-11-05-1023969.PMC4514427.pdf
Vaccine 2013;31:2839-47; PMID:23588084; http://dx.doi.org/ 10.1016/j.vaccine.2013.03.047 26.,Non-OADS,/arxiv_data1/oa_pdf/ec/a2/khvi-11-05-1023969.PMC4514427.pdf
Vaccine 2007; 25:6837-41; PMID:17714837; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/ec/a2/khvi-11-05-1023969.PMC4514427.pdf
Accessed on 15 August 2014 by http://www.nhi.gov.tw/00english/eindex.htm 29.,Non-OADS,/arxiv_data1/oa_pdf/ec/a2/khvi-11-05-1023969.PMC4514427.pdf
Int JEnviron Res Public Health 2014; 11(6):5651-64; PMID:24871257; http://dx.doi.org/10.3390/ ijerph110605651 31.,Non-OADS,/arxiv_data1/oa_pdf/ec/a2/khvi-11-05-1023969.PMC4514427.pdf
Available at http://nidss.cdc.gov.tw (accessed on 14 May 2014).,OADS,/arxiv_data1/oa_pdf/ec/a2/khvi-11-05-1023969.PMC4514427.pdf
Vaccine 2010; 28:5332-7;PMID:20665978; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/ec/a2/khvi-11-05-1023969.PMC4514427.pdf
"Pediatrics 2007; 120:e244-52; PMID:17671037; http://dx.doi.org/10.1542/ peds.2006-3331 34. International Monetary Fund, Taiwan province of China: inﬂation, average consumer prices.",Non-OADS,/arxiv_data1/oa_pdf/ec/a2/khvi-11-05-1023969.PMC4514427.pdf
http://kcdb.bipm.,Non-OADS,/arxiv_data1/oa_pdf/c5/a1/10967_2011_Article_1193.PMC4514584.pdf
http://sea.helcom.ﬁ/Monas/ CombineManual2/CombineHome.htm 27.,OADS,/arxiv_data1/oa_pdf/b3/ec/10967_2011_Article_1546.PMC4514633.pdf
Bond characteristics are evaluated in terms of electron density q(proportional to bond strength) and bond ellipticity e e¼k1=k2/C01 ð1Þ at bond critical points (BCP) where k1\k2\0\k3are the eigenvalues of the Hessian of the BCP electron density.AIM2000 [ 35] software package is utilized for QTAIM analysis ( http://www.aim2000.de/ ).,OADS,/arxiv_data1/oa_pdf/c0/9b/10967_2010_Article_823.PMC4514639.pdf
http://classic.chem.,Non-OADS,/arxiv_data1/oa_pdf/c0/9b/10967_2010_Article_823.PMC4514639.pdf
"2595 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/11/48/btv153.PMC4514923.pdf
Its source is available at http://bioinformatics.intec.ugent.be/halvade under GPL license.,OADS,/arxiv_data1/oa_pdf/2d/0e/btv179.PMC4514927.pdf
"To illustrate this, we consider the re-cently proposed Best Practices pipeline for DNA sequencing analysis(Van der Auwera et al., 2013 ) that consists of the Burrow-Wheeler Aligner (BWA) ( Li and Durbin, 2009 ) for the alignment step, Picard (http://picard.sourceforge.net) for data preparation and the GenomeAnalysis Toolkit (GATK) ( Depristo et al., 2011 ;McKenna et al., 2010 ) for variant calling.",Non-OADS,/arxiv_data1/oa_pdf/2d/0e/btv179.PMC4514927.pdf
"2482 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2d/0e/btv179.PMC4514927.pdf
"For data preprocessing, Halvadecan use either Picard or elPrep (http://github.com/exascience/elprep)with SAMtools ( Liet al., 2009 ).",OADS,/arxiv_data1/oa_pdf/2d/0e/btv179.PMC4514927.pdf
"The dbSNP databaseand human genome reference found in the GATK hg19 resourcebundle (ftp://ftp.broadinstitute.org/bundle/2.8/hg19/) were used.The reference genome was stripped of all alternate allele informa-tion and contains chromosomes 1 through 22, M, X and Y.",OADS,/arxiv_data1/oa_pdf/2d/0e/btv179.PMC4514927.pdf
The Halvade source code is available athttp://bioinformatics.intec.ugent.be/halvade under GPL license.,OADS,/arxiv_data1/oa_pdf/2d/0e/btv179.PMC4514927.pdf
Availability and implementation: The code is available under GNU GPL at https://github.com/sta matak/ExaML.Contact: Alexandros.Stamatakis@h-its.org Supplementary information: Supplementary data are available at Bioinformatics online.,OADS,/arxiv_data1/oa_pdf/aa/3d/btv184.PMC4514929.pdf
"2577 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/aa/3d/btv184.PMC4514929.pdf
3 User support and future work User support is provided via the RAxML Google group at: https://groups.google.com/forum/?hl ¼en#!forum/raxml.,Non-OADS,/arxiv_data1/oa_pdf/aa/3d/btv184.PMC4514929.pdf
Availability and implementation: SPARSE is freely available at http://www.bioinf.uni-freiburg.de/ Software/SPARSE.,OADS,/arxiv_data1/oa_pdf/69/41/btv185.PMC4514930.pdf
"2489 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/69/41/btv185.PMC4514930.pdf
"2421 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9f/78/btv189.PMC4514932.pdf
"(2014) and visualized in Geneious (created by Biomatters, available from http://www.geneious.com).",OADS,/arxiv_data1/oa_pdf/9f/78/btv189.PMC4514932.pdf
"For example, on 12 January 2013, Beijing had PM2.5 readingsof 700 –900μg/m 3,28far beyond the normal value of 500 μg/m3indicated in the Air Quality Index (AQI) technical guidelines.29Between early 2013 and early 2014, several cities in the north were ratedas ‘hazardous ’(http://aqicn.org/map/) for months at a time, with extremely poor visi-bility and school and airport closures.",Non-OADS,/arxiv_data1/oa_pdf/96/1b/jech-2014-203892.PMC4514977.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ To cite Li F, Liu Y, Lü J, et al.J Epidemiol Community Health 2015; 69:201 –204.",Non-OADS,/arxiv_data1/oa_pdf/96/1b/jech-2014-203892.PMC4514977.pdf
http://www.euro.who.int/__data/assets/pdf_ ﬁle/0020/101684/E90191.pdf (accessed 1 Apr 2014).,OADS,/arxiv_data1/oa_pdf/96/1b/jech-2014-203892.PMC4514977.pdf
Physical activity survey of urban and rural areas in China in 2007. http://www.gov.cn/test/2012-04/19/content_2117453.htm (accessed29 Mar 2014).,OADS,/arxiv_data1/oa_pdf/96/1b/jech-2014-203892.PMC4514977.pdf
http://www.epa.gov/airnow/aqi_brochure_08-09.pdf (accessed 30 Mar 2014).,OADS,/arxiv_data1/oa_pdf/96/1b/jech-2014-203892.PMC4514977.pdf
http://english.mep.gov.cn/News_service/news_release/201401/t20140106_266046.htm# (accessed 29 Mar2014).,Non-OADS,/arxiv_data1/oa_pdf/96/1b/jech-2014-203892.PMC4514977.pdf
http://english.mep.gov.cn/ News_service/infocus/201309/t20130924_260707.,Non-OADS,/arxiv_data1/oa_pdf/96/1b/jech-2014-203892.PMC4514977.pdf
http://www.npc.gov.,Non-OADS,/arxiv_data1/oa_pdf/96/1b/jech-2014-203892.PMC4514977.pdf
http://www.semc.gov.cn/aqi/home/English.aspx (accessed 1 Apr 2014).,Non-OADS,/arxiv_data1/oa_pdf/96/1b/jech-2014-203892.PMC4514977.pdf
http://www.bjmemc.com.cn/ (accessed 1 Apr 2014).,OADS,/arxiv_data1/oa_pdf/96/1b/jech-2014-203892.PMC4514977.pdf
"http://www.cdc.gov/nceh/airpollution/airquality/pdfs/Air_Quality_and_Outdoor_Activity_Guidance.pdf(accessed 27 May 2014).Commentary 204 Li F, et al.J Epidemiol Community Health March 2015 Vol 69 No 3",Non-OADS,/arxiv_data1/oa_pdf/96/1b/jech-2014-203892.PMC4514977.pdf
To view please visit the journal online (http://dx.doi.org/10.1136/jfprhc-2013-100705).,Non-OADS,/arxiv_data1/oa_pdf/a3/6c/jfprhc-2013-100705.PMC4514978.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Baker D, Middleton E. Cervical screening and health inequality in England in the 1990s.",Non-OADS,/arxiv_data1/oa_pdf/a3/6c/jfprhc-2013-100705.PMC4514978.pdf
2004. http://www.ons.gov.uk/ons/search/index.html?content-type=Reference+table&pubdateRangeT ype=allDates&newquery=Census+2001+National+Report+for+England+and+W ales+-+National+Report+for+England+and+W ales%3A+All+people+Part+1+%28T able+S103%29&pageSize=50&applyFilters=true [accessed 3 October2013].,Non-OADS,/arxiv_data1/oa_pdf/a3/6c/jfprhc-2013-100705.PMC4514978.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 Scadding GK, Durham SR, Mirakian R, et al.",Non-OADS,/arxiv_data1/oa_pdf/0a/6e/archdischild-2014-306300.PMC4514979.pdf
76 http://leicestershire.formulary.co.uk/chaptersSubDetails.asp?FormularySectionID= 12&SubSectionRef=12.02.01&SubSectionID=A100 582 Scadding GK.,Non-OADS,/arxiv_data1/oa_pdf/0a/6e/archdischild-2014-306300.PMC4514979.pdf
Available at: http:// healthaffairs.org/blog/2013/02/07/the-patient-engagement-pill- lessons-from-epilepsy/; archiv ed at: http://www.webcitation.,Non-OADS,/arxiv_data1/oa_pdf/74/61/NEUROLOGY2014624676.PMC4515038.pdf
"Accessed at http://www.bloomberg.com/news/2014-03-05/hepatit is-c-drug-price-limit ing-state-medicaid- approvals.html on April 17, 2014.",Non-OADS,/arxiv_data1/oa_pdf/58/90/jvh0022-0630.PMC4515086.pdf
Available from: http://www.bloomberg.com/ news/2014-03-05/hepatitis-c-drug-price-limiting-state-medicaid-approv als.html.,Non-OADS,/arxiv_data1/oa_pdf/58/90/jvh0022-0630.PMC4515086.pdf
Available at: http://www.chi cagobusiness.com/article/20140729/NEWS03/140729819/i llinois-medic aid-restricts-who-can-get-game-chang ing-hepatitis-drug# (accessed 29August 2013).,Non-OADS,/arxiv_data1/oa_pdf/58/90/jvh0022-0630.PMC4515086.pdf
"Peak recognitionfor p63 ChIP-seq and RNAPII ChIP-seq datasets was performedusing MACS2, an updated version of MACS [68] that is specifi-cally designed to process mixed signal types (https://github.com/taoliu/MACS) with default settings and a P-value threshold of 1E-9 using a genomic DNA as background control, and resultsare summarized in Supplementary Table S19.",OADS,/arxiv_data1/oa_pdf/c8/e3/embr0016-0863.PMC4515125.pdf
"R foundation for Statistical Computing.Vienna, Austria, http://www.R-project.org/, Bioconductor [74])using the z-scores calculated from the log10 (RPKM) values.",OADS,/arxiv_data1/oa_pdf/c8/e3/embr0016-0863.PMC4515125.pdf
GO analysis was performed with DAVID (http://david.abcc.ncifcrf.gov/).,OADS,/arxiv_data1/oa_pdf/c8/e3/embr0016-0863.PMC4515125.pdf
"ENCODE data H3K27ac ChIP-seq (GSM733674), H3K4me1 ChIP-seq (GSM733698), H3K27me3 ChIP-seq (GSM733701), H3K9me1 ChIP-seq(GSM733655), H3K9me3 ChIP-seq (GSM1003528), and Open chro-matin by DNaseI HS (GSM816635) data from NHEK was down-loaded from the ENCODE UCSC browser (http://genome.ucsc.edu/ENCODE/).",OADS,/arxiv_data1/oa_pdf/c8/e3/embr0016-0863.PMC4515125.pdf
"Supplementary information for this article is available online: http://embor.embopress.org Acknowledgements This work is supported by NWO/ALW/MEERVOUD/ 836.12.010 (HZ), NGI/ BioRange program of the NBIC (MO), Radboud University fellowship (HZ), andNCMLS PhD fellowship (ENK).",Non-OADS,/arxiv_data1/oa_pdf/c8/e3/embr0016-0863.PMC4515125.pdf
figshare: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c8/e3/embr0016-0863.PMC4515125.pdf
"Keywords:  Anterior cruciate ligament reconstruction, Anatomy, Tunnel, Remnant Copyright © 2015 by The Korean Orthopaedic Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7b/4c/cios-7-143.PMC4515452.pdf
"Clinics in Orthopedic Surgery  • pISSN 2005-291X    eISSN 2005-4408 Received January 1, 2015; Accepted January 25, 2015 Correspondence to: Takeshi Muneta, MD   Department of Joint Surgery and Sports Medicine, Graduate School of  Medicine, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo- ku, Tokyo 113-8519, Japan Tel: +81-3-5803-5953, Fax: +81-3-5803-4020 E-mail: muneta.orj@tmd.ac.jp Review Article    Clinics in Orthopedic Surgery 2015;7:143-151   •  http://dx.doi.org/10.4055/cios.2015.7.2.143",Non-OADS,/arxiv_data1/oa_pdf/7b/4c/cios-7-143.PMC4515452.pdf
http://dx.doi.org/10.1177/0363546514567069.,Non-OADS,/arxiv_data1/oa_pdf/7b/4c/cios-7-143.PMC4515452.pdf
http://dx.doi.org/10.1007/s00167-014- 3300-2.,Non-OADS,/arxiv_data1/oa_pdf/7b/4c/cios-7-143.PMC4515452.pdf
"Keywords:  Hip fractures, Radiography, Intramedullary nailing Copyright © 2015 by The Korean Orthopaedic Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fe/66/cios-7-152.PMC4515453.pdf
"Clinics in Orthopedic Surgery  • pISSN 2005-291X    eISSN 2005-4408 Received July 20, 2014; Accepted December 4, 2014 Correspondence to: Takafumi Hiranaka, MD Department of Orthopedic Surgery, Takatsuki General Hospital, 1-3-13  Kosobe-cho, Takatsuki 569-1192, Japan Tel: +81-72-681-3801, Fax: +81-72-682-3834 E-mail: takafumi.hiranaka@gmail.comOriginal Article    Clinics in Orthopedic Surgery 2015;7:152-157   •  http://dx.doi.org/10.4055/cios.2015.7.2.152",Non-OADS,/arxiv_data1/oa_pdf/fe/66/cios-7-152.PMC4515453.pdf
"Keywords:  Internal snapping hip syndrome, Femoroacetabular impingement, Arthroscopy, Iliopsoas tendon tenotomy Copyright © 2015 by The Korean Orthopaedic Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e8/cc/cios-7-158.PMC4515454.pdf
"Clinics in Orthopedic Surgery  • pISSN 2005-291X    eISSN 2005-4408 Received July 20, 2014; Accepted December 8, 2014 Correspondence to: Yong-Chan Ha, MD  Department of Orthopaedic Surgery, Chung-Ang University College of  Medicine, 102 Heukseok-ro, Dongjak-gu, Seoul 156-755, Korea Tel: +82-2-6299-1577, Fax: +82-2-822-1710 E-mail: hayongch@naver.comOriginal Article    Clinics in Orthopedic Surgery 2015;7:158-163   •  http://dx.doi.org/10.4055/cios.2015.7.2.158",Non-OADS,/arxiv_data1/oa_pdf/e8/cc/cios-7-158.PMC4515454.pdf
"Keywords:  Nerve block, Epidural anesthesia, Morphine, Total hip arthroplasty Copyright © 2015 by The Korean Orthopaedic Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ba/ba/cios-7-164.PMC4515455.pdf
"Clinics in Orthopedic Surgery  • pISSN 2005-291X    eISSN 2005-4408 Received October 3, 2014; Accepted February 15, 2015 Correspondence to: Tomonori Tetsunaga, MD  Department of Orthopaedic Surgery, Okayama Medical Center, 1711-1  Tamasu, Kitaku, Okayama 701-1192, Japan Tel: +81-86-294-9911, Fax: +81-86-294-9255 E-mail: tomonori_t31@yahoo.co.jpOriginal Article    Clinics in Orthopedic Surgery 2015;7:164-170   •  http://dx.doi.org/10.4055/cios.2015.7.2.164",Non-OADS,/arxiv_data1/oa_pdf/ba/ba/cios-7-164.PMC4515455.pdf
"Keywords:  Patellofemoral joint, Arthroplasty, Survivorship, Survival rate Copyright © 2015 by The Korean Orthopaedic Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/63/cd/cios-7-171.PMC4515456.pdf
"Clinics in Orthopedic Surgery  • pISSN 2005-291X    eISSN 2005-4408 Received February 27, 2014; Accepted August 19, 2014 Correspondence to: Sebastian Dawson-Bowling, FRCS (Tr&Orth)  Orthopaedic Department, East Sussex Healthcare NHS Trust, The  Conquest Hospital, Hastings, East Sussex TN37 7RD, UK Tel: +44-1424-755255 , Fax: +44-1424-757553 E-mail: sebd_b@hotmail.comOriginal Article    Clinics in Orthopedic Surgery 2015;7:171-176   •  http://dx.doi.org/10.4055/cios.2015.7.2.171",Non-OADS,/arxiv_data1/oa_pdf/63/cd/cios-7-171.PMC4515456.pdf
Available from: http://www.njrcentre.org.uk/njrcentre/ Portals/0/Documents/England/Reports/9th_annual_report/ NJR%209th%20Annual%20Report%202012.pdf.,Non-OADS,/arxiv_data1/oa_pdf/63/cd/cios-7-171.PMC4515456.pdf
"Keywords:  Anterior cruciate ligament, Meniscus, Reapir, Viper, All inside Copyright © 2015 by The Korean Orthopaedic Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/95/93/cios-7-177.PMC4515457.pdf
"Clinics in Orthopedic Surgery  • pISSN 2005-291X    eISSN 2005-4408 Received June 19, 2014; Accepted November 10, 2014 Correspondence to: Churl Hong Chun, MD  Department of Orthopedic Surgery, Wonkwang University School of  Medicine, 460 Iksan-daero, Iksan 570-974, Korea Tel: +82-63-859-1360, Fax: +82-63-852-9329  E-mail: cch@wonkwang.ac.krOriginal Article    Clinics in Orthopedic Surgery 2015;7:177-184   •  http://dx.doi.org/10.4055/cios.2015.7.2.177",Non-OADS,/arxiv_data1/oa_pdf/95/93/cios-7-177.PMC4515457.pdf
"Keywords:  Knee, Osteoarthritis, Osteotomy, Comparative study, Aescula plate, TomoFix plate Copyright © 2015 by The Korean Orthopaedic Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/53/44/cios-7-185.PMC4515458.pdf
"Clinics in Orthopedic Surgery  • pISSN 2005-291X    eISSN 2005-4408 Received August 8, 2014; Accepted November 24, 2014 Correspondence to: Hee-Soo Kyung, MD Department of Orthopedic Surgery, Kyungpook National University School  of Medicine, 130 Dongdeok-ro, Jung-gu, Daegu 700-721, Korea Tel: +82-53-420-5636, Fax: +82-53-422-6605 E-mail: hskyung@knu.ac.krOriginal Article    Clinics in Orthopedic Surgery 2015;7:185-190   •  http://dx.doi.org/10.4055/cios.2015.7.2.185",Non-OADS,/arxiv_data1/oa_pdf/53/44/cios-7-185.PMC4515458.pdf
"Keywords:  Knee, Arthroplasty, Rehabilitation, Gait Copyright © 2015 by The Korean Orthopaedic Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/36/56/cios-7-191.PMC4515459.pdf
"Correspondence to: Lee Yaari, MD  Department of Orthopedic Surgery, Rabin Medical Center, 39 Jabotinski  St., Petah, Tikva 49100, Israel Tel: +972-3-9377377, Fax: +972-9-9615134 E-mail: leeyaari@gmail.comOriginal Article    Clinics in Orthopedic Surgery 2015;7:191-198   •  http://dx.doi.org/10.4055/cios.2015.7.2.191",Non-OADS,/arxiv_data1/oa_pdf/36/56/cios-7-191.PMC4515459.pdf
"Keywords:  Arthroplasty, Replacement, Knee, Minimally invasive, Survival rate Copyright © 2015 by The Korean Orthopaedic Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e3/0c/cios-7-199.PMC4515460.pdf
"Clinics in Orthopedic Surgery  • pISSN 2005-291X    eISSN 2005-4408 Received April 6, 2014; Accepted December 29, 2014 Correspondence to: Jee Hyoung Kim, MD  Department of Orthopedic Surgery, Seoul Sacred Heart General Hospital,  259 Wangsan-ro, Dongdaemoon-gu, Seoul 130-011, Korea  Tel: +82-2-966-1616, Fax: +82-2-968-2394  E-mail: kjhnav@naver.com Original Article    Clinics in Orthopedic Surgery 2015;7:199-206   •  http://dx.doi.org/10.4055/cios.2015.7.2.199",Non-OADS,/arxiv_data1/oa_pdf/e3/0c/cios-7-199.PMC4515460.pdf
"Keywords:  Implant waste, Knee arthroplasty, Hip arthroplasty Copyright © 2015 by The Korean Orthopaedic Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/03/43/cios-7-207.PMC4515461.pdf
"Clinics in Orthopedic Surgery  • pISSN 2005-291X    eISSN 2005-4408 Received February 19, 2014; Accepted December 30, 2014 Correspondence to: Kiel J. Pfefferle, MD  Department of Orthopaedic Surgery, Summa Health Systems, 444 N Main  St, Akron, OH 44310, USA Tel: +1-330-379-5681, Fax: +1-330-379-5053 E-mail: Kiel.pfefferle@gmail.comOriginal Article    Clinics in Orthopedic Surgery 2015;7:207-210   •  http://dx.doi.org/10.4055/cios.2015.7.2.207",Non-OADS,/arxiv_data1/oa_pdf/03/43/cios-7-207.PMC4515461.pdf
"Keywords:  Arthroplasty, replacement, knee, Computer assisted surgery, Blood loss, Tourniquets, Adverse effects Copyright © 2015 by The Korean Orthopaedic Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c1/0b/cios-7-211.PMC4515462.pdf
"Clinics in Orthopedic Surgery  • pISSN 2005-291X    eISSN 2005-4408 Received January 5, 2015; Accepted March 4, 2015 Correspondence to: Rajesh Malhotra, MS   Department of Orthopaedics, 5th Floor, Academic Block, All India Institute  of Medical Sciences, Ansari Nagar East, New Delhi 110029, India Tel: +91-11-26593589, Fax: +91-11-26588663 E-mail: rmalhotra62@gmail.comOriginal Article    Clinics in Orthopedic Surgery 2015;7:211-216   •  http://dx.doi.org/10.4055/cios.2015.7.2.211",Non-OADS,/arxiv_data1/oa_pdf/c1/0b/cios-7-211.PMC4515462.pdf
"Keywords:  Navigation, Total knee arthroplasty, Anterior femur, Notching Copyright © 2015 by The Korean Orthopaedic Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/95/dc/cios-7-217.PMC4515463.pdf
"Clinics in Orthopedic Surgery  • pISSN 2005-291X    eISSN 2005-4408 Received May 9, 2014; Accepted March 3, 2015 Correspondence to: Seong-Il Wang, MD   Department of Orthopedic Surgery, Chonbuk National University Hospital,  20 Geonji-ro, Deokjin-gu, Jeonju 561-712, Korea Tel: +82-63-250-1760, Fax: +82-63-271-6538 E-mail: wsi1205@naver.comOriginal Article    Clinics in Orthopedic Surgery 2015;7:217-224   •  http://dx.doi.org/10.4055/cios.2015.7.2.217",Non-OADS,/arxiv_data1/oa_pdf/95/dc/cios-7-217.PMC4515463.pdf
"Keywords:  Knee, Arthroplasty, Computer-assisted surgery, Quantitative evaluation, Deformities  Copyright © 2015 by The Korean Orthopaedic Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/31/d5/cios-7-225.PMC4515464.pdf
"Clinics in Orthopedic Surgery  • pISSN 2005-291X    eISSN 2005-4408 Received January 7, 2015; Accepted January 9, 2015 Correspondence to: Laurent D. Angibaud, BS  Engineering and Development, Knee, Exactech Inc., 2320 NW 66th Court,  Gainesville, FL 32653, USA Tel: +1-352-514-6551, Fax: +1-352-378-2617 E-mail: Laurent.Angibaud@exac.comOriginal Article    Clinics in Orthopedic Surgery 2015;7:225-233   •  http://dx.doi.org/10.4055/cios.2015.7.2.225",Non-OADS,/arxiv_data1/oa_pdf/31/d5/cios-7-225.PMC4515464.pdf
"Keywords:  Rotator cuff, Arthroscopic repair, Gender, Pain, Function Copyright © 2015 by The Korean Orthopaedic Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/26/4a/cios-7-234.PMC4515465.pdf
"Clinics in Orthopedic Surgery  • pISSN 2005-291X    eISSN 2005-4408 Received October 9, 2014; Accepted December 14, 2014 Correspondence to: Chul-Hyun Cho, MD   Department of Orthopedic Surgery, Dongsan Medical Center and Pain  Research Center, Keimyung University School of Medicine, 56 Dalseong- ro, Jung-gu, Daegu 700-712, Korea Tel: +82-53-250-7729, Fax: +82-53-250-7205 E-mail: oscho5362@dsmc.or.krOriginal Article    Clinics in Orthopedic Surgery 2015;7:234-240   •  http://dx.doi.org/10.4055/cios.2015.7.2.234",Non-OADS,/arxiv_data1/oa_pdf/26/4a/cios-7-234.PMC4515465.pdf
"Keywords:  Elbow joint, Lateral collateral ligament, Dislocation, Ligament repair Copyright © 2015 by The Korean Orthopaedic Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/dd/41/cios-7-241.PMC4515466.pdf
"Clinics in Orthopedic Surgery  • pISSN 2005-291X    eISSN 2005-4408 Received October 1, 2014; Accepted December 17, 2014 Correspondence to: Youn Moo Heo, MD  Department of Orthopedic Surgery, Konyang University Hospital, Konyang  University College of Medicine, 158 Gwanjeodong-ro, Seo-gu, Daejeon  302-718, Korea Tel: +82-42-600-6937, Fax: +82-42-545-2373 E-mail: hurym1973@hanmail.netOriginal Article    Clinics in Orthopedic Surgery 2015;7:241-247   •  http://dx.doi.org/10.4055/cios.2015.7.2.241",Non-OADS,/arxiv_data1/oa_pdf/dd/41/cios-7-241.PMC4515466.pdf
"Keywords:  Bone neoplasms, Ilizarov technique, Bone lengthening Copyright © 2015 by The Korean Orthopaedic Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/76/65/cios-7-248.PMC4515467.pdf
"Clinics in Orthopedic Surgery  • pISSN 2005-291X    eISSN 2005-4408 Received October 3, 2014; Accepted February 22, 2015 Correspondence to: Sung Taek Jung, MD Department of Orthopaedic Surgery, Chonnam National University  Hospital, Chonnam National University Medical School, 42 Jebong-ro,  Dong-gu, Gwangju 501-757, Korea Tel: +82-62-227-1640, Fax: +82-62-225-7794  E-mail: stjung@jnu.ac.krOriginal Article    Clinics in Orthopedic Surgery 2015;7:248-253   •  http://dx.doi.org/10.4055/cios.2015.7.2.248",Non-OADS,/arxiv_data1/oa_pdf/76/65/cios-7-248.PMC4515467.pdf
"Keywords:  Synovial sarcoma, Oncologic outcomes, Magnetic resonance imaging Copyright © 2015 by The Korean Orthopaedic Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9d/1b/cios-7-254.PMC4515468.pdf
"Clinics in Orthopedic Surgery  • pISSN 2005-291X    eISSN 2005-4408 Received December 4, 2014; Accepted February 23, 2015 Correspondence to: Han Soo Kim, MD Department of Orthopedic Surgery, Seoul National University Hospital,  Seoul National University College of Medicine, 101 Daehak-ro, Jongno- gu, Seoul 110-744, Korea Tel: +82-2-2072-1265, Fax: +82-2-764-2718 E-mail: hankim@snu.ac.krOriginal Article    Clinics in Orthopedic Surgery 2015;7:254-260   •  http://dx.doi.org/10.4055/cios.2015.7.2.254",Non-OADS,/arxiv_data1/oa_pdf/9d/1b/cios-7-254.PMC4515468.pdf
"Copyright © 2015 by The Korean Orthopaedic Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/50/6e/cios-7-261.PMC4515469.pdf
Technical Note    Clinics in Orthopedic Surgery 2015;7:261-263   •  http://dx.doi.org/10.4055/cios.2015.7.2.261,Non-OADS,/arxiv_data1/oa_pdf/50/6e/cios-7-261.PMC4515469.pdf
"Keywords:  Popliteal cyst, Neoplasm, Biopsy Copyright © 2015 by The Korean Orthopaedic Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9d/30/cios-7-264.PMC4515470.pdf
"Clinics in Orthopedic Surgery  • pISSN 2005-291X    eISSN 2005-4408 Received March 16, 2012; Accepted June 1, 2012 Correspondence to: Jeong-Ho Kang, MD Department of Orthopaedic Surgery, Gangneung Asan Hospital, University of  Ulsan College of Medicine, 38 Bangdong-gil, Sacheon-myeon, Gangneung  210-711, Korea Tel: +82-33-610-3243, Fax: +82-33-641-8050 E-mail: theknee@naver.comCase Report    Clinics in Orthopedic Surgery 2015;7:264-268   •  http://dx.doi.org/10.4055/cios.2015.7.2.264",Non-OADS,/arxiv_data1/oa_pdf/9d/30/cios-7-264.PMC4515470.pdf
"Keywords:  Knee injury, Varus, Posterolateral complex, Medial plateau fracture, Posterior cruciate ligament Copyright © 2015 by The Korean Orthopaedic Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/62/b7/cios-7-269.PMC4515471.pdf
"Clinics in Orthopedic Surgery  • pISSN 2005-291X    eISSN 2005-4408 Received August 2, 2012; Accepted October 11, 2012 Correspondence to: Jung Ha Lee, MD  Department of Orthopaedic Surgery, National Police Hospital, 123 Song-i- ro, Songpa-gu, Seoul 138-708, Korea Tel: +82-2-3400-1243, Fax: +82-2-3400-1243 E-mail: ssophy@hanmail.netCase Report    Clinics in Orthopedic Surgery 2015;7:269-274   •  http://dx.doi.org/10.4055/cios.2015.7.2.269",Non-OADS,/arxiv_data1/oa_pdf/62/b7/cios-7-269.PMC4515471.pdf
"Original  Article Obstet Gynecol Sci 2015;58(4):261-267 http://dx.doi.org/10.5468/ogs.2015.58.4.261 pISSN 2287-8572  · eISSN 2287-8580www.ogscience.org 261Introduction Current invasive prenatal diagnostic methods for fetal chro - mosomal aneuploidies, such as amniocentesis and chorionic  villus sampling, induce a potential risk to a fetal [1].",Non-OADS,/arxiv_data1/oa_pdf/0d/11/ogs-58-261.PMC4515474.pdf
"Original  Article Obstet Gynecol Sci 2015;58(4):268-276 http://dx.doi.org/10.5468/ogs.2015.58.4.268 pISSN 2287-8572  · eISSN 2287-8580www.ogscience.org 268Introduction During the process of long bone measurement, locating the  precise anatomic plane to perform ultrasound biometry and  reducing inter- and intra-operator measurement error are  critical for diagnosis.",Non-OADS,/arxiv_data1/oa_pdf/c8/30/ogs-58-268.PMC4515475.pdf
"Original  Article Obstet Gynecol Sci 2015;58(4):277-283 http://dx.doi.org/10.5468/ogs.2015.58.4.277 pISSN 2287-8572  · eISSN 2287-8580www.ogscience.org 277Introduction Since the introduction of systemic chemotherapy in 1956 [1],  gestational trophoblastic neoplasia (GTN) has evolved into one  of the most curable gynecologic malignancies.",Non-OADS,/arxiv_data1/oa_pdf/a0/93/ogs-58-277.PMC4515476.pdf
"Original  Article Obstet Gynecol Sci 2015;58(4):284-288 http://dx.doi.org/10.5468/ogs.2015.58.4.284 pISSN 2287-8572  · eISSN 2287-8580www.ogscience.org 284Introduction Ovarian cancer is the most fatal gynecologic malignancy, and  it is the eighth leading cause of cancer death among Korean  women [1,2].",Non-OADS,/arxiv_data1/oa_pdf/11/e9/ogs-58-284.PMC4515477.pdf
Available from: http://www.pm360online.com/salpingec - tomy-associated-with-reduced-ovarian-cancer-risk.,Non-OADS,/arxiv_data1/oa_pdf/11/e9/ogs-58-284.PMC4515477.pdf
Available from: http://www.sgo.org/clinical-practice/guidelines/sgo-clinical-practice- statement-salpingectomy-for-ovarian-cancer-prevention .,Non-OADS,/arxiv_data1/oa_pdf/11/e9/ogs-58-284.PMC4515477.pdf
"Original  Article Obstet Gynecol Sci 2015;58(4):289-293 http://dx.doi.org/10.5468/ogs.2015.58.4.289 pISSN 2287-8572  · eISSN 2287-8580www.ogscience.org 289Introduction Because of the advantages of laparoscopy such as less pain,  shorter hospital stay, improved cosmesis, and fewer postop - erative complications, it has replaced open surgery and has  become the standard of care for many operations for benign  gynecologic disease [1-3].",Non-OADS,/arxiv_data1/oa_pdf/51/c9/ogs-58-289.PMC4515478.pdf
"Copyright © 2015 Korean Society of Obstetrics and Gynecology Original  Article Obstet Gynecol Sci 2015;58(4):294-301 http://dx.doi.org/10.5468/ogs.2015.58.4.294 pISSN 2287-8572  · eISSN 2287-8580www.ogscience.org 294Introduction Ovarian mature cystic teratoma is a benign tumor of the ovary  comprised of ectodermal, mesodermal, and endodermal layers  of germ cells.",Non-OADS,/arxiv_data1/oa_pdf/70/ca/ogs-58-294.PMC4515479.pdf
"Original  Article Obstet Gynecol Sci 2015;58(4):302-308 http://dx.doi.org/10.5468/ogs.2015.58.4.302 pISSN 2287-8572  · eISSN 2287-8580www.ogscience.org 302Introduction Female sexual dysfunction (FSD) is defined as recurrent or  persistent deficiency in sexual desire and arousal, difficulty or  absence of reaching orgasm and genital pain [1].",Non-OADS,/arxiv_data1/oa_pdf/d1/00/ogs-58-302.PMC4515480.pdf
http://dx.doi.org/10.1089/thy.2015.0015.,Non-OADS,/arxiv_data1/oa_pdf/d1/00/ogs-58-302.PMC4515480.pdf
Copyright © 2015 Korean Society of Obstetrics and Gynecology Case Report Obstet Gynecol Sci 2015;58(4):309-313 http://dx.doi.org/10.5468/ogs.2015.58.4.309 pISSN 2287-8572  · eISSN 2287-8580www.ogscience.org 309Introduction Congenital microphthalmia is a rare anomaly of the fetal orbit  resulting from developmental defects of the primary optic ves - icle [1].,Non-OADS,/arxiv_data1/oa_pdf/1c/4d/ogs-58-309.PMC4515481.pdf
Copyright © 2015 Korean Society of Obstetrics and Gynecology Case Report Obstet Gynecol Sci 2015;58(4):314-318 http://dx.doi.org/10.5468/ogs.2015.58.4.314 pISSN 2287-8572  · eISSN 2287-8580www.ogscience.org 314Introduction Benign metastatic leiomyomatosis (BML) is defined as a muscle  tumor in association with one or more smooth muscle tumors  of the uterus and without evidence of any extrauterine primary  site.,Non-OADS,/arxiv_data1/oa_pdf/92/5f/ogs-58-314.PMC4515482.pdf
Copyright © 2015 Korean Society of Obstetrics and Gynecology Case Report Obstet Gynecol Sci 2015;58(4):319-322 http://dx.doi.org/10.5468/ogs.2015.58.4.319 pISSN 2287-8572  · eISSN 2287-8580www.ogscience.org 319Introduction Post hysterectomy complications at the vault site such as a  bleeding incident can be commonly observed at a short term  postoperative period.,Non-OADS,/arxiv_data1/oa_pdf/e4/3c/ogs-58-319.PMC4515483.pdf
Copyright © 2015 Korean Society of Obstetrics and Gynecology Case Report Obstet Gynecol Sci 2015;58(4):323-326 http://dx.doi.org/10.5468/ogs.2015.58.4.323 pISSN 2287-8572  · eISSN 2287-8580www.ogscience.org 323Introduction Castleman and Towne [1].,Non-OADS,/arxiv_data1/oa_pdf/13/8d/ogs-58-323.PMC4515484.pdf
"Copyright © 2015 Korean Society of Obstetrics and Gynecology Case Report Obstet Gynecol Sci 2015;58(4):327-330 http://dx.doi.org/10.5468/ogs.2015.58.4.327 pISSN 2287-8572  · eISSN 2287-8580www.ogscience.org 327Introduction Tamoxifen has been widely used for adjuvant treatment of  breast cancer, but several gynecological side effects after its  use have been noted, including endometrial hyperplasia, endo - metrial polyps, endometrial carcinoma, and rare complications  such as endometriosis, adenomyosis, and cervical polyps [1-3].",Non-OADS,/arxiv_data1/oa_pdf/66/1f/ogs-58-327.PMC4515485.pdf
Copyright © 2015 Korean Society of Obstetrics and Gynecology Letter to the Editor Obstet Gynecol Sci 2015;58(4):331-332 http://dx.doi.org/10.5468/ogs.2015.58.4.331 pISSN 2287-8572  · eISSN 2287-8580www.ogscience.org 331We read with great interest the article by Oh et al.,Non-OADS,/arxiv_data1/oa_pdf/74/99/ogs-58-331.PMC4515486.pdf
Available  from: http://research.nhgri.nih.gov/projects/bic/.,OADS,/arxiv_data1/oa_pdf/74/99/ogs-58-331.PMC4515486.pdf
"Copyright © 2015 The Korean Academy of Family Medicine This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9f/bb/kjfm-36-159.PMC4515507.pdf
"Keywords:  Medical Education; Cost Received: April 30, 2015, Accepted: July 9, 2015 *Corresponding Author: Kieran Walsh  Tel: +44-0207-383-6550, Fax: +44-0207-383-6242, E-mail: kmwalsh@bmj.comhttp://dx.doi.org/10.4082/kjfm.2015.36.4.159  • Korean J Fam Med 2015;36:159-161 eISSN: 2092-6715Editorial",Non-OADS,/arxiv_data1/oa_pdf/9f/bb/kjfm-36-159.PMC4515507.pdf
"160  www.kjfm.or.kr http://dx.doi.org/10.4082/kjfm.2015.36.4.159 Medical education is expensive.1) As a result, in many coun - tries, healthcare professional students, especially medical stu - dents, must take out loans to pay for their studies.",Non-OADS,/arxiv_data1/oa_pdf/9f/bb/kjfm-36-159.PMC4515507.pdf
http://dx.doi.org/10.4082/kjfm.2015.36.4.159www.kjfm.or.kr   161 debt.9) We should strive to prevent this hidden curriculum from  emerging.,Non-OADS,/arxiv_data1/oa_pdf/9f/bb/kjfm-36-159.PMC4515507.pdf
Available from: http://bma.org.uk/developing-your-career/be - coming-a-doctor/equality-and-diversity-in-medical-schools.,Non-OADS,/arxiv_data1/oa_pdf/9f/bb/kjfm-36-159.PMC4515507.pdf
"Copyright © 2015 The Korean Academy of Family Medicine This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c3/16/kjfm-36-162.PMC4515508.pdf
"Keywords:  Economic Cycle; Economic Recession; Gross Domestic Product; Health; Hypertension; Stress Received: April 30, 2015, Accepted: July 13, 2015 *Corresponding Author: Be-Long Cho  Tel: +82-2-2072-2195, Fax: +82-2-766-3276, E-mail: belong@snu.ac.krhttp://dx.doi.org/10.4082/kjfm.2015.36.4.162  • Korean J Fam Med 2015;36:162-167 eISSN: 2092-6715Original Article",Non-OADS,/arxiv_data1/oa_pdf/c3/16/kjfm-36-162.PMC4515508.pdf
• Effects of the 2008 Global Economic Crisis http://dx.doi.org/10.4082/kjfm.2015.36.4.162www.kjfm.or.kr   163 INTRODUCTION A number of studies have been conducted on the association  between economics and health.,Non-OADS,/arxiv_data1/oa_pdf/c3/16/kjfm-36-162.PMC4515508.pdf
• Effects of the 2008 Global Economic Crisis 164  www.kjfm.or.kr http://dx.doi.org/10.4082/kjfm.2015.36.4.162 KNHANES data.,OADS,/arxiv_data1/oa_pdf/c3/16/kjfm-36-162.PMC4515508.pdf
"• Effects of the 2008 Global Economic Crisis http://dx.doi.org/10.4082/kjfm.2015.36.4.162www.kjfm.or.kr   165 analysis to confirm the stability of the model, which included  dummy variables to represent a year effect.",Non-OADS,/arxiv_data1/oa_pdf/c3/16/kjfm-36-162.PMC4515508.pdf
• Effects of the 2008 Global Economic Crisis 166  www.kjfm.or.kr http://dx.doi.org/10.4082/kjfm.2015.36.4.162 the accumulated data are not sufficient to carry out long-term  studies regarding morbidity.,Non-OADS,/arxiv_data1/oa_pdf/c3/16/kjfm-36-162.PMC4515508.pdf
• Effects of the 2008 Global Economic Crisis http://dx.doi.org/10.4082/kjfm.2015.36.4.162www.kjfm.or.kr   167 13.,Non-OADS,/arxiv_data1/oa_pdf/c3/16/kjfm-36-162.PMC4515508.pdf
Available from: http://databank.worldbank.org/data/home.,OADS,/arxiv_data1/oa_pdf/c3/16/kjfm-36-162.PMC4515508.pdf
"Copyright © 2015 The Korean Academy of Family Medicine This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/40/7e/kjfm-36-168.PMC4515509.pdf
"Keywords:  Friedewald Formula; HiSens Reagent; Low Density Lipoprotein Cholesterol  Received: April 23, 2015, Accepted: May 18, 2015 *Corresponding Author: Sang-Keun Hahm  Tel: +82-2-901-3672, Fax: +82-2-901-3467, E-mail: hahmsang@naver.comhttp://dx.doi.org/10.4082/kjfm.2015.36.4.168  • Korean J Fam Med 2015;36:168-173 eISSN: 2092-6715Original Article",Non-OADS,/arxiv_data1/oa_pdf/40/7e/kjfm-36-168.PMC4515509.pdf
"• Comparison of Low Density Lipoprotein Cholesterol Measurement  http://dx.doi.org/10.4082/kjfm.2015.36.4.168www.kjfm.or.kr   169 INTRODUCTION Low density lipoprotein cholesterol (LDLC) is a major risk fac ­ tor in atherosclerosis and coronary heart disease (CHD) and a  main target for diagnosis and treatment of hyperlipidemia.1)  The National Cholesterol Education Program Adult Treatment  Panel III (NCEP ATP III) guidelines for hyperlipidemia, which  are the most commonly referred to guidelines, were recently  updated to ATP IV .2,3) These guidelines suggest that the calcu ­ lated LDLC (CLDLC), assessed using the Friedewald formula,  should be the primary lipid target for CHD risk reduction.4) The  reference method for measuring LDLC is beta quantification.1,5)  Friedewald­estimated LDLC is used in clinical practice because  it is more convenient and less expensive than the more compli ­ cated and time­consuming beta quantification.6) However, the  CLDLC is inaccurate when triglycerides (TG) are greater than  400 mg/dL, which occurs in dysbetalipoproteinemia and hy ­ perlipoproteinemia secondary to diabetes, as well as when pa ­ tients have not fasted.7­10)  Because of the limitations of the Friedewald calculation, ho ­ mogenous methods capable of full automation have been in ­ troduced for directly quantifying LDLC.11) The direct LDLC (DL­ DLC) quantification produces variable results due to differenc ­ es in the homogenization method and reagents.",Non-OADS,/arxiv_data1/oa_pdf/40/7e/kjfm-36-168.PMC4515509.pdf
• Comparison of Low Density Lipoprotein Cholesterol Measurement 170  www.kjfm.or.kr http://dx.doi.org/10.4082/kjfm.2015.36.4.168 3.,Non-OADS,/arxiv_data1/oa_pdf/40/7e/kjfm-36-168.PMC4515509.pdf
• Comparison of Low Density Lipoprotein Cholesterol Measurement  http://dx.doi.org/10.4082/kjfm.2015.36.4.168www.kjfm.or.kr   171 slightly low (P = 0.054).,Non-OADS,/arxiv_data1/oa_pdf/40/7e/kjfm-36-168.PMC4515509.pdf
• Comparison of Low Density Lipoprotein Cholesterol Measurement 172  www.kjfm.or.kr http://dx.doi.org/10.4082/kjfm.2015.36.4.168 Table 3.,Non-OADS,/arxiv_data1/oa_pdf/40/7e/kjfm-36-168.PMC4515509.pdf
• Comparison of Low Density Lipoprotein Cholesterol Measurement  http://dx.doi.org/10.4082/kjfm.2015.36.4.168www.kjfm.or.kr   173 protein cholesterol by homogenous assay in comparison with Friede ­ wald formula.,OADS,/arxiv_data1/oa_pdf/40/7e/kjfm-36-168.PMC4515509.pdf
"Copyright © 2015 The Korean Academy of Family Medicine This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/48/2d/kjfm-36-174.PMC4515510.pdf
"Keywords:  Test Anxiety; Attachment Style; Alexithymia Received: April 30, 2015, Accepted: July 9, 2015 *Corresponding Author: Ali Zakiei  Tel: +98-918-7190274, Fax: +98-833-4216143, E-mail: zakieiali@gmail.comhttp://dx.doi.org/10.4082/kjfm.2015.36.4.174  • Korean J Fam Med 2015;36:174-179 eISSN: 2092-6715Original Article",Non-OADS,/arxiv_data1/oa_pdf/48/2d/kjfm-36-174.PMC4515510.pdf
"• Emotion, Attachment, and Test Anxiety http://dx.doi.org/10.4082/kjfm.2015.36.4.174www.kjfm.or.kr   175 INTRODUCTION Test anxiety is characterized by an emotional state involving  fear and worry about the situations that an individual may face  during performance evaluation.",Non-OADS,/arxiv_data1/oa_pdf/48/2d/kjfm-36-174.PMC4515510.pdf
"• Emotion, Attachment, and Test Anxiety 176  www.kjfm.or.kr http://dx.doi.org/10.4082/kjfm.2015.36.4.174 and 0.72, which denotes the proper internal consistency of the  scale.",Non-OADS,/arxiv_data1/oa_pdf/48/2d/kjfm-36-174.PMC4515510.pdf
"• Emotion, Attachment, and Test Anxiety http://dx.doi.org/10.4082/kjfm.2015.36.4.174www.kjfm.or.kr   177 and a correlation coefficient of 0.31 between the anxious at - tachment style and alexithymia, which were both significant at  the P < 0.001 level.",Non-OADS,/arxiv_data1/oa_pdf/48/2d/kjfm-36-174.PMC4515510.pdf
"• Emotion, Attachment, and Test Anxiety 178  www.kjfm.or.kr http://dx.doi.org/10.4082/kjfm.2015.36.4.174 systems (including anxiety) may increase.",Non-OADS,/arxiv_data1/oa_pdf/48/2d/kjfm-36-174.PMC4515510.pdf
"• Emotion, Attachment, and Test Anxiety http://dx.doi.org/10.4082/kjfm.2015.36.4.174www.kjfm.or.kr   179 tients with psoriasis: clinical correlates and psychometric properties of  the Toronto Alexithymia Scale-20.",Non-OADS,/arxiv_data1/oa_pdf/48/2d/kjfm-36-174.PMC4515510.pdf
"Copyright © 2015 The Korean Academy of Family Medicine This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/dc/1d/kjfm-36-180.PMC4515511.pdf
"Keywords:  Chest Pain; Cognitions; Patients Received: February 19, 2015, Accepted: July 9, 2015 *Corresponding Author: Saeid Komasi  Tel: +98-833-8380698, Fax: +98-833-8360043, E-mail: S_komasi63@yahoo.comhttp://dx.doi.org/10.4082/kjfm.2015.36.4.180  • Korean J Fam Med 2015;36:180-185 eISSN: 2092-6715Original Article",Non-OADS,/arxiv_data1/oa_pdf/dc/1d/kjfm-36-180.PMC4515511.pdf
"• Cognitions of Non-Coronary Patients http://dx.doi.org/10.4082/kjfm.2015.36.4.180www.kjfm.or.kr   181 INTRODUCTION Discomfort in the chest is one of the most common complaints  reported by patients in clinical practice.1) This, in many cases,  not only does not stem from the heart, as in nearly 66% of the  patients, the existence of a clear physical cause could not be de - termined.2) This can indicate the role of psychological factors3,4)  and their impact on the perception of chest pain.5) The existing  evidence shows that most patients with chest pain indicate an  unknown etiology and use avoidant and emotion-focused cop - ing styles,6,7) and the few patients who use problem-bound  strategies have less flexible styles than do other people with op - positional styles.8) This leads this group of patients to be unsatis - fied and uneasy despite the physician’s assurance regarding the  negativity of the assessment results.9) They generally believe this  pain will lead to heart attack or the emergence of a serious dis - ease or even death.",Non-OADS,/arxiv_data1/oa_pdf/dc/1d/kjfm-36-180.PMC4515511.pdf
• Cognitions of Non-Coronary Patients 182  www.kjfm.or.kr http://dx.doi.org/10.4082/kjfm.2015.36.4.180 quired data.,OADS,/arxiv_data1/oa_pdf/dc/1d/kjfm-36-180.PMC4515511.pdf
"• Cognitions of Non-Coronary Patients http://dx.doi.org/10.4082/kjfm.2015.36.4.180www.kjfm.or.kr   183 way individuals comment on, interpret, and define the life inci - dents that can regulate the quantity and quality of the behav - iors and emotions,16) it is somewhat predictable that we would  observe higher scores on these beliefs in patients with severe  pain.",Non-OADS,/arxiv_data1/oa_pdf/dc/1d/kjfm-36-180.PMC4515511.pdf
• Cognitions of Non-Coronary Patients 184  www.kjfm.or.kr http://dx.doi.org/10.4082/kjfm.2015.36.4.180 mance.21) One of those beliefs that leads to negative perfor - mance is problem avoiding.,Non-OADS,/arxiv_data1/oa_pdf/dc/1d/kjfm-36-180.PMC4515511.pdf
• Cognitions of Non-Coronary Patients http://dx.doi.org/10.4082/kjfm.2015.36.4.180www.kjfm.or.kr   185 Res 1994;38:365-71.,Non-OADS,/arxiv_data1/oa_pdf/dc/1d/kjfm-36-180.PMC4515511.pdf
"Copyright © 2015 The Korean Academy of Family Medicine This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/42/75/kjfm-36-186.PMC4515512.pdf
"Keywords:  Influenza Vaccines; Vaccination; Residence Characteristics; Aged Received: February 19, 2015, Accepted: July 9, 2015 *Corresponding Author: Joo-Yeon Kim  Tel: +82-2-2276-7941, Fax: +82-2-2276-8533, E-mail: willywalnut@naver.comhttp://dx.doi.org/10.4082/kjfm.2015.36.4.186  • Korean J Fam Med 2015;36:186-190 eISSN: 2092-6715Original Article",Non-OADS,/arxiv_data1/oa_pdf/42/75/kjfm-36-186.PMC4515512.pdf
"• Association between Living Arrangements and Influenza Vaccination http://dx.doi.org/10.4082/kjfm.2015.36.4.186www.kjfm.or.kr   187 INTRODUCTION Influenza is a worldwide public health problem.1) This disease  often causes severe complications such as pneumonia, the  sixth-leading cause of death in Korea during the year 2013.2)  According to the World Health Organization, global influenza  epidemics annually result in 3 to 5 million cases of severe ill - ness and 250,000 to 500,000 deaths.",Non-OADS,/arxiv_data1/oa_pdf/42/75/kjfm-36-186.PMC4515512.pdf
• Association between Living Arrangements and Influenza Vaccination 188  www.kjfm.or.kr http://dx.doi.org/10.4082/kjfm.2015.36.4.186 women.,Non-OADS,/arxiv_data1/oa_pdf/42/75/kjfm-36-186.PMC4515512.pdf
"• Association between Living Arrangements and Influenza Vaccination http://dx.doi.org/10.4082/kjfm.2015.36.4.186www.kjfm.or.kr   189 enza vaccination, such as age, sex, educational level, household  income, place of residence, contact with the health care system,  hospitalization, and comorbidities.",Non-OADS,/arxiv_data1/oa_pdf/42/75/kjfm-36-186.PMC4515512.pdf
Available from: http://www.who.int/mediacentre/factsheets/ fs211/en/.,Non-OADS,/arxiv_data1/oa_pdf/42/75/kjfm-36-186.PMC4515512.pdf
Available from: http://kostat.go.kr.,Non-OADS,/arxiv_data1/oa_pdf/42/75/kjfm-36-186.PMC4515512.pdf
• Association between Living Arrangements and Influenza Vaccination 190  www.kjfm.or.kr http://dx.doi.org/10.4082/kjfm.2015.36.4.186 vaccine coverage rates and perceptions on vaccination in South Korea.,Non-OADS,/arxiv_data1/oa_pdf/42/75/kjfm-36-186.PMC4515512.pdf
Available from: http://www.cdc.go.kr.,Non-OADS,/arxiv_data1/oa_pdf/42/75/kjfm-36-186.PMC4515512.pdf
"Copyright © 2015 The Korean Academy of Family Medicine This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/99/c0/kjfm-36-191.PMC4515513.pdf
"Keywords:  Carbapenemase; Enterobacteriaceae ; Enterobacter cloacae ; Drug Resistance, Bacterial Received: April 30, 2015, Accepted:  July 9, 2015 *Co-corresponding Authors: Hee Jung Yoon, Sehoon Shim  Tel: +82-42-611-300, Fax: +82-42-259-1162, E-mail: yhj822@eulji.ac.kr Hee Jung Yoon and Sehoon Shim contributed equally to this work as co-corresponding authors.http://dx.doi.org/10.4082/kjfm.2015.36.4.191  • Korean J Fam Med 2015;36:191-194 eISSN: 2092-6715Case Report",Non-OADS,/arxiv_data1/oa_pdf/99/c0/kjfm-36-191.PMC4515513.pdf
in 2014 192  www.kjfm.or.kr http://dx.doi.org/10.4082/kjfm.2015.36.4.191 INTRODUCTION Carbapenem was developed from thienamycin in 1980 and  has a broad antibacterial spectrum that includes gram-nega - tive and gram-positive bacteria such as Pseudomonas aerugi - nosa  and Enterobacteriaceae .,Non-OADS,/arxiv_data1/oa_pdf/99/c0/kjfm-36-191.PMC4515513.pdf
"in 2014 http://dx.doi.org/10.4082/kjfm.2015.36.4.191www.kjfm.or.kr   193 low-up cerebrospinal fluid culture and blood tests were per - formed, and the patient was kept under observation without  treatment, as no infection was found.",Non-OADS,/arxiv_data1/oa_pdf/99/c0/kjfm-36-191.PMC4515513.pdf
in 2014 194  www.kjfm.or.kr http://dx.doi.org/10.4082/kjfm.2015.36.4.191 ment.,Non-OADS,/arxiv_data1/oa_pdf/99/c0/kjfm-36-191.PMC4515513.pdf
"Copyright © 2015 The Korean Academy of Family Medicine This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/44/34/kjfm-36-195.PMC4515514.pdf
"Comments on Statistical Issues in July  2015 Kyung Do Han, Yong Gyu Park Department of Biostatistics, The Catholic University of Korea College of Medicine, Seoul, Koreahttp://dx.doi.org/10.4082/kjfm.2015.36.4.195  • Korean J Fam Med 2015;36:195 Commentary eISSN: 2092-6715 In this section, we raise some questions about the  Methods and Results which described in the article ti - tled, “Generalized joint laxity is associated with primary  occurrence and treatment outcome of lumbar disc her - niation, ” published in May 2015 by Han et al.1) SUMMARY As they described in the background, this study aimed  to (1) evaluate the relationship between generalized  joint laxity (GJL) and lumbar disc herniation (LDH),  and (2) compare clinical outcomes after conservative  treatment in LDH patients with and without GJL.",Non-OADS,/arxiv_data1/oa_pdf/44/34/kjfm-36-195.PMC4515514.pdf
Available	from:	http://www.stedmansonline.,Non-OADS,/arxiv_data1/oa_pdf/9f/1b/JISPCD-5-141.PMC4515794.pdf
Available	from:	http://www.who.int/csr/disease/coronavirus_ infections/mers‑5‑february‑2015.pdf?ua=1.,Non-OADS,/arxiv_data1/oa_pdf/aa/3f/JISPCD-5-163.PMC4515797.pdf
Available	from:	http://www.who.int/csr/don/16‑april	 ‑2015‑mers‑saudi‑arabia/en/.,Non-OADS,/arxiv_data1/oa_pdf/aa/3f/JISPCD-5-163.PMC4515797.pdf
Available	 from:	http://www.who.int/csr/don/2014_05_15_mers/en/.,OADS,/arxiv_data1/oa_pdf/aa/3f/JISPCD-5-163.PMC4515797.pdf
Available	from:	http://www.thelancet.com.,Non-OADS,/arxiv_data1/oa_pdf/aa/3f/JISPCD-5-163.PMC4515797.pdf
Available	from:	http://www.thelancet.,Non-OADS,/arxiv_data1/oa_pdf/aa/3f/JISPCD-5-163.PMC4515797.pdf
Available	from:	http://www.who.int/csr/ disease/coronavirus_infections/MERS_CoV_Update_20_ Jan_2014.pdf.,Non-OADS,/arxiv_data1/oa_pdf/aa/3f/JISPCD-5-163.PMC4515797.pdf
Available	 from:	http://www.who.int/mediacentre/news/ statements/2015/8th‑mers‑emergency‑committee/en/.,Non-OADS,/arxiv_data1/oa_pdf/aa/3f/JISPCD-5-163.PMC4515797.pdf
Available	from:	http://www.who.int/csr/disease/coronavirus_ infections/case_definition/en/.,Non-OADS,/arxiv_data1/oa_pdf/aa/3f/JISPCD-5-163.PMC4515797.pdf
Available	from:	http://www.who.int/csr/ disease/coronavirus_infections/update_20130517/en/index.,Non-OADS,/arxiv_data1/oa_pdf/aa/3f/JISPCD-5-163.PMC4515797.pdf
Available	from:	http://www.who.int/csr/disease/ coronavirus_infections/InterimGuidance‑ClinicalManagement_ NovelCoronavirus_11Feb13.pdf.,Non-OADS,/arxiv_data1/oa_pdf/aa/3f/JISPCD-5-163.PMC4515797.pdf
Available	from:	http://www.who.int/csr/ disease/coronavirus_infections/MERS_CoV_Update_09_ May_2014.pdf?ua=1.,Non-OADS,/arxiv_data1/oa_pdf/aa/3f/JISPCD-5-163.PMC4515797.pdf
Available	from:	 http://www.cdc.gov/coronavirus/mers/downloads/ mers‑infection‑control‑guidance‑051414.pdf.,Non-OADS,/arxiv_data1/oa_pdf/aa/3f/JISPCD-5-163.PMC4515797.pdf
Available	 from:	http://www.feridologo.com.br/curpapaina.htm.,Non-OADS,/arxiv_data1/oa_pdf/29/32/JISPCD-5-183.PMC4515800.pdf
"Available	from:	http://www.english.wh.gov.cn/ publish/english/2012‑04/20/1201204231744218195.html, 	 2012.",Non-OADS,/arxiv_data1/oa_pdf/d4/db/JISPCD-5-205.PMC4515803.pdf
HYPERLINK	 “http://www.ncbi.nlm.nih.gov/ pubmed/?term	 =	Comparing	+	streptococcus	 +	mutans	+	 and	+	lactobacillus	 +	colony	+	count	+	changes	+	following	 +	green	+	tea	+	mouth	+	rinse	+	or	+	sodium	+	fluoride	 +	mouth	+	rinse	+	use	+	in	+	children	(randomized	 +	 double‑blind	 +	controlled	+	clinical	+	trial).”	\o	“Dental	 research	journal.”	Dent	Res	J	(Isfahan)	2011;8(Suppl	1):S58‑63.,Non-OADS,/arxiv_data1/oa_pdf/18/54/JISPCD-5-218.PMC4515805.pdf
Available	 from:	http://www.ehow.com/how_4899641_ make‑green‑	tea‑extract.html.,Non-OADS,/arxiv_data1/oa_pdf/18/54/JISPCD-5-218.PMC4515805.pdf
Available	 from:	http://www.indigo.com/Test‑Strips/ pH‑test‑strips.html.,Non-OADS,/arxiv_data1/oa_pdf/18/54/JISPCD-5-218.PMC4515805.pdf
Available	from:	http://www.cancer.org	 .,Non-OADS,/arxiv_data1/oa_pdf/e5/6d/JISPCD-5-248.PMC4515810.pdf
Available	from:	http://www.oralcancerfoundation.org/	 facts/index.htm.,Non-OADS,/arxiv_data1/oa_pdf/e5/6d/JISPCD-5-248.PMC4515810.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ba/42/rjv085.PMC4515855.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/31/a7/rjv086.PMC4515856.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/li- censes/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly ci ted.",Non-OADS,/arxiv_data1/oa_pdf/6a/1d/sfv028.PMC4515887.pdf
"Although these re- ports are encouraging, the long-term use of ketoconazole, espe-cially at high doses, in subjects with CYP24A1 mutations is not advisable due to toxicity of the drug ( https://www.gov.uk/drug- safety-update/oral-ketoconazol e-do-not-prescribe-or-use-for- fungal-infections-risk-of-liver-injury-outweighs-bene ﬁts), with more recent MHRA warnings in respect of its use as medicaltherapy of endogenous Cushing ’s syndrome.",Non-OADS,/arxiv_data1/oa_pdf/6a/1d/sfv028.PMC4515887.pdf
[1] and others and has an allele frequency of 0.06% reported in the Exome Aggregation Consortium (ExAC) database ( http://exac.broad institute.org/ ) generated from whole exome sequencing data of >60 000 individuals.,OADS,/arxiv_data1/oa_pdf/6a/1d/sfv028.PMC4515887.pdf
"( B) Clinical course of patient and response of serum calcium (adjusted for albumin, reference range 2.2 –2.6 mmo/L) and 1,25 dihydroxy vitamin D levels (using an validated immunoassay ( http://www.idsplc.com/en-gb/products/ids-isys-125-dihydroxy-vitamin-d-is-2400 ), reference range 20 –120 pmol/L) to therapy with variable prednisolone dose (mg) and ﬂuconazole 50 mg od.454 |J.",Non-OADS,/arxiv_data1/oa_pdf/6a/1d/sfv028.PMC4515887.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/df/46/sfv031.PMC4515888.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/li- censes/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly ci ted.",Non-OADS,/arxiv_data1/oa_pdf/48/2c/sfv032.PMC4515889.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/06/77/sfv034.PMC4515890.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f8/ca/sfv036.PMC4515891.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7f/83/sfv037.PMC4515892.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/28/40/sfv038.PMC4515893.pdf
"Bethesda, MD: National Institutes of Health, National Insti-tutes of Diabetes and Digestive and Kidney Diseases, 2012.http://www.usrds.org/2012/view/v2 51.",Non-OADS,/arxiv_data1/oa_pdf/28/40/sfv038.PMC4515893.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a3/c9/sfv039.PMC4515894.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/li- censes/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly ci ted.",Non-OADS,/arxiv_data1/oa_pdf/94/4f/sfv040.PMC4515895.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/51/b0/sfv041.PMC4515896.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1c/04/sfv042.PMC4515897.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/58/0e/sfv043.PMC4515898.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/54/4d/sfv044.PMC4515899.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/41/5d/sfv045.PMC4515900.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7d/78/sfv046.PMC4515901.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4d/ee/sfv048.PMC4515903.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9f/2d/sfv049.PMC4515904.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d1/c6/sfv050.PMC4515905.pdf
"Leeds University 2012. http://www.leeds.ac.uk/hsphr/ research/AUPBS/ptda.html (12 March 2014, date last accessed) 10.",Non-OADS,/arxiv_data1/oa_pdf/d1/c6/sfv050.PMC4515905.pdf
"2013 [updated March 15];http://homedialysis.org/match-d (22 March 2015, date last accessed) 11.",Non-OADS,/arxiv_data1/oa_pdf/d1/c6/sfv050.PMC4515905.pdf
"Chapter L. 2012. http://ipdas.ohri.ca/IPDAS-Chapter-L.pdf (22 March 2015, date last accessed) 21.",Non-OADS,/arxiv_data1/oa_pdf/d1/c6/sfv050.PMC4515905.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/79/45/sfv051.PMC4515906.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e4/08/sfv052.PMC4515907.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a7/36/sfv058.PMC4515908.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/65/49/sfv065.PMC4515909.pdf
"Clin Nephrol 2014; 82: 326 –331 10.http://www.abstracts2view.com/asn_2012/view.php?nu= 5013&terms=&type=abstract (27 June 2015, date last accessed) 11.",OADS,/arxiv_data1/oa_pdf/65/49/sfv065.PMC4515909.pdf
"Pediatr Nephrol 2014; 29: 1283 –1287 28.https://clinicaltrials.gov/ (28 June 2015, date last accessed)452 |Editorial CommentCLINICAL KIDNEY JOURNAL",Non-OADS,/arxiv_data1/oa_pdf/65/49/sfv065.PMC4515909.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Clayton E, Ross L. Implications of disclosing individual results of clinical research.",Non-OADS,/arxiv_data1/oa_pdf/3d/fc/medethics-2014-102078.PMC4515978.pdf
"Dr Foster Unit, PCPH Imperial College London, London, UK Correspondence to Dr Milagros Ruiz, Dr Foster Unit, PCPH Imperial College London, 3 Dorset Rise, London EC4Y8EN, UK; m.ruiz@imperial.ac.uk Received 8 August 2014 Revised 17 April 2015 Accepted 2 May 2015 ▸http://dx.doi.org/10.1136/ bmjqs-2015-004360 To cite: Ruiz M, Bottle A, Aylin PP.",Non-OADS,/arxiv_data1/oa_pdf/d5/14/bmjqs-2014-003467.PMC4515980.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Freemantle N, Richardson M, W ood J, et al.",Non-OADS,/arxiv_data1/oa_pdf/d5/14/bmjqs-2014-003467.PMC4515980.pdf
"http://www.hcup-us.ahrq.gov/home.jsp 25 T ovim DB, W oodman R, Harrison JE, et al.",OADS,/arxiv_data1/oa_pdf/d5/14/bmjqs-2014-003467.PMC4515980.pdf
Recorded outside the ‘traditional ’healthcare system structures.Patients like me: An online (http://www.patientslikeme.com) quantitative personal research platform for patients with life-changing illnesses.,Non-OADS,/arxiv_data1/oa_pdf/64/2b/bmjqs-2015-004278.PMC4515981.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Plato.,Non-OADS,/arxiv_data1/oa_pdf/64/2b/bmjqs-2015-004278.PMC4515981.pdf
http://www.pubmedcentral.nih.gov/ articlerender.fcgi?artid=4114428&tool=pmcentrez&rendertype=abstract (accessed 12 Feb 2015).,OADS,/arxiv_data1/oa_pdf/64/2b/bmjqs-2015-004278.PMC4515981.pdf
"http://dx.doi.org/10.1002/14651858.CD002098 30 Steventon A, Bardsley M, Billings J, et al .",OADS,/arxiv_data1/oa_pdf/64/2b/bmjqs-2015-004278.PMC4515981.pdf
"http://www.ncbi.nlm.nih.gov/pmc/articles/ PMC3988932/?report=reader http://dx.doi.org/10.1016/j.socscimed.2014.01.013 32 Craig R, Mindell J.",OADS,/arxiv_data1/oa_pdf/64/2b/bmjqs-2015-004278.PMC4515981.pdf
Leeds: 2014. http://www.hscic.gov.,Non-OADS,/arxiv_data1/oa_pdf/64/2b/bmjqs-2015-004278.PMC4515981.pdf
"2014.http://www.health.org.uk/public/cms/75/76/313/4772/Measuringwhatreallymatters.pdf?realName=7HWr4a.pdf 43 Austin PC, Mamdani MM, Stukel TA, et al.T h eu s eo ft h e propensity score for estimating treatment effects: administrative versus clinical data.",OADS,/arxiv_data1/oa_pdf/64/2b/bmjqs-2015-004278.PMC4515981.pdf
2015. https://www.nomisweb.co.uk/reports/lmp/gor/2092957698/report.aspx (accessed 24 Mar 2015).,Non-OADS,/arxiv_data1/oa_pdf/64/2b/bmjqs-2015-004278.PMC4515981.pdf
http://sekhon.polisci.,Non-OADS,/arxiv_data1/oa_pdf/64/2b/bmjqs-2015-004278.PMC4515981.pdf
http://qof.hscic.,Non-OADS,/arxiv_data1/oa_pdf/64/2b/bmjqs-2015-004278.PMC4515981.pdf
"2010. http://www.rcgp.org.uk/Clinical-and-research/Practice-management-resources/~/media/Files/Informatics/Health_Informatics_Enabling_Patient_Access.ashx 86 Cresswell KM, Sheikh A.",Non-OADS,/arxiv_data1/oa_pdf/64/2b/bmjqs-2015-004278.PMC4515981.pdf
http://www.england.nhs.,Non-OADS,/arxiv_data1/oa_pdf/64/2b/bmjqs-2015-004278.PMC4515981.pdf
https://www.hed.nhs.uk/ (accessed 23 Feb 2015).,Non-OADS,/arxiv_data1/oa_pdf/64/2b/bmjqs-2015-004278.PMC4515981.pdf
"The Health Foundation, 2015. http://www.health.org.uk/public/cms/75/76/313/5504/ Constructivecomfort-acceleratingchangeintheNHS.pdf?",Non-OADS,/arxiv_data1/oa_pdf/64/2b/bmjqs-2015-004278.PMC4515981.pdf
http://www.esrc.ac.uk/_images/Dialogue_on_Data_report_tcm8-30270.pdf 109 Department of Business Skills & Innovation.,Non-OADS,/arxiv_data1/oa_pdf/64/2b/bmjqs-2015-004278.PMC4515981.pdf
http://datadonors.org/ (accessed 25 Mar 2015).,OADS,/arxiv_data1/oa_pdf/64/2b/bmjqs-2015-004278.PMC4515981.pdf
"https://opensnp.org/ (accessed 23 Mar 2015).Original research Deeny SR, et al.BMJ Qual Saf 2015; 24:505 –515.",OADS,/arxiv_data1/oa_pdf/64/2b/bmjqs-2015-004278.PMC4515981.pdf
See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 Solling C. Organ-protective and immunomodulatory effects of erythropoietin —an update on recent clinical trials.,Non-OADS,/arxiv_data1/oa_pdf/83/f1/jnnp-2014-308996.PMC4515982.pdf
To view please visit the journal online (http://dx.doi.org/10.1136/gutjnl-2014-308285).,Non-OADS,/arxiv_data1/oa_pdf/f5/93/gutjnl-2014-308285.PMC4515984.pdf
"Division of Epidemiology and Public Health, City Hospital Campus, The University of Nottingham, Nottingham, UK Correspondence to Dr Alyshah Abdul Sultan,Division of Epidemiology and Public Health, City Hospital campus, The University ofNottingham, Room B121,Clinical Science Building 2, Hucknall Road, Nottingham, NG5 1PB, UK;alyshah.sultan@hotmail.com Received 19 August 2014 Revised 1 October 2014 Accepted 2 October 2014Published Online First24 October 2014 ▸http://dx.doi.org/10.1136/ gutjnl-2014-308567 To cite: Abdul Sultan A, Crooks CJ, Card T, et al.Gut 2015; 64:1220 –1226.ABSTRACT Introduction Quantifying excess cause-speci ﬁc mortality among people with coeliac disease (CD)compared with the general population accounting forcompeting risks will allow accurate information to begiven on risk of death from speci ﬁc causes.",Non-OADS,/arxiv_data1/oa_pdf/f5/93/gutjnl-2014-308285.PMC4515984.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 West J, Fleming KM, Tata LJ, et al.",Non-OADS,/arxiv_data1/oa_pdf/f5/93/gutjnl-2014-308285.PMC4515984.pdf
http://www.cprd.com/intro.asp (accessed 19 Apr 2013).,Non-OADS,/arxiv_data1/oa_pdf/f5/93/gutjnl-2014-308285.PMC4515984.pdf
Final general practice registered populations 2011. http://www.ic.nhs.uk/statistics-and-data-collections/ population-and-geography/gp-registered-populations/attribution-dataset- gpregistered-populationscaledto-ons-population-estimates-201 (accessed 23 Apr2014).,Non-OADS,/arxiv_data1/oa_pdf/f5/93/gutjnl-2014-308285.PMC4515984.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Acheson D, Barker D, Chambers J, et al .Independent inquiry into inequalities in health.",Non-OADS,/arxiv_data1/oa_pdf/ea/46/jech-2014-204362.PMC4515985.pdf
To viewplease visit the journal online (http://dx.doi.org/10.1136/ annrheumdis-2013-203933).,OADS,/arxiv_data1/oa_pdf/13/00/annrheumdis-2013-203933.PMC4515988.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Manzi S, Meilahn EN, Rairie JE, et al.",Non-OADS,/arxiv_data1/oa_pdf/13/00/annrheumdis-2013-203933.PMC4515988.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 van Nies JA, Krabben A, Schoones JW, et al.",Non-OADS,/arxiv_data1/oa_pdf/8a/da/annrheumdis-2013-204601.PMC4515990.pdf
"Funding This research was performed within the framework of CTMM, the Center for Translational Molecular Medicine (http://www.ctmm.nl), project INCOAG (grant01C-201), and supported by the Dutch Heart Foundation.",Non-OADS,/arxiv_data1/oa_pdf/4c/57/heartjnl-2014-306685.PMC4515992.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Dangas GD, Caixeta A, Mehran R, et al.",Non-OADS,/arxiv_data1/oa_pdf/4c/57/heartjnl-2014-306685.PMC4515992.pdf
To viewplease visit the journal online (http://dx.doi.org/10.1136/ gutjnl-2014-307118).,OADS,/arxiv_data1/oa_pdf/24/32/gutjnl-2014-307118.PMC4515993.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Kappelman MD, Rifas-Shiman SL, Kleinman K, et al.",Non-OADS,/arxiv_data1/oa_pdf/24/32/gutjnl-2014-307118.PMC4515993.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1A path to bundled payment around a rehospitalization .,Non-OADS,/arxiv_data1/oa_pdf/6a/a4/bmjinnov-2015-000048.PMC4515994.pdf
"See: http://creativecommons.org/licenses/ by-nc/4.0/ To cite Viner RM, Ross D, Hardy R, et al.J Epidemiol Community Health 2015; 69:719–720.Received 26 November 2014 Accepted 21 December 2014Published Online First 2 February 2015 ▸http://dx.doi.org/10.1136/jech-2015-205607 J Epidemiol Community Health 2015; 69:719–720.",Non-OADS,/arxiv_data1/oa_pdf/e7/11/jech-2014-205300.PMC4515995.pdf
To view please visit the journal online(http://dx.doi.org/10.1136/gutjnl-2014-306998).,Non-OADS,/arxiv_data1/oa_pdf/6a/12/gutjnl-2014-306998.PMC4515997.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Rothenberg ME, Hogan SP.",Non-OADS,/arxiv_data1/oa_pdf/6a/12/gutjnl-2014-306998.PMC4515997.pdf
To view please visit the journal online (http://dx.doi.org/10.1136/heartjnl-2015-307516).,Non-OADS,/arxiv_data1/oa_pdf/5f/b4/heartjnl-2015-307516.PMC4515998.pdf
"Nufﬁeld Department of Population Health, British Heart Foundation Centre on Population Approaches forNon-Communicable DiseasePrevention, University of Oxford, Oxford, UK Correspondence to Dr Nick Townsend, Nuf ﬁeld Department of PopulationHealth, British Heart Foundation Centre on Population Approaches forNon-Communicable DiseasePrevention, Old Road Campus, University of Oxford, Oxford OX3 7LF, UK;nicholas.townsend@dph.ox.ac.uk Received 15 January 2015 Revised 17 March 2015Accepted 24 March 2015Published Online First 3 June 2015 ▸http://dx.doi.org/10.1136/ heartjnl-2015-307887 To cite: Bhatnagar P, Wickramasinghe K, Williams J, et al.Heart 2015; 101:1182–1189.ABSTRACT Cardiovascular disease (CVD) presents a signi ﬁcant burden to the UK.",Non-OADS,/arxiv_data1/oa_pdf/5f/b4/heartjnl-2015-307516.PMC4515998.pdf
"http://www.statistics.gov.uk (accessed January 2014); Scotland, National Records of Scotland (2014) Deaths, by sex, age and cause.",Non-OADS,/arxiv_data1/oa_pdf/5f/b4/heartjnl-2015-307516.PMC4515998.pdf
http://www.gro-scotland.,Non-OADS,/arxiv_data1/oa_pdf/5f/b4/heartjnl-2015-307516.PMC4515998.pdf
http://www.hesonline.nhs.uk (accessed January 2014); Informa tion Services Division Scotland (2015) Main diagnosis discharges from hospital 2012/2013.,Non-OADS,/arxiv_data1/oa_pdf/5f/b4/heartjnl-2015-307516.PMC4515998.pdf
http://www.hesonline.nhs.uk (accessed January 2014); Information Services Division Scotland (2015) Main diagnosisdischarges from hospital 2012/2013.,Non-OADS,/arxiv_data1/oa_pdf/5f/b4/heartjnl-2015-307516.PMC4515998.pdf
http://www.infoandstats.wales.nhs.uk (accessed January 2014); Hospital Information Branch (2012).,Non-OADS,/arxiv_data1/oa_pdf/5f/b4/heartjnl-2015-307516.PMC4515998.pdf
Northern Ireland Episode Based Acute Inpatient and Day Case Activity Data (2012/2013)http://www.dhsspsni.gov.uk (accessed January 2014).,OADS,/arxiv_data1/oa_pdf/5f/b4/heartjnl-2015-307516.PMC4515998.pdf
See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 GBD 2013 Mortality and Causes of Death Collaborators.,Non-OADS,/arxiv_data1/oa_pdf/5f/b4/heartjnl-2015-307516.PMC4515998.pdf
To view please visit the journal online(http://dx.doi.org/10.1136/thoraxjnl-2014-206719).,Non-OADS,/arxiv_data1/oa_pdf/47/db/thoraxjnl-2014-206719.PMC4515999.pdf
"Lebrikizumab was well tolerated and noclinically important safety signals were observed.Conclusions These data are consistent with, and extend, previously published results demonstrating the efﬁcacy of lebrikizumab in improving rate of asthma exacerbations and lung function in patients withmoderate-to-severe asthma who remain uncontrolleddespite current standard-of-care treatment.Trial registration numbers The LUTE study was registered under NCT01545440 and the VERSE studyunder NCT01545453 at http://www.clinicaltrials.govINTRODUCTION Asthma is a complex, heterogeneous disease charac- terised by a variable clinical course, severity andresponse to treatment.",Non-OADS,/arxiv_data1/oa_pdf/47/db/thoraxjnl-2014-206719.PMC4515999.pdf
See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 National Heart Lung and Blood Institute.,Non-OADS,/arxiv_data1/oa_pdf/47/db/thoraxjnl-2014-206719.PMC4515999.pdf
2007. http://www.nhlbi.nih.gov/guidelines/asthma/asthsumm.pdf 2 Wenzel SE.,Non-OADS,/arxiv_data1/oa_pdf/47/db/thoraxjnl-2014-206719.PMC4515999.pdf
"2011. http://www.ginasthma.org/ 17 Yuk IH, Nishihara J, Walker D Jr, et al.",OADS,/arxiv_data1/oa_pdf/47/db/thoraxjnl-2014-206719.PMC4515999.pdf
To viewplease visit the journal online(http://dx.doi.org/10.1136/ annrheumdis-2013-204739).,OADS,/arxiv_data1/oa_pdf/e3/f8/annrheumdis-2013-204739.PMC4516000.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Woolf A, P ﬂeger B.",Non-OADS,/arxiv_data1/oa_pdf/e3/f8/annrheumdis-2013-204739.PMC4516000.pdf
"To viewplease visit the journal online (http://dx.doi.org/10.1136/ neurintsurg-2014-011293) 1Department of Neurological Surgery, Stony Brook University Medical Center, Stony Brook, New York, USA 2Semmes-Murphey Clinic, Memphis, Tennessee, USA 3Siemens Medical Imaging, Erlangen, Germany Correspondence to Dr D Fiorella, Department ofNeurological Surgery, Stony Brook University Medical Center, Cerebrovascular Center,Health Sciences CenterT-12 080, Stony Brook, NY 11794-8122, USA; david.",Non-OADS,/arxiv_data1/oa_pdf/53/45/neurintsurg-2014-011293.PMC4516001.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 Struffert T, Deuerling-Zheng Y, Kloska S, et al.",Non-OADS,/arxiv_data1/oa_pdf/53/45/neurintsurg-2014-011293.PMC4516001.pdf
To viewplease visit the journal online(http://dx.doi.org/10.1136/ jnnp-2014-308826).,OADS,/arxiv_data1/oa_pdf/2a/c4/jnnp-2014-308826.PMC4516002.pdf
"W e compared the results Table 2 CMTNS for common mutations CMT subtype (mutation)Mean CMTNS (n) SDMean CMTNS adjusted forage andgender Previous reports CMT1A (PMP22 dup)13.7 (324) 6.5 13.6 13.2 –14.6 (Shy et al ; 4 Pareyson et al5) CMT1X ( GJB1 ) 13 (53) 6.8 15 11 –16, 2nd –3rd decades (Shy et al ;7 Siskind et al30) CMT2A ( MFN2 ) 14.3 (42) 8.7 12.6 21 (Feely et al8) CMT1B ( MPZ ) 13.7 (42) 7.7 13.4 HNPP ( PMP22 ) 4.5 (12) 2.1 The diseases and genes are named according to OMIM (http://www.ncbi.nlm.nih.gov/ Omim/) and HUGO (http://www.genenames.org/), respectively.CMT, Charcot-Marie-Tooth; CMTNS, CMT Neuropathy Score; dup, duplicate; HNPP,hereditary neuropathy with liability to pressure palsy.Table 3 Mean CTMNS for individual sites SiteMean CMTNS/SD (n) CMT1A CMT1B CMT2A CMT1X London 14.7/6.4 (38) 19.8/8.6 (5) 17.5/9.1 (8) 14.1/4.1 (14) Milan 9/6.2 (20) 10.6/6.5 (5) 17 (1) 10.5/8.1 (4)Detroit 13.7/6.9 (135) 12/7.5 (19) 15.4/9.9 (17) 14.6/8.2 (23)Iowa 12.5/5.1 (33) 14/5.6 (3) 16/7.4 (6) 8.8/6.7 (4)All others 14.4/6.1 (93) 15.4/8 (10) 8.5/5.2 (10) 9.9/4.2 (8) CMT, Charcot-Marie-Tooth; CMTNS, CMT Neuropathy Score.Table 1 Frequency of CMT subtypes CMT subtype (mutation) nPatients with genetic diagnosis (n=997; %)Total patients (n=1652; %)Total patients reported in prior studies at WS (n=787; %) and L (n=425; %)10 14 Frequency of common CMT subtypes CMT1A ( PMP22 dup) 614 61.6 37.2 36.9 WS/39.5 L CMT1X ( GJB1 ) 107 10.7 6.5 10.2 WS/10.8 L CMT2A ( MFN2 ) 70 7.0 4.2 2.7 WS/2.8 L CMT1B ( MPZ ) 67 6.7 4.1 5.7 WS/3.1 L HNPP ( PMP22 del) 31 3.1 1.9 6.1 WS/5.7 L Total 889 89.2 53.8 61.5 WS/62.5 L Frequency of rare CMT1 subtypes CMT1C ( LITAF ) 2 0.20 0.12 0.6 WS/0.9 L CMT1D ( EGR2 ) 1 0.10 0.06 0.1 WS CMT1E ( PMP22 ) 17 1.7 1.0 0.6 WS/1.4 L CMT1F ( NEFL ) 4 0.40 0.24 0.5 L Frequency of rare CMT2 subtypes CMT2C ( TRPV4 ) 3 0.30 0.18 0.7 L CMT2D ( GARS ) 2 0.20 0.12 0.4 WS CMT2E ( NEFL ) 7 0.70 0.42 0.5 WS CMT2K ( GDAP1 ) 3 0.30 0.18 0.6 WS Frequency of CMT4 subtypes CMT4A ( GDAP1 ) 6 0.60 0.36 0.1 WS/0.5 L CMT4B1 ( MTMR2 ) 2 0.20 0.12 0.2 L CMT4C ( SH3TC2 ) 14 1.4 0.85 0.4 WS/1.2 L CMT4F ( PRX) 3 0.30 0.18 0.1 WS CMT4H ( FGD4 ) 1 0.10 0.06 CMT4J ( FIG4 ) 4 0.40 0.24 0.3 WS AR CMT2A ( LMNA ) 2 0.2 0.12 Frequency of HMN subtypes HMN2B ( HSPB1 ) 7 0.70 0.42 0.5 L HMN2A ( HSPB8 ) 1 0.10 0.06 HMN5A ( BSCL2 ) 5 0.50 0.30 0.2 L Frequency of HSN subtypes HSN1 ( SPTLC1 ) 24 2.4 1.5 The diseases and genes are named according to OMIM (http://www.ncbi.nlm.nih.gov/Omim/) and HUGO (http://www.genenames.org/), respectively.",Non-OADS,/arxiv_data1/oa_pdf/2a/c4/jnnp-2014-308826.PMC4516002.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Skre H. Genetic and clinical aspects of Charcot-Marie-Tooth ’s disease.,Non-OADS,/arxiv_data1/oa_pdf/2a/c4/jnnp-2014-308826.PMC4516002.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Amundson R. Disability, ideology, and quality of life: bias in biomedical ethics.",Non-OADS,/arxiv_data1/oa_pdf/e5/4c/medethics-2014-102127.PMC4516004.pdf
To viewplease visit the journal online (http://dx.doi.org/10.1136/ jnnp-2014-307897).,OADS,/arxiv_data1/oa_pdf/db/35/jnnp-2014-307897.PMC4516005.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Hop JW, Rinkel GJ, Algra A, et al.",Non-OADS,/arxiv_data1/oa_pdf/db/35/jnnp-2014-307897.PMC4516005.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Melli M, Brown PR.",Non-OADS,/arxiv_data1/oa_pdf/36/1e/jech-2014-205058.PMC4516006.pdf
http://www.fhi.se/en/Publications/Summaries/Survey-of-mental-health-among- children-and-adolescents.,Non-OADS,/arxiv_data1/oa_pdf/36/1e/jech-2014-205058.PMC4516006.pdf
"Secondary Survey of mental health among school children, 2011. http://www.fhi.se/en/Publications/Summaries/Survey-of-mental-health-among-children-and-adolescents 35 Hagquist C. Psychometric properties of the PsychoSomatic Problems scale: a Rasch analysis on adolescent data.",Non-OADS,/arxiv_data1/oa_pdf/36/1e/jech-2014-205058.PMC4516006.pdf
"To viewplease visit the journal online (http://dx.doi.org/10.1136/ ejhpharm-2015-000664) 1Pharmacy Department, Chelsea and Westminster Hospital NHS Foundation Trust, London, UK 2National Institute of Health Research (NIHR) Collaboration for Leadership in Applied Health Research and CareNorthwest London (CLAHRCNWL), London, UK 3Department of Pharmacy, King ’s College London, London, UK 4Department of Medicine for the Elderly, Chelsea and Westminster Hospital NHSFoundation Trust, London, UK 5Pharmacy Department, London North West Healthcare NHS Trust (Northwick ParkHospital), London, UK Correspondence to Dr Alan J Poots, National Institute of Health Research (NIHR) Collaboration forLeadership in Applied HealthResearch and Care Northwest London (CLAHRC NWL), London SW10 9NH, UK;a.poots@imperial.ac.uk Received 12 February 2015 Revised 8 April 2015 Accepted 30 April 2015Published Online First3 June 2015 To cite: Jubraj B, Marvin V, Poots AJ, et al.Eur J Hosp Pharm 2015; 22:243 –248.ABSTRACT Objectives Our aim was to explore junior doctors ’ attitudes and awareness around concepts related tomedication review, in order to ﬁnd ways to change the culture for reviewing, altering and stopping inappropriateor unnecessary medicines.",Non-OADS,/arxiv_data1/oa_pdf/a3/1e/ejhpharm-2015-000664.PMC4516007.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Department of Health Publications, Policy and Guidance.",Non-OADS,/arxiv_data1/oa_pdf/a3/1e/ejhpharm-2015-000664.PMC4516007.pdf
To view please visit the journal online (http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/c9/48/jnnp-2014-309460.PMC4516009.pdf
"See: http://creativecommons.org/licenses/ by-nc/4.0/ To cite De Pablo-Fernandez E, Doherty K M, Holton JL, et al.J Neurol Neurosurg Psychiatry 2015; 86:934–936.",Non-OADS,/arxiv_data1/oa_pdf/c9/48/jnnp-2014-309460.PMC4516009.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5f/74/main.PMC4516028.pdf
2352-345X http://dx.doi.org/10.1016/j.jcmgh.2015.06.003July 2015 Editorial 349,Non-OADS,/arxiv_data1/oa_pdf/5f/74/main.PMC4516028.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/88/69/cia-10-1201.PMC4516029.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2015:10 1201–1212Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  1201OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S8745 6A stewardship intervention program for safe  medication management and use of antidiabetic  drugs rui-yi Zhao1 Xiao-wen he1 Yan-min shan1 ling-ling Zhu2 Quan Zhou3 1Clinical nurse specialist section,   Division of nursing, 2geriatric VIP  Care Ward, Division of nursing,   3Department of Pharmacy, second  Affiliated hospital, school of  Medicine, Zhejiang University,   hangzhou, Zhejiang Province, People’s  republic of ChinaBackground:  Diabetes patients are complex due to considerations of polypharmacy,  multimorbidities, medication adherence, dietary habits, health literacy, socioeconomic status,  and cultural factors.",Non-OADS,/arxiv_data1/oa_pdf/88/69/cia-10-1201.PMC4516029.pdf
"Keywords:  diabetes nursing specialists, injection technique, insulin, medication errors, oral  hypoglycemic agents, pharmacy, quality improvements Introduction Diabetes patients are usually complex due to consideration of polypharmacy,  multimorbidities, medication adherence, dietary habits, health literacy, socioeconomic Correspondence: Quan Zhou Department of Pharmacy, second  Affiliated Hospital, School of Medicine,  Zhejiang University, hangzhou 310009,  Zhejiang Province, People’s republic  of China Tel +86 571 8778 4615 Fax +86 571 8702 2776 email zhouquan142602@zju.edu.c n Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Zhao et al Running head recto: Safe medication management and use of antidiabetic drugs DOI: http://dx.doi.org/10.2147/CIA.S87456",Non-OADS,/arxiv_data1/oa_pdf/88/69/cia-10-1201.PMC4516029.pdf
Available from: http://www.ismp.org/Tools/highAlertMedicationLists.,OADS,/arxiv_data1/oa_pdf/88/69/cia-10-1201.PMC4516029.pdf
Available from: http://www.jointcommissioninternational.,Non-OADS,/arxiv_data1/oa_pdf/88/69/cia-10-1201.PMC4516029.pdf
Available from:  http://www.diab.net.cn/guideline.js p11.,Non-OADS,/arxiv_data1/oa_pdf/88/69/cia-10-1201.PMC4516029.pdf
Available from:  http://diab.net.cn/uploadfile/zhusheguideline.pd f 30.,Non-OADS,/arxiv_data1/oa_pdf/88/69/cia-10-1201.PMC4516029.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/88/69/cia-10-1201.PMC4516029.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/88/69/cia-10-1201.PMC4516029.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ff/63/ceg-8-205.PMC4516030.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinical and Experimental Gastroenterology 2015:8 205–213Clinical and Experimental Gastroenterology Dove press submit your manuscript | www.dovepress.co m Dove press  205OriG inal rEsEarChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CEG.S8192 2impact of switching from mycophenolate mofetil  to enteric-coated mycophenolate sodium on  gastrointestinal side effects in patients with  autoimmune disease: a Phase iii, open-label,   single-arm, multicenter study Bernhard Manger1 Falk hiepe2 Matthias schneider3 Margitta Worm4 Peter Wimmer5 Eva-Maria Paulus5 andreas schwarting6 1University hospital Erlangen,   Med Clinic iii Polyclinic, Erlangen,   2rheumatology, University hospital  Charité, Campus Mitte, Berlin,  3Policlinic of rheumatology, heinrich- heine-Universität, Düsseldorf,   4Department of Dermatology,   Venereology and allergology,   University hospital Charité, Campus  Mitte, Berlin, 5novartis Pharma  Gmbh, nürnberg, 6Department  of internal Medicine, Johannes  Gutenberg University, Mainz, Germany Correspondence: Bernhard Manger   Department of Medicine  3, University  of Erlangen-nuremberg, Ulmenweg  18,  D-91054 Erlangen, Germany   Tel +49 9131 853 2075   Fax +49 9131 853 2078   Email bernhard.manger@uk-erlangen.d eBackground:  The purpose of this study was to assess changes in gastrointestinal symptom  severity in patients with autoimmune disease who were switched from mycophenolate mofetil  to enteric-coated mycophenolate sodium (EC-MPS).",Non-OADS,/arxiv_data1/oa_pdf/ff/63/ceg-8-205.PMC4516030.pdf
"Available from: http://www.ema.europa.eu/docs/en_GB/ document_library /EPAR_-_Public_assessment_report/human/002015/ WC500110152.pd f. Accessed July  22, 2014.",Non-OADS,/arxiv_data1/oa_pdf/ff/63/ceg-8-205.PMC4516030.pdf
"Clinical and Experimental Gastroenterology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-and-experimental-gastroenterology-journa lClinical and Experimental Gastroenterology is an international, peer- reviewed, open access journal, publishing all aspects of gastroenterology  in the clinic and laboratory, including: Pathology, pathophysiology  of gastrointestinal disease; Investigation and treatment of gastointes - tinal disease; Pharmacology of drugs used in the alimentary tract; Immunology/genetics/genomics related to gastrointestinal disease.",Non-OADS,/arxiv_data1/oa_pdf/ff/63/ceg-8-205.PMC4516030.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ff/63/ceg-8-205.PMC4516030.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/9f/dd/ceor-7-397.PMC4516031.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinicoEconomics and Outcomes Research 2015:7 397–407ClinicoEconomics and Outcomes Research Dove press submit your manuscript | www.dovepress.co m Dove press  397ORiginal REsEaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CEOR.S7870 4Retrospective analysis of drug utilization, health  care resource use, and costs associated with   iFn therapy for adjuvant treatment of   malignant melanoma Ying Zhang1 Trong Kim le1 James W shaw2 srividya Kotapati3 1Center for Observational Research  and Data sciences, Worldwide health  Economics and Outcomes Research,   Bristol-Myers squibb Research and  Development, hopewell, nJ, Usa;   2Worldwide health Economics and  Outcomes Research, Bristol-Myers  squibb Research and Development,   Princeton, nJ, Usa;  3Worldwide  health Economics and Outcomes  Research, Bristol-Myers squibb  Research and Development,   Wallingford Center, CT, Usa Correspondence: srividya Kotapati   Worldwide health Economics and  Outcomes Research, Bristol-Myers  squibb Research and Development,   5 Research Parkway, Wallingford,   CT 06492, Usa   Tel +1 203 677 5037  Fax +1 203 677 5797  Email s rividya.",Non-OADS,/arxiv_data1/oa_pdf/9f/dd/ceor-7-397.PMC4516031.pdf
"Available from: http://www.nccn.org/ professionals/physician_gls/pdf/melanoma.pd f. Accessed October  30,  2014.",Non-OADS,/arxiv_data1/oa_pdf/9f/dd/ceor-7-397.PMC4516031.pdf
Available from: http://www.bls.gov/cpi /.,Non-OADS,/arxiv_data1/oa_pdf/9f/dd/ceor-7-397.PMC4516031.pdf
"ClinicoEconomics and Outcomes Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinicoeconomics-and-outcomes-research-journa lClinicoEconomics & Outcomes Research is an international, peer- reviewed open-access journal focusing on Health Technology Assess - ment, Pharmacoeconomics and Outcomes Research in the areas of  diagnosis, medical devices, and clinical, surgical and pharmacological  intervention.",Non-OADS,/arxiv_data1/oa_pdf/9f/dd/ceor-7-397.PMC4516031.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/9f/dd/ceor-7-397.PMC4516031.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ce/de/bctt-7-193.PMC4516032.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pBreast Cancer: Targets and Therapy 2015:7 193–209Breast Cancer: Targets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  193Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/BCTT .S5170 2Optical imaging for breast cancer prescreening Anuradha Godavarty1 Suset Rodriguez1 Y oung-Jin Jung2 Stephanie Gonzalez1 1Optical imaging Laboratory,   Department of Biomedical  engineering, Florida international  University, Miami, FL, USA;   2Department of Radiological Science,   Dongseo University, Busan, South  Korea Correspondence: Anuradha Godavarty   Optical imaging Laboratory, Department  of Biomedical engineering, Florida  international University,  10555 west  Flagler Street, eC  3365, Miami,   FL 33174, USA   Tel +1 305 348 7340  Fax +1 305 348 6954  email godavart@fiu.ed uAbstract:  Breast cancer prescreening is carried out prior to the gold standard screening using  X-ray mammography and/or ultrasound.",Non-OADS,/arxiv_data1/oa_pdf/ce/de/bctt-7-193.PMC4516032.pdf
Available from: http://cancer.gov/cancertopics/ pdq/treatment/breast/Patien t. Accessed Nov  2014.,Non-OADS,/arxiv_data1/oa_pdf/ce/de/bctt-7-193.PMC4516032.pdf
"Available from:  http://www.cancer.gov/cancertopics/factsheet/Therapy/adjuvant-breas t.  Accessed November  3, 2014.",Non-OADS,/arxiv_data1/oa_pdf/ce/de/bctt-7-193.PMC4516032.pdf
"Available from: http://www.cancer.org/cancer/breastcancer/ detailedguide/breast-cancer-diagnosi s. Accessed November  2, 2014.",Non-OADS,/arxiv_data1/oa_pdf/ce/de/bctt-7-193.PMC4516032.pdf
"Breast Cancer: Targets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/breast-cancer---targets-and-therapy-journa lBreast Cancer: Targets and Therapy is an international, peer-   reviewed open access journal focusing on breast cancer research,  identification of therapeutic targets and the optimal use of preven - tative and integrated treatment interventions to achieve improved  outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/ce/de/bctt-7-193.PMC4516032.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/08/08/cia-10-1189.PMC4516033.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2015:10 1189–1200Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  1189RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S8186 8On the utility of within-participant research  design when working with patients with  neurocognitive disorders Hanna Steinunn  Steingrimsdottir erik Arntzen Department of Behavioral Science,   Oslo and Akershus University College,   Oslo, NorwayAbstract:  Within-participant research designs are frequently used within the field of behavior  analysis to document changes in behavior before, during, and after treatment.",Non-OADS,/arxiv_data1/oa_pdf/08/08/cia-10-1189.PMC4516033.pdf
"Division 12  of the American Psychological Association has, for instance, published standards for Correspondence: Hanna Steinunn  Steingrimsdottir; erik Arntzen Department of Behavioral Science,  Oslo and Akershus University College,  PO Box 4 St Olavs Plass, 0130 Oslo,  Norway email hannasteinunn@simnet.i s;   erik.arntzen@equivalence.ne tJournal name: Clinical Interventions in Aging Article Designation: Review Y ear: 2015 Volume: 10 Running head verso: Steingrimsdottir and Arntzen Running head recto: Within-participant research design and NCD DOI: http://dx.doi.org/10.2147/CIA.S81868",Non-OADS,/arxiv_data1/oa_pdf/08/08/cia-10-1189.PMC4516033.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/08/08/cia-10-1189.PMC4516033.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/08/08/cia-10-1189.PMC4516033.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c7/08/ceor-7-409.PMC4516034.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinicoEconomics and Outcomes Research 2015:7 409–421ClinicoEconomics and Outcomes Research Dove press submit your manuscript | www.dovepress.co m Dove press  409ORiginal REsEaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CEOR.S8636 9health and economic outcomes associated with  uncontrolled surgical bleeding: a retrospective  analysis of the Premier Perspectives Database Mitra Corral1 nicole Ferko2 sarah hollmann2 Michael s Broder3 Eunice Chang3 1Ethicon Biosurgery, somerville, nJ,   Usa; 2Cornerstone Research group,   Burlington, On , Canada; 3Partnership  for health analytic Research, Beverly  hills, C a, Usa Correspondence: nicole Ferko   Cornerstone Research group, suite 204,  3228 south service Road, Burlington,   On l7n3h8, Canada   Tel +1 905 637 6231 (ext 236)   Fax +1 905 637 5014   Email nferko@cornerstone-research.co mBackground:  Bleeding remains a common occurrence in surgery.",Non-OADS,/arxiv_data1/oa_pdf/c7/08/ceor-7-409.PMC4516034.pdf
"ClinicoEconomics and Outcomes Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinicoeconomics-and-outcomes-research-journa lClinicoEconomics & Outcomes Research is an international, peer- reviewed open-access journal focusing on Health Technology Assess - ment, Pharmacoeconomics and Outcomes Research in the areas of  diagnosis, medical devices, and clinical, surgical and pharmacological  intervention.",Non-OADS,/arxiv_data1/oa_pdf/c7/08/ceor-7-409.PMC4516034.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/c7/08/ceor-7-409.PMC4516034.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1f/9c/mdv110.PMC4516045.pdf
"Notably, RNA-seq analysis revealed that only 12 of the 23 predicted SNVs were expressed and of the 4 previ-ously reported in cancers (COSMIC, http://cancer.sanger.ac.uk/ cosmic ), only ABL1 (C>T, p.T315I) and ABL1 (T>G, p.F359V) were expressed (Table 1).",OADS,/arxiv_data1/oa_pdf/1f/9c/mdv110.PMC4516045.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/05/fd/mdv133.PMC4516046.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/64/dc/mdv155.PMC4516048.pdf
"CASE REPORT  Esophageal lichen planus* Janine Pichler de Oliveira1 Natalia Caballero Uribe1 Luna Azulay Abula ﬁ a1,2 Leonardo Pereira Quintella1,3  DOI: http://dx.doi.org/10.1590/abd1806-4841.20153255   Abstract:    Lichen planus is a chronic in ﬂ ammatory disease that affects the skin, mucous membranes, nails and  scalp.",Non-OADS,/arxiv_data1/oa_pdf/b3/24/abd-90-03-0394.PMC4516088.pdf
©2015 by Anais Brasileiros de Dermatologia DOI: http://dx.doi.org/10.1590/abd1806-4841.20153298   Abstract:    Genital molluscum contagiosum is rare in children.,Non-OADS,/arxiv_data1/oa_pdf/19/11/abd-90-03-0403.PMC4516089.pdf
"©2015 by Anais Brasileiros de Dermatologia DOI: http://dx.doi.org/10.1590/abd1806-4841.20153446   Abstract:    BACKGROUND : Basal cell carcinoma is the most frequent cancer in fair-skinned populations and dermos- copy is an important, non-invasive technique that aids in the diagnosis of Basal cell carcinoma.",Non-OADS,/arxiv_data1/oa_pdf/20/7b/abd-90-03-0351.PMC4516090.pdf
"LETTERS Fabiane Mulinari-Brenner1 Luiz Eduardo Fabricio de Melo Garbers2 Carla Cristina Marques1 Patrícia Kiyori Watanabe1Comments on the article: “Update on therapy for super ﬁ cial  mycoses: review article part I”*  DOI: http://dx.doi.org/10.1590/abd1806-4841.20154003    ▲  Received on 06.09.2014 Approved by the Advisory Board and accepted for publication on 10.09.2014 *  Study conducted at the  Universidade Federal do Paraná  (UFPR) – Curitiba (PR), Brazil.",Non-OADS,/arxiv_data1/oa_pdf/3b/2b/abd-90-03-0436.PMC4516091.pdf
DERMATOPATHOLOGY  Histopathological analysis of the therapeutic response to  cryotherapy with liquid nitrogen in patients with multiple  actinic keratosis* Marina Câmara de Oliveira1 Flávia Trevisan1 Clovis Antônio Lopes Pinto1 Célia Antônia Xavier1 Jaqueline Campoi Calvo Lopes Pinto1  DOI: http://dx.doi.org/10.1590/abd1806-4841.20153302   Abstract:    Actinic keratoses are premalignant lesions of the skin caused by excessive sun exposure.,Non-OADS,/arxiv_data1/oa_pdf/17/4e/abd-90-03-0384.PMC4516092.pdf
Disponível em: http://www.euroderm.org/images/stories/guidelines/guideline_Management_Actinic_Keratoses-update2011.pdf.,Non-OADS,/arxiv_data1/oa_pdf/17/4e/abd-90-03-0384.PMC4516092.pdf
"INVESTIGATION  Translation, cross-cultural adaptation and validation of the  vitiligo-speci ﬁ c health-related quality of life instrument  (VitiQoL) into Brazilian Portuguese* Juliana Catucci Boza1 Roopal V Kundu2 Amanda Fabbrin1 Roberta Horn1 Natalia Giongo1 Tania Ferreira Cestari1  DOI: http://dx.doi.org/10.1590/abd1806-4841.20153684   Abstract:    BACKGROUND : Vitiligo, although asymptomatic, highly compromises patients´ quality of life (QoL).",Non-OADS,/arxiv_data1/oa_pdf/57/70/abd-90-03-0358.PMC4516093.pdf
©2015 by Anais Brasileiros de Dermatologia DOI: http://dx.doi.org/10.1590/abd1806-4841.20153704   Abstract:    BACKGROUND : Lichen planus is considered to be the most common dermatological disease involving the  oral mucosa.,Non-OADS,/arxiv_data1/oa_pdf/b3/6c/abd-90-03-0321.PMC4516094.pdf
"LETTERS Viroj Wiwanitkit1American cutaneous leishmaniasis in Brazil*  DOI: http://dx.doi.org/10.1590/abd1806-4841.20154006    ▲  Received on 07.09.2014 Approved by the Advisory Board and accepted for publication on 10.09.2014 * Study conducted at the Surin Rajabhat University – Surin, Thailand.",Non-OADS,/arxiv_data1/oa_pdf/56/82/abd-90-03-0441.PMC4516095.pdf
©2015 by Anais Brasileiros de Dermatologia DOI: http://dx.doi.org/10.1590/abd1806-4841.20154003r  LETTERS ▲438  An Bras Dermatol.,Non-OADS,/arxiv_data1/oa_pdf/59/ce/abd-90-03-0438.PMC4516096.pdf
"IMAGES  IN TROPICAL  DERMATOLOGY  Tuberculoid leprosy presenting as a “racket” lesion* Letícia Stella Gardini Brandão1 Gabriela Franco Marques1 Jaison Antônio Barreto1 Ana Paula Cota Pinto Coelho1 Ana Paula de Paiva Serrano1  DOI: http://dx.doi.org/10.1590/abd1806-4841.20153401   Abstract:    The “racket” lesion is a rare presentation of tuberculoid leprosy, which consists of a thickened nerve  branch emerging from a tuberculoid plaque.",Non-OADS,/arxiv_data1/oa_pdf/a5/a3/abd-90-03-0420.PMC4516097.pdf
"©2015 by Anais Brasileiros de Dermatologia DOI: http://dx.doi.org/10.1590/abd1806-4841.20153395   Abstract:  The Iso-Kikuchi Syndrome is a rare condition characterized by nail dysplasia involving the index ﬁ n- gers, including micronychia, polyonychia, anonychia, irregular lunula, malalignment and hemionychogryphosis.",Non-OADS,/arxiv_data1/oa_pdf/9a/2c/abd-90-03-0423.PMC4516098.pdf
"©2015 by Anais Brasileiros de Dermatologia DOI: http://dx.doi.org/10.1590/abd1806-4841.20153645   Abstract:    BACKGROUND : Currently, the cosmetic industry is overwhelmed in keeping up with the safety assessment  of the increasing number of new products entering the market.",Non-OADS,/arxiv_data1/oa_pdf/ed/be/abd-90-03-0347.PMC4516099.pdf
COMMUNICATION Serum levels of 25-hydroxy vitamin D in psoriatic patients* Manuela Ferrasso Zuchi1 Paula de Oliveira Azevedo1 Anber Ancel Tanaka1 Juliano Vilaverde Schmitt2 Luis Eduardo Agner Machado Martins1  DOI: http://dx.doi.org/10.1590/abd1806-4841.20153524   Abstract:  Studies have shown a relationship between vitamin D and psoriasis.,Non-OADS,/arxiv_data1/oa_pdf/e9/23/abd-90-03-0430.PMC4516100.pdf
©2015 by Anais Brasileiros de Dermatologia DOI: http://dx.doi.org/10.1590/abd1806-4841.20153248   Abstract:    BACKGROUND : Melanoma inhibitory activity is a protein secreted by melanoma cells and has been used as  a tumor marker.,Non-OADS,/arxiv_data1/oa_pdf/15/58/abd-90-03-0327.PMC4516101.pdf
Available from: http://www.nccn.org/professionals/physician_gls/f_guidelines.asp.,Non-OADS,/arxiv_data1/oa_pdf/15/58/abd-90-03-0327.PMC4516101.pdf
Available from: http://www.esmo.org/Guidelines-Practice/Clinical-Practice-Guidelines/Melanoma 7.,Non-OADS,/arxiv_data1/oa_pdf/15/58/abd-90-03-0327.PMC4516101.pdf
Available from: http://www.aad.org/File%20Library/Global%20navigation/Education%20and%20quality%20care/guideline-treatment-of-cutaneous-melanoma.pdf.,Non-OADS,/arxiv_data1/oa_pdf/15/58/abd-90-03-0327.PMC4516101.pdf
Available from: http://www.guideline.gov/content.aspx?id=24161.,Non-OADS,/arxiv_data1/oa_pdf/15/58/abd-90-03-0327.PMC4516101.pdf
Available from: https://www.nhmrc.gov.au/_files_nhmrc/publications/attachments/cp111.pdf.,Non-OADS,/arxiv_data1/oa_pdf/15/58/abd-90-03-0327.PMC4516101.pdf
"©2015 by Anais Brasileiros de Dermatologia DOI: http://dx.doi.org/10.1590/abd1806-4841.20153263   Abstract:    Besides being an uncommon clinicopathological entity, interstitial granulomatous dermatitis, also de- scribed as interstitial granulomatous dermatitis with arthritis (IGDA), has shown a wide spectrum of clinical manifestations, such as linear and erythematous lesions, papules, plaques and nodules.",Non-OADS,/arxiv_data1/oa_pdf/ad/62/abd-90-03-0391.PMC4516102.pdf
"©2015 by Anais Brasileiros de Dermatologia DOI: http://dx.doi.org/10.1590/abd1806-4841.20153304   Abstract:    Although basal cell carcinoma can be effectively managed through surgical excision, the most suitable  surgical margins have not yet been fully determined.",Non-OADS,/arxiv_data1/oa_pdf/0c/1a/abd-90-03-0377.PMC4516103.pdf
"©2015 by Anais Brasileiros de Dermatologia DOI: http://dx.doi.org/10.1590/abd1806-4841.20153774   Abstract:  In vivo Confocal Microscopy is a method for non-invasive, real-time visualization of microscopic struc- tures and cellular details of the epidermis and dermis, which has a degree of resolution similar to that obtained with histology.",Non-OADS,/arxiv_data1/oa_pdf/39/57/abd-90-03-0411.PMC4516104.pdf
"CONTINUING  MEDICAL  EDUCATION Solar ultraviolet radiation: properties, characteristics and  amounts observed in Brazil and South America* Marcelo de Paula Corrêa1  DOI: http://dx.doi.org/10.1590/abd1806-4841.20154089   Abstract:   The bene ﬁ cial and harmful effects of human exposure to solar ultraviolet radiation (UV-R) are topics  that arouse great interest not only among physicians and scientists, but also the general public and the media.",Non-OADS,/arxiv_data1/oa_pdf/be/df/abd-90-03-0297.PMC4516105.pdf
"In ﬁ gure 6(b), regarding summer sol- stice, therefore the longest day in the year, when the Sun passes closer to zenith, the   FIGURE  6: Numerical UVI simulation at solar noon, for clear sky conditions (no clouds)A) Winter solstice B) Summer solstice Source: Division of Satellites and Environmental Systems - CPTEC/INPE (http://satelite.cptec.inpe.br) RevistaABD3Vol90ingles.indd   305 RevistaABD3Vol90ingles.indd   305 22/05/15   12:02 22/05/15   12:02",Non-OADS,/arxiv_data1/oa_pdf/be/df/abd-90-03-0297.PMC4516105.pdf
Disponível em: http://www.inca.gov.br/estimativa/2014/ 8.,Non-OADS,/arxiv_data1/oa_pdf/be/df/abd-90-03-0297.PMC4516105.pdf
Available from: http://www.who.int/uv/publications/en/UVIGuide.pdf 15.,Non-OADS,/arxiv_data1/oa_pdf/be/df/abd-90-03-0297.PMC4516105.pdf
"INVESTIGATION  Distribution pattern of psoriasis, anxiety and depression as  possible causes of sexual dysfunction in patients with  moderate to severe psoriasis* Alejandro Molina-Leyva1,2 Ana Almodovar-Real1 Jose Carlos-Ruiz Carrascosa1 Ignacio Molina-Leyva1 Ramon Naranjo-Sintes1 Jose Juan Jimenez-Moleon3  DOI: http://dx.doi.org/10.1590/abd1806-4841.20153254   Abstract:    BACKGROUND : Psoriasis may signi ﬁ cantly impair sexual function.",Non-OADS,/arxiv_data1/oa_pdf/9b/42/abd-90-03-0338.PMC4516106.pdf
"LETTERS Cleft-like appearance of accessory nipple  in digital microscopy* Engin Senel1   DOI: http://dx.doi.org/10.1590/abd1806-4841.20153917    ▲  Received on 07.08.2014 Approved by the Advisory Board and accepted for publication on 02.10.2014 *  Study conducted at the Hitit University, Faculty of  Medicine, Department of  Dermatology – Çorum, Turkey.",Non-OADS,/arxiv_data1/oa_pdf/d1/54/abd-90-03-0434.PMC4516107.pdf
2015;90(3):314-9.INVESTIGATION  Nail involvement in adult patients with plaque-type  psoriasis: prevalence and clinical features * Karen Regina Rosso Schons1 André Avelino Costa Beber2 Maristela de Oliveira Beck2 Odirlei André Monticielo3  DOI: http://dx.doi.org/10.1590/abd1806-4841.20153736   Abstract:    BACKGROUND : Psoriasis is a disease of worldwide distribution with a prevalence of 1 to 3%.,Non-OADS,/arxiv_data1/oa_pdf/d8/1a/abd-90-03-0314.PMC4516108.pdf
"©2015 by Anais Brasileiros de Dermatologia DOI: http://dx.doi.org/10.1590/abd1806-4841.20153113   Abstract:    Psoriasis is a chronic in ﬂ ammatory disease that affects primarily the skin and joints, with a worldwide  incidence of 2-3%.",Non-OADS,/arxiv_data1/oa_pdf/35/b9/abd-90-03-0367.PMC4516109.pdf
"©2015 by Anais Brasileiros de Dermatologia DOI: http://dx.doi.org/10.1590/abd1806-4841.20153059   Abstract:    Brachioradial pruritus is a chronic sensory neuropathy of unknown etiology which affects the skin of  the shoulders, arms and forearms on the insertion of the brachioradialis muscle.",Non-OADS,/arxiv_data1/oa_pdf/e9/f2/abd-90-03-0401.PMC4516110.pdf
"IMAGES  IN DERMATOLOGY  Phenotypic spectrum of a patient with Gorlin’s syndrome  and role of dermoscopy in the early detection of  basal cell carcinomas* Catarina Moreira1,2 Paulo Morais3 Paulo Santos1 Miguel Castro1 Filomena Azevedo1  DOI: http://dx.doi.org/10.1590/abd1806-4841.20153676   Abstract:    Gorlin’s syndrome is an autosomal dominant disorder, mainly characterized by the presence of mul- tiple and early-onset basal cell carcinomas, odontogenic keratocysts and palmoplantar pits.",Non-OADS,/arxiv_data1/oa_pdf/3f/e6/abd-90-03-0416.PMC4516111.pdf
"426COMMUNICATION Evaluation of the therapeutic results of actinic keratosis  treated with topical 5% ﬂ uorouracil by re ﬂ ectance confocal  laser microscopy: preliminary study* Priscila Ishioka1,2 Marcus Maia2 Sarita Bartholomei Rodrigues2 Alessandra Cristina Marta2 Sérgio Henrique Hirata1   DOI: http://dx.doi.org/10.1590/abd1806-4841.20153437   Abstract:    Topical treatment for actinic keratosis with 5% ﬂ uorouracil has a recurrence rate of 54% in 12 months  of follow-up.",Non-OADS,/arxiv_data1/oa_pdf/22/da/abd-90-03-0426.PMC4516112.pdf
Available from: http://www.euroderm.org/index.php/edf-guidelines 6.,Non-OADS,/arxiv_data1/oa_pdf/22/da/abd-90-03-0426.PMC4516112.pdf
"©2015 by Anais Brasileiros de Dermatologia DOI: http://dx.doi.org/10.1590/abd1806-4841.20153945   Abstract:    Brazilian physician and researcher Henrique da Rocha Lima was born in 1879 in the city of Rio de Ja- neiro, where he studied medicine and obtained the degree of M.D.",Non-OADS,/arxiv_data1/oa_pdf/80/3e/abd-90-03-0363.PMC4516114.pdf
Disponível em: https://www.agencia.fiocruz.br/a-trajet%C3%B3ria-de-henrique-da-rocha-lima-e-as-rela%C3%A7%C3%B5es-teuto-brasileiras 5.,Non-OADS,/arxiv_data1/oa_pdf/80/3e/abd-90-03-0363.PMC4516114.pdf
"INVESTIGATION  Onychomycosis due to opportunistic molds* Erick Obed Martínez-Herrera1 Stefanie Arroyo-Camarena2 Diana Luz Tejada-García3 Carlos Francisco Porras-López1 Roberto Arenas2  DOI: http://dx.doi.org/10.1590/abd1806-4841.20153521   Abstract:    BACKGROUND : Onychomycosis are caused by dermatophytes and Candida, but rarely by non- dermato- phyte molds.",Non-OADS,/arxiv_data1/oa_pdf/94/55/abd-90-03-0334.PMC4516115.pdf
"©2015 by Anais Brasileiros de Dermatologia DOI: http://dx.doi.org/10.1590/abd1806-4841.20153283   Abstract:    Milker’s nodule is an occupational viral skin disease of universal distribution, caused by the Paravac- cinia virus and that occurs in individuals who deal with dairy cattle herds.",Non-OADS,/arxiv_data1/oa_pdf/a4/66/abd-90-03-0407.PMC4516116.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8f/f9/main.PMC4516138.pdf
Direct link to deposited data http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE67041 .,OADS,/arxiv_data1/oa_pdf/8f/f9/main.PMC4516138.pdf
"Speci ﬁcations [standardized info for the reader ] Where applicable, please follow the Ontology for Biomedical Investigations: http://obi-ontology.org/page/Main_Page .",Non-OADS,/arxiv_data1/oa_pdf/8f/f9/main.PMC4516138.pdf
Organism/cell line/tissue Human /MCF7 cells (ATCC ) Sex N/A Sequencer or array type Illumina MiSeq Data format Raw fastq and processed bedgraph ﬁles Experimental factors N/A Experimental features ChIPseq and short-capped RNA analysis of Pol II pausing Consent N/A Sample source location N/A http://dx.doi.org/10.1016/j.gdata.2015.06.021 2213-5960/© 2015 The Authors.,OADS,/arxiv_data1/oa_pdf/8f/f9/main.PMC4516138.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8f/f9/main.PMC4516138.pdf
Contents lists available at ScienceDirect Genomics Data journal homepage: http://www.journa ls.elsevier.com/genomics-data/,Non-OADS,/arxiv_data1/oa_pdf/8f/f9/main.PMC4516138.pdf
All buffers are from http://genome.ucsc.edu/ENCODE/protocols/ general/UTA_ChIPseq_protocol.pdf .,OADS,/arxiv_data1/oa_pdf/8f/f9/main.PMC4516138.pdf
Versions of all software used in this analysis are available for down- load here: https://github.com/kzarns/ChIP-Seq/tree/master/tools .,OADS,/arxiv_data1/oa_pdf/8f/f9/main.PMC4516138.pdf
"43 (2015) 3938 –3949, http://dx.doi.org/10.1093/nar/ gkv263 .",Non-OADS,/arxiv_data1/oa_pdf/8f/f9/main.PMC4516138.pdf
"Science 327 (2010) 335 –338, http://dx.doi.org/10.1126/science.",Non-OADS,/arxiv_data1/oa_pdf/8f/f9/main.PMC4516138.pdf
"12(2002) 656 –664, http://dx.doi.org/10.1101/gr.229202 Article published online before March 2002.",Non-OADS,/arxiv_data1/oa_pdf/8f/f9/main.PMC4516138.pdf
"10 (2009) R25, http://dx.doi.org/10.1186/gb-2009-10-3-r25 .",Non-OADS,/arxiv_data1/oa_pdf/8f/f9/main.PMC4516138.pdf
"http://www.R-project.org [6] Gregory R. Warnes, B.B., Lodewijk Bonebakker, Robert Gentleman, Wolfgang Huber Andy Liaw, Thomas Lumley, Martin Maechler, Arni Magnusson, Steffen Moeller, Marc Schwartz and Bill Venables (2015) gplots: Various R Programming Tools for Plotting Data.",Non-OADS,/arxiv_data1/oa_pdf/8f/f9/main.PMC4516138.pdf
"R package version 2.16.0. http://CRAN.R-project.org/package=gplots [7] E. Neuwirth, RColorBrewer: ColorBrewer palettes.",Non-OADS,/arxiv_data1/oa_pdf/8f/f9/main.PMC4516138.pdf
"R package version 1.0 –1.5, 2011 http://CRAN.R-project.org/package=RColorBrewer .",Non-OADS,/arxiv_data1/oa_pdf/8f/f9/main.PMC4516138.pdf
"R package version 1, 2012 http://cran.r-project.org/web/packages/reshape2/index.",Non-OADS,/arxiv_data1/oa_pdf/8f/f9/main.PMC4516138.pdf
40 (2011) 1 –29http://www.jstatsoft.org/v40/i01/ .,Non-OADS,/arxiv_data1/oa_pdf/8f/f9/main.PMC4516138.pdf
"15(2014) R85, http://dx.doi.org/10.1186/gb-2014-15-6-r85 .",Non-OADS,/arxiv_data1/oa_pdf/8f/f9/main.PMC4516138.pdf
"46 (2014) 1311 –1320, http://dx.doi.org/10.1038/ng.",Non-OADS,/arxiv_data1/oa_pdf/8f/f9/main.PMC4516138.pdf
"Cell 161 (2015) 541 –554, http://dx.doi.org/10.1016/j.cell.2015.03.010 .",OADS,/arxiv_data1/oa_pdf/8f/f9/main.PMC4516138.pdf
"Cell 151 (2012) 1488 –1500, http://dx.doi.org/10.1016/j.cell.",OADS,/arxiv_data1/oa_pdf/8f/f9/main.PMC4516138.pdf
http://www.imgw.pl .,Non-OADS,/arxiv_data1/oa_pdf/aa/7c/10967_2013_Article_2566.PMC4516142.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d5/f2/opth-9-1373.PMC4516176.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2015:9 1373–1378Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1373Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S8645 0relationship between progression of visual  field defect and intraocular pressure in primary  open-angle glaucoma T omoko naito1 Keiji Y oshikawa2 shiro Mizoue3 Mami nanno4 Tairo Kimura5 hirotaka suzumura6 Fumio shiraga1 1Department of Ophthalmology,   Okayama University graduate  school of Medicine, Okayama, Japan;   2Y oshikawa eye Clinic, T okyo, Japan;   3Department of Ophthalmology,   ehime University graduate school  of Medicine, ehime, Japan; 4Kagurazaka  Minamino eye Clinic, 5Ueno eye  Clinic, 6suzumura eye Clinic,   T okyo,  JapanPurpose:  To analyze the relationship between intraocular pressure (IOP) and the progression  of visual field defects in Japanese primary open-angle glaucoma (POAG) and normal-tension  glaucoma (NTG) patients.",Non-OADS,/arxiv_data1/oa_pdf/d5/f2/opth-9-1373.PMC4516176.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/d5/f2/opth-9-1373.PMC4516176.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/d5/f2/opth-9-1373.PMC4516176.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/13/91/copd-10-1403.PMC4516177.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2015:10 1403–1407International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1403OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S6982 9Is dynamometry able to infer the risk of muscle  mass loss in patients with COPD?,Non-OADS,/arxiv_data1/oa_pdf/13/91/copd-10-1403.PMC4516177.pdf
"It is estimated that, in 2020, it  will be the third highest cause of death worldwide.2,3 Among the systemic manifestations observed in COPD are the progressive decrease  of skeletal muscle mass and the presence of several bioenergetic abnormalities, mainly  expressed by low body weight.1 The disease’s systemic effects can greatly increase  the clinical symptoms, such as limitation of exercise capacity and peripheral muscle  weakness and can have a negative impact on quality of life.4,5 Weight loss and low  body mass index (BMI) have been suggested to be associated with worse health status  and higher mortality rates in these patients.6–8 The aging process initiates sarcopenia, a syndrome characterized by progressive  decrease of strength and muscle mass.9,10 Muscle mass loss is prevalent in patients  with COPD as a result of both the disease and aging.11–13 Pulmonary rehabilitation programs are aimed at maintenance or improvement  of physical and nutritional condition of individuals with COPD.14 In this sense, the Correspondence: Marceli rocha leite Departamento de Fisioterapia,  Universidade estadual Paulista, rua  roberto simonsen, number 305,  Presidente Prudente, são Paulo,  19060-900, Brazil email marcelirocha@hotmail.co m Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Ramos et al Running head recto: Risk of muscle mass loss in patients with COPD DOI: http://dx.doi.org/10.2147/COPD.S69829",Non-OADS,/arxiv_data1/oa_pdf/13/91/copd-10-1403.PMC4516177.pdf
Available from: http://www.goldcopd.org /.,Non-OADS,/arxiv_data1/oa_pdf/13/91/copd-10-1403.PMC4516177.pdf
Available from: http://www.goldchronic obstructive pulmonary disease.,Non-OADS,/arxiv_data1/oa_pdf/13/91/copd-10-1403.PMC4516177.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/13/91/copd-10-1403.PMC4516177.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/13/91/copd-10-1403.PMC4516177.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b3/6d/opth-9-1365.PMC4516178.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/b3/6d/opth-9-1365.PMC4516178.pdf
"Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.Dove pres sClinical Ophthalmology Clinical Ophthalmology 2015:9 1365Dove press submit your manuscript | www.dovepress.co m Dove press  1365COrrigendumopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OPTH.S9138 8The efficacy and safety of add-on 0.1% brimonidine tartrate preserved  with sodium chlorite in on-treatment Japanese normal-tension glaucoma  patients [Corrigendum] Tsumura T, Y oshikawa K, Kimura T, et al.",Non-OADS,/arxiv_data1/oa_pdf/b3/6d/opth-9-1365.PMC4516178.pdf
"The authors wish to advise of the following errors: on page  1684, right column, line 18, “10.72” should be replaced with  “−10.72”; on page 1685, right column, line 2, “ ,−6D” should  be replaced with “ ,−6dB”.Journal name: Clinical Ophthalmology Article Designation: Corrigendum Y ear: 2015 Volume: 9 Running head verso: Tsumura et al Running head recto: The efficacy and safety of add-on 0.1% brimonidine tartrate preserved DOI: http://dx.doi.org/10.2147/OPTH.S91388",Non-OADS,/arxiv_data1/oa_pdf/b3/6d/opth-9-1365.PMC4516178.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/9b/2d/dddt-9-3729.PMC4516179.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 3729–3740Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3729Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S8598 7Clinicopathological significance of matrix  metalloproteinase-7 protein expression  in esophageal cancer: a meta-analysis shuai Miao1 shi-Yao Zhou2 chun-shan han3 le-n ing Zhang3 hong-Bin sun3 Bin Yang3 1Department of Geriatrics,   China-Japan Union Hospital of Jilin  University, 2Department of Clinical  Medicine, Jilin University, 3Department  of Thoracic Surgery, China-Japan  Union Hospital of Jilin University,   changchun, People’s republic  of ChinaBackground:  The MMP-7 basement membrane and extracellular matrix may be essential for  tumor invasion and metastasis, and the results presented herein showed a relationship between  MMP-7 expression and esophageal cancer (EC).",Non-OADS,/arxiv_data1/oa_pdf/9b/2d/dddt-9-3729.PMC4516179.pdf
"Keywords:  MMP-7, esophagus carcinoma, statistical analysis Introduction Esophageal cancer (EC) is regarded as a malignancy originating from the esophagus,  which runs between the throat and the stomach.1 Generally speaking, the clinical  symptoms of EC are composed of trouble swallowing, odynophagia, a hoarse voice,  weight loss, a dry cough, enlarged lymph nodes (LNs) around the clavicle, and possibly  coughing up or vomiting blood.2 EC, the eighth-most common malignancy globally,  affects over 450,000 people around the world, and its prevalence is still increasing at a  rapid speed.3 It was estimated that 18,170 new cases of EC were diagnosed, and 15,450  EC-related deaths occurred, in the US in 2014.4 In addition, the incidence of EC in correspondence: Bin Yang Department of Thoracic Surgery,  China-Japan Union Hospital of Jilin   University, 126 Xiantai street,  changchun, Jilin 130033,  People’s Republic of China Tel +86 431 8499 5958 Fax +86 431 8464 1026 email binyang7120@126.co m Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Miao et al Running head recto: MMP-7 expression and EC DOI: http://dx.doi.org/10.2147/DDDT.S85987",Non-OADS,/arxiv_data1/oa_pdf/9b/2d/dddt-9-3729.PMC4516179.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/9b/2d/dddt-9-3729.PMC4516179.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/9b/2d/dddt-9-3729.PMC4516179.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/34/44/opth-9-1315.PMC4516180.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2015:9 1315–1320Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1315Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S8862 4Clinical experience with fixed bimonthly  aflibercept dosing in treatment-experienced  patients with neovascular age-related macular  degeneration arshad M Khanani sierra eye associates, reno, nV, UsaPurpose:  To evaluate the durability of fixed bimonthly dosing of intravitreal aflibercept for  neovascular age-related macular degeneration.",Non-OADS,/arxiv_data1/oa_pdf/34/44/opth-9-1315.PMC4516180.pdf
"Keywords:  age-related macular degeneration, AMD, bimonthly, regimen, aflibercept, case  studies, retinal fluid Introduction Therapies that target vascular endothelial growth factor (VEGF) have revolutionized  the treatment of neovascular (or wet) age-related macular degeneration (nAMD) and  have become the standard of care for this condition.1 Ranibizumab (Lucentis®; Novartis Pharma AG, Basel, Switzerland, and  Genentech, Inc., South San Francisco, CA, USA), a recombinant, humanized  anti-VEGF Fab fragment that neutralizes all forms of VEGF-A,2 was approved  for intravitreal use to treat nAMD by the Food and Drug Administration (FDA)  in 2006.3 According to the European summary of product characteristics, patients  can be given monthly injections until maximal visual acuity (VA) is achieved,  followed by flexible dosing, where treatment and monitoring intervals are based  on disease activity as assessed by VA and/or anatomical parameters visual - ized using optical coherence tomography (OCT) or other appropriate imaging  modalities.3Correspondence: arshad M Khanani sierra eye associates, 950 ryland street,  reno, nV 89502, Usa Tel +1 775 329 0286 Fax +1 775 329 4243 email arshad.khanani@gmail.co m Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Khanani Running head recto: Fixed bimonthly aflibercept in nAMD DOI: http://dx.doi.org/10.2147/OPTH.S88624",Non-OADS,/arxiv_data1/oa_pdf/34/44/opth-9-1315.PMC4516180.pdf
Available from: http://www.ema.europa.eu/docs/en_GB/ document_library/EPAR_-_Product_Information/human/000715/ WC500043546.pd f. Accessed November 2014.,Non-OADS,/arxiv_data1/oa_pdf/34/44/opth-9-1315.PMC4516180.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/34/44/opth-9-1315.PMC4516180.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/34/44/opth-9-1315.PMC4516180.pdf
Available from: http://www.ema.europa.eu/docs/en_GB/document_ library/EPAR_-_Product_Information/human/002392/WC500135815.,Non-OADS,/arxiv_data1/oa_pdf/34/44/opth-9-1315.PMC4516180.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/44/3d/ott-8-1785.PMC4516181.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 1785–1794OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1785Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S8538 3  MTa1 promotes proliferation and invasion  in human gastric cancer cells Yuan Yao1 shuting Feng1 Mingming Xiao2 Yan li1 li Yang1 Jiao gong1 1Digestive system Department,   2Department of Pathology,   The People’s hospital of liaoning  Province, shenyang, liaoning,   People’s  republic of chinaAbstract:  Although metastasis-associated protein 1 (MTA1) has been widely li nked to tumor  metastasis, the relevant mechanisms remain to be elucidated, especially in gastric cancer.",Non-OADS,/arxiv_data1/oa_pdf/44/3d/ott-8-1785.PMC4516181.pdf
"MTA1 was proved to be a candidate metastasis-associated gene by differential  expression screening of metastatic cell lines.9 A series of studies have demonstrated correspondence: Yuan Yao Digestive system Department,  The People’s hospital of liaoning  Province, Wenyi road, no 33,  shenhe District, shenyang, liaoning  110016, People’s republic of china Tel +86 135 9141 6243 Fax +86 24 2481 0540 email yaoyuan_sy@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2015 Volume: 8 Running head verso: Y ao et al Running head recto: MTA1 promotes proliferation and invasion DOI: http://dx.doi.org/10.2147/OTT.S85383",Non-OADS,/arxiv_data1/oa_pdf/44/3d/ott-8-1785.PMC4516181.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/44/3d/ott-8-1785.PMC4516181.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/44/3d/ott-8-1785.PMC4516181.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f8/19/ott-8-1843.PMC4516182.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 1843–1847OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1843Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S7825 4expression of ars in triple negative breast cancer  tumors: a potential prognostic factor?,Non-OADS,/arxiv_data1/oa_pdf/f8/19/ott-8-1843.PMC4516182.pdf
"Kuenen-Boumeester et al showed that AR expres - sion was associated with better disease free survival at the univariate analysis but the  association dissipated at the multivariate approach;11 on the other hand, the Nurses  Health Study suggested a non-significant association between AR status and breast correspondence: Flora Zagouri Department of clinical Therapeutics,  alexandra general hospital, Medical  School, University of Athens, Vas Sofias  ave and lourou street, athens 11521,  greece Tel +30 21 3216 2541 Fax +30 21 3216 2511 email florazagouri@yahoo.co.u k Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2015 Volume: 8 Running head verso: Giannos et al Running head recto: AR expression in triple negative breast cancer DOI: http://dx.doi.org/10.2147/OTT.S78254",Non-OADS,/arxiv_data1/oa_pdf/f8/19/ott-8-1843.PMC4516182.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/f8/19/ott-8-1843.PMC4516182.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/f8/19/ott-8-1843.PMC4516182.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/26/d6/dddt-9-3741.PMC4516183.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 3741–3754Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3741Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S8437 0Escherichia coli  nissle 1917 bacterial ghosts retain  crucial surface properties and express chlamydial  antigen: an imaging study of a delivery system for  the ocular surface Jacqueline Montanaro1 aleksandra inic-Kanada1 angela ladurner1 elisabeth stein1 sandra Belij1 nora Bintner1 simone schlacher1 nadine schuerer1 Ulrike Beate Mayr2 Werner lubitz2 nikolaus leisch3 Talin Barisani-asenbauer1 1laura Bassi centres of expertise,   OcUVac – centre of Ocular  inflammation and infection, centre  for Pathophysiology, infectiology,   and immunology, Medical University  of Vienna, Vienna, austria; 2BirD-c  gmbh & co K g, Kritzendorf, austria;   3Department of ecogenomics and  systems Biology, University of Vienna,   Vienna, austriaAbstract:  To target chronic inflammatory ocular surface diseases, a drug delivery platform is  needed that is safe, possesses immunomodulatory properties, and can be used either for drug  delivery, or as a foreign antigen carrier.",Non-OADS,/arxiv_data1/oa_pdf/26/d6/dddt-9-3741.PMC4516183.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/26/d6/dddt-9-3741.PMC4516183.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/26/d6/dddt-9-3741.PMC4516183.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ec/b6/dddt-9-3779.PMC4516184.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 3779–3787Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3779Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S8304 7Design, development, drug-likeness, and molecular  docking studies of novel piperidin-4-imine  derivatives as antitubercular agents rajappan revathi1 ramachandran Venkatesha  Perumal2 Karkala sreedhara  ranganath Pai3 govindakarnavar  arunkumar4 Dharmarajan sriram5 suvarna ganesh Kini1 1Department of Pharmaceutical  chemistry, Manipal college of  Pharmaceutical sciences, Manipal  University, Manipal, 2Bharathi college  of Pharmacy, Bharathi nagara,   3Department of Pharmacology,   Manipal college of Pharmaceutical  sciences, Manipal University, Manipal,   4Manipal centre of Virus research,   Manipal University, Manipal, Karnataka,   india; 5Pharmacy group, Birla institute  of T echnology and science-Pilani,   hyderabad campus, hyderabad, indiaAbstract:  Tuberculosis remains one of the major grievous diseases worldwide.",Non-OADS,/arxiv_data1/oa_pdf/ec/b6/dddt-9-3779.PMC4516184.pdf
"In particular, in fatty acid elongation, the enzyme enoyl-acyl carrier protein (EACP)  reductase plays a major role; it catalyzes the unsaturated fatty acids by NADH-dependent  correspondence: suvarna ganesh Kini Department of Pharmaceutical  chemistry, Manipal college of  Pharmaceutical sciences, Manipal  University, Manipal, Karnataka, india Tel +91 820 292 2482 ext 225 Fax +91 820 257 1998 email suvarna.gk@manipal.ed u Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Revathi et al Running head recto: Novel piperidin-4-imine derivatives as antitubercular agents DOI: http://dx.doi.org/10.2147/DDDT.S83047",Non-OADS,/arxiv_data1/oa_pdf/ec/b6/dddt-9-3779.PMC4516184.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/ec/b6/dddt-9-3779.PMC4516184.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ec/b6/dddt-9-3779.PMC4516184.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c1/2d/copd-10-1363.PMC4516185.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2015:10 1363–1370International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1363OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S8657 2self-reported alcohol intake and risk of acute  exacerbations of chronic obstructive pulmonary  disease: a prospective cohort study erin e Wetherbee1,2 Dennis e niewoehner1,2 Joseph h sisson3 sarah M lindberg4 John e Connett4 Ken M Kunisaki1,2 1Pulmonary section, Minneapolis  Veterans affairs health Care system,   2Division of Pulmonary, allergy,   Critical Care and sleep Medicine,   Department of Medicine, University  of Minnesota, Minneapolis, M n, Usa;   3Pulmonary, Critical Care, sleep  and allergy Division, Department  of Internal Medicine, University  of nebraska Medical Center, Omaha,   ne, Usa; 4Division of Biostatistics,   school of Public health, University  of Minnesota, Minneapolis, M n, UsaObjective:  To evaluate the relationship between alcohol consumption and the risk of acute  exacerbation of COPD (AECOPD).",Non-OADS,/arxiv_data1/oa_pdf/c1/2d/copd-10-1363.PMC4516185.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/c1/2d/copd-10-1363.PMC4516185.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/c1/2d/copd-10-1363.PMC4516185.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/0d/ce/opth-9-1347.PMC4516186.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2015:9 1347–1351Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1347Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S8267 8Micropulse diode laser trabeculoplasty in  nigerian patients Olufemi emmanuel  Babalola1,2 1rachel eye Center, abuja, nigeria;   2Department of Ophthalmology,   College of health sciences, Bingham  University, new Karu, nigeriaIntroduction:  The term micropulse laser trabeculoplasty suggests that only a fraction of the laser  power is applied to the trabeculum to effect pressure lowering.",Non-OADS,/arxiv_data1/oa_pdf/0d/ce/opth-9-1347.PMC4516186.pdf
"Correspondence: Olufemi emmanuel  Babalola rachel eye Center, PO Box 4108, garki,  abuja, nigeria email Bablo57@gmail.co m Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Babalola  Running head recto: Micropulse diode laser trabeculoplasty in Nigerians DOI: http://dx.doi.org/10.2147/OPTH.S82678",Non-OADS,/arxiv_data1/oa_pdf/0d/ce/opth-9-1347.PMC4516186.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/0d/ce/opth-9-1347.PMC4516186.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/0d/ce/opth-9-1347.PMC4516186.pdf
The poster’s abstract was  published in e PosterAbstracts ( http://www.myschedule.,Non-OADS,/arxiv_data1/oa_pdf/0d/ce/opth-9-1347.PMC4516186.pdf
"Available from: http://www.iridex.com/portals/0/physician-education/ pdf/Gossage%20532%20MLT%202012.pd f. Accessed May 7, 2014.",Non-OADS,/arxiv_data1/oa_pdf/0d/ce/opth-9-1347.PMC4516186.pdf
Available from: http://clinicaltrials.gov/ct2/show/NCT01956942.,Non-OADS,/arxiv_data1/oa_pdf/0d/ce/opth-9-1347.PMC4516186.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/87/24/dmso-8-327.PMC4516187.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015:8 327–338Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Video abstract Point your Smar tPhone at the code abo ve.",Non-OADS,/arxiv_data1/oa_pdf/87/24/dmso-8-327.PMC4516187.pdf
"Or use: http://youtu.be/pHAH0qgAVo IDove press submit your manuscript | www.dovepress.co m Dove press  327Original reSearchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DMSO.S8369 6The humanistic and economic burden associated  with increasing body mass index in the eU5 Shaloo gupta1 lance richard2 anna Forsythe3 1Kantar health, Princeton, nJ, USa;   2eisai europe ltd, hatfield, UK;  3eisai  inc., Woodcliff lake, nJ, USa correspondence: Shaloo gupta   health Outcomes Practice, Kantar  health,  1 independence Way,   Suite 220, Princeton, nJ  08540, USa   Tel +1 609 720 5484  Fax +1 609 987 5514  email shaloo.gupta@kantarhealth.co mObjectives:  This study evaluated the association of body mass index (BMI) with health-related  quality of life (HRQoL), health utilities, health care resource utilization, productivity, activity  impairment, and the associated costs.",Non-OADS,/arxiv_data1/oa_pdf/87/24/dmso-8-327.PMC4516187.pdf
Available from: http://www.euro.,Non-OADS,/arxiv_data1/oa_pdf/87/24/dmso-8-327.PMC4516187.pdf
"Available from: http://www.cdc.gov/obesity/data/adult.htm l. Accessed  March  25, 2014.",Non-OADS,/arxiv_data1/oa_pdf/87/24/dmso-8-327.PMC4516187.pdf
Available  from: http://epp.eurostat.ec.europa.eu/portal/page/portal/product_ details/dataset?p_product_code =ILC_DI0 3.,OADS,/arxiv_data1/oa_pdf/87/24/dmso-8-327.PMC4516187.pdf
"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/diabetes-metabolic-syndrome-and-obesity-targets-and-therapy-journa lDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy is  an international, peer-reviewed open-access journal committed to  the rapid publication of the latest laboratory and clinical findings  in the fields of diabetes, metabolic syndrome and obesity research.",Non-OADS,/arxiv_data1/oa_pdf/87/24/dmso-8-327.PMC4516187.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/87/24/dmso-8-327.PMC4516187.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/2f/e5/dhps-7-129.PMC4516188.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pDrug, Healthcare and Patient Safety 2015:7 129–138Drug, Healthcare and Patient Safety Dove press submit your manuscript | www.dovepress.co m Dove press  129Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DHPS.S5054 9Cardiovascular effects of hormone therapy for  prostate cancer Jason F Lester1 Malcolm D Mason1,2 1velindre Hospital, whitchurch,   2School of Medicine, Cardiff  University, Heath Park, Cardiff, UK Correspondence: Jason F Lester   velindre Hospital, whitchurch, Cardiff,  CF14 2TL, UK   email Jason.lester2@wales.nhs.u kAbstract:  Androgen deprivation therapy (ADT) has been the mainstay of treatment for advanced  prostate cancer for decades, and has been shown to control disease and improve symptoms.",Non-OADS,/arxiv_data1/oa_pdf/2f/e5/dhps-7-129.PMC4516188.pdf
"Drug, Healthcare and Patient Safety Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-healthcare-and-patient-safety-journa lDrug, Healthcare and Patient Safety is an international, peer-reviewed  open-access journal exploring patient safety issues in the healthcare  continuum from diagnostic and screening interventions through to treat - ment, drug therapy and surgery.",Non-OADS,/arxiv_data1/oa_pdf/2f/e5/dhps-7-129.PMC4516188.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/2f/e5/dhps-7-129.PMC4516188.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/15/fd/copd-10-1393.PMC4516189.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2015:10 1393–1402International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1393OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S8326 9Constant-load exercise decreases the serum  concentration of myeloperoxidase in healthy  smokers and smokers with COPD Olaf holz1,* stefan roepcke2,* henrik Watz3 Uwe T egtbur4 gezim lahu2 Jens M hohlfeld1 1Fraunhofer Institute for T oxicology  and experimental Medicine (ITeM),   german Center for lung research  (DZl, Brea Th), hannover,   germany; 2Takeda Pharmaceuticals  International gmbh, glattpark- Opfikon, switzerland; 3Pulmonary  research Institute at lung Clinic  grosshansdorf, german Center  for lung research (DZl, arCn ),   grosshansdorf, 4Institute for sports  Medicine, hannover Medical school  (Mhh), hannover, germany *These authors contributed equally  to this workAbstract:  There is an ongoing demand for easily accessible biomarkers related to  pathophysiological processes in chronic obstructive pulmonary disease (COPD).",Non-OADS,/arxiv_data1/oa_pdf/15/fd/copd-10-1393.PMC4516189.pdf
"Systemic inflammation is thought to play an important role in the pathogenesis of  COPD.1–3 Among others, peripheral blood levels of fibrinogen, adiponectin, interleukin  6 (IL6), and C-reactive protein (CRP) were shown to be increased2,4,5 and to be related  to exercise tolerance,6,7 exacerbation rate,8 and mortality.1 However, the differences  between the mean absolute resting levels in IL6 and CRP between COPD patients and Correspondence: Olaf holz Department of Clinical airway research,  Fraunhofer Institute for Toxicology and  experimental Medicine, Clinical research  Center (CrC), 30625 hannover,  germany Tel +49 511 5350 8141 Fax +49 511 5350 8104 email olaf.holz@item.fraunhofer.d e Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Holz et al Running head recto: Constant-load exercise decreases serum MPO DOI: http://dx.doi.org/10.2147/COPD.S83269",Non-OADS,/arxiv_data1/oa_pdf/15/fd/copd-10-1393.PMC4516189.pdf
"Lactate was measured as part of a metabolite panel  using electrospray ionization tandem mass spectrometry at  Biocrates Life Science AG, Austria, according to their standard  operating procedure.21 The experimental procedure is described  in detail by the patent US 2007/0004044 (accessible at   http://www.freepatentsonline.com/20070004044.htm l).22 statistical analysis Data are displayed as arithmetic mean and standard deviation  (SD) or median and interquartile ranges (IQRs).",OADS,/arxiv_data1/oa_pdf/15/fd/copd-10-1393.PMC4516189.pdf
Available from: http://www.goldcopd.com/.,Non-OADS,/arxiv_data1/oa_pdf/15/fd/copd-10-1393.PMC4516189.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/15/fd/copd-10-1393.PMC4516189.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/15/fd/copd-10-1393.PMC4516189.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e3/0a/dhps-7-121.PMC4516190.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pDrug, Healthcare and Patient Safety 2015:7 121–127Drug, Healthcare and Patient Safety Dove press submit your manuscript | www.dovepress.co m Dove press  121Original reSearcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DHPS.S8489 0Drug utilization in selected health facilities of  South West Shoa Zone, Oromia region, ethiopia Mengistu Kebede Dereje Kebebe Borga eshetu Mulisa Bobasa Department of Pharmacy, Jimma  University, Jimma, ethiopia correspondence: eshetu Mulisa Bobasa   Department of Pharmacy,   Jimma University, PO Box  378,   Jimma, Oromia, ethiopia   Tel +251 93 246 7361  email mulisa2e@yahoo.co mBackground:  Sustaining the availability and rational use of safe and effective drugs is a major  problem in developing countries.",Non-OADS,/arxiv_data1/oa_pdf/e3/0a/dhps-7-121.PMC4516190.pdf
"Drug, Healthcare and Patient Safety Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-healthcare-and-patient-safety-journa lDrug, Healthcare and Patient Safety is an international, peer-reviewed  open-access journal exploring patient safety issues in the healthcare  continuum from diagnostic and screening interventions through to treat - ment, drug therapy and surgery.",Non-OADS,/arxiv_data1/oa_pdf/e3/0a/dhps-7-121.PMC4516190.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/e3/0a/dhps-7-121.PMC4516190.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b2/4b/dddt-9-3811.PMC4516191.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 3811–3816Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3811Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S7356 1Developments in managing severe chronic pain:  role of oxycodone–naloxone extended release Guido Fanelli1 Andrea Fanelli2 1Anesthesia and intensive Care  Unit, University of Parma, Parma,   2Anesthesia and intensive Care  Unit, Policlinico S Orsola-Malpighi,   Bologna,  italyAbstract:  Chronic pain is a highly disabling condition, which can significantly reduce patients’  quality of life.",Non-OADS,/arxiv_data1/oa_pdf/b2/4b/dddt-9-3811.PMC4516191.pdf
"Guidelines for the management of chronic pain recommend opioids for the treat - ment of moderate-to-severe pain in patients whose pain is not responsive to initial  therapies with paracetamol and/or NSAIDs.8 Despite their analgesic efficacy being Correspondence: Andrea Fanelli Anesthesia and intensive Care  Unit, Policlinico S Orsola-Malpighi,  via Albertoni 15, 40138 Bologna, italy Tel +39 051 636 3268 Fax +39 051 636 4333 email andrea.fanelli@aosp.bo.i t Journal name: Drug Design, Development and Therapy Article Designation: Review Y ear: 2015 Volume: 9 Running head verso: Fanelli and Fanelli Running head recto: Developments in managing severe chronic pain DOI: http://dx.doi.org/10.2147/DDDT.S73561",Non-OADS,/arxiv_data1/oa_pdf/b2/4b/dddt-9-3811.PMC4516191.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/b2/4b/dddt-9-3811.PMC4516191.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/b2/4b/dddt-9-3811.PMC4516191.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/5e/50/ott-8-1815.PMC4516192.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 1815–1821OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1815Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S7949 8Diffuse anterior retinoblastoma: current concepts Jing Yang1–3 Yalong Dang1–3 Yu Zhu1 Chun Zhang2,3 1Department of Ophthalmology,   The First Affiliated Hospital,   Zhengzhou University, Zhengzhou  City, Henan Province, 2Department  of Ophthalmology, Peking University  Third Hospital, 3Clinical Stem Cell  Research Center, Peking University  Third Hospital, Beijing, People’s  Republic of ChinaAbstract:  Diffuse anterior retinoblastoma is a rare variant of retinoblastoma seeding in the  area of the vitreous base and anterior chamber.",Non-OADS,/arxiv_data1/oa_pdf/5e/50/ott-8-1815.PMC4516192.pdf
"When RB1-deficient retino - blasts undergo p53-mediated apoptosis and exit the cell cycle, subsequently, MDMX  (Mdm2 p53 binding protein homolog) protein overexpresses following MDMX  gene  amplifies, which are strongly selected for during tumor progression as a mechanism  to suppress the p53 response in RB1-deficient retinal cells.22–25Correspondence: Yu Zhu Department of Ophthalmology,   The First Affiliated Hospital of  Zhengzhou University, 1 Jianshe Road,  erqi District, Zhengzhou, Henan,   People’s Republic of China Tel/fax +86 371 6686 2921 email asiadragon@163.co m  Chun Zhang Department of Ophthalmology, Peking  University Third Hospital, Beijing,  People’s Republic of China Tel +86 10 8226 6715 email zhangc1@yahoo.co m Journal name: OncoTargets and Therapy Article Designation: Review Y ear: 2015 Volume: 8 Running head verso: Y ang et al Running head recto: Diffuse anterior retinoblastoma DOI: http://dx.doi.org/10.2147/OTT.S79498",Non-OADS,/arxiv_data1/oa_pdf/5e/50/ott-8-1815.PMC4516192.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets­and­therapy­journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/5e/50/ott-8-1815.PMC4516192.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/5e/50/ott-8-1815.PMC4516192.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a8/12/ott-8-1795.PMC4516193.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 1795–1803OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1795Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S8007 5Identification of the key genes connected with  plasma cells of multiple myeloma using expression  profiles Kefeng Zhang1 Zhongyang Xu1 Zhaoyun Sun2 1spinal surgery, Jining no 1 People’s  hospital, Jining, 2Department of  Orthopedics, The People’s Hospital of  laiwu city, laiwu, shandong Province,   People’s Republic of ChinaObjective:  To uncover the potential regulatory mechanisms of the relevant genes that contribute  to the prognosis and prevention of multiple myeloma (MM).",Non-OADS,/arxiv_data1/oa_pdf/a8/12/ott-8-1795.PMC4516193.pdf
"Keywords:  multiple myeloma, functional enrichment, transcription factor analysis, PPI network,  pathway enrichment Introduction Multiple myeloma (MM) is a malignant plasma cell (PC) disorder and is character - ized by the infiltration of malignant PCs, which are the endpoint of B-cell differentia - tion, in the bone marrow.1–4 The mortality of MM is relatively high; approximately  63,000 individuals die from MM annually, accounting for 0.9% of all cancer deaths.5  Therefore, many studies have been conducted to explore the molecular mechanisms  of MM etiology.6,7 MM is known to be associated with heterogeneous cytogenetic abnormalities,  including hyperdiploid and nonhyperdiploid karyotypes.8 In patients with a nonhy - perdiploid karyotype, many chromosomal translocations are involved, which could Correspondence: Kefeng Zhang spinal surgery, Jining no 1 People’s  Hospital, No 6 Jiankang Road, Jining  272011, shandong Province, People’s  Republic of China Tel +86 537 225 3252 Fax +86 537 675 1976 email kefzh1213@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2015 Volume: 8 Running head verso: Zhang et al Running head recto: Genes related to the plasma cells of MM DOI: http://dx.doi.org/10.2147/OTT.S80075",Non-OADS,/arxiv_data1/oa_pdf/a8/12/ott-8-1795.PMC4516193.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/a8/12/ott-8-1795.PMC4516193.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/a8/12/ott-8-1795.PMC4516193.pdf
Available from: http://www.ncbi.nlm.nih.,Non-OADS,/arxiv_data1/oa_pdf/a8/12/ott-8-1795.PMC4516193.pdf
Available from: http://www.geneontology.,Non-OADS,/arxiv_data1/oa_pdf/a8/12/ott-8-1795.PMC4516193.pdf
28. http://www.genome.jp/kegg/pathway.htm l.  29.,OADS,/arxiv_data1/oa_pdf/a8/12/ott-8-1795.PMC4516193.pdf
Available from: http://string-db.org /.,OADS,/arxiv_data1/oa_pdf/a8/12/ott-8-1795.PMC4516193.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/2e/32/copd-10-1409.PMC4516194.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2015:10 1409–1416International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1409OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S8225 9smoking duration, respiratory symptoms, and  COPD in adults aged $45 years with a smoking  history Y ong liu,1 roy a Pleasants,2  Janet B Croft,1 anne g  Wheaton,1 Khosrow  heidari,3 ann M Malarcher,4  Jill a Ohar,5 Monica Kraft,6  David M Mannino,7 Charlie  strange8 1Division of Population health,   Centers for Disease Control and  Prevention, atlanta, ga, 2Division  of Pulmonary, allergy, and Critical  Care Medicine, Duke University  school of Medicine, Durham, nC,   3Chronic Disease epidemiology  Office, Department of health and  environmental Control, south  Carolina, sC, 4Office of smoking and  health, Centers for Disease Control  and Prevention, atlanta, ga, 5section  on Pulmonary, Critical Care, allergy  and Immunologic Disease, Wake  Forest University, Winston salem, nC,   6Department of Medicine, University  of arizona, Phoenix, aZ, 7Division of  Pulmonary, Critical Care, and sleep  Medicine, Pulmonary epidemiology  research laboratory, University of  Kentucky, lexington, KY, 8Division of  Pulmonary, Critical Care, allergy and  sleep Medicine, Medical University of  south Carolina, Charleston, sC, UsaBackground:  The purpose of this study was to assess the relationship of smoking duration  with respiratory symptoms and history of chronic obstructive pulmonary disease (COPD) in  the South Carolina Behavioral Risk Factor Surveillance System survey in 2012.",Non-OADS,/arxiv_data1/oa_pdf/2e/32/copd-10-1409.PMC4516194.pdf
"Most studies show that smoking has greater adverse effects on respiratory function  among women than among men.5–11 However, other studies have not been consistent  with that finding.12–15 The sex difference in many previous studies of international  populations or small study populations was observed when using self-reported Correspondence: Yong liu Division of Population health, Centers  for Disease Control and Prevention,  4770 Buford highway ne, Mail stop F-78,  atlanta, ga 30341, Usa Tel +1 770 488 5528 Fax +1 770 488 5964 email ikd8@cdc.go v Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Liu et al Running head recto: Smoking duration and COPD DOI: http://dx.doi.org/10.2147/COPD.S82259",Non-OADS,/arxiv_data1/oa_pdf/2e/32/copd-10-1409.PMC4516194.pdf
"The state-based BRFSS has collected data from  households with landline and cellular telephones, and has  incorporated a new sample weighting method since 2011  (http://www.cdc.gov/brfss/annual_data/annual_2011.",OADS,/arxiv_data1/oa_pdf/2e/32/copd-10-1409.PMC4516194.pdf
The  2012 South Carolina BRFSS combined response rate (the  number of respondents who completed the survey as a  proportion of all eligible and likely eligible persons using  standards set by the American Association of Public Opin - ion Research Response Rate Formula #4 [ http://www.aapor.,OADS,/arxiv_data1/oa_pdf/2e/32/copd-10-1409.PMC4516194.pdf
"Available from: http://ash.org/wp-content/uploads/2014/01/full- report.pd f. Accessed May 23, 2015.",Non-OADS,/arxiv_data1/oa_pdf/2e/32/copd-10-1409.PMC4516194.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/2e/32/copd-10-1409.PMC4516194.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/2e/32/copd-10-1409.PMC4516194.pdf
"Available from: http://www.ahrq.gov/professionals/ clinicians-providers/guidelines-recommendations/tobacco/clinicians/ update/index.htm l. Accessed May 23, 2015.",Non-OADS,/arxiv_data1/oa_pdf/2e/32/copd-10-1409.PMC4516194.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/8f/a4/dddt-9-3685.PMC4516195.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 3685–3693Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3685Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S8821 8The efficacy and safety of pemetrexed-based  doublet therapy compared to pemetrexed alone  for the second-line treatment of advanced non- small-cell lung cancer: an updated meta-analysis anyuan Zhong1,* Xiaolu Xiong2,* Minhua shi1 huajun Xu3 1Department of respiratory Diseases,   the second affiliated hospital  of soochow University, suzhou,   2Department of endocrinology, Drum  T ower clinical Medical college of  nanjing Medical University, nanjing,   3Department of Otolaryngology,   shanghai Jiao Tong University  affiliated sixth People’s hospital,   Otolaryngology institute of shanghai  Jiao Tong University, shanghai, People’s  Republic of China *These authors contribute equally  to this workBackground:  Pemetrexed is currently recommended as the second-line treatment for patients  with advanced non-small-cell lung cancer (NSCLC).",Non-OADS,/arxiv_data1/oa_pdf/8f/a4/dddt-9-3685.PMC4516195.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/8f/a4/dddt-9-3685.PMC4516195.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/8f/a4/dddt-9-3685.PMC4516195.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/8e/08/ott-8-1835.PMC4516196.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 1835–1842OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1835Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S8111 5association between GSTP1  polymorphisms and  prognosis of osteosarcoma in patients treated  with chemotherapy: a meta-analysis Feifei Pu1,* Fengxia chen2,* songfeng chen1 Baichuan Wang1 Jianxiang liu1 Zengwu shao1 1Department of Orthopedics, Union  hospital, T ongji Medical college,   huazhong University of science and  T echnology, Wuhan, hubei, People’s  republic of china; 2Department of  Medical Oncology, general hospital  of The Yangtze river shipping, Wuhan,   hubei, People’s republic of china *These authors contributed equally  to this workObjective:  The aim of this study was to evaluate the relationship between GSTP1  polymorphisms  and prognosis of osteosarcoma in patients treated with chemotherapy, by performing a meta- analysis.",Non-OADS,/arxiv_data1/oa_pdf/8e/08/ott-8-1835.PMC4516196.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/8e/08/ott-8-1835.PMC4516196.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/8e/08/ott-8-1835.PMC4516196.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/db/df/dddt-9-3789.PMC4516197.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 3789–3799Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3789Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S8867 2colon-targeted delivery of budesonide using dual  ph- and time-dependent polymeric nanoparticles  for colitis therapy Muhammad naeem1 Moonjeong choi1 Jiafu cao1 Yujeong lee1 Muhammad ikram2 sik Y oon2 Jaewon lee1 hyung ryong Moon1 Min-soo Kim1 Yunjin Jung1 Jin-Wook Y oo1 1college of Pharmacy, Pusan national  University, Busan, 2Pusan national  University school of Medicine,   Yangsan, south KoreaAbstract:  Single pH-dependent drug delivery systems have been widely used for colon-targeted  delivery, but their efficiency is often hampered by the variation in gut pH.",Non-OADS,/arxiv_data1/oa_pdf/db/df/dddt-9-3789.PMC4516197.pdf
"Consequently, innovative strategies for specific and sufficient drug delivery  to the inflamed colon for a prolonged period in a sustained manner while reducing the  risk of systemic adverse effects are required for successful IBD treatment.5correspondence: Jin-Wook Yoo college of Pharmacy, Pusan national  University, Busan 609-735, south Korea  Tel +82 51 510 2807 Fax +82 51 513 6754 email jinwook@pusan.ac.k rJournal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Naeem et al Running head recto: Dual pH/time-dependent nanoparticles for colitis therapy DOI: http://dx.doi.org/10.2147/DDDT.S88672",Non-OADS,/arxiv_data1/oa_pdf/db/df/dddt-9-3789.PMC4516197.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/db/df/dddt-9-3789.PMC4516197.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/db/df/dddt-9-3789.PMC4516197.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c8/5a/copd-10-1417.PMC4516198.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2015:10 1417–1425International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1417OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S8313 5Validation of an administrative claims-based  diagnostic code for pneumonia in a Us-based  commercially insured COPD population David M Kern1 Jill Davis2 setareh a Williams3 Ozgur T unceli1 Bingcao Wu1 sally hollis4 Charlie strange5 Frank Trudo2 1healthCore, Inc., Wilmington, De,   2astraZeneca Pharmaceuticals,   Wilmington, De, 3astraZeneca  Pharmaceuticals, gaithersburg, MD,   Usa; 4astraZeneca Pharmaceuticals,   Cheshire, UK; 5Department of  Medicine, Division of Pulmonary  and Critical Care Medicine, Medical  University of south Carolina,   Charleston, sC, UsaObjective:  To estimate the accuracy of claims-based pneumonia diagnoses in COPD patients  using clinical information in medical records as the reference standard.",Non-OADS,/arxiv_data1/oa_pdf/c8/5a/copd-10-1417.PMC4516198.pdf
"Typi - cally maintained in regularly updated repositories, claims data provide convenient  and easy access to researchable details on demographics, clinical characteristics,  health care utilization – frequency and type of prescription medication fills, inpatient Correspondence: David M Kern healthCore, Inc., 800 Delaware avenue,  Wilmington, De 19801, Usa Tel +1 302 230 2102 Fax +1 302 230 2020 email dkern@healthcore.co m Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Kern et al Running head recto: Validation of an administrative claims-based diagnostic code for pneumonia DOI: http://dx.doi.org/10.2147/COPD.S83135",Non-OADS,/arxiv_data1/oa_pdf/c8/5a/copd-10-1417.PMC4516198.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/c8/5a/copd-10-1417.PMC4516198.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/c8/5a/copd-10-1417.PMC4516198.pdf
"Available from:  http://www.cdc.gov/nchs/data/nhds/2average/2010ave2_firstlist.pd f.  Accessed June 22, 2015.",OADS,/arxiv_data1/oa_pdf/c8/5a/copd-10-1417.PMC4516198.pdf
"Available from: http://www.cdc.gov/nchs/data/ nvsr/nvsr61/nvsr61_04.pd f. Accessed June 13, 2015.",OADS,/arxiv_data1/oa_pdf/c8/5a/copd-10-1417.PMC4516198.pdf
Available from: http://clinicaltrials.gov/show/ NCT0192112 7.,Non-OADS,/arxiv_data1/oa_pdf/c8/5a/copd-10-1417.PMC4516198.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/79/2b/ott-8-1773.PMC4516199.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 1773–1783OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1773Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S7245 7mir-32 functions as a tumor suppressor and  directly targets SOX9  in human non-small cell  lung cancer Dan Zhu hui chen Xiguang Yang Weisong chen linying Wang Jilin Xu long Yu Department of respiratory Medicine,   Jinhua Municipal central hospital,   Jinhua, People’s republic of chinaPurpose:  MicroRNA-32 (miR-32) is dysregulated in certain human malignancies and correlates  with tumor progression.",Non-OADS,/arxiv_data1/oa_pdf/79/2b/ott-8-1773.PMC4516199.pdf
"Previous studies have demonstrated  diverse genetic alterations in NSCLC; however, the molecular mechanisms underlying  NSCLC carcinogenesis and progression are highly complex, and the further identifi - cation of new candidate molecules that participate in these processes is important for  improving the diagnosis, prevention, and treatment of this disease.correspondence: Dan Zhu  Department of respiratory Medicine,  Jinhua Municipal central hospital, Jinhua  321000, People’s republic of china email manuzhudan@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2015 Volume: 8 Running head verso: Zhu et al Running head recto: Decreased microRNA-32 in non-small cell lung cancer DOI: http://dx.doi.org/10.2147/OTT.S72457",Non-OADS,/arxiv_data1/oa_pdf/79/2b/ott-8-1773.PMC4516199.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/79/2b/ott-8-1773.PMC4516199.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/79/2b/ott-8-1773.PMC4516199.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b2/5b/ott-8-1805.PMC4516200.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 1805–1814OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1805Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S7846 1Upregulation of nucleostemin in colorectal cancer  and its effects on cell malignancy Bin Wei1,* Qiaoying huang2,* Xiaogang Zhong3 1Department of gastroenterology  and Peripheral Vascular surgery,   The People’s hospital of guangxi  Zhuang autonomous region,   2Department of Medical Molecular  Biology, The First affiliated hospital  of guangxi University of chinese  Medicine research, 3Department of  gastroenterology and Peripheral  Vascular surgery, The People’s  hospital of guangxi Zhuang  autonomous region, nanning,   guangxi, People’s republic of china *These authors contributed equally  to this workObjective:  Nucleostemin (NS) is a new protein localized in the nucleolus of most stem cells  and tumor cells, which regulates their self-renewal and cell cycle progression.",Non-OADS,/arxiv_data1/oa_pdf/b2/5b/ott-8-1805.PMC4516200.pdf
"However, the long-term  survival rate of, as well as accurate prognosis for, patients with CRC remains poor.3  Current knowledge of molecular alterations that are important for CRC, including  epigenetic and genetic changes in key tumor suppressors and oncogenes, is extensive;  however, it still represents the tip of the iceberg of knowledge that needs to be resolved  for a complete understanding of CRC pathogenesis.4 In 2002, Tsai and McKay discovered that a novel gene called nucleostemin (NS)  is apparently expressed in stem cells of embryonic and adult rat central nervous  systems.5,6 The protein coded by the NS gene was found in the nucleoli of undiffer - entiated cells, such as adult and embryonic stem cells, neural stem cells, and human  bone marrow stem cells, but not in differentiated counterpart cells, indicating that NS  gene is silenced during normal cell differentiation.7,8 Interestingly, recent reports correspondence: Xiaogang Zhong Department of gastroenterology and  Peripheral Vascular surgery, The People’s  hospital of guangxi Zhuang autonomous  region, no 6 Taoyuan road, nanning,  guangxi 530021, People’s republic  of china email zhongxiaogang1234@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2015 Volume: 8 Running head verso: Wei et al Running head recto: Upregulated nucleostemin in colorectal cancer DOI: http://dx.doi.org/10.2147/OTT.S78461",Non-OADS,/arxiv_data1/oa_pdf/b2/5b/ott-8-1805.PMC4516200.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/b2/5b/ott-8-1805.PMC4516200.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/b2/5b/ott-8-1805.PMC4516200.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/95/24/dddt-9-3705.PMC4516201.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 3705–3727Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3705Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S8530 2Targeting brain cells with glutathione-modulated  nanoliposomes: in vitro and in vivo study heba F salem1 sayed M ahmed2 ashraf e hassaballah3 Mahmoud M Omar1,4 1Department of Pharmaceutics  and industrial Pharmacy, Beni-suef  University, 2Department of industrial  Pharmacy, assiut University,   3Department of clinical Pathology,   Faculty of Medicine, assiut University,   assuit, 4Department of Pharmaceutics  and industrial Pharmacy, Deraya  University, egyptBackground:  The blood–brain barrier prevents many drug moieties from reaching the central  nervous system.",Non-OADS,/arxiv_data1/oa_pdf/95/24/dddt-9-3705.PMC4516201.pdf
"The blood–brain barrier protects the brain by regulating transport in and out  of the brain.5 Many receptors are overexpressed on the brain cells such as the cloned   μ opioid receptor,6 the low-density lipoprotein receptor,7 N-methyl- d-aspartate recep - tor, insulin receptor,8 kinin-B2 receptors (BK-B2R),9 angiotensin II AT1 and AT2  receptors,10 and glutathione.11–13correspondence: heba F salem Department of Pharmaceutics and  industrial Pharmacy, Beni-suef University,  Beni-suef, egypt Tel +20 100 933 2419 email salem_h_farouk@yahoo.co m Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Salem et al Running head recto: Targeting brain cells with glutathione-modulated nanoliposomes DOI: http://dx.doi.org/10.2147/DDDT.S85302",Non-OADS,/arxiv_data1/oa_pdf/95/24/dddt-9-3705.PMC4516201.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/95/24/dddt-9-3705.PMC4516201.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/95/24/dddt-9-3705.PMC4516201.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c2/d9/dmso-8-315.PMC4516202.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015:8 315–325Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  315REVIEWopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DMSO.S8400 5Type 2 diabetes mellitus development programs  in the new regulatory environment with  cardiovascular safety requirements Fred Yang1 Murray Stewart2 June Ye2 David DeMets3 1AstraZeneca, Gaithersburg, MD,  USA; 2GlaxoSmithKline, Upper  Merion, PA, USA; 3Department of  Biostatistics and Medical Informatics,  University of Wisconsin–Madison,  Madison, WI, USA Correspondence: Fred Yang   AstraZeneca, One Medimmune   Way, Building 200, Gaithersburg,   MD 20878, USA   Tel +1 267 980 9451   Email fredyyang@yahoo.co mAbstract:  For type 2 diabetes mellitus treatment and clinical development, proper evaluation  of cardiovascular risk has been required by regulatory agencies (eg, the US Food and Drug  Administration) since cardiovascular safety is very important in this patient population.",Non-OADS,/arxiv_data1/oa_pdf/c2/d9/dmso-8-315.PMC4516202.pdf
"Available  from: http://www.fda.gov/downloads/drugs/ guidancecomplianceregu - latoryinformation /guidances/ucm071627.pd f. Accessed January 31,  2012.",Non-OADS,/arxiv_data1/oa_pdf/c2/d9/dmso-8-315.PMC4516202.pdf
Available from: https://clinicaltrials.gov/ct2/show/NCT0114433 8.,Non-OADS,/arxiv_data1/oa_pdf/c2/d9/dmso-8-315.PMC4516202.pdf
Available  from: http://www.clinicaltrials.gov/ct2/show/NCT0124342 4.,Non-OADS,/arxiv_data1/oa_pdf/c2/d9/dmso-8-315.PMC4516202.pdf
Available from: http://www.clinicaltrials.gov/ct2/ show/NCT0189753 2.,Non-OADS,/arxiv_data1/oa_pdf/c2/d9/dmso-8-315.PMC4516202.pdf
Available from: http://www.clinicaltrials.gov/ct2/show/NCT011790 48?term=NCT01179048&rank= 1.,Non-OADS,/arxiv_data1/oa_pdf/c2/d9/dmso-8-315.PMC4516202.pdf
Available from: http://www.clinicaltrials.gov/ ct2/show/NCT0114725 0.,Non-OADS,/arxiv_data1/oa_pdf/c2/d9/dmso-8-315.PMC4516202.pdf
"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/diabetes-metabolic-syndrome-and-obesity-targets-and-therapy-journa lDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy is  an international, peer-reviewed open-access journal committed to  the rapid publication of the latest laboratory and clinical findings  in the fields of diabetes, metabolic syndrome and obesity research.",Non-OADS,/arxiv_data1/oa_pdf/c2/d9/dmso-8-315.PMC4516202.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/c2/d9/dmso-8-315.PMC4516202.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/75/80/opth-9-1353.PMC4516203.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2015:9 1353–1358Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1353Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S8698 0refractive index and its impact on pseudophakic  dysphotopsia Bryce r radmall1 anne Floyd2 Zack Oakey3 randall J Olson4 1Department of Ophthalmology,   Casey eye institute, Oregon health  and science University, Portland,   Or, 2Department of Ophthalmology,   louisiana state University health  sciences Center, shreveport, la,   3Department of Ophthalmology, gavin  herbert eye institute, University  of California, irvine, C a, 4Department  of Ophthalmology and  Visual sciences,   John a. Moran eye Center, University  of Utah, salt lake City, UT, UsaPurpose:  It has been shown that the biggest dissatisfier for uncomplicated cataract surgery  patients is pseudophakic dysphotopsia (PD).",Non-OADS,/arxiv_data1/oa_pdf/75/80/opth-9-1353.PMC4516203.pdf
"A PD survey created for a recent analysis of normal pseudophakic patients  in a supernormal population was validated by its strong correlation with the National Correspondence: randall J Olson John a. Moran eye Center, Department  of Ophthalmology, University of Utah,  65 Mario Capecchi Drive,   salt lake City, UT 84132, Usa Tel +1 801 585 6622 Fax +1 801 581 3357 email randallj.olson@hsc.utah.ed u Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Radmall et al Running head recto: Refractive index impact on PD DOI: http://dx.doi.org/10.2147/OPTH.S86980",Non-OADS,/arxiv_data1/oa_pdf/75/80/opth-9-1353.PMC4516203.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/75/80/opth-9-1353.PMC4516203.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/75/80/opth-9-1353.PMC4516203.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/0d/83/opth-9-1367.PMC4516204.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2015:9 1367–1372Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1367Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S8822 5Comparison of cumulative dissipated energy   between the Infiniti and Centurion  phacoemulsification systems Ming Chen1 erik anderson2 geoffrey hill3 John J Chen4 Thomas Patrianakos2 1Department of surgery, University  of hawaii, honolulu,  hi, 2Department  of Ophthalmology, John h stroger, Jr  hospital of Cook County, Chicago, il,    3Department of Ophthalmology,   UT southwestern Medical Center,   Dallas, TX, 4Biostatistics Core, John a  Burns school of Medicine, University  of hawaii, honolulu, hi, UsaPurpose:  To compare cumulative dissipated energy between two phacoemulsification  machines.",Non-OADS,/arxiv_data1/oa_pdf/0d/83/opth-9-1367.PMC4516204.pdf
"The purpose of this study was simply to compare the CDE between the single  Centurion and single Infiniti phacoemulsification systems in a larger number of cases  to see which one uses less CDE under similar age, sex, and complication rate ( P.0.05)  among five surgeons in one surgical center.Correspondence: Ming Chen Department of Ophthalmology,  University of hawaii, 55 south  Kukui street, suite C-109, honolulu,  hi 96813, Usa Fax +1 808 523 0466 email drmingchen808@gmail.co m Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Chen et al Running head recto: Comparison of CDE between phacoemulsification systems DOI: http://dx.doi.org/10.2147/OPTH.S88225",Non-OADS,/arxiv_data1/oa_pdf/0d/83/opth-9-1367.PMC4516204.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/0d/83/opth-9-1367.PMC4516204.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/0d/83/opth-9-1367.PMC4516204.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/65/73/cia-10-1173.PMC4516205.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2015:10 1173–1187Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  1173OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S8649 3Oral treatment with herbal formula B307  alleviates cardiac failure in aging r6/2 mice  with huntington’s disease via suppressing  oxidative stress, inflammation, and apoptosis Ching-lung lin1 sheue-er Wang2 Chih-hsiang hsu1 shuenn-Jyi sheu3 Chung-hsin Wu1 1Department of life science,   national Taiwan normal University,   Taipei, 2Department of Pathological  Inspection, soeurs de saint Paul  de Chartres Medical Corporate  Body, Taoyuan City, 3Brion  research Institute of Taiwan,   new Taipei City, TaiwanAbstract:  Cardiac failure is often observed in aging patients with Huntington’s disease (HD).",Non-OADS,/arxiv_data1/oa_pdf/65/73/cia-10-1173.PMC4516205.pdf
"Huntington’s disease (HD) has  been considered primarily a neurodegenerative disease, but cardiac failure is also a  cause of death in HD patients.3–5 In addition to the brain, mutant huntingtin protein and  poly-Q aggregates have also been found in cardiomyocytes of HD patients.6 Huntingtin Correspondence: Chung-hsin Wu Department of life science, national  Taiwan normal University, no 88,  Tingzhou road, section 4, Wenshan  District, Taipei 11677, Taiwan Tel +886 2 7734 6363 Fax +886 2 2931 2904 email megawu@ntnu.edu.t w Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Lin et al Running head recto: Oral B307 treatment alleviates cardiac failure in aging R6/2 mice DOI: http://dx.doi.org/10.2147/CIA.S86493 Point your SmartPhone at the code above.",Non-OADS,/arxiv_data1/oa_pdf/65/73/cia-10-1173.PMC4516205.pdf
Or use: http://youtu.be/dZ815Qs3PP wVideo abstract,Non-OADS,/arxiv_data1/oa_pdf/65/73/cia-10-1173.PMC4516205.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/65/73/cia-10-1173.PMC4516205.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/65/73/cia-10-1173.PMC4516205.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/bc/99/dddt-9-3801.PMC4516206.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pDrug Design, Development and Therapy 2015:9 3801–3809Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3801Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S6839 1Adjunctive therapies to reduce thrombotic events  in patients with a history of myocardial infarction:  role of vorapaxar Mohamed Farag1,2 Hiten Patel1 Diana A Gorog1–3 1Department of Cardiology, east  and North Hertfordshire NHS Trust,   Stevenage, 2Postgraduate Medical  School, University of Hertfordshire,   Hatfield, 3National Heart and  Lung institute, imperial College,   London,  UKAbstract:  Acute myocardial infarction (AMI) is generally attributed to coronary atherothrombotic  disease.",Non-OADS,/arxiv_data1/oa_pdf/bc/99/dddt-9-3801.PMC4516206.pdf
"In recent studies, some 10%–15%  of patients went on to have a major adverse cardiac event during the first 12 months  after AMI, which was attributed predominantly to thrombotic complications.12–15 Correspondence: Diana A Gorog Postgraduate Medical School, University  of Hertfordshire, Hatfield, Hertfordshire  AL10 9AB, UK Tel +44 20 7034 8934 email d.gorog@nhs.ne t Journal name: Drug Design, Development and Therapy Article Designation: Review Y ear: 2015 Volume: 9 Running head verso: Farag et al Running head recto: Role of vorapaxar in myocardial infarction DOI: http://dx.doi.org/10.2147/DDDT.S68391",Non-OADS,/arxiv_data1/oa_pdf/bc/99/dddt-9-3801.PMC4516206.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/bc/99/dddt-9-3801.PMC4516206.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/bc/99/dddt-9-3801.PMC4516206.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/31/17/opth-9-1359.PMC4516207.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2015:9 1359–1364Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1359Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S8435 4Posterior corneal curvature changes following  refractive small incision lenticule extraction sri ganesh Utsav Patel sheetal Brar Phaco and refractive surgery  Department, nethradhama  superspeciality eye hospital,   Bengaluru, Karnataka, indiaPurpose:  To compare the posterior corneal curvature changes, in terms of corneal power and  asphercity, following Refractive Small Incision Lenticule Extraction (ReLEx SMILE) procedure  for low, moderate, and high myopia.",Non-OADS,/arxiv_data1/oa_pdf/31/17/opth-9-1359.PMC4516207.pdf
"The anterior corneal sur - face is reshaped directly during refractive surgery and has been studied largely by  corneal topography.1–4 The posterior corneal surface may also change, not from direct  application of refractive techniques but from intraocular pressure (IOP) changes and  post-operative corneal thinning, as in radial keratotomy.5,6 Since it is believed that the first sign of kerectasia appears on the posterior corneal  surface7–10 and not on the anterior, the importance of recognizing a change in the pos - terior corneal surface after refractive surgery deserves attention.Correspondence: Utsav Patel Phaco and refractive surgery  Department, nethradhama  superspeciality eye hospital,   # 256/14, Kanakapura Main road,  7th Block, Jayanagar, Bengaluru 560 070,  Karnataka, india Tel +91 80 2608 8000 Fax +91 80 2663 3770 email utsav5093@gmail.co m Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Ganesh et al Running head recto: Posterior corneal curvature changes following ReLEx SMILE DOI: http://dx.doi.org/10.2147/OPTH.S84354",Non-OADS,/arxiv_data1/oa_pdf/31/17/opth-9-1359.PMC4516207.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/31/17/opth-9-1359.PMC4516207.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/31/17/opth-9-1359.PMC4516207.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/13/ad/dddt-9-3695.PMC4516208.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 3695–3704Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3695Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S8672 4Mechanisms underlying probucol-induced  hERG-channel deficiency Yuan-Qi shi1,* cai-chuan Yan1,* Xiao Zhang1 Meng Yan1 li-rong liu1 huai-Ze geng1 lin lv1 Bao-Xin li1,2 1Department of Pharmacology, harbin  Medical University, 2state-Province  Key laboratory of Biopharmaceutical  engineering, harbin, heilongjiang,   People’s republic of china *These authors contributed equally  to this workAbstract:  The hERG  gene encodes the pore-forming α-subunit of the rapidly activating  delayed rectifier potassium channel ( IKr), which is important for cardiac repolarization.",Non-OADS,/arxiv_data1/oa_pdf/13/ad/dddt-9-3695.PMC4516208.pdf
"Therefore,  a better mechanistic understanding of probucol-induced hERG-channel abnormality may correspondence: Bao-Xin li Department of Pharmacology, harbin  Medical University, 157 Baojian road,  harbin, heilongjiang 150081, People’s  republic of china Tel +86 451 8667 1354 Fax +86 451 8666 7511 email libx64@hotmail.co m Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Shi et al Running head recto: Probucol-induced hERG-channel deficiency DOI: http://dx.doi.org/10.2147/DDDT.S86724",Non-OADS,/arxiv_data1/oa_pdf/13/ad/dddt-9-3695.PMC4516208.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/13/ad/dddt-9-3695.PMC4516208.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/13/ad/dddt-9-3695.PMC4516208.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/92/63/jpr-8-417.PMC4516209.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pJournal of Pain Research 2015:8 417–429Journal of Pain Research Video abstract Point your Smar tPhone at the code abo ve.,Non-OADS,/arxiv_data1/oa_pdf/92/63/jpr-8-417.PMC4516209.pdf
"Or use: http://youtu.be/H4LbZDWK9N UDove press submit your manuscript | www.dovepress.co m Dove press  417ORiginal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/JPR.S8461 5in silico ordinary differential equation/partial  differential equation hemodialysis model   estimates methadone removal during dialysis Oscar a linares1 William e schiesser2 Jeffrey Fudin3–6 Thien c Pham6 Jeffrey J Bettinger6 Roy O Mathew6 annemarie l Daly7 1Translational genomic Medicine  lab, Plymouth Pharmacokinetic  Modeling study group, Plymouth,  Mi, 2Department of chemical and  Biomolecular engineering, lehigh  University, Bethlehem, P a, 3University  of connecticut school of Pharmacy,  storrs, cT, 4Western new england  college of Pharmacy, springfield, M a,  5albany college of Pharmacy and health  sciences, albany, nY, 6stratton V a Medical  center, albany, nY, 7grace hospice of  ann arbor, ann arbor, M i, Usa correspondence: Oscar a linares   Translational genomic Medicine lab,  Plymouth Pharmacokinetic Modeling  study group, 46425 southview lane,  Plymouth, Mi 48170, Usa   email oal inaresmd@gmail.co mBackground:  There is a need to have a model to study methadone’ s losses during hemodialysis  to provide informed methadone dose recommendations for the practitioner.",Non-OADS,/arxiv_data1/oa_pdf/92/63/jpr-8-417.PMC4516209.pdf
"Available from: http://www.usp.org/pdf/EN/referenceStandards/ msds/1398009.pd f. Accessed January 28, 2015.",Non-OADS,/arxiv_data1/oa_pdf/92/63/jpr-8-417.PMC4516209.pdf
"Journal of Pain Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-pain-research-journa lThe Journal of Pain Research is an international, peer-reviewed, open  access, online journal that welcomes laboratory and clinical findings  in the fields of pain research and the prevention and management  of pain.",Non-OADS,/arxiv_data1/oa_pdf/92/63/jpr-8-417.PMC4516209.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/92/63/jpr-8-417.PMC4516209.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/de/2d/ott-8-1831.PMC4516210.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 1831–1833OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1831LeTTeropen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S9053 8expression of PD-1 by CD4+CD25+CD127low  Treg cells in the peripheral blood of lung cancer  patients AnYuan Zhong Xue Pan MinHua Shi Department of respiratory Diseases,   the Second Affiliated Hospital of  Soochow University, Suzhou, People’s  republic of ChinaDear editor Lung cancer is the most commonly diagnosed cancer and the leading cause of cancer  death worldwide,1 with the majority of patients presenting with advanced disease.2  Treg cells diminish the activation and function of lymphocytes via cell-cell contact and  secretion of soluble mediators.3 PD-1 is expressed on the surface of activated T and B  cells and regulates their activation and proliferation.4 PD-L1 binds to the PD-1 recep - tor, leading to, among other responses, negative regulation of immune activity.",Non-OADS,/arxiv_data1/oa_pdf/de/2d/ott-8-1831.PMC4516210.pdf
"While the mechanisms underlying the increase  in lung cancer-associated Tregs are not known, the overall increase in the number of  immunosuppressive immune cells present in these patients may play an important role  in both the development and progression of lung cancer.9,10 Costimulatory molecule receptors interacting with their corresponding ligand  mediate both positive and negative costimulatory signals, which regulate immune Correspondence: MinHua Shi Department of respiratory Diseases, the  Second Affiliated Hospital of Soochow  University, 1055 Sanxiang road, Suzhou  215004, People’s republic of China email shiminhua@163.co m Journal name: OncoTargets and Therapy Article Designation: Letter Y ear: 2015 Volume: 8 Running head verso: Zhong et al Running head recto: Expression of PD-1 by CD4+CD25+CD127low Treg cells DOI: http://dx.doi.org/10.2147/OTT.S90538",Non-OADS,/arxiv_data1/oa_pdf/de/2d/ott-8-1831.PMC4516210.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/de/2d/ott-8-1831.PMC4516210.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/de/2d/ott-8-1831.PMC4516210.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b0/d5/copd-10-1383.PMC4516211.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Journal of COPD 2015:10 1383–1392International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1383RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/COPD.S5548 8Clinical role of dual bronchodilation with an  indacaterol–glycopyrronium combination in the  management of COPD: its impact on patient- related outcomes and quality of life Correspondence: Andrea Rossi Pulmonary Unit, University and General  Hospital Borgo Trento-Polo Confortini,  P le Stefani 1, verona 37126, Italy Tel +39 045 8122 439 Fax +39 045 8122 049 email andrea.rossi_03@univr.i t Andrea Rossi1 erika Zanardi2 venerino Poletti3 Mario Cazzola4 1Pulmonary Unit, University of verona,   verona, 2Department of Respiratory  and General Rehabilitation, ULSS 20,   verona, 3Pulmonary Unit, GB Morgani  Hospital, AUSL 20, Forli, 4Pulmonary  Unit, University of Rome, T or vergata,   ItalyAbstract:  Chronic obstructive pulmonary disease (COPD) is the result of persistent and pro - gressive pathologic abnormalities in the small airways, most often associated with alveolar loss.",Non-OADS,/arxiv_data1/oa_pdf/b0/d5/copd-10-1383.PMC4516211.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/b0/d5/copd-10-1383.PMC4516211.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/b0/d5/copd-10-1383.PMC4516211.pdf
"Available from: http://guidance.nice.org.uk/ CG101/Guidance/pdf/Englis h. Accessed April 24, 2015.",Non-OADS,/arxiv_data1/oa_pdf/b0/d5/copd-10-1383.PMC4516211.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/20/e0/dddt-9-3755.PMC4516212.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 3755–3766Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3755Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S8851 2Bu-shen-ning-Xin decoction: inhibition of  osteoclastogenesis by abrogation of the ranKl- induced nF aTc1 and nF- κB signaling pathways  via selective estrogen receptor α ling Wang1,2,* Xue-Min Qiu1,2,* Yu-Yan gui1,2 Ying-Ping Xu1,2 hans-Jürgen gober3 Da-Jin li1 1laboratory for reproductive  immunology, hospital and institute of  Obstetrics and gynecology, iBs, Fudan  University shanghai Medical college,   2shanghai Key laboratory of Female  reproductive endocrine related  Diseases, shanghai, People’s republic  of china; 3Department of Pharmacy,   Wagner Jauregg hospital and  children’s hospital, Wagner Jauregg  Weg, linz, austria *These authors contributed equally  to this workIntroduction:  Bu-Shen-Ning-Xin decoction (BSNXD) is a traditional Chinese medicinal  composition that has been used as a remedy for postmenopausal osteoporosis, but the mecha - nisms affecting bone metabolism are not fully understood.",Non-OADS,/arxiv_data1/oa_pdf/20/e0/dddt-9-3755.PMC4516212.pdf
"Keywords:  herbal formula, osteoclastogenesis, estrogen receptor α, NF- κB, NFATc1 Introduction Postmenopausal osteoporosis (PMO) is a major health concern in countries with  an aging population (ie, People’s Republic of China) and occurs due to estrogen  deprivation postmenopause.1 The balance between osteoblast-mediated bone for - mation and osteoclast-mediated bone resorption is disrupted by estrogen deficiency  in favor of increased osteoclast-mediated bone resorption, thereby leading to bone  loss.2correspondence: Da-Jin li laboratory for reproductive  immunology, hospital and institute of  Obstetrics and gynecology, iBs, Fudan  University shanghai Medical college,  413 Zhaozhou road, shanghai 200011,  People’s republic of china Tel +86 21 63457331 email djli@shmu.edu.c n Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Wang et al Running head recto: Effects of TCM on osteoclastogenesis and BMD in OVX mice DOI: http://dx.doi.org/10.2147/DDDT.S88512",Non-OADS,/arxiv_data1/oa_pdf/20/e0/dddt-9-3755.PMC4516212.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/20/e0/dddt-9-3755.PMC4516212.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/20/e0/dddt-9-3755.PMC4516212.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/fb/9a/copd-10-1371.PMC4516213.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2015:10 1371–1382International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1371OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S8146 8Characteristics of prevalent and new COPD cases  in greece: the gOlDen study Correspondence: eirini Mitsiki Medical Department, novartis hellas,  12th Km national road no 1, athens,  greece   Tel +30 210 289 7392   email eirini.mitsiki@novartis.co m Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Mitsiki et al Running head recto: Epidemiology and characteristics of COPD patients in Greece DOI: http://dx.doi.org/10.2147/COPD.S81468 eirini Mitsiki1 eleni Bania2 Christos Varounis1 Konstantinos I  gourgoulianis2 evangelos C alexopoulos3 1Medical Department, novartis hellas,   athens, 2Department of respiratory  Medicine, Medical school, University  of Thessaly, University hospital of  larissa, larissa, 3school of social  sciences, hellenic Open University,   athens, greeceBackground:  Greece has one of the highest rates of smoking and chronic obstructive pulmo - nary disease (COPD) in Europe.",Non-OADS,/arxiv_data1/oa_pdf/fb/9a/copd-10-1371.PMC4516213.pdf
Available from: http://www.goldcopd.,Non-OADS,/arxiv_data1/oa_pdf/fb/9a/copd-10-1371.PMC4516213.pdf
Available from: http://www.goldcopd.,Non-OADS,/arxiv_data1/oa_pdf/fb/9a/copd-10-1371.PMC4516213.pdf
Available from: http://ec.europa.eu/health/ph_publication/ eb_health_en.pdf.,Non-OADS,/arxiv_data1/oa_pdf/fb/9a/copd-10-1371.PMC4516213.pdf
"Available from:  http://www.statistics.gr/portal/page/portal/ESYE/PAGE-databas e.  Accessed December 7, 2013.",OADS,/arxiv_data1/oa_pdf/fb/9a/copd-10-1371.PMC4516213.pdf
Available from:  http://www.hts.org.g r/.,Non-OADS,/arxiv_data1/oa_pdf/fb/9a/copd-10-1371.PMC4516213.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/fb/9a/copd-10-1371.PMC4516213.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/fb/9a/copd-10-1371.PMC4516213.pdf
These  This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bc/cd/nihms591957.PMC4516227.pdf
ACCESSION NUMBERS Next generation sequencing data sets are available at http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE55391  (GEO accession  number: GSE55391).,OADS,/arxiv_data1/oa_pdf/bc/cd/nihms591957.PMC4516227.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures, four figures, and one table and can be found with this  article online at http://dx.doi.org/10.1016/j.celrep.2014.04.040 .",OADS,/arxiv_data1/oa_pdf/bc/cd/nihms591957.PMC4516227.pdf
Generation of Lentivirally Transduced Cells Production of lentivirus and subsequent infection of neuroblastoma cells followed the  protocol found at http://www.addgene.org/tools/protocols/plko/ .,OADS,/arxiv_data1/oa_pdf/bc/cd/nihms591957.PMC4516227.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/27/0a/tcrm-11-1077.PMC4516253.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpTherapeutics and Clinical Risk Management 2015:11 1077–1080Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  1077LeTTeRopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TCRM.S8825 0Transmural dispersion of repolarization and atrial  electromechanical coupling: complementary  indices for quantifying cardiac electrical  heterogeneity in patients with conversion disorder Alptug T okatli1 Omer Yiginer2 Gokhan Degirmencioglu2 Fethi Kilicaslan3 Mehmet Uzun2 1Department of Cardiology,   Golcuk Military Hospital, Kocaeli,   2Department of Cardiology, GATA  Haydarpasa Hospital, 3Department  of Cardiology, Medipol University,   Istanbul, T urkeyDear editor We read with great interest the article entitled “P-wave and QT dispersion in patients with  conversion disorder” by Izci et al1 in Therapeutics and Clinical Risk Management .",Non-OADS,/arxiv_data1/oa_pdf/27/0a/tcrm-11-1077.PMC4516253.pdf
"Pd is an accepted  marker of atrial depolarization heterogeneity and the altered propagation of sinus Correspondence: Alptug Tokatli Golcuk Asker Hastanesi, Kardiyoloji  Servisi, 12 Donanma Street, Golcuk,  Kocaeli 41910, Turkey Tel +90 26 2426 0271 Fax +90 26 2414 1111 email alptugtokatli@gmail.co m Journal name: Therapeutics and Clinical Risk Management Article Designation: Letter Y ear: 2015 Volume: 11 Running head verso: Tokatli et al Running head recto: Quantifying cardiac electrical heterogeneity in CD DOI: http://dx.doi.org/10.2147/TCRM.S88250",Non-OADS,/arxiv_data1/oa_pdf/27/0a/tcrm-11-1077.PMC4516253.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/27/0a/tcrm-11-1077.PMC4516253.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/27/0a/tcrm-11-1077.PMC4516253.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e0/7b/ijn-10-4669.PMC4516254.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 4669–4690International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  4669OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S8350 7reducible chimeric polypeptide consisting of  octa- d-arginine and tetra- l-histidine peptides as  an efficient gene delivery vector Xiaoyu Wang1,2,* Zongguang Tai1,* Jing Tian1,* Wei Zhang3 chong Yao1 lijuan Zhang1 Yuan gao1 Quangang Zhu1 Jing gao4 shen gao1 1Department of Pharmaceutics,   changhai hospital, second Military  Medical University, shanghai,   2Department of Pharmaceutics,   chengDu Military general  hospital, chengDu, 3Department of  Pharmaceutics, shanghai Pulmonary  hospital, T ongji University, shanghai,   4Department of Pharmaceutical  science, school of Pharmacy, second  Military Medical University, shanghai,   People’s republic of china *These authors contributed equally  to this workAbstract:  Cationic oligopeptide as a nonviral gene delivery vector has aroused much research  interest recently, but its further application is limited by its low transfection efficiency.",Non-OADS,/arxiv_data1/oa_pdf/e0/7b/ijn-10-4669.PMC4516254.pdf
"After internalization, the complexes are mainly localized in endosomes and then these  merge into lysosomes to eliminate exogenous substances.8 Therefore, efficient endosomal  escape is a critical step for gene delivery.9 Histidine has been studied as a proton-buffering  moiety that can swell and burst the endosomes to facilitate gene transfection.10,11 Although some studies have reported the combined use of histidine and lysine,12,13  the lysine peptide lacks cell-penetrating properties as compared with the arginine correspondence: Jing gao Department of Pharmaceutical science,  school of Pharmacy, second Military  Medical University, 325 guohe road,  shanghai 200433, People’s republic of  china Tel +86 21 8187 1293 email gjsmmu@126.co m  shen gao Department of Pharmaceutics, changhai  hospital, second Military Medical  University, 168 changhai road, shanghai  200433, People’s republic of china Tel +86 21 3116 2297 email liullk@126.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Wang et al Running head recto: Chimeric polypeptide as an efficient gene delivery vector DOI: http://dx.doi.org/10.2147/IJN.S83507",Non-OADS,/arxiv_data1/oa_pdf/e0/7b/ijn-10-4669.PMC4516254.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/e0/7b/ijn-10-4669.PMC4516254.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/e0/7b/ijn-10-4669.PMC4516254.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/fe/c5/ijn-10-4653.PMC4516255.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 4653–4667International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  4653OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S8768 1styrene maleic acid micelles as a nanocarrier  system for oral anticancer drug delivery – dual  uptake through enterocytes and M-cells Neha N Parayath1 hayley Nehoff1 Philipp Müller1 sebastien Taurin1 Khaled greish1,2 1Department of Pharmacology  and T oxicology, University of Otago,   Dunedin, New Zealand; 2Department  of Oncology, Faculty of Medicine, suez  canal University, Ismaileya, egyptAbstract:  Drug delivery systems could potentially overcome low bioavailability and  gastrointestinal toxicity, which are the major challenges for the development of oral anticancer  drugs.",Non-OADS,/arxiv_data1/oa_pdf/fe/c5/ijn-10-4653.PMC4516255.pdf
"Nanosized formulations take advantage of the wide fenestrations of tumor vas - culature and the impaired lymphatic drainage to selectively accumulate in the tumor  tissue.9 Exploiting this enhanced permeability and retention (EPR) effect improves correspondence: Khaled greish Department of Pharmacology and  Toxicology, University of Otago, adams  Building, 3rd Floor, 18 Frederick street,  Dunedin 9016, New Zealand Tel +64 3 479 4095 Fax +64 3 479 9140 email khaled.greish@otago.ac.n z Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Parayath et al Running head recto: Styrene maleic acid micelles for oral anticancer drug delivery DOI: http://dx.doi.org/10.2147/IJN.S87681",Non-OADS,/arxiv_data1/oa_pdf/fe/c5/ijn-10-4653.PMC4516255.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/fe/c5/ijn-10-4653.PMC4516255.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/fe/c5/ijn-10-4653.PMC4516255.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/bf/07/ijn-10-4623.PMC4516256.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 4623–4637International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  4623OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S8445 2Immobilization of collagen peptide on dialdehyde  bacterial cellulose nanofibers via covalent bonds  for tissue engineering and regeneration Xiaoxiao Wen1 Yudong Zheng1 Jian Wu2 lu-Ning Wang1 Zhenya Yuan1 Jiang Peng3 haoye Meng3 1school of Materials science and  engineering, University of science  and T echnology Beijing, Beijing,   People’s republic of china; 2suzhou  Institute of Nano-T ech and Nano- Bionics, chinese academy of sciences,   soochow, People’s republic of china;   3Institute of Orthopedics, chinese  Pla general hospital, Beijing,   People’s republic of chinaAbstract:  Bacterial cellulose (BC) is an alternative nanostructured biomaterial to be utilized  for a wide range of biomedical applications.",Non-OADS,/arxiv_data1/oa_pdf/bf/07/ijn-10-4623.PMC4516256.pdf
"Several attempts have been made to fabricate collagen/BC and collagen hydrolysate/BC   composites for implantation.2,6,8,9 Collagen not only plays a supporting role in cell correspondence: Yudong Zheng school of Materials science and  engineering, University of science and  Technology Beijing, NO 30 Xueyuan  road, haidian District, Beijing 100083,  People’s republic of china Tel +86 10 6233 0802 email zhengyudong@mater.ustb.edu.c n Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Wen et al Running head recto: Immobilization of collagen peptide on dialdehyde BC nanofibers DOI: http://dx.doi.org/10.2147/IJN.S84452",Non-OADS,/arxiv_data1/oa_pdf/bf/07/ijn-10-4623.PMC4516256.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/bf/07/ijn-10-4623.PMC4516256.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/bf/07/ijn-10-4623.PMC4516256.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/fe/15/ijn-10-4639.PMC4516257.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 4639–4651International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  4639OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S8599 9Study of magnetic silk fibroin nanoparticles for  massage-like transdermal drug delivery ai-Zheng chen1–3 lin-Qing chen1 shi-Bin Wang1–3 Ya-Qiong Wang1 Jun-Zhe Zha1 1college of chemical engineering,   2Institute of Pharmaceutical  engineering, 3Institute of Biomaterials  and Tissue engineering, huaqiao  University, Xiamen, People’s Republic  of chinaAbstract:  A synergistic approach by the combination of magnetic nanoparticles with an  alternating magnetic field for transdermal drug delivery was investigated.",Non-OADS,/arxiv_data1/oa_pdf/fe/15/ijn-10-4639.PMC4516257.pdf
"However, there are correspondence: ai-Zheng chen college of chemical engineering, huaqiao  University, 668 Jimei avenue, Xiamen,  Fujian 361021, People’s Republic of China Tel/fax +86 592 616 2326 email azchen@hqu.edu.c n shi-Bin Wang college of chemical engineering, huaqiao  University, 668 Jimei avenue, Xiamen,  Fujian 361021, People’s Republic of China Tel/fax +86 592 616 2288 email sbwang@hqu.edu.c nJournal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Chen et al Running head recto: Magnetic silk fibroin nanoparticles DOI: http://dx.doi.org/10.2147/IJN.S85999",Non-OADS,/arxiv_data1/oa_pdf/fe/15/ijn-10-4639.PMC4516257.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/fe/15/ijn-10-4639.PMC4516257.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/fe/15/ijn-10-4639.PMC4516257.pdf
Available at: http://www.statcan .gc.ca/cgi-bin/imdb/p2SV.pl?,Non-OADS,/arxiv_data1/oa_pdf/f8/1c/NEUROLOGY2014629253.PMC4516290.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/22/fe/ndt-11-1785.PMC4516334.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2015:11 1785–1791Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1785OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S86103effects of maintenance lithium treatment on  serum parathyroid hormone and calcium levels:  a retrospective longitudinal naturalistic study Umberto albert1 David De cori1 andrea aguglia1 Francesca Barbaro1 Fabio lanfranco2 Filippo Bogetto1 giuseppe Maina3 1anxiety and Mood Disorders Unit,   rita levi Montalcini Department  of Neuroscience, University  of T urin, T orino, italy; 2Division of  endocrinology, Diabetology and  Metabolism, Department of Medical  sciences, University of T urin, T orino,   italy; 3Department of Mental health,   san luigi-gonzaga hospital, University  of T urin, Orbassano, italyObjective:  The aim of this retrospective longitudinal naturalistic study was to evaluate the  effects of maintenance lithium treatment on parathyroid hormone (PTH) and calcium levels.",Non-OADS,/arxiv_data1/oa_pdf/22/fe/ndt-11-1785.PMC4516334.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/22/fe/ndt-11-1785.PMC4516334.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/22/fe/ndt-11-1785.PMC4516334.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/24/0e/mder-8-305.PMC4516335.pdf
"Information on how to request permission may be found at: http://www.dovepress.com/permissions.ph pMedical Devices: Evidence and Research 2015:8 305–316Medical Devices: Evidence and Research Dove press submit your manuscript | www.dovepress.co m Dove press  305REviEwopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/MDER.S5004 8Cybersecurity vulnerabilities in medical devices:   a complex environment and multifaceted problem Patricia AH williams Andrew J woodward eHealth Research Group and Security  Research institute, Edith Cowan  University, Perth, wA, Australia Correspondence: Patricia AH williams   School of Computer and Security  Science, Edith Cowan University,   270 Joondalup Drive, Joondalup,   wA 6027, Australia   Tel +61 8 6304 5039   Fax +61 8 6304 2599   Email trish.williams@ecu.edu.a uAbstract:  The increased connectivity to existing computer networks has exposed medical  devices to cybersecurity vulnerabilities from which they were previously shielded.",Non-OADS,/arxiv_data1/oa_pdf/24/0e/mder-8-305.PMC4516335.pdf
Available  from: http://www.sans.org/reading-room/ whitepapers /firewall s/health- care-cyberthreat-report- widespread - compromises- detected- compliance- nightmare-horizon-3473 5.,Non-OADS,/arxiv_data1/oa_pdf/24/0e/mder-8-305.PMC4516335.pdf
"Available from: http://www.fda.gov/downloads/ MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/ UCM356190.pd f. Accessed June 9, 2015.",Non-OADS,/arxiv_data1/oa_pdf/24/0e/mder-8-305.PMC4516335.pdf
"Available from: http://www.fda.gov/downloads/ AboutFDA/CentersOffices/OfficeofMedicalProductsandTobacco/ CDRH/CDRH Reports/ UCM391521.pd f. Accessed June 9, 2015.",OADS,/arxiv_data1/oa_pdf/24/0e/mder-8-305.PMC4516335.pdf
Available from:  http://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/ GeneralHos pitalDevicesandSupplies/MedicalDeviceDataSystems/ ucm251897.ht m. Accessed June.,Non-OADS,/arxiv_data1/oa_pdf/24/0e/mder-8-305.PMC4516335.pdf
"Available from: http://www.imdrf.org/ docs/imdrf/final/technical/imdrf-tech-140918-samd-framework-risk- categorization-141013.pd f. Accessed June 9, 2015.",Non-OADS,/arxiv_data1/oa_pdf/24/0e/mder-8-305.PMC4516335.pdf
"Available from: http://spectrum.ieee.org/biomedical/devices/ medical-devices-are-vulnerable-to-hacks-but-risk-is-low-overal l.  Accessed June 9, 2015.",OADS,/arxiv_data1/oa_pdf/24/0e/mder-8-305.PMC4516335.pdf
"Available  from: http://www.livescience.com/39889-medical-devices-vulnerable- to-hackers.htm l. Accessed June 9, 2015.",Non-OADS,/arxiv_data1/oa_pdf/24/0e/mder-8-305.PMC4516335.pdf
"Available from: https://congress.isc2.org/sites/default/ files /Session2 145-MedicalDeviceSecurityAsPartOverallRisk   Management Process.pd f. Accessed June 9, 2015.",OADS,/arxiv_data1/oa_pdf/24/0e/mder-8-305.PMC4516335.pdf
Available from: http://secure-medicine.org /.,Non-OADS,/arxiv_data1/oa_pdf/24/0e/mder-8-305.PMC4516335.pdf
Available from: http://www.healthcareinfosecurity.com/medical- device-security-raises-concerns-a-364 4.,Non-OADS,/arxiv_data1/oa_pdf/24/0e/mder-8-305.PMC4516335.pdf
Available from: https://info.publicintelligence.net/ FBI- HealthCareCyberIntrusions .pdf.,Non-OADS,/arxiv_data1/oa_pdf/24/0e/mder-8-305.PMC4516335.pdf
Available  from: http://www.healthcareitnews.com/print/6102 1.,Non-OADS,/arxiv_data1/oa_pdf/24/0e/mder-8-305.PMC4516335.pdf
"Available from: http://www.mddionline.com/article/fda-guidance- wireless-devices-what-you-need-kno w. Accessed June 9, 2015.",Non-OADS,/arxiv_data1/oa_pdf/24/0e/mder-8-305.PMC4516335.pdf
Available  from: http://www.reuters.com/article/2014/10/22/us-cybersecurity- medicaldevices-insight-idUSKCN0IB0DQ2014102 2.,Non-OADS,/arxiv_data1/oa_pdf/24/0e/mder-8-305.PMC4516335.pdf
"Available from: http://spectrum.ieee.org/tech-talk/biomedical/devices/ feds-probe-cybersecurity-dangers-in-medical-device s. Accessed June 9,  2015.",OADS,/arxiv_data1/oa_pdf/24/0e/mder-8-305.PMC4516335.pdf
Available form: http://www.healthcareinfosecurity.com/interviews.,Non-OADS,/arxiv_data1/oa_pdf/24/0e/mder-8-305.PMC4516335.pdf
2013:16. http://www2.deloitte.,Non-OADS,/arxiv_data1/oa_pdf/24/0e/mder-8-305.PMC4516335.pdf
Available from: http://www.fda.,Non-OADS,/arxiv_data1/oa_pdf/24/0e/mder-8-305.PMC4516335.pdf
"Medical Devices: Evidence and Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/medical-devices-evidence-and-research-journa lMedical Devices: Evidence and Research is an international, peer- reviewed, open access journal that focuses on the evidence, technology,  research, and expert opinion supporting the use and application of  medical devices in the diagnosis, treatment and management of clini - cal conditions and physiological processes.",Non-OADS,/arxiv_data1/oa_pdf/24/0e/mder-8-305.PMC4516335.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f5/76/ndt-11-1799.PMC4516336.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2015:11 1799–1803Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1799Case repor Topen access to scientific and medical research open access Full T ext article http: //dx.doi.org/10.2147/NDT .S8612 0sudden loss of the deep brain stimulation effect  with high impedance without macroscopic  fracture: a case report and review of the  published literature Hui-Jun Yang1 Ji Y oung Yun2 Y oung eun Kim3 Y ong Hoon Lim4 Han-Joon Kim5 sun Ha paek4 Beom s Jeon5 1Department of Neurology,   Ulsan University Hospital, Ulsan,   2Department of Neurology, ewha  Womans University Mokdong  Hospital, seoul, 3Department of  Neurology, Hallym University  sacred Heart Hospital, anyang,   4Department of Neurosurgery,   seoul National University Hospital,   seoul, 5Department of Neurology  and Movement Disorder Center,   parkinson’s Disease study Group and  Neuroscience research Institute,   seoul National University Hospital,   seoul, south KoreaAbstract:  The number of deep brain stimulation (DBS) hardware complications has increased  during the past decade.",Non-OADS,/arxiv_data1/oa_pdf/f5/76/ndt-11-1799.PMC4516336.pdf
"Cases with no  evidence of macroscopic fracture are more challenging, and optimal approach has not Correspondence: Beom s Jeon Department of Neurology, seoul  National University Hospital,   101 Daehak- ro, Jongno-Gu, seoul 110-744,   south Korea Tel +82 2 2072 2876 Fax +82 2 2072 0839 email brain@snu.ac.k r Journal name: Neuropsychiatric Disease and Treatment Article Designation: Case report Y ear: 2015 Volume: 11 Running head verso: Y ang et al Running head recto: DBS system open circuit without macroscopic fracture DOI: http://dx.doi.org/10.2147/NDT.S86120",Non-OADS,/arxiv_data1/oa_pdf/f5/76/ndt-11-1799.PMC4516336.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/f5/76/ndt-11-1799.PMC4516336.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/f5/76/ndt-11-1799.PMC4516336.pdf
"Available from: http://www.medtronic.co.kr/ wcm/groups/mdtcom_sg/@mdt/@neuro/documents/documents/ dbs-mr i-impedances.pd f. Accessed June 1, 2015.",OADS,/arxiv_data1/oa_pdf/f5/76/ndt-11-1799.PMC4516336.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/31/dc/tcrm-11-1081.PMC4516337.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpTherapeutics and Clinical Risk Management 2015:11 1081–1087Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  1081Case seRiesopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S8694 8Treatment of degloving injury involving multiple  fingers with combined abdominal superficial  fascial flap, dorsalis pedis flap, dorsal toe flap,  and toe-web flap Fengshan Han Guangnan Wang Gaoshan Li Juan Ping Zhi Mao Department of Microsurgery, PLA 205  Hospital, Jinzhou, People’s Republic  of ChinaBackground:  Our aim was to summarize the treatment of degloving injury involving multiple  fingers using combined abdominal superficial fascial flap, dorsalis pedis flap, dorsal toe flap,  and toe-web flap.",Non-OADS,/arxiv_data1/oa_pdf/31/dc/tcrm-11-1081.PMC4516337.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/31/dc/tcrm-11-1081.PMC4516337.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/31/dc/tcrm-11-1081.PMC4516337.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/6e/d0/imcrj-8-145.PMC4516338.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Medical Case Reports Journal 2015:8 145–150International Medical Case Reports Journal Dove press submit your manuscript | www.dovepress.co m Dove press  145Case seRIesopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IMCRJ.S8382 1Cyanoacrylate tissue glue for wound repair in  early posttrabeculectomy conjunctival bleb leak: a  case series abdul-Rahim Haslinda Yaakub azhany Rasid Noor-Khairul embong Zunaina ahmad-Tajudin Liza- sharmini Department of Ophthalmology,   school of Medical sciences, Health  Campus, Universiti sains Malaysia,   Kubang Kerian, Kelantan, Malaysia Correspondence: Yaakub azhany   Department of Ophthalmology, school  of Medical sciences, Health Campus,  Universiti sains Malaysia,  16150 Kubang  Kerian, Kelantan, Malaysia   Tel +60 1 9767 6362   Fax +60 1 9765 3370  email azhany@usm.m yAbstract:  We demonstrated a noninvasive management of early bleb leak following trabeculec - tomy using cyanoacrylate tissue glue (CATG).",Non-OADS,/arxiv_data1/oa_pdf/6e/d0/imcrj-8-145.PMC4516338.pdf
"International Medical Case Reports Journal Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-medical-case-reports-journal-journa lThe International Medical Case Reports Journal is an international,  peer-reviewed open-access journal publishing original case reports  from all medical specialties.",Non-OADS,/arxiv_data1/oa_pdf/6e/d0/imcrj-8-145.PMC4516338.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/6e/d0/imcrj-8-145.PMC4516338.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a0/3c/ijwh-7-735.PMC4516339.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Women’s Health 2015:7 735–744International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  735RevIeWopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJWH.S6079 8From bladder to systemic syndrome: concept  and treatment evolution of interstitial cystitis Sara Dinis1,2 Joana Tavares de Oliveira3,4 Rui Pinto1,5 Francisco Cruz1,5 CA T ony Buffington6 Paulo Dinis1,5 1Faculty of Medicine, University  of Porto, 2Department of Obstetrics  and Gynecology, Hospital de São  João, Porto, 3Faculty of veterinary  Medicine, ULHT, Lisbon, 4Institute  of Molecular Pathology and  Immunology (IPATIMUP), University  of Porto, 5Department of Urology,   Hospital de São João, Porto, Portugal;   6Department of veterinary Clinical  Sciences, College of veterinary  Medicine, The Ohio State University,   OH, USAAbstract:  Interstitial cystitis, presently known as bladder pain syndrome, has been recognized  for over a century but is still far from being understood.",Non-OADS,/arxiv_data1/oa_pdf/a0/3c/ijwh-7-735.PMC4516339.pdf
"These are observed predominantly in the bladder lateral walls in up to 50%  of the patients.1Correspondence: Paulo Dinis Department of Urology, Hospital São  João, 4200 Porto, Portugal email paulodinisoliveira@gmail.co m Journal name: International Journal of Women’s Health Article Designation: Review Y ear: 2015 Volume: 7 Running head verso: Dinis et al Running head recto: From bladder to systemic syndrome  DOI: http://dx.doi.org/10.2147/IJWH.S60798",Non-OADS,/arxiv_data1/oa_pdf/a0/3c/ijwh-7-735.PMC4516339.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/a0/3c/ijwh-7-735.PMC4516339.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/a0/3c/ijwh-7-735.PMC4516339.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/1f/9a/imcrj-8-141.PMC4516340.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Medical Case Reports Journal 2015:8 141–144International Medical Case Reports Journal Dove press submit your manuscript | www.dovepress.co m Dove press  141Case Repo Rtopen access to scientific and medical research open access Full text article http: //dx.doi.org/10.2147/IMCRJ.S8596 4acute macular edema following intracorporeal  prostaglandin injection for erectile dysfunction Masumi G asahi Calvin Chou Ron p Gallemore Retina Macula Institute, torrance,    Ca, Usa Correspondence: Ron p Gallemore   4201 torrance Boulevard,   torrance, Ca 90503, Usa   tel +1 310 944 9393   Fax +1 310 944 3393   email rongallemoremd@gmail.co mPurpose:  We aimed to describe the first case of macular edema following intracorporeal injec - tion of alprostadil, a prostaglandin E1.",Non-OADS,/arxiv_data1/oa_pdf/1f/9a/imcrj-8-141.PMC4516340.pdf
"International Medical Case Reports Journal Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-medical-case-reports-journal-journa lThe International Medical Case Reports Journal is an international,  peer-reviewed open-access journal publishing original case reports  from all medical specialties.",Non-OADS,/arxiv_data1/oa_pdf/1f/9a/imcrj-8-141.PMC4516340.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/1f/9a/imcrj-8-141.PMC4516340.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/54/1b/tacg-8-171.PMC4516341.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pThe Application of Clinical Genetics 2015:8 171–179The Application of Clinical Genetics Dove press submit your manuscript | www.dovepress.co m Dove press  171Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TACG.S5661 2Alström syndrome: current perspectives María Álvarez-Satta Sheila Castro-Sánchez Diana valverde Departamento de Bioquímica,   Genética e inmunología, Facultad de  Biología, Universidad de vigo, vigo,   Spain Correspondence: Diana valverde   Departamento de Bioquímica, Genética  e inmunología, Facultad de Biología,  Universidad de vigo, Campus As Lagoas- Marcosende s/n, 36310 vigo, Spain   Tel +34 986 811 953   email dianaval@uvigo.e sAbstract:  Alström syndrome (ALMS) is a rare genetic disorder that has been included in  the ciliopathies group, in the last few years.",Non-OADS,/arxiv_data1/oa_pdf/54/1b/tacg-8-171.PMC4516341.pdf
Available  from: http://www.orpha.net /.,Non-OADS,/arxiv_data1/oa_pdf/54/1b/tacg-8-171.PMC4516341.pdf
"Available from: http://www.ncbi.nlm.nih.gov/protei n.  Accessed March 13, 2015.",OADS,/arxiv_data1/oa_pdf/54/1b/tacg-8-171.PMC4516341.pdf
"The Application of Clinical Genetics Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/the-application-of-clinical-genetics-journa lThe Application of Clinical Genetics is an international, peer-reviewed  open access journal that welcomes laboratory and clinical findings in  the field of human genetics.",Non-OADS,/arxiv_data1/oa_pdf/54/1b/tacg-8-171.PMC4516341.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/54/1b/tacg-8-171.PMC4516341.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d3/03/prbm-8-211.PMC4516342.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pPsychology Research and Behavior Management 2015:8 211–223Psychology Research and Behavior Management Dove press submit your manuscript | www.dovepress.co m Dove press  211Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PRBM.S7510 6Cognitive-behavioral therapy for obsessive– compulsive disorder: access to treatment,  prediction of long-term outcome with neuroimaging Joseph O’Neill1 Jamie D Feusner2 1Division of Child Psychiatry, 2Division  of Adult Psychiatry, UCLA Semel  institute for Neuroscience and  Human Behavior, Los Angeles, CA,   USA Correspondence: Joseph O’Neill   Division of Child Psychiatry, UCLA   Semel institute for Neuroscience,   760 westwood Plaza #58-227A,   Los Angeles, CA 90024-1759, USA   email joneill@mednet.ucla.ed uAbstract:  This article reviews issues related to a major challenge to the field for obsessive– compulsive disorder (OCD): improving access to cognitive-behavioral therapy (CBT).",Non-OADS,/arxiv_data1/oa_pdf/d3/03/prbm-8-211.PMC4516342.pdf
"The International Obsessive–Compulsive Disorder  Foundation (IOCDF , http://iocdf.org /) has done tremendous  work in these areas over the years.",Non-OADS,/arxiv_data1/oa_pdf/d3/03/prbm-8-211.PMC4516342.pdf
"The issue of the shortage of trained CBT therapists is  being countered in part by the IOCDF , which offers CBT  training for licensed therapists by top leaders in the field  through their Behavior Therapy Training Institute (BTTI)  http://iocdf.org /professionals/training-institute/btti/  three  times per year at relatively modest cost due to partial subsi - dization through the foundation.",Non-OADS,/arxiv_data1/oa_pdf/d3/03/prbm-8-211.PMC4516342.pdf
"Psychology Research and Behavior Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/psychology-research-and-behavior-management-journa lPsychology Research and Behavior Management is an international, peer- reviewed, open access journal focusing on the science of psychology and  its application in behavior management to develop improved outcomes  in the clinical, educational, sports and business arenas.",Non-OADS,/arxiv_data1/oa_pdf/d3/03/prbm-8-211.PMC4516342.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/d3/03/prbm-8-211.PMC4516342.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/74/c2/ppa-9-1043.PMC4516344.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2015:9 1043–1051Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  1043OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S8190 1Patient willingness for repeat screening and  preference for cT colonography and optical  colonoscopy in A crin 6664: the national cT  colonography trial ilana F gareen1,2 Bettina siewert3 David J Vanness4 Benjamin herman2 cD Johnson5 constantine gatsonis2,6 1Department of epidemiology, Brown  University school of Public health,   Providence, ri, UsA; 2center for  statistical sciences, Brown University  school of Public health, Providence,   ri, UsA; 3Department of radiology,   Beth israel Deaconess Medical center,   Boston, MA, UsA; 4Population health  sciences, University of Wisconsin,   Madison, Wi, UsA; 5Mayo clinic,   scottsdale, AZ, UsA; 6Department  of Biostatistics, Brown University  school of Public health, Providence,   ri, UsABackground:  Current American Cancer Society recommendations for colon cancer screening  include optical colonoscopy every 10 years or computed tomography colonography (CTC) every  5 years.",Non-OADS,/arxiv_data1/oa_pdf/74/c2/ppa-9-1043.PMC4516344.pdf
"Keywords:  CT colonography, colonoscopy, bowel preparation, adherence, patient  preference Introduction Colorectal cancer is a major cause of morbidity and mortality in the United States,  with 143,460 new cases and 51,690 deaths attributed to colorectal cancer in 2012.1  The US Preventive Services Task Force currently recommends that adults aged  50–75 at low-risk for colon cancer receive regular screening according to one of  three regimens: 1) annual screening with high-sensitivity fecal occult blood test - ing (FOBT); 2) sigmoidoscopy every 5 years, with high-sensitivity FOBT every   3 years; or 3) screening colonoscopy every 10 years.2,3 Colorectal cancer mortality  reduction has been demonstrated for FOBT, sigmoidoscopy, and colonoscopy with correspondence: ilana F gareen center for statistical sciences, Brown  University school of Public health, Box  g-s121-7, Providence, ri 02912, UsA Tel +1 401 863 1758 Fax +1 401 863 9182 email igareen@stat.brown.ed u Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Gareen et al Running head recto: CTC patient preference and planned adherence DOI: http://dx.doi.org/10.2147/PPA.S81901",Non-OADS,/arxiv_data1/oa_pdf/74/c2/ppa-9-1043.PMC4516344.pdf
"Available from: http://www.acrin.org/Portals/0/ Protocols/6664/ACRIN_6664_AdminUpdate_080410_master.pd f.  Accessed May 19, 2015.",OADS,/arxiv_data1/oa_pdf/74/c2/ppa-9-1043.PMC4516344.pdf
"24. http://www.acrin.org/Portals/0/Protocols/6664/forms/6664participant_ ques.pd f. Accessed May 19, 2015.",OADS,/arxiv_data1/oa_pdf/74/c2/ppa-9-1043.PMC4516344.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/74/c2/ppa-9-1043.PMC4516344.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b8/73/ppa-9-1033.PMC4516345.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2015:9 1033–1041Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  1033OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S8340 3Development of an unsupportive social  interaction scale for patients with diabetes Orna Baron-epel1 Anthony David heymann2,3 nurit Friedman3 giora Kaplan4 1school of Public health, Faculty of  social Welfare and health sciences,   University of haifa, haifa, israel;   2Department of Family Medicine,   T el Aviv University, T el Aviv, israel;   3Maccabi healthcare services, T el Aviv,   4Psychosocial Aspects of health, The  gertner institute for epidemiology  and health Policy research, sheba  Medical center, ramat gan, israelObjectives:  The positive aspects of social support and its impact on health have been studied  extensively.",Non-OADS,/arxiv_data1/oa_pdf/b8/73/ppa-9-1033.PMC4516345.pdf
"Satisfaction with support is  a predictor, for example, of improved diabetes-specific quality of life and blood glucose  monitoring.8,9 However, nonsupportive behaviors seem to predict poor adherence with  recommended medications.9 In a study of 46 individuals with diabetes, it was suggested  that negative social support may interfere with effective diabetes management.10correspondence: Orna Baron-epel school of Public health, Faculty of social  Welfare and health sciences, University  of haifa, 199 Abba Khoushy, Mount  carmel, haifa, israel Tel +972 4 828 8009 Fax +972 4 828 8637 email ornaepel@research.haifa.ac.i l Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Baron-Epel et al Running head recto: Unsupportive social interaction scale for patients with diabetes DOI: http://dx.doi.org/10.2147/PPA.S83403",Non-OADS,/arxiv_data1/oa_pdf/b8/73/ppa-9-1033.PMC4516345.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/b8/73/ppa-9-1033.PMC4516345.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/29/d7/imcrj-8-151.PMC4516346.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Medical Case Reports Journal 2015:8 151–153International Medical Case Reports Journal Dove press submit your manuscript | www.dovepress.co m Dove press  151Case Repo Rtopen access to scientific and medical research open access Full text article http: //dx.doi.org/10.2147/IMCRJ.S8829 5Combination immunotherapy in the treatment of  chronic bilateral panuveitis and uveitic glaucoma  during acute dengue fever infection in the  Caribbean Kevin p stewart1,2 Jan B tawakol3,4 tasnim Khan3,4 Joseph a Capriotti1,2 1plessen ophthalmology Consultants,   2Department of surgery, Juan F Luis  Hospital, 3plessen Healthcare, LLC,   4Department of Medicine, Juan F Luis  Hospital, Christiansted, United states  Virgin Islands Correspondence: Joseph a Capriotti   plessen ophthalmology Consultants, po  Box 5981, Christiansted 00820, United  states Virgin Islands   tel +1 340 773 2015   email jacapriottimd@gmail.co mBackground:  Ocular manifestations of the dengue fever virus include bilateral panuveitis that  can occur after the acute systemic infection has resolved.",Non-OADS,/arxiv_data1/oa_pdf/29/d7/imcrj-8-151.PMC4516346.pdf
"International Medical Case Reports Journal Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-medical-case-reports-journal-journa lThe International Medical Case Reports Journal is an international,  peer-reviewed open-access journal publishing original case reports  from all medical specialties.",Non-OADS,/arxiv_data1/oa_pdf/29/d7/imcrj-8-151.PMC4516346.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/29/d7/imcrj-8-151.PMC4516346.pdf
Available from: http://www.who.int/mediacentre/factsheets/fs117/ en/.,Non-OADS,/arxiv_data1/oa_pdf/29/d7/imcrj-8-151.PMC4516346.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e5/d9/prom-6-191.PMC4516347.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pPatient Related Outcome Measures 2015:6 191–203Patient Related Outcome Measures Dove press submit your manuscript | www.dovepress.co m Dove press  191ORiginal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/PROM.S7517 3evaluation of performance quality of an advanced  scope physiotherapy role in a hospital emergency  department J Morris1 K Vine1 K grimmer2 1Physiotherapy Department, The  canberra hospital, cnr hindmarsh  Dr & Yamba Dr, garran, acT,   2international centre for allied  health evidence, University of south  australia, city east campus, adelaide,   sa, australiaBackground:  Physiotherapists working in advanced and extended scope roles internationally  make a difference to workflow, performance targets, and patient satisfaction in areas tradition - ally served by medicine and nursing.",Non-OADS,/arxiv_data1/oa_pdf/e5/d9/prom-6-191.PMC4516347.pdf
"One FTE provided a  within scope (usual) physiotherapy role (working in second - ary contact roles), this PT is employed at a Health Profes - sional 2 level ( http://www.jobs.act.gov.au/__data/assets/pdf_file/0012/530031/Health-Professionals-Agreement.",Non-OADS,/arxiv_data1/oa_pdf/e5/d9/prom-6-191.PMC4516347.pdf
Available from: http://www.aihw.,Non-OADS,/arxiv_data1/oa_pdf/e5/d9/prom-6-191.PMC4516347.pdf
"Available from: Accessed July  7,  2013. http://www.acem.org.au/media/P06_Policy_on_ATS_v4_Jul-13_.",Non-OADS,/arxiv_data1/oa_pdf/e5/d9/prom-6-191.PMC4516347.pdf
Available from: http://www.myhospitals.,Non-OADS,/arxiv_data1/oa_pdf/e5/d9/prom-6-191.PMC4516347.pdf
Available from:http://www.myhospitals.gov.au/hospital/the-canberra- hospital/services/emergency-department/time-in-emergency.,Non-OADS,/arxiv_data1/oa_pdf/e5/d9/prom-6-191.PMC4516347.pdf
"Available from: http://apps.who.int/classification/ icd10/browse/2010/e n. Accessed November  12, 2013.",OADS,/arxiv_data1/oa_pdf/e5/d9/prom-6-191.PMC4516347.pdf
"Patient Related Outcome Measures Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-related-outcome-measures-journa lPatient Related Outcome Measures is an international, peer-reviewed,  open access journal focusing on treatment outcomes specifically  relevant to patients.",Non-OADS,/arxiv_data1/oa_pdf/e5/d9/prom-6-191.PMC4516347.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/e5/d9/prom-6-191.PMC4516347.pdf
"Patient Related Outcome Measures 2015:6submit your manuscript | www.dovepress.co m Dove press Dove press Dove pres s 203advanced scope physiotherapy in eD Supplementary material state and territory legislation documents  relating to medicines •	Victorian Drugs, Poisons and Controlled Substances Act   1981:  http://www.legislation.vic.gov.au/Domino/Web_Notes/ LDMS/LTObject_Store/LTObjSt7.nsf/DDE300B846E ED9C7CA257616000A3571/3E94BBFB45B6850AC A257A700000A6DF/$FILE/81-9719aa099%20autho - rised.pd f •	Controlled Substances Act  1984 – South Australia:  http://www.legislation.sa.gov.au/LZ/C/A/ CONTROLLED %20SUBSTANCES%20ACT%20 1984/2004.09.29/1984.52.PD F •	Health (Drugs and Poisons) Regulation  1996 – Queen- sland:  http://www.legislation.qld.gov.au/LEGISLTN/ CURRENT/H/HealDrAPoR96.pd f •	Poisons Act  1971 – Tasmania:  http://www.thelaw.tas.gov.au/tocview/index.",Non-OADS,/arxiv_data1/oa_pdf/e5/d9/prom-6-191.PMC4516347.pdf
"w3p;cond=all;doc_id=81%2B%2B197 1%2BAT%40E N%2B20100214000000;histon=;prompt=;rec=;term=p oisons%20act•	Poisons and Therapeutic Drugs Act  1966 – New South  Wales:  http://www.legislation.nsw.gov.au/maintop/view/inforce/ act+31+ 1966+cd+0+ N •	Poisons and Therapeutic Goods Regulation  2002:  http://www.legislation.nsw.gov.au/fullhtml/inforce/ subordleg+639+2002+FIRST+0+ N •	Northern Territory Poisons and Dangerous Drugs Act:  http://www.austlii.edu.au/au/legis/nt/consol_act/ padda296 / •	Western Australia Poisons Act  1964:  http://www.austlii.edu.au/au/legis/wa/consol_act/ pa1964121 / •	Poisons Regulations  1965:  http://www.austlii.edu.au/au/legis/wa/consol_reg/ pr1965230/s40.htm l •	Australian Capital Territory – Medicines, Poisons and  Therapeutic Goods Act  2008:  http://www.legislation.act.gov.au/a/2008-26/current/ pdf/2008-26.pd f.",Non-OADS,/arxiv_data1/oa_pdf/e5/d9/prom-6-191.PMC4516347.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/43/7d/jpr-8-431.PMC4516348.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pJournal of Pain Research 2015:8 431–436Journal of Pain Research Dove press submit your manuscript | www.dovepress.co m Dove press  431ORiginal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/JPR.S8673 2The influence of repeated pain stimulation on the  emotional aspect of pain: a preliminary study  in healthy volunteers hiroshi Maeoka Makoto hiyamizu atsushi Matsuo shu Morioka Department of Physical Therapy,   Faculty of health science, Kio  University, Koryo-cho, Kitakatsuragi- gun, nara, Japan correspondence: hiroshi Maeoka   Department of Physical Therapy, Faculty  of health science, Kio University,   4-2-2 Umami-naka, Koryo-cho,  Kitakatsuragi-gun, nara,  635-0832, Japan   Tel +81 745 54 1601  Fax +81 745 54 1600  email h.maeoka@kio.ac.j pPurpose:  Pain is a multidimensional experience with sensory-discriminative, cognitive-evaluative,  and affective-motivational components.",Non-OADS,/arxiv_data1/oa_pdf/43/7d/jpr-8-431.PMC4516348.pdf
"Journal of Pain Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-pain-research-journa lThe Journal of Pain Research is an international, peer-reviewed, open  access, online journal that welcomes laboratory and clinical findings  in the fields of pain research and the prevention and management  of pain.",Non-OADS,/arxiv_data1/oa_pdf/43/7d/jpr-8-431.PMC4516348.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/43/7d/jpr-8-431.PMC4516348.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/7f/76/ndt-11-1793.PMC4516349.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2015:11 1793–1798Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1793OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S8390 4Markers of neurodevelopmental impairments  in early-onset psychosis Maria giuseppina  Petruzzelli1 lucia Margari1 Francesco craig1 Maria gloria campa1 Domenico Martinelli2 adriana Pastore3 Marta simone1 Francesco Margari3 1child and adolescence Neuropsychiatry  Unit, Department of  Basic Medical  sciences, Neuroscience and sense  Organs, University “ aldo Moro” of Bari,  2Department of Medical and surgical  sciences; University of Foggia, Foggia,  3Psychiatry Unit, Department of Basic  Medical sciences, Neuroscience and  sense Organ, University “ aldo Moro”  of Bari, Bari, italyBackground:  The aim of this study was to assess the association between the clinical and  neurobiological markers of neurodevelopmental impairments and early-onset schizophrenia  spectrum psychosis.",Non-OADS,/arxiv_data1/oa_pdf/7f/76/ndt-11-1793.PMC4516349.pdf
"70120,  Bari, italy email lucia.margari@uniba.i t Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2015 Volume: 11 Running head verso: Petruzzelli et al Running head recto: Neurodevelopment in early psychosis DOI: http://dx.doi.org/10.2147/NDT.S83904",Non-OADS,/arxiv_data1/oa_pdf/7f/76/ndt-11-1793.PMC4516349.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/7f/76/ndt-11-1793.PMC4516349.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/7f/76/ndt-11-1793.PMC4516349.pdf
"All rights reserved.www.rpped.com.br EDITORIAL Use of molecular test for adenovirus detection   between different pediatric patients Aplicação de teste molecular para detecção   de adenovírus em pacientes pediátricos distintos Terezinha Maria de Paiva Laboratório de Vírus Respiratórios/NDR/CV, Instituto Adolfo Lutz, São Paulo, Brazil Received 24 february 2015 DOI of original articles: http://dx.doi.org/10.1016/j.rpped.2015.03.005, http://dx.doi.org/10.1016/j.rpped.2014.09.004  E-mail: tterezinha@uol.com.brThe evolution of the methodologies used in the diagnosis of  acute respiratory infections of viral etiology is due to the  advancement of molecular biology, immunology, genetics and  biotechnology.",Non-OADS,/arxiv_data1/oa_pdf/16/cd/0103-0582-rpp-33-02-00134.PMC4516364.pdf
DOI of original article: http://dx.doi.org/10.1016/j.rpped.2014.09.004 *Corresponding author.,OADS,/arxiv_data1/oa_pdf/8f/5d/0103-0582-rpp-33-02-00136.PMC4516365.pdf
DOI of original article: http://dx.doi.org/10.1016/j.rpped.2014.09.005 *Corresponding author.,OADS,/arxiv_data1/oa_pdf/96/19/0103-0582-rpp-33-02-00142.PMC4516366.pdf
DOI of original article: http://dx.doi.org/10.1016/j.rpped.2014.09.006 * Corresponding author.,OADS,/arxiv_data1/oa_pdf/3f/4c/0103-0582-rpp-33-02-00150.PMC4516367.pdf
DOI of original article: http://dx.doi.org/10.1016/j.rpped.2014.11.006 *Corresponding author.,OADS,/arxiv_data1/oa_pdf/06/50/0103-0582-rpp-33-02-00154.PMC4516368.pdf
Available from: http://bvsms.saude.gov.br/bvs/ publicacoes/anvisa/diagnostico.pdf  8.,OADS,/arxiv_data1/oa_pdf/06/50/0103-0582-rpp-33-02-00154.PMC4516368.pdf
Available from: http://tabnet.datasus.gov.br/cgi/idb2012/ g14_08.htm 11.,OADS,/arxiv_data1/oa_pdf/06/50/0103-0582-rpp-33-02-00154.PMC4516368.pdf
Available from: http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/06/50/0103-0582-rpp-33-02-00154.PMC4516368.pdf
Available from: http://dab.saude.gov.br/portaldab/biblioteca.,Non-OADS,/arxiv_data1/oa_pdf/06/50/0103-0582-rpp-33-02-00154.PMC4516368.pdf
Available from:  http://tabnet.datasus.gov.br/cgi/idb2012/g11.htm  26.,OADS,/arxiv_data1/oa_pdf/06/50/0103-0582-rpp-33-02-00154.PMC4516368.pdf
DOI of original article: http://dx.doi.org/10.1016/j.rpped.2014.09.003 *Corresponding author.,OADS,/arxiv_data1/oa_pdf/62/93/0103-0582-rpp-33-02-00167.PMC4516370.pdf
Available from: http://www.ibge.gov.br 13.,Non-OADS,/arxiv_data1/oa_pdf/62/93/0103-0582-rpp-33-02-00167.PMC4516370.pdf
Available  from: http://www.atlasbrasil.org.br 14.,Non-OADS,/arxiv_data1/oa_pdf/62/93/0103-0582-rpp-33-02-00167.PMC4516370.pdf
Available from: http://www.who.int/dietphysicalactivity/ factsheet young people/en/ 15.,Non-OADS,/arxiv_data1/oa_pdf/62/93/0103-0582-rpp-33-02-00167.PMC4516370.pdf
Available from: http://www.abep.org/new/ 21.,Non-OADS,/arxiv_data1/oa_pdf/62/93/0103-0582-rpp-33-02-00167.PMC4516370.pdf
Available from:  http://www.healthypeople.gov/2020/default.aspx 27.,Non-OADS,/arxiv_data1/oa_pdf/62/93/0103-0582-rpp-33-02-00167.PMC4516370.pdf
DOI of original article: http://dx.doi.org/10.1016/j.rpped.2014.09.002 *Corresponding author.,OADS,/arxiv_data1/oa_pdf/32/e7/0103-0582-rpp-33-02-00174.PMC4516371.pdf
Available from: http://www.who.int/mediacentre/factsheets/fs317/en/index.html 2.,Non-OADS,/arxiv_data1/oa_pdf/32/e7/0103-0582-rpp-33-02-00174.PMC4516371.pdf
DOI of original article: http://dx.doi.org/10.1016/j.rpped.2014.11.010 *Corresponding author.,OADS,/arxiv_data1/oa_pdf/e2/79/0103-0582-rpp-33-02-00181.PMC4516372.pdf
DOI of original article: http://dx.doi.org/10.1016/j.rpped.2014.11.001 *Corresponding author.,OADS,/arxiv_data1/oa_pdf/59/a1/0103-0582-rpp-33-02-00187.PMC4516373.pdf
DOI of original article: http://dx.doi.org/10.1016/j.rpped.2014.10.001 *Corresponding author.,OADS,/arxiv_data1/oa_pdf/6e/d2/0103-0582-rpp-33-02-00194.PMC4516374.pdf
Available from: http://www.who.int/ gho/ncd/en/.,OADS,/arxiv_data1/oa_pdf/6e/d2/0103-0582-rpp-33-02-00194.PMC4516374.pdf
Available  from: http://www.cidades.ibge.gov.br 17.,Non-OADS,/arxiv_data1/oa_pdf/6e/d2/0103-0582-rpp-33-02-00194.PMC4516374.pdf
DOI of original article: http://dx.doi.org/10.1016/j.rpped.2014.04.006 *Corresponding author.E-mail: martins.andreamebl@gmail.com (A.M.E.B.L.,Non-OADS,/arxiv_data1/oa_pdf/2f/55/0103-0582-rpp-33-02-00204.PMC4516375.pdf
DOI of original article: http://dx.doi.org/10.1016/j.rpped.2015.03.002   *Corresponding author.,OADS,/arxiv_data1/oa_pdf/a6/6f/0103-0582-rpp-33-02-00211.PMC4516376.pdf
Available from: http://bvsms.saude.gov.br/bvs/publicacoes/pnds_crianca_mulher.pdf 9.,Non-OADS,/arxiv_data1/oa_pdf/a6/6f/0103-0582-rpp-33-02-00211.PMC4516376.pdf
Available from: http://ibge.gov.br/home/estatistica/populacao/condicaodevida/pof/2008_2009_encaa/pof_20082009_encaa.pdf 10.,Non-OADS,/arxiv_data1/oa_pdf/a6/6f/0103-0582-rpp-33-02-00211.PMC4516376.pdf
Available from: http://www.fnde.gov.br/arquivos/category/110-alimentacao-e-nutricao?,Non-OADS,/arxiv_data1/oa_pdf/a6/6f/0103-0582-rpp-33-02-00211.PMC4516376.pdf
DOI of original article: http://dx.doi.org/10.1016/j.rpped.2015.03.001   *Corresponding author.,OADS,/arxiv_data1/oa_pdf/8b/9b/0103-0582-rpp-33-02-00222.PMC4516377.pdf
Available from: http://www.who.int/entity/dietphysicalactivity/childhood/WHO_newchild hoodobesity_PREVENTION 27nov_HR_PRINT_OK.pdf 4.,Non-OADS,/arxiv_data1/oa_pdf/8b/9b/0103-0582-rpp-33-02-00222.PMC4516377.pdf
Available from: http://www.mpto.mp.br/static/caops/patrimonio-publico/files/files/nocoes-de-epidemiologia.pdf [accessed 11 Jun 2014].,Non-OADS,/arxiv_data1/oa_pdf/8b/9b/0103-0582-rpp-33-02-00222.PMC4516377.pdf
DOI of original article: http://dx.doi.org/10.1016/j.rpped.2015.03.003   *Corresponding author.,OADS,/arxiv_data1/oa_pdf/83/ff/0103-0582-rpp-33-02-00230.PMC4516378.pdf
DOI of original article: http://dx.doi.org/10.1016/j.rpped.2014.12.004   *Corresponding author.,OADS,/arxiv_data1/oa_pdf/41/5d/0103-0582-rpp-33-02-00241.PMC4516379.pdf
Available from: http://www.jfsp.jus.br/20110329- fibrosecistica/ 18.,Non-OADS,/arxiv_data1/oa_pdf/41/5d/0103-0582-rpp-33-02-00241.PMC4516379.pdf
DOI of original article: http://dx.doi.org/10.1016/j.rpped.2014.09.001   *Corresponding author.,OADS,/arxiv_data1/oa_pdf/41/a3/0103-0582-rpp-33-02-00246.PMC4516380.pdf
"ERRATUM Erratum of ‘‘Physical, clinical, and psychosocial  parameters of adolescentes with different degrees   of excess weight’’ Errata de ‘‘Parâmetros físicos, clínicos e psicossociais   de adolescentes com diferentes graus de excesso de peso’’ Vanessa Drieli Seron Antonini*, Danilo Fernandes da Silva,   Josiane Aparecida Alves Bianchini, Carlos Andres Lopera, Amanda Caroline Moreira,  João Carlos Locateli, Nelson Nardo Junior Universidade Estadual de Maringá (UEM), Maringá, PR, Brazil DOI of original articles: http://dx.doi.org/10.1016/j.rpped.2015.03.004, http://dx.doi.org/10.1016/j.rpped.2014.04.003   *Corresponding author.",Non-OADS,/arxiv_data1/oa_pdf/60/df/0103-0582-rpp-33-02-00251.PMC4516381.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/ by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d1/bb/main.PMC4516391.pdf
"http://dx.doi.org/10.1016/j.gendis.2015.02.005 2352-3042/Copyright ª2015, Chongqing Medical University.",Non-OADS,/arxiv_data1/oa_pdf/d1/bb/main.PMC4516391.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).HOSTED BY Available online at www.sciencedirect.com ScienceDirect journal homepage: http://ees.elsevier.com/gendis/default.asp Genes &Diseases (2015) 2, 108e132",Non-OADS,/arxiv_data1/oa_pdf/d1/bb/main.PMC4516391.pdf
"To visualize the mutations, we chose the crystal structure of the b2-adrenoreceptor ( b2AR), which was numbered according to an advanced numbering scheme, taking into account helical irregularities (can be accessed at http://tools.gpcr.org/docs/numbering ).",OADS,/arxiv_data1/oa_pdf/d1/bb/main.PMC4516391.pdf
Supplementary data Supplementary data related to this article can be found athttp://dx.doi.org/10.1016/j.gendis.2015.02.005 .,OADS,/arxiv_data1/oa_pdf/d1/bb/main.PMC4516391.pdf
Available at: http://archive.cupe.ca/updir/CUPELTC-ReportEng1.pdf.,OADS,/arxiv_data1/oa_pdf/cb/c2/10.1177_1024529415580262.PMC4516401.pdf
Available at: http://www.ltlmagazine.com/article/new-caregivers-who-help-residents-age-place(accessed 7 July 2014).,Non-OADS,/arxiv_data1/oa_pdf/cb/c2/10.1177_1024529415580262.PMC4516401.pdf
Available at: http://ukpin.org.uk/home/standards/standards-SCID.pdf.,Non-OADS,/arxiv_data1/oa_pdf/49/84/cei0181-0267.PMC4516442.pdf
Available at: http://ukpin.org.uk/home/standards/standards-CVID.pdf.,Non-OADS,/arxiv_data1/oa_pdf/49/84/cei0181-0267.PMC4516442.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/01/e0/nihms-695721.PMC4516580.pdf
"To date, research has  focused on exogenous chemical and biological factors without considering physiological  factors such as EMF (see https://www.osha.gov/SLTC/elfradiation/healtheffects.html ).",Non-OADS,/arxiv_data1/oa_pdf/01/e0/nihms-695721.PMC4516580.pdf
This article is distributed under the terms of an Attribution–Non­ commercial–Share Alike–No Mirror Sites license for the first six months after the publication  date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/e5/d1/JGP_201511422.PMC4516779.pdf
"After six months it is available under a Creative  Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as de­ scribed at http://creativecommons.org/licenses/by ­nc­sa/3.0/).The Journal of General Physiology",Non-OADS,/arxiv_data1/oa_pdf/e5/d1/JGP_201511422.PMC4516779.pdf
The  online supplemental material is available at http://www.jgp.org/ cgi/content/full/jgp.201511422/DC1.,Non-OADS,/arxiv_data1/oa_pdf/e5/d1/JGP_201511422.PMC4516779.pdf
"http://dx.doi.org/10.1016/j.bpj.2011.02.042 Amico-Ruvio, S.A., M.A.",OADS,/arxiv_data1/oa_pdf/e5/d1/JGP_201511422.PMC4516779.pdf
"http://dx.doi.org/10.1124/ mol.112.078998 Brimecombe, J.C., W.K.",OADS,/arxiv_data1/oa_pdf/e5/d1/JGP_201511422.PMC4516779.pdf
"http://dx.doi .org/10.1113/jphysiol.2005.095497 Gallagher, M.J., H. Huang, D.B.",OADS,/arxiv_data1/oa_pdf/e5/d1/JGP_201511422.PMC4516779.pdf
"47:10027– 10032. http://dx.doi.org/10.1021/bi800690b Kapanidis, A.N., Y.W.",Non-OADS,/arxiv_data1/oa_pdf/e5/d1/JGP_201511422.PMC4516779.pdf
"http://dx.doi.org/10.1021/ja017074a Karakas, E., N. Simorowski, and H. Furukawa.",OADS,/arxiv_data1/oa_pdf/e5/d1/JGP_201511422.PMC4516779.pdf
"http://dx.doi.org/10.1038/emboj .2009.338 Karakas, E., N. Simorowski, and H. Furukawa.",OADS,/arxiv_data1/oa_pdf/e5/d1/JGP_201511422.PMC4516779.pdf
"http://dx.doi.org/10.1038/ nature10180 Kew, J.N., G. Trube, and J.A.",OADS,/arxiv_data1/oa_pdf/e5/d1/JGP_201511422.PMC4516779.pdf
"http://dx.doi.org/10.1113/jphysiol.1996.sp021807 Low, C.-M., F. Zheng, P .",OADS,/arxiv_data1/oa_pdf/e5/d1/JGP_201511422.PMC4516779.pdf
"http://dx.doi.org/10.1085/jgp.201411287 Madry, C., I. Mesic, H. Betz, and B. Laube.",OADS,/arxiv_data1/oa_pdf/e5/d1/JGP_201511422.PMC4516779.pdf
"http://dx.doi.org/10.1124/ mol.107.040071 Mott, D.D., J.J. Doherty, S. Zhang, M.S.",OADS,/arxiv_data1/oa_pdf/e5/d1/JGP_201511422.PMC4516779.pdf
"http://dx.doi.org/10.1038/ 3661 Pahk, A.J., and K. Williams.",OADS,/arxiv_data1/oa_pdf/e5/d1/JGP_201511422.PMC4516779.pdf
"http://dx.doi.org/10 .1016/S0304-3940(97)00176-6 Paoletti, P., P. Ascher, and J. Neyton.",OADS,/arxiv_data1/oa_pdf/e5/d1/JGP_201511422.PMC4516779.pdf
"http://dx.doi.org/10.1016/S0896-6273(00)00163-X Paoletti, P., C. Bellone, and Q. Zhou.",OADS,/arxiv_data1/oa_pdf/e5/d1/JGP_201511422.PMC4516779.pdf
"http://dx.doi.org/10.1038/ nrn3504 Perin-Dureau, F., J. Rachline, J. Neyton, and P. Paoletti.",Non-OADS,/arxiv_data1/oa_pdf/e5/d1/JGP_201511422.PMC4516779.pdf
"http://dx.doi.org/10 .1523/JNEUROSCI.3967-04.2005 Rambhadran, A., J. Gonzalez, and V. Jayaraman.",OADS,/arxiv_data1/oa_pdf/e5/d1/JGP_201511422.PMC4516779.pdf
"http://dx.doi.org/10.1074/jbc.M109 .085035 Sirrieh, R.E., D.M.",Non-OADS,/arxiv_data1/oa_pdf/e5/d1/JGP_201511422.PMC4516779.pdf
"http://dx.doi.org/10.1074/jbc .M113.482356 Sirrieh, R.E., D.M.",Non-OADS,/arxiv_data1/oa_pdf/e5/d1/JGP_201511422.PMC4516779.pdf
"http://dx.doi.org/10.1074/jbc.M115.649723 Tang, C.M.",Non-OADS,/arxiv_data1/oa_pdf/e5/d1/JGP_201511422.PMC4516779.pdf
"http://dx.doi.org/10.1124/jpet.112.192286 Tovar, K.R., and G.L.",OADS,/arxiv_data1/oa_pdf/e5/d1/JGP_201511422.PMC4516779.pdf
"32:8065– 8073. http://dx.doi.org/10.1523/JNEUROSCI.0538-12.2012 Traynelis, S.F., M. Hartley, and S.F.",OADS,/arxiv_data1/oa_pdf/e5/d1/JGP_201511422.PMC4516779.pdf
"http://dx.doi.org/10.1126/ science.7754371 Traynelis, S.F., L.P. Wollmuth, C.J.",OADS,/arxiv_data1/oa_pdf/e5/d1/JGP_201511422.PMC4516779.pdf
"http://dx.doi.org/10.1016/ j.neuron.2015.02.008 Zheng, F., K. Erreger, C.-M. Low, T. Banke, C.J.",OADS,/arxiv_data1/oa_pdf/e5/d1/JGP_201511422.PMC4516779.pdf
http://dx.doi.org/10.1038/nn0901-894,Non-OADS,/arxiv_data1/oa_pdf/e5/d1/JGP_201511422.PMC4516779.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publi- cation date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/da/37/JGP_201411353.PMC4516780.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).The Journal of General Physiology",Non-OADS,/arxiv_data1/oa_pdf/da/37/JGP_201411353.PMC4516780.pdf
"We represented the structure of the paddle chimera channel  Kv1.2/2.1 in a VMD environment (http://www.ks.uiuc.edu;   Humphrey et al., 1996).",OADS,/arxiv_data1/oa_pdf/da/37/JGP_201411353.PMC4516780.pdf
The online supplemental material is available at http://www.jgp .org/cgi/content/full/jgp.201411353/DC1.,Non-OADS,/arxiv_data1/oa_pdf/da/37/JGP_201411353.PMC4516780.pdf
"http://dx.doi .org/10.1085/jgp.60.5.588 Blatz, A.L., and K.L.",OADS,/arxiv_data1/oa_pdf/da/37/JGP_201411353.PMC4516780.pdf
"http://dx.doi.org/10.1038/323718a0 Brelidze, T.I., and K.L.",OADS,/arxiv_data1/oa_pdf/da/37/JGP_201411353.PMC4516780.pdf
"http://dx.doi.org/10.1085/jgp.200509286 Brelidze, T.I., X. Niu, and K.L.",OADS,/arxiv_data1/oa_pdf/da/37/JGP_201411353.PMC4516780.pdf
"http://dx.doi.org/10.1016/j .bpj.2010.08.053 Eisenman, G., R. Latorre, and C. Miller.",OADS,/arxiv_data1/oa_pdf/da/37/JGP_201411353.PMC4516780.pdf
"http://dx.doi .org/10.1016/S0006-3495(86)83546-9 Enderby, J.E.",OADS,/arxiv_data1/oa_pdf/da/37/JGP_201411353.PMC4516780.pdf
"http://dx.doi.org/10.1039/cs9952400159 Feller, S.E., Y. Zhang, R.W.",OADS,/arxiv_data1/oa_pdf/da/37/JGP_201411353.PMC4516780.pdf
"http://dx.doi.org/10.1063/ 1.470648 Ferry, J.D.",OADS,/arxiv_data1/oa_pdf/da/37/JGP_201411353.PMC4516780.pdf
"http://dx.doi.org/10.1085/ jgp.20.1.95 Geng, Y., X. Niu, and K.L.",OADS,/arxiv_data1/oa_pdf/da/37/JGP_201411353.PMC4516780.pdf
"http://dx.doi.org/10.1085/jgp.20028569 Hall, J.E.",OADS,/arxiv_data1/oa_pdf/da/37/JGP_201411353.PMC4516780.pdf
"http://dx.doi.org/10.1085/jgp.66.4.531 Harris, R.E., H.P.",OADS,/arxiv_data1/oa_pdf/da/37/JGP_201411353.PMC4516780.pdf
"http://dx.doi.org/10.1016/S0006- 3495(98)77891-9 Heginbotham, L., and R. MacKinnon.",OADS,/arxiv_data1/oa_pdf/da/37/JGP_201411353.PMC4516780.pdf
"http://dx.doi.org/10.1016/S0006-3495(93)81244-X Heginbotham, L., Z. Lu, T. Abramson, and R. MacKinnon.",OADS,/arxiv_data1/oa_pdf/da/37/JGP_201411353.PMC4516780.pdf
"66:1061– 1067. http://dx.doi.org/10.1016/S0006-3495(94)80887-2 Hénin, J., W. Shinoda, and M.L.",OADS,/arxiv_data1/oa_pdf/da/37/JGP_201411353.PMC4516780.pdf
"112:7008– 7015. http://dx.doi.org/10.1021/jp800687p Hille, B.",Non-OADS,/arxiv_data1/oa_pdf/da/37/JGP_201411353.PMC4516780.pdf
http://dx.doi.org/10 .1016/0263-7855(96)00018-5the size of a water molecule.,OADS,/arxiv_data1/oa_pdf/da/37/JGP_201411353.PMC4516780.pdf
"We thank Ramón Latorre and Bill Griesar (WSU-Vancouver and  http://nwnoggin.org) for critical reading of the manuscript, to the Galvani group for suggestions, and to Lorena Prado and Vicky Prado for excellent technical help.",Non-OADS,/arxiv_data1/oa_pdf/da/37/JGP_201411353.PMC4516780.pdf
"http://dx.doi.org/10.1016/S0006-3495(83)84416-6 Andersen, O.S., and J. Procopio.",OADS,/arxiv_data1/oa_pdf/da/37/JGP_201411353.PMC4516780.pdf
"http://dx.doi.org/10.1038/417523a Jogini, V., and B. Roux.",OADS,/arxiv_data1/oa_pdf/da/37/JGP_201411353.PMC4516780.pdf
"http://dx.doi .org/10.1016/j.jmb.2005.09.031 Jorgensen, W.L., J. Chandrasekhar, J.D.",OADS,/arxiv_data1/oa_pdf/da/37/JGP_201411353.PMC4516780.pdf
"http://dx.doi .org/10.1063/1.445869 Latorre, R., and C. Miller.",OADS,/arxiv_data1/oa_pdf/da/37/JGP_201411353.PMC4516780.pdf
"http://dx.doi.org/ 10.1007/BF01870671 Läuger, P. 1976.",Non-OADS,/arxiv_data1/oa_pdf/da/37/JGP_201411353.PMC4516780.pdf
"http://dx.doi.org/10.1016/0005- 2736(76)90320-5 Long, S.B., E.B.",OADS,/arxiv_data1/oa_pdf/da/37/JGP_201411353.PMC4516780.pdf
"http://dx.doi.org/10.1126/science .1116269 Long, S.B., X. Tao, E.B.",OADS,/arxiv_data1/oa_pdf/da/37/JGP_201411353.PMC4516780.pdf
"http://dx.doi .org/10.1038/nature06265 MacKerell, A.D., Jr., D. Bashford, M. Bellott, R.L.",OADS,/arxiv_data1/oa_pdf/da/37/JGP_201411353.PMC4516780.pdf
"http://dx.doi.org/10 .1002/jcc.20065 MacKinnon, R., and C. Miller.",OADS,/arxiv_data1/oa_pdf/da/37/JGP_201411353.PMC4516780.pdf
"http://dx.doi.org/10.1021/bi00446a019 Miller, C. 2001.",Non-OADS,/arxiv_data1/oa_pdf/da/37/JGP_201411353.PMC4516780.pdf
"http://dx.doi.org/10.1038/35102000 Moscoso, C., A. Vergara-Jaque, V. Márquez-Miranda, R.V.",Non-OADS,/arxiv_data1/oa_pdf/da/37/JGP_201411353.PMC4516780.pdf
"http://dx.doi.org/10.1016/j.bpj.2012.08.015 Naranjo, D., and R. Latorre.",OADS,/arxiv_data1/oa_pdf/da/37/JGP_201411353.PMC4516780.pdf
"http://dx.doi.org/10.1016/S0006- 3495(93)81469-3 Nimigean, C.M., J.S.",OADS,/arxiv_data1/oa_pdf/da/37/JGP_201411353.PMC4516780.pdf
"http://dx.doi.org/10.1021/bi0348720 Parsegian, A.",Non-OADS,/arxiv_data1/oa_pdf/da/37/JGP_201411353.PMC4516780.pdf
"http://dx.doi.org/10.1038/221844a0 Phillips, J.C., R. Braun, W. Wang, J. Gumbart, E. Tajkhorshid,  E. Villa, C. Chipot, R.D.",Non-OADS,/arxiv_data1/oa_pdf/da/37/JGP_201411353.PMC4516780.pdf
"http://dx.doi.org/10.1002/jcc.20289 Richards, F.M.",Non-OADS,/arxiv_data1/oa_pdf/da/37/JGP_201411353.PMC4516780.pdf
"http://dx.doi.org/ 10.1146/annurev.bb.06.060177.001055 Sukhareva, M., D.H. Hackos, and K.J.",OADS,/arxiv_data1/oa_pdf/da/37/JGP_201411353.PMC4516780.pdf
"http://dx.doi.org/10.1085/jgp.200308905 Treptow, W., and M. Tarek.",OADS,/arxiv_data1/oa_pdf/da/37/JGP_201411353.PMC4516780.pdf
"http://dx.doi .org/10.1038/nature02468 Wilman, H.R., J. Shi, and C.M.",OADS,/arxiv_data1/oa_pdf/da/37/JGP_201411353.PMC4516780.pdf
"82:1960– 1970. http://dx.doi.org/10.1002/prot.24550 Yellen, G. 1984.",Non-OADS,/arxiv_data1/oa_pdf/da/37/JGP_201411353.PMC4516780.pdf
"84:157– 186. http://dx.doi.org/10.1085/jgp.84.2.157 Yu, H., S.Y.",OADS,/arxiv_data1/oa_pdf/da/37/JGP_201411353.PMC4516780.pdf
"http://dx.doi.org/10.1038/35102009 Zhou, Y., X.M.",Non-OADS,/arxiv_data1/oa_pdf/da/37/JGP_201411353.PMC4516780.pdf
"Whether resulting Location, Location, Location: Juxtaposed calcium-signaling  microdomains as a novel model of the vascular smooth muscle  myogenic response Nathan R. Tykocki1 and Mark T. Nelson1,2 1Department of Pharmacology, University of Vermont, Burlington, VT 05405 2Institute of Cardiovascular Sciences, University of Manchester, Manchester M13 9PL, England, UK © 2015 Tykocki and Nelson  This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publi- cation date (see http://www.rupress.org/terms).",Non-OADS,/arxiv_data1/oa_pdf/02/0c/JGP_201511468.PMC4516781.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).The Journal of General Physiology",Non-OADS,/arxiv_data1/oa_pdf/02/0c/JGP_201511468.PMC4516781.pdf
"http://dx.doi.org/10.1016/j.jtbi.2004 .11.013 Brayden, J.E., and M.T.",OADS,/arxiv_data1/oa_pdf/02/0c/JGP_201511468.PMC4516781.pdf
"http://dx.doi.org/10.1126/science.1373909 Bulley, S., Z.P.",Non-OADS,/arxiv_data1/oa_pdf/02/0c/JGP_201511468.PMC4516781.pdf
"http://dx.doi.org/10.1161/ CIRCRESAHA.112.277145 Davis, M.J. 2012.",Non-OADS,/arxiv_data1/oa_pdf/02/0c/JGP_201511468.PMC4516781.pdf
"http://dx.doi .org/10.1111/j.1549­8719.2011.00131.x Earley, S., and J.E.",OADS,/arxiv_data1/oa_pdf/02/0c/JGP_201511468.PMC4516781.pdf
"http://dx.doi.org/ 10.1146/annurev.physiol.67.032003.154341 Hill­Eubanks, D.C., M.E.",OADS,/arxiv_data1/oa_pdf/02/0c/JGP_201511468.PMC4516781.pdf
"http://dx.doi.org/10.1101/cshperspect.a004549 Jaggar, J.H., V.A.",OADS,/arxiv_data1/oa_pdf/02/0c/JGP_201511468.PMC4516781.pdf
"http://dx.doi.org/ 10.1085/jgp.201511380 Knot, H.J., and M.T.",OADS,/arxiv_data1/oa_pdf/02/0c/JGP_201511468.PMC4516781.pdf
"http://dx.doi .org/10.1111/j.1469­7793.1998.199br.x Knot, H.J., N.B.",OADS,/arxiv_data1/oa_pdf/02/0c/JGP_201511468.PMC4516781.pdf
"http://dx.doi.org/10.1111/j.1469­7793.1998.211br.x McCarron, J.G., G. Osol, and W. Halpern.",OADS,/arxiv_data1/oa_pdf/02/0c/JGP_201511468.PMC4516781.pdf
"http://dx.doi .org/10.1126/science.270.5236.633 Parekh, A.B.",OADS,/arxiv_data1/oa_pdf/02/0c/JGP_201511468.PMC4516781.pdf
"http://dx.doi.org/10.1113/jphysiol.2008.153460 Pérez, G.J., A.D. Bonev, and M.T.",Non-OADS,/arxiv_data1/oa_pdf/02/0c/JGP_201511468.PMC4516781.pdf
"http://dx.doi.org/ 10.1085/jgp.107.4.459 Welsh, D.G., A.D. Morielli, M.T.",Non-OADS,/arxiv_data1/oa_pdf/02/0c/JGP_201511468.PMC4516781.pdf
http://dx.doi.org/ 10.1161/hh0302.105662,Non-OADS,/arxiv_data1/oa_pdf/02/0c/JGP_201511468.PMC4516781.pdf
This article is distributed under the terms of an Attribution–Non- commercial–Share Alike–No Mirror Sites license for the first six months after the publication  date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/26/ff/JGP_201511388.PMC4516782.pdf
"After six months it is available under a Creative  Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as de- scribed at http://creativecommons.org/licenses/by-nc-sa/3.0/).The Journal of General Physiology",Non-OADS,/arxiv_data1/oa_pdf/26/ff/JGP_201511388.PMC4516782.pdf
The  online supplemental material is available at http://www.jgp.org/cgi/content/full/jgp.201511388/DC1.,Non-OADS,/arxiv_data1/oa_pdf/26/ff/JGP_201511388.PMC4516782.pdf
"http://dx.doi.org/10.1085/ jgp.200809984 Basilio, D., S.J.",Non-OADS,/arxiv_data1/oa_pdf/26/ff/JGP_201511388.PMC4516782.pdf
"http://dx.doi.org/10.1085/ jgp.200810170 Benson, E.L., P .D.",OADS,/arxiv_data1/oa_pdf/26/ff/JGP_201511388.PMC4516782.pdf
"http://dx.doi.org/10.1021/bi972657b Blaustein, R.O., and A. Finkelstein.",Non-OADS,/arxiv_data1/oa_pdf/26/ff/JGP_201511388.PMC4516782.pdf
"http://dx.doi .org/10.1085/jgp.96.5.905 Blaustein, R.O., T.M.",OADS,/arxiv_data1/oa_pdf/26/ff/JGP_201511388.PMC4516782.pdf
"http://dx.doi.org/10.1126/science.280.5364.734 Finkelstein, A.",OADS,/arxiv_data1/oa_pdf/26/ff/JGP_201511388.PMC4516782.pdf
364:209– 215. http://dx.doi.org/10.1098/rstb.2008.0126The cation-repulsive region will also favor deprotonation  of these residues.,Non-OADS,/arxiv_data1/oa_pdf/26/ff/JGP_201511388.PMC4516782.pdf
"http://dx.doi.org/10.1002/pro.2241 Hodgkin, A.L., and B. Katz.",Non-OADS,/arxiv_data1/oa_pdf/26/ff/JGP_201511388.PMC4516782.pdf
"http://dx.doi.org/10.1113/jphysiol.1949.sp004310 Jiang, J., B.L.",OADS,/arxiv_data1/oa_pdf/26/ff/JGP_201511388.PMC4516782.pdf
"http://dx.doi.org/10.1038/ nature14247 Katayama, H., B.E.",OADS,/arxiv_data1/oa_pdf/26/ff/JGP_201511388.PMC4516782.pdf
"http://dx.doi.org/10.1038/nsmb.1442 Kintzer, A.F., K.L.",OADS,/arxiv_data1/oa_pdf/26/ff/JGP_201511388.PMC4516782.pdf
"http://dx.doi.org/10.1016/j.jmb.2009.07.037 Krantz, B.A., R.A. Melnyk, S. Zhang, S.J.",OADS,/arxiv_data1/oa_pdf/26/ff/JGP_201511388.PMC4516782.pdf
"http://dx.doi.org/10.1126/science.1113380 Krantz, B.A., A. Finkelstein, and R.J. Collier.",OADS,/arxiv_data1/oa_pdf/26/ff/JGP_201511388.PMC4516782.pdf
"http://dx.doi .org/10.1016/j.jmb.2005.11.030 Leppla, S.H.",OADS,/arxiv_data1/oa_pdf/26/ff/JGP_201511388.PMC4516782.pdf
"http://dx.doi .org/10.1073/pnas.79.10.3162 Mueller, P., D.O.",OADS,/arxiv_data1/oa_pdf/26/ff/JGP_201511388.PMC4516782.pdf
"http://dx.doi.org/ 10.1021/j100796a529Nassi, S., R.J. Collier, and A. Finkelstein.",Non-OADS,/arxiv_data1/oa_pdf/26/ff/JGP_201511388.PMC4516782.pdf
"http://dx.doi.org/10.1021/bi0119518 Nguyen, T.L.",Non-OADS,/arxiv_data1/oa_pdf/26/ff/JGP_201511388.PMC4516782.pdf
"http://dx.doi.org/10.1080/ 07391102.2004.10531226 Robinson, R.A., and R.H. Stokes.",OADS,/arxiv_data1/oa_pdf/26/ff/JGP_201511388.PMC4516782.pdf
"http://dx.doi.org/10.1016/ j.jmb.2014.06.016 Teorell, T. 1953.",OADS,/arxiv_data1/oa_pdf/26/ff/JGP_201511388.PMC4516782.pdf
"http://dx.doi.org/10.1006/bbrc.1998.9040 Wynia-Smith, S.L., M.J. Brown, G. Chirichella, G. Kemalyan, and  B.A.",Non-OADS,/arxiv_data1/oa_pdf/26/ff/JGP_201511388.PMC4516782.pdf
"http://dx.doi.org/10.1074/jbc.M112.419598 Young, J.A., and R.J. Collier.",Non-OADS,/arxiv_data1/oa_pdf/26/ff/JGP_201511388.PMC4516782.pdf
"http://dx.doi.org/10.1146/annurev.biochem .75.103004.142728 Zhang, S., A. Finkelstein, and R.J. Collier.",OADS,/arxiv_data1/oa_pdf/26/ff/JGP_201511388.PMC4516782.pdf
http://dx.doi .org/10.1529/biophysj.104.050864,Non-OADS,/arxiv_data1/oa_pdf/26/ff/JGP_201511388.PMC4516782.pdf
"The molecular physiology of modesty Jon T. Sack1,2 and Drew C. Tilley1 1Department of Physiology and Membrane Biology and 2Department of Anesthesiology and Pain Medicine,  University of California, Davis, Davis, CA 95616 © 2015 Sack and Tilley  This article is distributed under the terms of an Attribution–Non- commercial–Share Alike–No Mirror Sites license for the first six months after the publication  date (see http://www.rupress.org/terms).",Non-OADS,/arxiv_data1/oa_pdf/6c/e3/JGP_201511469.PMC4516784.pdf
"After six months it is available under a Creative  Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as de- scribed at http://creativecommons.org/licenses/by-nc-sa/3.0/).The Journal of General Physiology",Non-OADS,/arxiv_data1/oa_pdf/6c/e3/JGP_201511469.PMC4516784.pdf
"http://dx.doi .org/10.1085/jgp.200709862 Chen, X., J. Yan, and R.W.",OADS,/arxiv_data1/oa_pdf/6c/e3/JGP_201511469.PMC4516784.pdf
"http://dx.doi.org/10.1016/0896- 6273(93)90340-W Díaz-Franulic, I., R.V.",OADS,/arxiv_data1/oa_pdf/6c/e3/JGP_201511469.PMC4516784.pdf
"http://dx.doi.org/ 10.1124/pr.57.4.10 Hackos, D.H., T.H.",OADS,/arxiv_data1/oa_pdf/6c/e3/JGP_201511469.PMC4516784.pdf
"http://dx.doi.org/10.1085/jgp.20028569 Heginbotham, L., and R. MacKinnon.",OADS,/arxiv_data1/oa_pdf/6c/e3/JGP_201511469.PMC4516784.pdf
"http://dx.doi.org/10.1016/S0006-3495(93)81244-X Jiang, Y., A. Lee, J. Chen, M. Cadene, B.T.",OADS,/arxiv_data1/oa_pdf/6c/e3/JGP_201511469.PMC4516784.pdf
"http://dx.doi.org/10.1038/ 417515a Liu, Y., M. Holmgren, M.E.",OADS,/arxiv_data1/oa_pdf/6c/e3/JGP_201511469.PMC4516784.pdf
"http://dx.doi.org/10.1016/S0896-6273(00)80357-8 Long, S.B., X. Tao, E.B.",OADS,/arxiv_data1/oa_pdf/6c/e3/JGP_201511469.PMC4516784.pdf
"http://dx.doi.org/10 .1038/nature06265 Lopez, G.A., Y.N.",Non-OADS,/arxiv_data1/oa_pdf/6c/e3/JGP_201511469.PMC4516784.pdf
"http://dx.doi.org/10.1038/367179a0 Moscoso, C., A. Vergara-Jaque, V. Márquez-Miranda, R.V.",Non-OADS,/arxiv_data1/oa_pdf/6c/e3/JGP_201511469.PMC4516784.pdf
"http://dx.doi.org/10.1016/j.bpj.2012.08.015 Nishida, M., and R. MacKinnon.",OADS,/arxiv_data1/oa_pdf/6c/e3/JGP_201511469.PMC4516784.pdf
"http://dx.doi .org/10.1016/S0092-8674(02)01227-8 Shi, N., W. Zeng, S. Ye, Y. Li, and Y. Jiang.",OADS,/arxiv_data1/oa_pdf/6c/e3/JGP_201511469.PMC4516784.pdf
"http://dx.doi.org/10.1016/j.jmb.2011.04.058 Sukhareva, M., D.H. Hackos, and K.J.",OADS,/arxiv_data1/oa_pdf/6c/e3/JGP_201511469.PMC4516784.pdf
"http://dx.doi.org/10.1085/jgp.200308905 Tang, Q.Y., X.H.",OADS,/arxiv_data1/oa_pdf/6c/e3/JGP_201511469.PMC4516784.pdf
"http://dx.doi.org/10.1085/jgp.200910251 Thompson, J., and T. Begenisich.",OADS,/arxiv_data1/oa_pdf/6c/e3/JGP_201511469.PMC4516784.pdf
"http://dx.doi.org/10.1085/jgp.117.5.373Cysteine accessibility studies indicate that residues, which  in the Shaker channel are inaccessible in the closed state (Liu et al., 1997), are accessible in closed BK channels (Zhou et al., 2011).",OADS,/arxiv_data1/oa_pdf/6c/e3/JGP_201511469.PMC4516784.pdf
"http://dx.doi.org/10.1085/jgp.200308951 Brelidze, T.I., and K.L.",OADS,/arxiv_data1/oa_pdf/6c/e3/JGP_201511469.PMC4516784.pdf
"http://dx.doi.org/10.1085/jgp.200509286 Brelidze, T.I., X. Niu, and K.L.",OADS,/arxiv_data1/oa_pdf/6c/e3/JGP_201511469.PMC4516784.pdf
"http://dx.doi.org/10.1073/ pnas.1532257100 Brohawn, S.G., J. del Mármol, and R. MacKinnon.",OADS,/arxiv_data1/oa_pdf/6c/e3/JGP_201511469.PMC4516784.pdf
"http://dx.doi.org/10.1126/ science.1213808 Carvacho, I., W. Gonzalez, Y.P.",OADS,/arxiv_data1/oa_pdf/6c/e3/JGP_201511469.PMC4516784.pdf
"http://dx.doi.org/10.1085/jgp .200609579 Yellen, G., M.E.",OADS,/arxiv_data1/oa_pdf/6c/e3/JGP_201511469.PMC4516784.pdf
"http://dx.doi.org/10.1126/science.2000494Zhou, Y., J.H.",OADS,/arxiv_data1/oa_pdf/6c/e3/JGP_201511469.PMC4516784.pdf
"http://dx.doi.org/10.1038/35102009 Zhou, Y., X.M.",Non-OADS,/arxiv_data1/oa_pdf/6c/e3/JGP_201511469.PMC4516784.pdf
© 2015 Combs and Lu  This article is distributed under the terms of an Attribution–Non- commercial–Share Alike–No Mirror Sites license for the first six months after the publication  date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/da/a9/JGP_201511359.PMC4516786.pdf
"After six months it is available under a Creative  Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as de- scribed at http://creativecommons.org/licenses/by-nc-sa/3.0/).The Journal of General Physiology",Non-OADS,/arxiv_data1/oa_pdf/da/a9/JGP_201511359.PMC4516786.pdf
"http://dx.doi.org/10.4049/jimmunol.165.1.297 Feske, S., Y. Gwack, M. Prakriya, S. Srikanth, S.H.",Non-OADS,/arxiv_data1/oa_pdf/da/a9/JGP_201511359.PMC4516786.pdf
"http://dx.doi.org/10.1038/ nature04702 Glenny, A.T., and N.F.",OADS,/arxiv_data1/oa_pdf/da/a9/JGP_201511359.PMC4516786.pdf
"http://dx.doi.org/10.1002/ path.1700400202 Grynkiewicz, G., M. Poenie, and R.Y.",Non-OADS,/arxiv_data1/oa_pdf/da/a9/JGP_201511359.PMC4516786.pdf
http://dx.doi.org/10.1146/annurev.immunol.,Non-OADS,/arxiv_data1/oa_pdf/da/a9/JGP_201511359.PMC4516786.pdf
"http://dx.doi.org/10.1038/ 35882 Imboden, J.B., and J.D.",OADS,/arxiv_data1/oa_pdf/da/a9/JGP_201511359.PMC4516786.pdf
"http://dx.doi.org/10.1084/jem.161.3.446 Isbister, G.K., and H.W.",OADS,/arxiv_data1/oa_pdf/da/a9/JGP_201511359.PMC4516786.pdf
"378:2039– 2047. http://dx.doi.org/10.1016/S0140-6736(10)62230-1 Lan, D.T., S. Taniguchi, S. Makino, T. Shirahata, and A. Nakane.",OADS,/arxiv_data1/oa_pdf/da/a9/JGP_201511359.PMC4516786.pdf
"http://dx.doi.org/ 10.1111/j.1348-0421.1998.tb02362.x Lan, D.T., S. Makino, T. Shirahata, M. Yamada, and A. Nakane.",OADS,/arxiv_data1/oa_pdf/da/a9/JGP_201511359.PMC4516786.pdf
"http://dx.doi.org/10.1292/jvms.61.1203 Lepple-Wienhues, A., C. Belka, T. Laun, A. Jekle, B. Walter, U.  Wieland, M. Welz, L. Heil, J. Kun, G. Busch, et al.",OADS,/arxiv_data1/oa_pdf/da/a9/JGP_201511359.PMC4516786.pdf
"http://dx.doi.org/10.1126/science .2581316 Lönnroth, K., and M. Raviglione.",OADS,/arxiv_data1/oa_pdf/da/a9/JGP_201511359.PMC4516786.pdf
"http://dx.doi.org/10.1055/s-0028-1085700 Matteson, D.R., and C. Deutsch.",OADS,/arxiv_data1/oa_pdf/da/a9/JGP_201511359.PMC4516786.pdf
"http://dx.doi.org/10.1038/307468a0 McNamara, P.J., G.A.",Non-OADS,/arxiv_data1/oa_pdf/da/a9/JGP_201511359.PMC4516786.pdf
"http://dx.doi.org/10.1111/j.1365-2958.1994.tb01080.x McNamara, P.J., W.A.",Non-OADS,/arxiv_data1/oa_pdf/da/a9/JGP_201511359.PMC4516786.pdf
"http://dx.doi.org/10.1182/ blood-2011-04-325225 Baird, G.J., and M.C.",Non-OADS,/arxiv_data1/oa_pdf/da/a9/JGP_201511359.PMC4516786.pdf
"http://dx.doi.org/10.1016/j.jcpa.2007.07.002 Breittmayer, J.P., A. Bernard, and C. Aussel.",OADS,/arxiv_data1/oa_pdf/da/a9/JGP_201511359.PMC4516786.pdf
"http://dx.doi.org/10.1113/jphysiol.1985.sp015548 Chandy, K.G., H. Wulff, C. Beeton, M. Pennington, G.A.",OADS,/arxiv_data1/oa_pdf/da/a9/JGP_201511359.PMC4516786.pdf
"http://dx.doi .org/10.1016/j.tips.2004.03.010 Church, L.D., G. Hessler, J.E.",OADS,/arxiv_data1/oa_pdf/da/a9/JGP_201511359.PMC4516786.pdf
"http://dx.doi.org/10.1189/jlb.1003456 Colina, C., A. Flores, C. Castillo, M.R.",Non-OADS,/arxiv_data1/oa_pdf/da/a9/JGP_201511359.PMC4516786.pdf
"http://dx.doi.org/10.1016/j.bbrc.2005.08.039 Colina, C., A. Flores, H. Rojas, A. Acosta, C. Castillo, M.R.",OADS,/arxiv_data1/oa_pdf/da/a9/JGP_201511359.PMC4516786.pdf
"http://dx.doi.org/ 10.1085/jgp.201310986 DeCoursey, T.E., K.G.",OADS,/arxiv_data1/oa_pdf/da/a9/JGP_201511359.PMC4516786.pdf
"http://dx.doi.org/10.1038/ 307465a0 Doery, H.M., B.J.",OADS,/arxiv_data1/oa_pdf/da/a9/JGP_201511359.PMC4516786.pdf
"http://dx.doi.org/10 .1038/1981091a0 Dolmetsch, R.E., and R.S.",OADS,/arxiv_data1/oa_pdf/da/a9/JGP_201511359.PMC4516786.pdf
"http://dx.doi.org/10.1085/jgp.103.3.365 Ellis, J.A.",OADS,/arxiv_data1/oa_pdf/da/a9/JGP_201511359.PMC4516786.pdf
"25:362– 368. http://dx.doi.org/10.1177/030098588802500505 Feldhaus, M.J., A.S. Weyrich, G.A.",Non-OADS,/arxiv_data1/oa_pdf/da/a9/JGP_201511359.PMC4516786.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/da/a9/JGP_201511359.PMC4516786.pdf
"http://dx.doi.org/10.1194/jlr .M300103-JLR200 Valiyaveetil, F.I., Y. Zhou, and R. MacKinnon.",OADS,/arxiv_data1/oa_pdf/da/a9/JGP_201511359.PMC4516786.pdf
"http://dx.doi.org/10.1021/bi026215y Vargas-Villarreal, J., B.D.",Non-OADS,/arxiv_data1/oa_pdf/da/a9/JGP_201511359.PMC4516786.pdf
"http://dx.doi.org/10.1016/j.cub.2006 .08.085 Waldmann, T.A.",OADS,/arxiv_data1/oa_pdf/da/a9/JGP_201511359.PMC4516786.pdf
"http://dx.doi.org/10.1038/nri1901 Wallis, R.S.",Non-OADS,/arxiv_data1/oa_pdf/da/a9/JGP_201511359.PMC4516786.pdf
"http://dx.doi.org/10.1016/S1473-3099(08)70227-5 Xu, Y., Y. Ramu, and Z. Lu.",OADS,/arxiv_data1/oa_pdf/da/a9/JGP_201511359.PMC4516786.pdf
"http://dx.doi.org/10.1038/nature06618 Zhang, S.L., A.V.",OADS,/arxiv_data1/oa_pdf/da/a9/JGP_201511359.PMC4516786.pdf
"http://dx.doi.org/10.1073/ pnas.0603161103 Zhou, Y., J.H.",OADS,/arxiv_data1/oa_pdf/da/a9/JGP_201511359.PMC4516786.pdf
"http://dx.doi.org/10.1038/35102009 Zumla, A., M. Raviglione, R. Hafner, and C.F.",Non-OADS,/arxiv_data1/oa_pdf/da/a9/JGP_201511359.PMC4516786.pdf
http://dx.doi.org/ 10.1056/NEJMra1200894Arcanobacterium haemolyticum : cloning and sequence homology.,OADS,/arxiv_data1/oa_pdf/da/a9/JGP_201511359.PMC4516786.pdf
"http://dx.doi.org/10.1016/0378-1119(95)00002-N Milescu, M., F. Bosmans, S. Lee, A.A. Alabi, J.I.",OADS,/arxiv_data1/oa_pdf/da/a9/JGP_201511359.PMC4516786.pdf
"http://dx.doi.org/10.1038/nsmb.1679 Partiseti, M., F. Le Deist, C. Hivroz, A. Fischer, H. Korn, and D.  Choquet.",Non-OADS,/arxiv_data1/oa_pdf/da/a9/JGP_201511359.PMC4516786.pdf
"http://dx.doi.org/ 10.1038/nature04880 Ramu, Y., Y. Xu, and Z. Lu.",OADS,/arxiv_data1/oa_pdf/da/a9/JGP_201511359.PMC4516786.pdf
"http://dx.doi.org/10.1073/ pnas.0701354104 Roos, J., P.J.",OADS,/arxiv_data1/oa_pdf/da/a9/JGP_201511359.PMC4516786.pdf
"http://dx.doi.org/10.1124/mol.105.015669 Souček, A., C. Michalec, and A. Soucková.",OADS,/arxiv_data1/oa_pdf/da/a9/JGP_201511359.PMC4516786.pdf
http://dx.doi.org/10.1016/0005-2744(71)90173-2,OADS,/arxiv_data1/oa_pdf/da/a9/JGP_201511359.PMC4516786.pdf
This article is distributed under the terms of an Attribution–   Noncommercial–Share Alike–No Mirror Sites license for the first six months  after the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/50/47/JEM_20150225.PMC4516788.pdf
"After six months  it is available under a Creative Commons License (Attribution–Noncommercial–   Share Alike 3.0 Unported license, as described at http://creativecommons.org/   licenses/by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/50/47/JEM_20150225.PMC4516788.pdf
"The  pattern of expression is consistent with information obtained  from BioGPS (http://biogps.org) showing that GPR18  is  highly expressed in testis and immune systems, including bone  marrow, lymph nodes, and tonsil.",Non-OADS,/arxiv_data1/oa_pdf/50/47/JEM_20150225.PMC4516788.pdf
"http://dx.doi.org/10.1056/NEJMcibr130441 4 Bento, A.F., R.F.",OADS,/arxiv_data1/oa_pdf/50/47/JEM_20150225.PMC4516788.pdf
"http://dx.doi   .org/10.4049/jimmunol.110130 5 Bohr, S., S.J.",OADS,/arxiv_data1/oa_pdf/50/47/JEM_20150225.PMC4516788.pdf
"http://dx.doi.org/10.1002/jcb.2324 5 Chiang, N., K. Gronert, C.B.",Non-OADS,/arxiv_data1/oa_pdf/50/47/JEM_20150225.PMC4516788.pdf
"http://dx.doi.org/10.1172/   JCI701 6 Chiang, N., G. Fredman, F. Bäckhed, S.F.",OADS,/arxiv_data1/oa_pdf/50/47/JEM_20150225.PMC4516788.pdf
"http://dx.doi   .org/10.1038/nature1104 2 Clària, J., B.T.",OADS,/arxiv_data1/oa_pdf/50/47/JEM_20150225.PMC4516788.pdf
"http://dx.doi.org/10.1152/   ajpcell.00351.201 2 Colas, R.A., M. Shinohara, J. Dalli, N. Chiang, and C.N.",OADS,/arxiv_data1/oa_pdf/50/47/JEM_20150225.PMC4516788.pdf
"http://dx.doi.org/10.1152/ajpcell.00024.201 4 Cotran, R.S., V. Kumar, and T. Collins, editors.",Non-OADS,/arxiv_data1/oa_pdf/50/47/JEM_20150225.PMC4516788.pdf
"http://dx.doi.org/10.1182/   blood-2012-04-42352 5 Deutschman, C.S., and K.J.",Non-OADS,/arxiv_data1/oa_pdf/50/47/JEM_20150225.PMC4516788.pdf
"http://dx.doi.org/10.1016/j.immuni   .2014.04.00 1 El Kebir, D., P. Gjorstrup, and J.G.",OADS,/arxiv_data1/oa_pdf/50/47/JEM_20150225.PMC4516788.pdf
"http://dx.doi.org/   10.1038/nm.250 7 Frediani, J.K., D.P.",OADS,/arxiv_data1/oa_pdf/50/47/JEM_20150225.PMC4516788.pdf
http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/50/47/JEM_20150225.PMC4516788.pdf
"http://dx.doi.org/10.1177/108705710833011 5 Plüddemann, A., S. Mukhopadhyay, and S. Gordon.",Non-OADS,/arxiv_data1/oa_pdf/50/47/JEM_20150225.PMC4516788.pdf
http://dx.doi.org/10.1111/   j.1600-065X.2010.00989.,Non-OADS,/arxiv_data1/oa_pdf/50/47/JEM_20150225.PMC4516788.pdf
"http://dx.doi.org/10.1016/j.fsi.2013.07.01 7 Raatz, S.K., M.Y.",OADS,/arxiv_data1/oa_pdf/50/47/JEM_20150225.PMC4516788.pdf
"http://dx.doi.org/   10.1021/jf202576 k Rossi, A.G., J.C. McCutcheon, N. Roy, E.R.",Non-OADS,/arxiv_data1/oa_pdf/50/47/JEM_20150225.PMC4516788.pdf
"http://dx.doi.org/10.1016/0005-2760(91)90073- Q Samuelson, L.C., L.J.",OADS,/arxiv_data1/oa_pdf/50/47/JEM_20150225.PMC4516788.pdf
"http://dx.doi.org/10.1007/s00335990027 2 Serhan, C.N.",Non-OADS,/arxiv_data1/oa_pdf/50/47/JEM_20150225.PMC4516788.pdf
"http://dx.doi.org/10.1038/nature1347 9 Serhan, C.N., and N. Chiang.",Non-OADS,/arxiv_data1/oa_pdf/50/47/JEM_20150225.PMC4516788.pdf
"http://dx.doi.org/10.1016/j.coph.2013.05.01 2 Serhan, C.N., and N.A.",OADS,/arxiv_data1/oa_pdf/50/47/JEM_20150225.PMC4516788.pdf
"http://dx.doi.org/10.1021/   cr100396 c Serhan, C.N., S. Hong, K. Gronert, S.P.",OADS,/arxiv_data1/oa_pdf/50/47/JEM_20150225.PMC4516788.pdf
"http://dx.doi.org/10.1084/jem.2002076 0 Sharp, G.J., T.R.",Non-OADS,/arxiv_data1/oa_pdf/50/47/JEM_20150225.PMC4516788.pdf
"http://dx.doi.org/   10.1146/annurev.pharmtox.011008.14561 6 Spite, M., L.V.",Non-OADS,/arxiv_data1/oa_pdf/50/47/JEM_20150225.PMC4516788.pdf
"461:1287– 1291. http://dx.doi.org/10.1038/nature0854 1 Tabas, I., and C.K.",Non-OADS,/arxiv_data1/oa_pdf/50/47/JEM_20150225.PMC4516788.pdf
"http://dx.doi   .org/10.1126/science.123072 0 Wang, X., H. Sumida, and J.G.",OADS,/arxiv_data1/oa_pdf/50/47/JEM_20150225.PMC4516788.pdf
"http://dx.doi.org/10.1084/jem.2014064 6 Winyard, P.G., and D.A.",OADS,/arxiv_data1/oa_pdf/50/47/JEM_20150225.PMC4516788.pdf
http://dx.doi.org/10.1385/159259374 7 World Health Organization.,Non-OADS,/arxiv_data1/oa_pdf/50/47/JEM_20150225.PMC4516788.pdf
194. http://www.who.int/mediacentre/factsheets/fs194/en/.,Non-OADS,/arxiv_data1/oa_pdf/50/47/JEM_20150225.PMC4516788.pdf
"http://dx.doi.org/   10.1006/geno.1997.475 2 Guo, Y., W. Zhang, C. Giroux, Y. Cai, P. Ekambaram, A.K.",Non-OADS,/arxiv_data1/oa_pdf/50/47/JEM_20150225.PMC4516788.pdf
"http://dx.doi.org/10.1016/j.neuropharm.2014.05.04 3 Kohno, M., H. Hasegawa, A. Inoue, M. Muraoka, T. Miyazaki, K. Oka,  and M. Yasukawa.",OADS,/arxiv_data1/oa_pdf/50/47/JEM_20150225.PMC4516788.pdf
"http://dx.doi.org/10.1016/   j.bbrc.2006.06.17 5 Krishnamoorthy, S., A. Recchiuti, N. Chiang, S. Yacoubian, C.-H. Lee, R.  Yang, N.A.",OADS,/arxiv_data1/oa_pdf/50/47/JEM_20150225.PMC4516788.pdf
"http://dx.doi.org/10.1096/fj.12-21951 9 Lee, H.N., and Y.J.",OADS,/arxiv_data1/oa_pdf/50/47/JEM_20150225.PMC4516788.pdf
"http://dx.doi.org/   10.1016/j.bcp.2013.07.00 2 Mas, E., K.D.",OADS,/arxiv_data1/oa_pdf/50/47/JEM_20150225.PMC4516788.pdf
"http://dx.doi.org/10.1373/clinchem.2012.19019 9 Mayer-Barber, K.D., B.B.",Non-OADS,/arxiv_data1/oa_pdf/50/47/JEM_20150225.PMC4516788.pdf
"http://dx.doi.org/10.1038/   nature1348 9 Mead, P.S., L. Slutsker, V. Dietz, L.F. McCaig, J.S.",OADS,/arxiv_data1/oa_pdf/50/47/JEM_20150225.PMC4516788.pdf
"http://dx.doi.org/10.3201/   eid0505.99050 2 Morita, M., K. Kuba, A. Ichikawa, M. Nakayama, J. Katahira, R. Iwamoto,  T. Watanebe, S. Sakabe, T. Daidoji, S. Nakamura, et al.",OADS,/arxiv_data1/oa_pdf/50/47/JEM_20150225.PMC4516788.pdf
"http://dx.doi.org/10.1016/   j.cell.2013.02.02 7 Nathan, C. 2012.",OADS,/arxiv_data1/oa_pdf/50/47/JEM_20150225.PMC4516788.pdf
"http://dx.doi.org/10.1126/scitranslmed.300308 1 Park, C.K., Z.Z.",Non-OADS,/arxiv_data1/oa_pdf/50/47/JEM_20150225.PMC4516788.pdf
31:18433– 18438. http://dx.doi.org/10.1523/JNEUROSCI.4192-11.201 1,Non-OADS,/arxiv_data1/oa_pdf/50/47/JEM_20150225.PMC4516788.pdf
This article is distributed under the terms of an Attribution–Noncommercial–Share  Alike–No Mirror Sites license for the first six months after the publication date  (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/bd/28/JEM_20142047.PMC4516789.pdf
"After six months it is available under a Cre - ative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported  license, as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/bd/28/JEM_20142047.PMC4516789.pdf
"http://dx.doi.org/10.1084/   jem.2010265 7 Barber, D.L., E.J.",OADS,/arxiv_data1/oa_pdf/bd/28/JEM_20142047.PMC4516789.pdf
"http://dx.doi.org/10.1038/nature0444 4 Berger, D.P., D. Homann, and M.B.",OADS,/arxiv_data1/oa_pdf/bd/28/JEM_20142047.PMC4516789.pdf
"http://dx.doi.org/10.1006/viro.1999.007 4 Bromley, S.K., D.A.",Non-OADS,/arxiv_data1/oa_pdf/bd/28/JEM_20142047.PMC4516789.pdf
"http://dx.doi   .org/10.4049/jimmunol.165.1.1 5 Brooks, D.G., M.J. Trifilo, K.H.",OADS,/arxiv_data1/oa_pdf/bd/28/JEM_20142047.PMC4516789.pdf
"http://dx.doi.org/   10.1038/nm149 2 Bukowski, J.F., C.A.",OADS,/arxiv_data1/oa_pdf/bd/28/JEM_20142047.PMC4516789.pdf
"http://dx.doi   .org/10.1002/cne.2166 8 Butovsky, O., S. Siddiqui, G. Gabriely, A.J.",Non-OADS,/arxiv_data1/oa_pdf/bd/28/JEM_20142047.PMC4516789.pdf
"http://dx.doi   .org/10.1172/JCI6263 6 D’Agostino, P .M., C. Kwak, H.A.",Non-OADS,/arxiv_data1/oa_pdf/bd/28/JEM_20142047.PMC4516789.pdf
"http://dx.doi.org/10.1146/annurev   .immunol.14.1.20 7 Kang, S.S., and D.B.",OADS,/arxiv_data1/oa_pdf/bd/28/JEM_20142047.PMC4516789.pdf
"http://dx.doi.org/10.2741/302 1 Kang, S.S., and D.B.",OADS,/arxiv_data1/oa_pdf/bd/28/JEM_20142047.PMC4516789.pdf
"http://dx.doi.org/10.4049/jimmunol.173.4.235 3 Kim, J.V ., S.S. Kang, M.L.",OADS,/arxiv_data1/oa_pdf/bd/28/JEM_20142047.PMC4516789.pdf
"http://dx.doi.org/10.1038/   nature0759 1 Knickelbein, J.E., K.M.",OADS,/arxiv_data1/oa_pdf/bd/28/JEM_20142047.PMC4516789.pdf
"http://dx.doi.org/10.1126/science.116416 4 Koff, W.C., D.R.",OADS,/arxiv_data1/oa_pdf/bd/28/JEM_20142047.PMC4516789.pdf
"340:1232910. http://dx.doi.org/10.1126/science.123291 0 Kreutzfeldt, M., A. Bergthaler, M. Fernandez, W. Brück, K. Steinbach,  M. Vorm, R. Coras, I. Blümcke, W.V.",OADS,/arxiv_data1/oa_pdf/bd/28/JEM_20142047.PMC4516789.pdf
"http://dx.doi.org/10.1084/jem.2012214 3 Kunz, S., J.M.",OADS,/arxiv_data1/oa_pdf/bd/28/JEM_20142047.PMC4516789.pdf
"http://dx.doi   .org/10.1128/JVI.00795­0 6 Lauterbach, H., E.I.",Non-OADS,/arxiv_data1/oa_pdf/bd/28/JEM_20142047.PMC4516789.pdf
"http://dx.doi   .org/10.1084/jem.2006003 9 Lauterbach, H., P. Truong, and D.B.",OADS,/arxiv_data1/oa_pdf/bd/28/JEM_20142047.PMC4516789.pdf
"4:53. http://dx.doi.org/10.1186/   1743­422X­4­5 3 Leen, A.M., G.D. Myers, U. Sili, M.H.",Non-OADS,/arxiv_data1/oa_pdf/bd/28/JEM_20142047.PMC4516789.pdf
"http://dx.doi.org/10.1038/nm147 5 Lindquist, R.L., G. Shakhar, D. Dudziak, H. Wardemann, T. Eisenreich,  M.L.",OADS,/arxiv_data1/oa_pdf/bd/28/JEM_20142047.PMC4516789.pdf
"http://dx.doi.org/   10.1038/ni113 9 Masopust, D., K. Murali­Krishna, and R. Ahmed.",Non-OADS,/arxiv_data1/oa_pdf/bd/28/JEM_20142047.PMC4516789.pdf
"81:2002– 2011. http://dx.doi.org/10.1128/JVI.01459­0 6 McGavern, D.B., and S.S. Kang.",OADS,/arxiv_data1/oa_pdf/bd/28/JEM_20142047.PMC4516789.pdf
"http://dx.doi.org/   10.1038/nri297 1 McGavern, D.B., U. Christen, and M.B.",OADS,/arxiv_data1/oa_pdf/bd/28/JEM_20142047.PMC4516789.pdf
"http://dx.doi.org/10.1038/ni84 3 McGavern, D.B., D. Homann, and M.B.",OADS,/arxiv_data1/oa_pdf/bd/28/JEM_20142047.PMC4516789.pdf
"http://dx.doi.org/10.1086/34426 4 McMahon, E.J., S.L.",OADS,/arxiv_data1/oa_pdf/bd/28/JEM_20142047.PMC4516789.pdf
"http://dx.doi.org/10.1128/JVI.00435­0 8 Fazakerley, J.K., P. Southern, F. Bloom, and M.J. Buchmeier.",Non-OADS,/arxiv_data1/oa_pdf/bd/28/JEM_20142047.PMC4516789.pdf
"http://dx.doi   .org/10.1099/0022­1317­72­7­161 1 Fischer, H.G., U. Bonifas, and G. Reichmann.",Non-OADS,/arxiv_data1/oa_pdf/bd/28/JEM_20142047.PMC4516789.pdf
"http://dx.doi   .org/10.4049/jimmunol.164.9.482 6 Friedman, R.S., P. Beemiller, C.M.",Non-OADS,/arxiv_data1/oa_pdf/bd/28/JEM_20142047.PMC4516789.pdf
"http://dx.doi.org/10.1084/jem.2009120 1 Gossa, S., D. Nayak, B.H.",OADS,/arxiv_data1/oa_pdf/bd/28/JEM_20142047.PMC4516789.pdf
"http://dx.doi   .org/10.1073/pnas.091150910 6 Guidotti, L.G., and F.V.",OADS,/arxiv_data1/oa_pdf/bd/28/JEM_20142047.PMC4516789.pdf
"http://dx.doi.org/10.1146/annurev.immunol.19.1.6 5 Guidotti, L.G., P. Borrow, A.",OADS,/arxiv_data1/oa_pdf/bd/28/JEM_20142047.PMC4516789.pdf
"http://dx.doi.org/10.1126/   science.284.5415.82 5 Haller, O., G. Kochs, and F. Weber.",OADS,/arxiv_data1/oa_pdf/bd/28/JEM_20142047.PMC4516789.pdf
"http://dx.doi.org/10.1016/j.virol.2005.09.02 4 Herz, J., B.H.",OADS,/arxiv_data1/oa_pdf/bd/28/JEM_20142047.PMC4516789.pdf
"18:730– 741. http://dx.doi.org/10.1017/S143192761200028 1 Heslop, H.E., M.K.",Non-OADS,/arxiv_data1/oa_pdf/bd/28/JEM_20142047.PMC4516789.pdf
"http://dx.doi.org/ 10.1038/   nm0997­103 7 Howe, C.L., R.G.",OADS,/arxiv_data1/oa_pdf/bd/28/JEM_20142047.PMC4516789.pdf
"9:50. http://dx.doi   .org/10.1186/1742­2094­9­5 0 Jamieson, B.D., L.D.",Non-OADS,/arxiv_data1/oa_pdf/bd/28/JEM_20142047.PMC4516789.pdf
"http://dx.doi.org/10.1371/journal.ppat.100224 6 Joly, E., and M.B.",Non-OADS,/arxiv_data1/oa_pdf/bd/28/JEM_20142047.PMC4516789.pdf
http://dx.doi.org/10.1126/science.189171 7,Non-OADS,/arxiv_data1/oa_pdf/bd/28/JEM_20142047.PMC4516789.pdf
"http://dx.doi.org/10.1126/science.135291 2 Rodriguez, M., M.J. Buchmeier, M.B.",OADS,/arxiv_data1/oa_pdf/bd/28/JEM_20142047.PMC4516789.pdf
"http://dx.doi.org/   10.1126/scitranslmed.300376 1 Sedgwick, J.D., S. Schwender, H. Imrich, R. Dörries, G.W.",Non-OADS,/arxiv_data1/oa_pdf/bd/28/JEM_20142047.PMC4516789.pdf
"http://dx.doi.org/10.1073/   pnas.88.16.743 8 Suvas, S., A.K.",Non-OADS,/arxiv_data1/oa_pdf/bd/28/JEM_20142047.PMC4516789.pdf
"http://dx.doi.org/10.4049/jimmunol.176.3.170 3 Tishon, A., H. Lewicki, G. Rall, M. Von Herrath, and M.B.",Non-OADS,/arxiv_data1/oa_pdf/bd/28/JEM_20142047.PMC4516789.pdf
"http://dx.doi.org/10.1006/   viro.1995.147 7 Tyler, K.L.",Non-OADS,/arxiv_data1/oa_pdf/bd/28/JEM_20142047.PMC4516789.pdf
"http://dx.doi.org/10.1001/archneurol   .2009.153 Tyler, K.L.",Non-OADS,/arxiv_data1/oa_pdf/bd/28/JEM_20142047.PMC4516789.pdf
"http://dx.doi.org/10.1001/   archneurol.2009.189 van den Pol, A.N.",Non-OADS,/arxiv_data1/oa_pdf/bd/28/JEM_20142047.PMC4516789.pdf
"http://dx.doi.org/10.1016/j.tins   .2006.06.00 2 Volkert, M. 1962.",OADS,/arxiv_data1/oa_pdf/bd/28/JEM_20142047.PMC4516789.pdf
http://dx.doi.org/10.1111/j.1699­ 0463.1962.tb04909.,Non-OADS,/arxiv_data1/oa_pdf/bd/28/JEM_20142047.PMC4516789.pdf
http://dx.doi.org/10.1111/j.1699­0463   .1963.tb05115.,Non-OADS,/arxiv_data1/oa_pdf/bd/28/JEM_20142047.PMC4516789.pdf
"http://dx.doi.org/10.1038/   nm120 2 Merkler, D., E. Horvath, W. Bruck, R.M.",OADS,/arxiv_data1/oa_pdf/bd/28/JEM_20142047.PMC4516789.pdf
"116:1254– 1263. http://dx.doi.org/10.1172/JCI2737 2 Mims, C.A.",OADS,/arxiv_data1/oa_pdf/bd/28/JEM_20142047.PMC4516789.pdf
"http://dx.doi.org/10.1111/imr.1209 3 Müller, U., U. Steinhoff, L.F. Reis, S. Hemmi, J. Pavlovic, R.M.",Non-OADS,/arxiv_data1/oa_pdf/bd/28/JEM_20142047.PMC4516789.pdf
"http://dx.doi   .org/10.1126/science.800922 1 Nath, A., and K.L.",OADS,/arxiv_data1/oa_pdf/bd/28/JEM_20142047.PMC4516789.pdf
"74:412– 422. http://dx.doi.org/10.1002/ana.2398 8 Nayak, D., K.R.",Non-OADS,/arxiv_data1/oa_pdf/bd/28/JEM_20142047.PMC4516789.pdf
"http://dx.doi.org/10.1371/journal .ppat.100339 5 Nayak, D., T.L.",Non-OADS,/arxiv_data1/oa_pdf/bd/28/JEM_20142047.PMC4516789.pdf
"http://dx.doi.org/   10.1146/annurev­immunol­032713­12024 0 Oldstone, M.B., P. Blount, P.J.",Non-OADS,/arxiv_data1/oa_pdf/bd/28/JEM_20142047.PMC4516789.pdf
"http://dx.doi.org/10.1038/321239a 0 Ousman, S.S., and P .",Non-OADS,/arxiv_data1/oa_pdf/bd/28/JEM_20142047.PMC4516789.pdf
"http://dx.doi.org/10.1038/nn.316 1 Oxenius, A., M.F.",Non-OADS,/arxiv_data1/oa_pdf/bd/28/JEM_20142047.PMC4516789.pdf
"http://dx.doi.org/10.1002/(SICI)1521­ 4141(199801)28:01<390::AID­IMMU390>3.0.CO;2­ O Papadopoulos, E.B., M. Ladanyi, D. Emanuel, S. Mackinnon, F. Boulad,  M.H.",Non-OADS,/arxiv_data1/oa_pdf/bd/28/JEM_20142047.PMC4516789.pdf
"http://dx.doi   .org/10.1056/NEJM19940428330170 3 Papadopoulou, A., U. Gerdemann, U.L.",Non-OADS,/arxiv_data1/oa_pdf/bd/28/JEM_20142047.PMC4516789.pdf
"http://dx.doi.org/10.1126/scitranslmed.300882 5 Phares, T.W ., S.A. Stohlman, D.R.",Non-OADS,/arxiv_data1/oa_pdf/bd/28/JEM_20142047.PMC4516789.pdf
"9:269. http://dx.doi.org/10.1186/1742 ­2094­  9­269 Pircher, H., K. Bürki, R. Lang, H. Hengartner, and R.M.",Non-OADS,/arxiv_data1/oa_pdf/bd/28/JEM_20142047.PMC4516789.pdf
"http://dx.doi.org/   10.1038/342559a 0 Planz, O., S. Ehl, E. Furrer, E. Horvath, M.A.",OADS,/arxiv_data1/oa_pdf/bd/28/JEM_20142047.PMC4516789.pdf
http://dx.doi.org/10.1128/CVI.00290­0 9,Non-OADS,/arxiv_data1/oa_pdf/bd/28/JEM_20142047.PMC4516789.pdf
This article is distributed under the terms of an Attribution–   Noncommercial–Share Alike–No Mirror Sites license for the first six months after the  publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/5a/cf/JEM_20150218.PMC4516791.pdf
"After six months it is available  under a Creative Commons License (Attribution–Noncommercial–Share Alike 3.0   Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/5a/cf/JEM_20150218.PMC4516791.pdf
cAssociated gene function according to DAVID Bioinformatics Database and Mouse Genome Database (MGD) at http://www.informatics.jax.org (September 2014).,OADS,/arxiv_data1/oa_pdf/5a/cf/JEM_20150218.PMC4516791.pdf
"http://dx.doi.org/10.1001/archinte.166.8.90 2 Bonizzi, G., M. Bebien, D.C. Otero, K.E.",Non-OADS,/arxiv_data1/oa_pdf/5a/cf/JEM_20150218.PMC4516791.pdf
"http://dx.doi.org/10.1038/sj.emboj.760039 1 Bradfield, J.P., H.Q.",OADS,/arxiv_data1/oa_pdf/5a/cf/JEM_20150218.PMC4516791.pdf
"http://dx.doi   .org/10.1371/journal.pgen.100229 3 Butler, A.E., J. Janson, S. Bonner-W eir, R. Ritzel, R.A. Rizza, and P .C.",Non-OADS,/arxiv_data1/oa_pdf/5a/cf/JEM_20150218.PMC4516791.pdf
"http://dx.doi.org/10.2337/diabetes.52.1.10 2 Campanati, A., G. Ganzetti, A.",Non-OADS,/arxiv_data1/oa_pdf/5a/cf/JEM_20150218.PMC4516791.pdf
"http://dx.doi.org/   10.1007/s00535-012-0678- 9 Cantley, J., S.N.",Non-OADS,/arxiv_data1/oa_pdf/5a/cf/JEM_20150218.PMC4516791.pdf
"http://dx.doi.org/10.3727/096368912X65872 8 Chen, J., Y. Meng, J. Zhou, M. Zhuo, F. Ling, Y. Zhang, H. Du, and X.  Wang.",OADS,/arxiv_data1/oa_pdf/5a/cf/JEM_20150218.PMC4516791.pdf
"2013:970435. http://dx.doi.org/10.1155/2013/   97043 5at 95°C for 10 s, followed by a three step cycle consisting of 95°C for 15 s   (4.8°C/s, denaturation), 63°C for 30 s (2.5°C/s, annealing), and 72°C for  30 s (4.8°C/s, elongation).",Non-OADS,/arxiv_data1/oa_pdf/5a/cf/JEM_20150218.PMC4516791.pdf
Online supplemental material is available at http://www.jem.org/cgi/   content/full/jem.20150218/DC1.,Non-OADS,/arxiv_data1/oa_pdf/5a/cf/JEM_20150218.PMC4516791.pdf
"http://dx.doi.org/10.1172/JCI11793 6 Hundal, R.S., K.F.",Non-OADS,/arxiv_data1/oa_pdf/5a/cf/JEM_20150218.PMC4516791.pdf
"http://dx.doi.org/10.1172/JCI021495 5 Jehle, P.M., D.R.",OADS,/arxiv_data1/oa_pdf/5a/cf/JEM_20150218.PMC4516791.pdf
"http://dx.doi.org/10.1677/joe.0.159029 7 Jurczyk, A., N. Roy, R. Bajwa, P. Gut, K. Lipson, C. Yang, L. Covassin,  W.J.",Non-OADS,/arxiv_data1/oa_pdf/5a/cf/JEM_20150218.PMC4516791.pdf
"http://dx.doi.org/10.1101/gr.074914.10 7 Kiechl, S., J. Wittmann, A. Giaccari, M. Knoflach, P. Willeit, A. Bozec,  A.R.",Non-OADS,/arxiv_data1/oa_pdf/5a/cf/JEM_20150218.PMC4516791.pdf
"http://dx.doi.org/10.1038/nm.308 4 Leclerc, I., and G.A.",OADS,/arxiv_data1/oa_pdf/5a/cf/JEM_20150218.PMC4516791.pdf
"http://dx.doi.org/10.2337/diabetes.53.suppl_   3.S67 Li, H., W. Gan, L. Lu, X. Dong, X. Han, C. Hu, Z. Yang, L. Sun, W. Bao,  P. Li, et al.",OADS,/arxiv_data1/oa_pdf/5a/cf/JEM_20150218.PMC4516791.pdf
"http://dx.doi.org/10.2337/db12-045 4 Li, N.F., Y.A.",OADS,/arxiv_data1/oa_pdf/5a/cf/JEM_20150218.PMC4516791.pdf
"http://dx.doi.org/10.1084/jem.2003011 6 Olesen, P., T. Ledet, and L.M.",OADS,/arxiv_data1/oa_pdf/5a/cf/JEM_20150218.PMC4516791.pdf
"48:561– 568. http://dx.doi.org/10.1007/s00125-004-1652- 8 Ortega, F.J., N. Pueyo, J.M.",Non-OADS,/arxiv_data1/oa_pdf/5a/cf/JEM_20150218.PMC4516791.pdf
"37:1532– 1538. http://dx.doi.org/10.1038/ijo.2013.2 3 Ortis, F., N. Naamane, D. Flamez, L. Ladrière, F. Moore, D.A.",Non-OADS,/arxiv_data1/oa_pdf/5a/cf/JEM_20150218.PMC4516791.pdf
"http://dx.doi.org/10.2337/db09-115 9 Peyot, M.L., E. Pepin, J. Lamontagne, M.G.",Non-OADS,/arxiv_data1/oa_pdf/5a/cf/JEM_20150218.PMC4516791.pdf
"http://dx.doi.org/10.2337/db09-145 2 Qu, H.Q., S.F.A.",Non-OADS,/arxiv_data1/oa_pdf/5a/cf/JEM_20150218.PMC4516791.pdf
"138:961– 975. http://dx.doi.org/10.1016/j.cell.2009.06.04 6 Choudhary, S., S. Sinha, Y. Zhao, S. Banerjee, P. Sathyanarayana, S.  Shahani, V. Sherman, R.G.",OADS,/arxiv_data1/oa_pdf/5a/cf/JEM_20150218.PMC4516791.pdf
"http://dx.doi.org/10.1210/   en.2011-134 3 Cnop, M., B. Abdulkarim, G. Bottu, D.A.",Non-OADS,/arxiv_data1/oa_pdf/5a/cf/JEM_20150218.PMC4516791.pdf
"63:1978– 1993. http://dx.doi.org/10.2337/db13-138 3 Dayeh, T., P. Volkov, S. Salö, E. Hall, E. Nilsson, A.H. Olsson, C.L.",OADS,/arxiv_data1/oa_pdf/5a/cf/JEM_20150218.PMC4516791.pdf
"http://dx.doi.org/   10.1371/journal.pgen.100416 0 Donath, M.Y., D.J.",Non-OADS,/arxiv_data1/oa_pdf/5a/cf/JEM_20150218.PMC4516791.pdf
"http://dx.doi   .org/10.2337/diabetes.48.4.73 8 Ferrannini, E., and A. Mari.",Non-OADS,/arxiv_data1/oa_pdf/5a/cf/JEM_20150218.PMC4516791.pdf
"http://dx.doi.org/10.1016/j.metabol.2014.05.01 2 Florez, J.C. 2008.",OADS,/arxiv_data1/oa_pdf/5a/cf/JEM_20150218.PMC4516791.pdf
"http://dx.doi.org/10.1007/s00125-008-   1025- 9 Fulda, S., and D. Vucic.",OADS,/arxiv_data1/oa_pdf/5a/cf/JEM_20150218.PMC4516791.pdf
"http://dx.doi   .org/10.1038/nrd362 7 Gardam, S., F. Sierro, A. Basten, F. Mackay, and R. Brink.",OADS,/arxiv_data1/oa_pdf/5a/cf/JEM_20150218.PMC4516791.pdf
"http://dx.doi.org/10.1016/j.immuni.2008.01.00 9 Gardam, S., V.M.",OADS,/arxiv_data1/oa_pdf/5a/cf/JEM_20150218.PMC4516791.pdf
"http://dx.doi.org/10.1182/blood-2010-10-31279 3 Goldfine, A.B., V. Fonseca, K.A.",Non-OADS,/arxiv_data1/oa_pdf/5a/cf/JEM_20150218.PMC4516791.pdf
"http://dx.doi.org/10.7326/0003-4819-159-1-   201307020-0000 3 Grey, S.T., C. Longo, T. Shukri, V.I.",Non-OADS,/arxiv_data1/oa_pdf/5a/cf/JEM_20150218.PMC4516791.pdf
"http://dx.doi.org/10.4049/jimmunol   .170.12.625 0 Grimm, C.H., U.C.",Non-OADS,/arxiv_data1/oa_pdf/5a/cf/JEM_20150218.PMC4516791.pdf
"http://dx.doi.org/10.1080/089169303100014106 8 Guan, W., A. Pluzhnikov, N.J. Cox, and M. Boehnke.",OADS,/arxiv_data1/oa_pdf/5a/cf/JEM_20150218.PMC4516791.pdf
"http://dx.doi.org/   10.1159/00011416 4 Hesselson, D., R.M.",Non-OADS,/arxiv_data1/oa_pdf/5a/cf/JEM_20150218.PMC4516791.pdf
http://dx.doi.org/10.1073/   pnas.97.1.47 2,Non-OADS,/arxiv_data1/oa_pdf/5a/cf/JEM_20150218.PMC4516791.pdf
"http://dx.doi.org/10.1136/jmg.2009   .06714 0 Rampersaud, E., C.M.",OADS,/arxiv_data1/oa_pdf/5a/cf/JEM_20150218.PMC4516791.pdf
"http://dx.doi.org/10.2337/db07-045 7 Rauert, H., A. Wicovsky, N. Müller, D. Siegmund, V. Spindler, J. Waschke,  C. Kneitz, and H. Wajant.",Non-OADS,/arxiv_data1/oa_pdf/5a/cf/JEM_20150218.PMC4516791.pdf
"http://dx.doi.org/10.1074/jbc.M109.03734 1 Reilly, S.M., S.H.",Non-OADS,/arxiv_data1/oa_pdf/5a/cf/JEM_20150218.PMC4516791.pdf
"http://dx.doi   .org/10.1038/nm.308 2 Seth, A., D.L.",OADS,/arxiv_data1/oa_pdf/5a/cf/JEM_20150218.PMC4516791.pdf
"http://dx.doi.org/10.1038/nm.275 6 Spranger, J., A. Kroke, M. Möhlig, K. Hoffmann, M.M.",OADS,/arxiv_data1/oa_pdf/5a/cf/JEM_20150218.PMC4516791.pdf
"http://dx.doi.org/10.2337/   diabetes.52.3.81 2 Sun, S.-C. 2011.",Non-OADS,/arxiv_data1/oa_pdf/5a/cf/JEM_20150218.PMC4516791.pdf
"21:71– 85. http://dx.doi.org/10.1038/cr.2010.17 7 Taneera, J., S. Lang, A. Sharma, J. Fadista, Y .",Non-OADS,/arxiv_data1/oa_pdf/5a/cf/JEM_20150218.PMC4516791.pdf
"http://dx.doi.org/10.1016/j.cmet.2012.06.00 6 Uysal, K.T., S.M.",OADS,/arxiv_data1/oa_pdf/5a/cf/JEM_20150218.PMC4516791.pdf
"http://dx.doi.org/10.1038/   39335 Vallabhapurapu, S., A. Matsuzawa, W. Zhang, P.-H. Tseng, J.J. Keats,  H. Wang, D.A.A.",Non-OADS,/arxiv_data1/oa_pdf/5a/cf/JEM_20150218.PMC4516791.pdf
"http://dx.doi.org/10.1038/   ni.167 8Varfolomeev, E., J.W.",OADS,/arxiv_data1/oa_pdf/5a/cf/JEM_20150218.PMC4516791.pdf
"http://dx.doi   .org/10.1016/j.cell.2007.10.03 0 Verchere, C.B., D.A.",OADS,/arxiv_data1/oa_pdf/5a/cf/JEM_20150218.PMC4516791.pdf
"http://dx.doi.org/10.1038/   ng.275 6 Wicksteed, B., M. Brissova, W .",OADS,/arxiv_data1/oa_pdf/5a/cf/JEM_20150218.PMC4516791.pdf
"http://dx.doi   .org/10.2337/diabetes.53.suppl_3.S21 5 Xie, P., Z.J.",Non-OADS,/arxiv_data1/oa_pdf/5a/cf/JEM_20150218.PMC4516791.pdf
"http://dx.doi.org/   10.4049/jimmunol.100029 0 Yeh, W.-C., A. Shahinian, D. Speiser, J. Kraunus, F. Billia, A. Wakeham,  J.L.",Non-OADS,/arxiv_data1/oa_pdf/5a/cf/JEM_20150218.PMC4516791.pdf
"http://dx.doi.org/10.1126/science.106162 0 Zammit, N.W., B.M.",Non-OADS,/arxiv_data1/oa_pdf/5a/cf/JEM_20150218.PMC4516791.pdf
"http://dx.doi.org/10.3727/096368912X65873 7 Zarnegar, B.J., Y. Wang, D.J.",Non-OADS,/arxiv_data1/oa_pdf/5a/cf/JEM_20150218.PMC4516791.pdf
http://dx.doi.org/10.1038/   ni.167 6,Non-OADS,/arxiv_data1/oa_pdf/5a/cf/JEM_20150218.PMC4516791.pdf
This article is distributed under the terms of an Attribution–   Noncommercial–Share Alike–No Mirror Sites license for the first six months  after the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/ea/eb/JEM_20141254.PMC4516794.pdf
"After six months  it is available under a Creative Commons License (Attribution–Noncommercial–   Share Alike 3.0 Unported license, as described at http://creativecommons.org/ licenses/by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/ea/eb/JEM_20141254.PMC4516794.pdf
The LDAs were calculated using the limiting dilution function of the Walter and Eliza Hall Institute Extreme Limiting Dilution Analysis (http://bioinf.wehi.edu.au/software/elda/index.html).,OADS,/arxiv_data1/oa_pdf/ea/eb/JEM_20141254.PMC4516794.pdf
"Using the Walter and Eliza Hall Institute Extreme Limiting Dilution Analysis (http://bioinf.wehi.edu.au/software/elda/index.html), we were able to calculate a sphere-initiating cell frequency.",OADS,/arxiv_data1/oa_pdf/ea/eb/JEM_20141254.PMC4516794.pdf
Gene enrichment and functional annotation analysis for a significant probe list was performed using DAVID (http://david.abcc.ncifcrf.gov) and Gene Set Enrichment Analysis (http://www.broadinstitute.org/gsea/msigdb/collections.jsp).,OADS,/arxiv_data1/oa_pdf/ea/eb/JEM_20141254.PMC4516794.pdf
Online supplemental material is available at http://www.jem.org/cgi/content/full/jem.20141254/DC1.,Non-OADS,/arxiv_data1/oa_pdf/ea/eb/JEM_20141254.PMC4516794.pdf
"http://dx.doi.org/10.1038/sj.onc.1207947 Boral, D., and D. Nie.",OADS,/arxiv_data1/oa_pdf/ea/eb/JEM_20141254.PMC4516794.pdf
"http://dx.doi.org/10   .2741/E561 Brabletz, S., O. Schmalhofer, and T. Brabletz.",OADS,/arxiv_data1/oa_pdf/ea/eb/JEM_20141254.PMC4516794.pdf
"http://dx.doi  .org/10.1002/path.2475 Bramis, J., P. Zacharatos, I. Papaconstantinou, A. Kotsinas, F. Sigala,  D.P.",Non-OADS,/arxiv_data1/oa_pdf/ea/eb/JEM_20141254.PMC4516794.pdf
"http://dx.doi.org/10 .1016/j.cell.2012.05.002 Liu, J., J. Stevens, C.A.",OADS,/arxiv_data1/oa_pdf/ea/eb/JEM_20141254.PMC4516794.pdf
"http://dx.doi.org/10.1016/S1097-2765(01)00241-6 Moon, B.S., H.Y.",OADS,/arxiv_data1/oa_pdf/ea/eb/JEM_20141254.PMC4516794.pdf
"http://dx.doi.org/10.1002/stem.586 Morris, E.J., J.Y.",OADS,/arxiv_data1/oa_pdf/ea/eb/JEM_20141254.PMC4516794.pdf
"http://dx.doi.org/10.1038/nature07310 Neufert, C., C. Becker, and M.F.",OADS,/arxiv_data1/oa_pdf/ea/eb/JEM_20141254.PMC4516794.pdf
"http://dx.doi   .org/10.1038/nprot.2007.279 Nevins, J.R. 2001.",OADS,/arxiv_data1/oa_pdf/ea/eb/JEM_20141254.PMC4516794.pdf
"http://dx.doi.org/10.1093/hmg/10.7.699 Niehrs, C., and S.P.",OADS,/arxiv_data1/oa_pdf/ea/eb/JEM_20141254.PMC4516794.pdf
"http://dx.doi.org/10.1038/emboj.2012.124 O’Brien, C.A., A. Kreso, P. Ryan, K.G.",Non-OADS,/arxiv_data1/oa_pdf/ea/eb/JEM_20141254.PMC4516794.pdf
"http://dx.doi.org/10.1016/j.ccr.2012.04.036 Oliveira, T.G., R.B.",OADS,/arxiv_data1/oa_pdf/ea/eb/JEM_20141254.PMC4516794.pdf
"http://dx.doi .org/10.1523/JNEUROSCI.3317-10.2010 Pastrana, E., V. Silva-Vargas, and F. Doetsch.",OADS,/arxiv_data1/oa_pdf/ea/eb/JEM_20141254.PMC4516794.pdf
"http://dx.doi.org/10.1016/j.stem.2011.04.007 Pauli, A., J.L.",OADS,/arxiv_data1/oa_pdf/ea/eb/JEM_20141254.PMC4516794.pdf
"http://dx.doi.org/ 10.1038/nrg2904 Pinto, D., S. Robine, F. Jaisser, F.E.",Non-OADS,/arxiv_data1/oa_pdf/ea/eb/JEM_20141254.PMC4516794.pdf
"http://dx.doi.org/ 10.1074/jbc.274.10.6476 Scott, S.A., P.E.",OADS,/arxiv_data1/oa_pdf/ea/eb/JEM_20141254.PMC4516794.pdf
"http://dx.doi.org/   10.1038/nchembio.140 Selvy, P.E., R.R.",OADS,/arxiv_data1/oa_pdf/ea/eb/JEM_20141254.PMC4516794.pdf
"http://dx.doi.org/10.1021/cr200296t Su, W., Q. Chen, and M.A.",OADS,/arxiv_data1/oa_pdf/ea/eb/JEM_20141254.PMC4516794.pdf
"http://dx.doi.org/10.2217/ fon.09.110 Tardat, M., R. Murr, Z. Herceg, C. Sardet, and E. Julien.",Non-OADS,/arxiv_data1/oa_pdf/ea/eb/JEM_20141254.PMC4516794.pdf
"http://dx.doi.org/ 10.1083/jcb.200706179 Trimarchi, J.M., and J.A.",OADS,/arxiv_data1/oa_pdf/ea/eb/JEM_20141254.PMC4516794.pdf
http://dx.doi.org/10.1038/nrm714is inversely associated with tumor growth in colon adenocarcinomas.,Non-OADS,/arxiv_data1/oa_pdf/ea/eb/JEM_20141254.PMC4516794.pdf
"http://dx.doi.org/10.1126/scisignal.2003257 Dalerba, P., R.W.",OADS,/arxiv_data1/oa_pdf/ea/eb/JEM_20141254.PMC4516794.pdf
"http://dx.doi.org/10.1146/ annurev.med.58.062105.204854 Dall’Armi, C., A. Hurtado-Lorenzo, H. Tian, E. Morel, A. Nezu, R.B.",Non-OADS,/arxiv_data1/oa_pdf/ea/eb/JEM_20141254.PMC4516794.pdf
"1:142. http://dx.doi.org/10.1038/ncomms1144 Donnenberg, V.S., and A.D. Donnenberg.",OADS,/arxiv_data1/oa_pdf/ea/eb/JEM_20141254.PMC4516794.pdf
"http://dx.doi.org/10.1177/0091270005276905 Fearon, E.R., and B. Vogelstein.",Non-OADS,/arxiv_data1/oa_pdf/ea/eb/JEM_20141254.PMC4516794.pdf
"http://dx.doi.org/10.1016/0092-   8674(90)90186-I Firestein, R., A.J.",OADS,/arxiv_data1/oa_pdf/ea/eb/JEM_20141254.PMC4516794.pdf
"http://dx.doi.org/10.1038/nature07179 Goodell, M.A., K. Brose, G. Paradis, A.S. Conner, and R.C.",OADS,/arxiv_data1/oa_pdf/ea/eb/JEM_20141254.PMC4516794.pdf
"http://dx.doi.org/10.1084/jem.183.4.1797 Henkels, K.M., G.P.",OADS,/arxiv_data1/oa_pdf/ea/eb/JEM_20141254.PMC4516794.pdf
"http://dx.doi.org/10.1038/onc.2013.207 Kang, D.W., M.H.",OADS,/arxiv_data1/oa_pdf/ea/eb/JEM_20141254.PMC4516794.pdf
"http://dx.doi.org/10.1074/jbc.M707416200 Kang, D.W., S.H.",OADS,/arxiv_data1/oa_pdf/ea/eb/JEM_20141254.PMC4516794.pdf
"http://dx.doi.org/10.1158/0008-5472.CAN-09-3470 Kang, D.W., K.Y.",Non-OADS,/arxiv_data1/oa_pdf/ea/eb/JEM_20141254.PMC4516794.pdf
"http://dx.doi.org/10.1158/0008-5472.CAN-10-2463 Kang, D.W., M.H.",OADS,/arxiv_data1/oa_pdf/ea/eb/JEM_20141254.PMC4516794.pdf
"http://dx.doi.org/10.1128/MCB.01519-12 Kennell, J., and K.M.",OADS,/arxiv_data1/oa_pdf/ea/eb/JEM_20141254.PMC4516794.pdf
"http://dx.doi.org/10.1002/ijc.21945 Li, V.S., S.S. Ng, P.J.",OADS,/arxiv_data1/oa_pdf/ea/eb/JEM_20141254.PMC4516794.pdf
This article is distributed under the terms of an Attribution–   Noncommercial–Share Alike–No Mirror Sites license for the first six months  after the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/ab/b2/JEM_20150032.PMC4516795.pdf
"After six months  it is available under a Creative Commons License (Attribution–Noncommercial– Share Alike 3.0 Unported license, as described at http://creativecommons.org/   licenses/by-nc-sa/3.0 /).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/ab/b2/JEM_20150032.PMC4516795.pdf
"98:2052– 2058. http://dx.doi.org/10.1182/blood.V98.7.205 2 Douglas, A.D., A.R.",Non-OADS,/arxiv_data1/oa_pdf/ab/b2/JEM_20150032.PMC4516795.pdf
"http://dx.doi   .org/10.4049/jimmunol.130204 5 Douglas, A.D., G.C.",Non-OADS,/arxiv_data1/oa_pdf/ab/b2/JEM_20150032.PMC4516795.pdf
"http://dx.doi.org/10.1016/   j.chom.2014.11.01 7 Ghevaert, C., N. Herbert, L. Hawkins, N. Grehan, P. Cookson, S.F.",OADS,/arxiv_data1/oa_pdf/ab/b2/JEM_20150032.PMC4516795.pdf
"http://dx.doi.org/10.1182/blood-   2013-02-48188 7 Heslop, H.E., E. Benaim, M.K.",Non-OADS,/arxiv_data1/oa_pdf/ab/b2/JEM_20150032.PMC4516795.pdf
"http://dx.doi.org/10.1016/S0140-6736(95)91621- 0 Hirsch, A.J., G.R.",OADS,/arxiv_data1/oa_pdf/ab/b2/JEM_20150032.PMC4516795.pdf
"79:11943– 11951. http://dx.doi.org/10.1128/JVI.79.18.11943-11951.200 5 Jacobson, J.M., J.P. Lalezari, M.A.",Non-OADS,/arxiv_data1/oa_pdf/ab/b2/JEM_20150032.PMC4516795.pdf
"http://dx.doi.org/10.1128/   AAC.00086-1 0 Koch, C., G. Staffler, R. Hüttinger, I. Hilgert, E. Prager, J. Cerný, P.  Steinlein, O. Majdic, V. Horejsí, and H. Stockinger.",OADS,/arxiv_data1/oa_pdf/ab/b2/JEM_20150032.PMC4516795.pdf
"http://dx.doi.org/10.1093/intimm/11.5.77 7 Lieberman-Blum, S.S., H.B.",Non-OADS,/arxiv_data1/oa_pdf/ab/b2/JEM_20150032.PMC4516795.pdf
"http://dx.doi.org/10.1016/S0149-2918(08)80048- 3 Macmillan, M.L., D. Couriel, D.J.",OADS,/arxiv_data1/oa_pdf/ab/b2/JEM_20150032.PMC4516795.pdf
"http://dx.doi.org/10.1182/blood-   2006-08-01399 5 Morgan, A., N.D. Jones, A.M. Nesbitt, L. Chaplin, M.W.",Non-OADS,/arxiv_data1/oa_pdf/ab/b2/JEM_20150032.PMC4516795.pdf
"http://dx.doi.org/10   .1016/j.cell.2013.02.02 7 Ord, R.L., J.C. Caldeira, M. Rodriguez, A. Noe, B. Chackerian, D.S.",OADS,/arxiv_data1/oa_pdf/ab/b2/JEM_20150032.PMC4516795.pdf
"13:326. http://dx.doi.org/10.1186/1475-2875-13-32 6 Prudêncio, M., and M.M.",Non-OADS,/arxiv_data1/oa_pdf/ab/b2/JEM_20150032.PMC4516795.pdf
"http://dx.doi.org/10.1093/jac/dkq26 1 Bushell, K.M., C. Söllner, B. Schuster-Boeckler, A. Bateman, and G.J.",OADS,/arxiv_data1/oa_pdf/ab/b2/JEM_20150032.PMC4516795.pdf
"http://dx.doi.org/10   .1101/gr.718780 8 Chen, Z.-N., L. Mi, J. Xu, F. Song, Q. Zhang, Z. Zhang, J.-L. Xing,  H.-J.",OADS,/arxiv_data1/oa_pdf/ab/b2/JEM_20150032.PMC4516795.pdf
"http://dx.doi.org/10.1016/j.ijrobp.2005.12.03 4 Chen, L., S. Lopaticki, D.T.",OADS,/arxiv_data1/oa_pdf/ab/b2/JEM_20150032.PMC4516795.pdf
"http://dx.doi.org/10.1371/journal   .ppat.100219 9 Chen, Q., A. Amaladoss, W .",Non-OADS,/arxiv_data1/oa_pdf/ab/b2/JEM_20150032.PMC4516795.pdf
"http://dx.doi.org/10.1073/   pnas.132331811 1 Chiu, C.Y.H., J. Healer, J.K. Thompson, L. Chen, A. Kaul, L. Savergave,  A. Raghuwanshi, C.S.",Non-OADS,/arxiv_data1/oa_pdf/ab/b2/JEM_20150032.PMC4516795.pdf
"5:314. http://dx.doi.org/10.3389/fmicb.2014.0031 4 Crosnier, C., L.Y.",Non-OADS,/arxiv_data1/oa_pdf/ab/b2/JEM_20150032.PMC4516795.pdf
http://dx.doi.org/10.1038/   nature1060 6,Non-OADS,/arxiv_data1/oa_pdf/ab/b2/JEM_20150032.PMC4516795.pdf
"http://dx.doi.org/10.3390/   ijms1206402 7 Qiu, X., G. Wong, J. Audet, A. Bello, L. Fernando, J.B. Alimonti, H. Fausther- Bovendo, H. Wei, J. Aviles, E. Hiatt, et al.",Non-OADS,/arxiv_data1/oa_pdf/ab/b2/JEM_20150032.PMC4516795.pdf
"http://dx.doi.org/10.1038/nature1377 7 Reddy, K.S., E. Amlabu, A.K.",OADS,/arxiv_data1/oa_pdf/ab/b2/JEM_20150032.PMC4516795.pdf
"http://dx.doi   .org/10.1073/pnas.141546611 2 Reeves, P.M., B. Bommarius, S. Lebeis, S. McNulty, J. Christensen,   A. Swimm, A. Chahroudi, R. Chavan, M.B.",Non-OADS,/arxiv_data1/oa_pdf/ab/b2/JEM_20150032.PMC4516795.pdf
"http://dx.doi.org/10   .1038/nm126 5 Takahashi, H., H. Okazaki, P .I.",OADS,/arxiv_data1/oa_pdf/ab/b2/JEM_20150032.PMC4516795.pdf
"2:1155– 1158. http://dx.doi.org/10.1016/S0140-6736(83)91212- 6Tran, T.M., A. Ongoiba, J. Coursen, C. Crosnier, A. Diouf, C.Y .",Non-OADS,/arxiv_data1/oa_pdf/ab/b2/JEM_20150032.PMC4516795.pdf
"http://dx.doi.org/10.1093/infdis/   jit553 W anaguru, M., W .",OADS,/arxiv_data1/oa_pdf/ab/b2/JEM_20150032.PMC4516795.pdf
"http://dx.doi   .org/10.1073/pnas.132077111 0 Wright, K.E., K.A.",Non-OADS,/arxiv_data1/oa_pdf/ab/b2/JEM_20150032.PMC4516795.pdf
"http://dx.doi.org/   10.1038/nature1371 5 Xu, J., Z.-Y .",OADS,/arxiv_data1/oa_pdf/ab/b2/JEM_20150032.PMC4516795.pdf
http://dx.doi.org/10.1002/hep   .2146 5,Non-OADS,/arxiv_data1/oa_pdf/ab/b2/JEM_20150032.PMC4516795.pdf
This article is distributed under the terms of an Attribution–   Noncommercial–Share Alike–No Mirror Sites license for the first six months  after the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/01/a4/JEM_20150407.PMC4516796.pdf
"After six months  it is available under a Creative Commons License (Attribution–Noncommercial– Share Alike 3.0 Unported license, as described at http://creativecommons.org/   licenses/by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/01/a4/JEM_20150407.PMC4516796.pdf
"http://dx.doi.org/10.1159/00021228 6 Chiu, W.S., J.F.",OADS,/arxiv_data1/oa_pdf/01/a4/JEM_20150407.PMC4516796.pdf
"http://dx.doi.org/10.1002/gene.2004 1 Cornish, J., K.E.",OADS,/arxiv_data1/oa_pdf/01/a4/JEM_20150407.PMC4516796.pdf
"http://dx.doi.org/   10.1016/S8756­3282(97)00144­ 0 Cundy, T., L. Wheadon, and A.",OADS,/arxiv_data1/oa_pdf/01/a4/JEM_20150407.PMC4516796.pdf
"http://dx.doi.org/10.1359/jbmr.04012 7 Cundy, T., J. Davidson, M.D.",OADS,/arxiv_data1/oa_pdf/01/a4/JEM_20150407.PMC4516796.pdf
"http://dx.doi.org/10.1056/NEJMoa05089 3 Dai, R.M., and C.C.",OADS,/arxiv_data1/oa_pdf/01/a4/JEM_20150407.PMC4516796.pdf
"http://dx.doi.org/10.1038/3508705 6 Dai, R.M., E. Chen, D.L.",OADS,/arxiv_data1/oa_pdf/01/a4/JEM_20150407.PMC4516796.pdf
"http://dx.doi.org/10.1038/ncprheum017 2 Deckers, M.M., M. Karperien, C. van der Bent, T. Yamashita, S.E.",OADS,/arxiv_data1/oa_pdf/01/a4/JEM_20150407.PMC4516796.pdf
"http://dx.doi.org/10.1210/endo.141.5.745 8 Dougall, W.C., M. Glaccum, K. Charrier, K. Rohrbach, K. Brasel, T. De  Smedt, E. Daro, J. Smith, M.E.",Non-OADS,/arxiv_data1/oa_pdf/01/a4/JEM_20150407.PMC4516796.pdf
"http://dx.doi.org/10.1101/gad.13.18.241 2 Galson, D.L., and G.D. Roodman.",OADS,/arxiv_data1/oa_pdf/01/a4/JEM_20150407.PMC4516796.pdf
"http://dx.doi.org/10.11005/jbm.2014.21.2.8 5 Hansen, M.F ., M. Seton, and A.",OADS,/arxiv_data1/oa_pdf/01/a4/JEM_20150407.PMC4516796.pdf
"http://dx.doi.org/   10.1359/jbmr.06s21 1 Hoyland, J.A., A.J.",OADS,/arxiv_data1/oa_pdf/01/a4/JEM_20150407.PMC4516796.pdf
"http://dx.doi.org/10.1002/jbmr.565009011 1 Izawa, T., W .",OADS,/arxiv_data1/oa_pdf/01/a4/JEM_20150407.PMC4516796.pdf
"http://dx.doi.org/10.1128/   MCB.00077­1 2 Jimi, E., K. Aoki, H. Saito, F .",OADS,/arxiv_data1/oa_pdf/01/a4/JEM_20150407.PMC4516796.pdf
"http://dx.doi.org/   10.1038/nm105 4 Koegl, M., T. Hoppe, S. Schlenker, H.D.",OADS,/arxiv_data1/oa_pdf/01/a4/JEM_20150407.PMC4516796.pdf
"http://dx.doi.org/10.1016/S0092 ­  8674(00)80574 ­7 Köhler, J.R. 2003.",OADS,/arxiv_data1/oa_pdf/01/a4/JEM_20150407.PMC4516796.pdf
http://dx.doi.org/   10.1046/j.1365 ­2958.2003.03556.,Non-OADS,/arxiv_data1/oa_pdf/01/a4/JEM_20150407.PMC4516796.pdf
"http://dx.doi.org/10   .1016/j.cmet.2010.12.00 2 Li, J.M., H. Wu, W .",OADS,/arxiv_data1/oa_pdf/01/a4/JEM_20150407.PMC4516796.pdf
"http://dx.doi.org/10.1128/MCB.01190­1 3 Matsuoka, K., K.A.",OADS,/arxiv_data1/oa_pdf/01/a4/JEM_20150407.PMC4516796.pdf
http://dx.doi.org/10.1002/jbmr.218 7The immunoprecipitates were subjected to SDS­PAGE and immunoblotted  with anti­I B antibody.,Non-OADS,/arxiv_data1/oa_pdf/01/a4/JEM_20150407.PMC4516796.pdf
Online supplemental material  is available at http://www.jem.org/cgi/content/full/jem.20150407/DC 1.,Non-OADS,/arxiv_data1/oa_pdf/01/a4/JEM_20150407.PMC4516796.pdf
"http://dx.doi.org/10.1038/ng.56 2 Albagha, O.M., S.E.",Non-OADS,/arxiv_data1/oa_pdf/01/a4/JEM_20150407.PMC4516796.pdf
"http://dx.doi.org/10.1038/ng.84 5 Babst, M., D.J.",OADS,/arxiv_data1/oa_pdf/01/a4/JEM_20150407.PMC4516796.pdf
"http://dx.doi.org/10   .1016/S1534­5807(02)00220­ 4 Bakwin, H., and M.S.",OADS,/arxiv_data1/oa_pdf/01/a4/JEM_20150407.PMC4516796.pdf
http://dx.doi.org/10.1016/S0022­3476(56)80143­ 1,Non-OADS,/arxiv_data1/oa_pdf/01/a4/JEM_20150407.PMC4516796.pdf
"172:1045– 1056. http://dx.doi.org/10.1083/jcb.20050904 1 Sims, N.A., and J.H.",OADS,/arxiv_data1/oa_pdf/01/a4/JEM_20150407.PMC4516796.pdf
"http://dx.doi.org/10.1016/j.semcdb.2008   .07.01 6 Soriano, P ., C. Montgomery, R. Geske, and A. Bradley.",OADS,/arxiv_data1/oa_pdf/01/a4/JEM_20150407.PMC4516796.pdf
"http://dx.doi.org/10.1016/0092­8674(91)90499­ O Takeshita, S., T. Fumoto, K. Matsuoka, K.A.",OADS,/arxiv_data1/oa_pdf/01/a4/JEM_20150407.PMC4516796.pdf
"http://dx.doi.org/10.1172/JCI6949 3 Tang, Y., X. Wu, W. Lei, L. Pang, C. Wan, Z. Shi, L. Zhao, T.R.",Non-OADS,/arxiv_data1/oa_pdf/01/a4/JEM_20150407.PMC4516796.pdf
"http://dx.doi.org/10.1038/nm.197 9 Teitelbaum, S.L., and F.P.",OADS,/arxiv_data1/oa_pdf/01/a4/JEM_20150407.PMC4516796.pdf
"http://dx.doi.org/   10.1038/nrg112 2 T eti, A.",OADS,/arxiv_data1/oa_pdf/01/a4/JEM_20150407.PMC4516796.pdf
"BoneKEy  Rep 2:449. http://dx.doi.org/10.1038/bonekey.2013.18 3 Tsang, H.T., J.W.",OADS,/arxiv_data1/oa_pdf/01/a4/JEM_20150407.PMC4516796.pdf
"http://dx.doi.org/10.1016/j.ygeno.2006.04.00 3 van Staa, T.P., P. Selby, H.G.",OADS,/arxiv_data1/oa_pdf/01/a4/JEM_20150407.PMC4516796.pdf
"http://dx.doi.org/10   .1359/jbmr.2002.17.3.46 5 Watts, G.D., J. Wymer, M.J. Kovach, S.G. Mehta, S. Mumm, D. Darvish, A.  Pestronk, M.P .",OADS,/arxiv_data1/oa_pdf/01/a4/JEM_20150407.PMC4516796.pdf
"http://dx.doi.org/10.1038/ng133 2 Wei, S., X.M.",Non-OADS,/arxiv_data1/oa_pdf/01/a4/JEM_20150407.PMC4516796.pdf
"http://dx.doi.org/   10.1189/jlb.050630 4 Whyte, M.P., C. Tau, W.H.",OADS,/arxiv_data1/oa_pdf/01/a4/JEM_20150407.PMC4516796.pdf
"http://dx.doi.org/10.1016/j.bone.2014.07.01 9 Xian, L., X. Wu, L. Pang, M. Lou, C.J.",OADS,/arxiv_data1/oa_pdf/01/a4/JEM_20150407.PMC4516796.pdf
"http://dx.doi.org/10.1038/nm.279 3 Yamanaka, K., Y. Sasagawa, and T. Ogura.",OADS,/arxiv_data1/oa_pdf/01/a4/JEM_20150407.PMC4516796.pdf
"http://dx.doi.org/10.1016/j.bbamcr.2011.07.00 1 Zajac, A.J., and P.E.",OADS,/arxiv_data1/oa_pdf/01/a4/JEM_20150407.PMC4516796.pdf
"http://dx.doi.org/   10.1016/j.cmet.2006.05.01 2 Zou, W ., H. Kitaura, J. Reeve, F .",OADS,/arxiv_data1/oa_pdf/01/a4/JEM_20150407.PMC4516796.pdf
"http://dx.doi.org/10   .1083/jcb.20061108 3Murrin, R.J., and P .",OADS,/arxiv_data1/oa_pdf/01/a4/JEM_20150407.PMC4516796.pdf
"http://dx.doi.org/   10.1007/s12031­011­9627­ y Naot, D., U. Bava, B. Matthews, K.E.",Non-OADS,/arxiv_data1/oa_pdf/01/a4/JEM_20150407.PMC4516796.pdf
"http://dx.doi.org/10.1359/jbmr.06110 8 Novack, D.V .",Non-OADS,/arxiv_data1/oa_pdf/01/a4/JEM_20150407.PMC4516796.pdf
"http://dx.doi.org/10.1038/cr.2010.15 9 Ota, K., P .",OADS,/arxiv_data1/oa_pdf/01/a4/JEM_20150407.PMC4516796.pdf
"http://dx.doi.org/10.1210/en.2013­127 2 Polyzos, S.A., P .N.",Non-OADS,/arxiv_data1/oa_pdf/01/a4/JEM_20150407.PMC4516796.pdf
"http://dx.doi.org/10.1210/jc.2013­376 2 Raiborg, C., and H. Stenmark.",OADS,/arxiv_data1/oa_pdf/01/a4/JEM_20150407.PMC4516796.pdf
"http://dx.doi   .org/10.1016/S0140­6736(08)61035­ 1 Rape, M., T. Hoppe, I. Gorr, M. Kalocay, H. Richly, and S. Jentsch.",OADS,/arxiv_data1/oa_pdf/01/a4/JEM_20150407.PMC4516796.pdf
"http://dx.doi.org/10.1016/S0092­8674(01)00595­ 5 Rebel, A., K. Malkani, M. Basle, C. Bregeon, A. Patezour, and R. Filmon.",OADS,/arxiv_data1/oa_pdf/01/a4/JEM_20150407.PMC4516796.pdf
"http://dx.doi.org/10.1111/j.1749­6632   .2009.05214. x Roodman, G.D., and J.J. Windle.",OADS,/arxiv_data1/oa_pdf/01/a4/JEM_20150407.PMC4516796.pdf
"http://dx.doi.org/10.1172/JCI2428 1 Roodman, G.D., N. Kurihara, Y. Ohsaki, A. Kukita, D. Hosking, A.  Demulder, J.F.",OADS,/arxiv_data1/oa_pdf/01/a4/JEM_20150407.PMC4516796.pdf
"http://dx.doi.org/10.1172/JCI11558 4 Rusten, T.E., T. Vaccari, and H. Stenmark.",OADS,/arxiv_data1/oa_pdf/01/a4/JEM_20150407.PMC4516796.pdf
"http://dx.doi.org/10   .1038/ncb238 1 Ryu, J., H.J.",OADS,/arxiv_data1/oa_pdf/01/a4/JEM_20150407.PMC4516796.pdf
"http://dx.doi.org/   10.1038/sj.emboj.760143 0 Saki, F., Z. Karamizadeh, S. Nasirabadi, S. Mumm, W.H.",Non-OADS,/arxiv_data1/oa_pdf/01/a4/JEM_20150407.PMC4516796.pdf
"http://dx.doi.org/10.1002/jbmr.186 8 Schweitzer, K., P .M.",OADS,/arxiv_data1/oa_pdf/01/a4/JEM_20150407.PMC4516796.pdf
"http://dx.doi.org/10.1038/sj.emboj.760160 0 Shim, J.H., C. Xiao, M.S.",OADS,/arxiv_data1/oa_pdf/01/a4/JEM_20150407.PMC4516796.pdf
This article is distributed under the terms of an Attribution–   Noncommercial–Share Alike–No Mirror Sites license for the first six months  after the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/0b/c4/JEM_20142358.PMC4516797.pdf
"After six months  it is available under a Creative Commons License (Attribution–Noncommercial– Share Alike 3.0 Unported license, as described at http://creativecommons.org/   licenses/by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/0b/c4/JEM_20142358.PMC4516797.pdf
"http://dx.doi.org/10.1146/ annurev.immunol.021908.13255 4 Alon, R., and S.W.",OADS,/arxiv_data1/oa_pdf/0b/c4/JEM_20142358.PMC4516797.pdf
"http://dx.doi.org/10   .1016/j.ceb.2012.06.00 1 Anthis, N.J., K.L.",OADS,/arxiv_data1/oa_pdf/0b/c4/JEM_20142358.PMC4516797.pdf
"http://dx.doi.org/   10.1074/jbc.M50350820 0 Bachir, A.I., J. Zareno, K. Moissoglu, E.F.",Non-OADS,/arxiv_data1/oa_pdf/0b/c4/JEM_20142358.PMC4516797.pdf
"http://dx.doi.org/10.1016/j.cub.2014.07.01 1 Block, H., J.M.",OADS,/arxiv_data1/oa_pdf/0b/c4/JEM_20142358.PMC4516797.pdf
"http://dx.doi.org/10.1084/jem.2011149 3 Bonventre, J.V., and J.M.",OADS,/arxiv_data1/oa_pdf/0b/c4/JEM_20142358.PMC4516797.pdf
"14:2199– 2210. http://dx.doi.org/10.1097/01.ASN.0000079785.13922.F 6 Call, D.R., J.A.",OADS,/arxiv_data1/oa_pdf/0b/c4/JEM_20142358.PMC4516797.pdf
"http://dx.doi.org/10.1016/S0002-9440(10)64014- X Camirand, G., Q. Li, A.J.",OADS,/arxiv_data1/oa_pdf/0b/c4/JEM_20142358.PMC4516797.pdf
http://dx.doi.org/10.1111/j.1600-6143.2011.03671.,Non-OADS,/arxiv_data1/oa_pdf/0b/c4/JEM_20142358.PMC4516797.pdf
"http://dx.doi.org/10   .1074/jbc.M110.15577 0 Chen, W., J. Lou, E.A.",Non-OADS,/arxiv_data1/oa_pdf/0b/c4/JEM_20142358.PMC4516797.pdf
"http://dx.doi.org/10.1083/   jcb.20120109 1 Coxon, A., P. Rieu, F.J. Barkalow, S. Askari, A.H. Sharpe, U.H.",Non-OADS,/arxiv_data1/oa_pdf/0b/c4/JEM_20142358.PMC4516797.pdf
http://dx.doi.org/   10.1016/S1074-7613(00)80278- 2cocktail (1:50; Thermo Fisher Scientific).,OADS,/arxiv_data1/oa_pdf/0b/c4/JEM_20142358.PMC4516797.pdf
"http://dx.doi   .org/10.1172/JCI3870 2 Lu, H., C.W.",OADS,/arxiv_data1/oa_pdf/0b/c4/JEM_20142358.PMC4516797.pdf
"http://dx.doi.org/10.1172/JCI11929 3 Massena, S., G. Christoffersson, E. Hjertström, E. Zcharia, I. Vlodavsky, N.  Ausmees, C. Rolny, J.P. Li, and M. Phillipson.",OADS,/arxiv_data1/oa_pdf/0b/c4/JEM_20142358.PMC4516797.pdf
"http://dx.doi   .org/10.1182/blood-2010-01-26607 2 McDonald, B., K. Pittman, G.B.",Non-OADS,/arxiv_data1/oa_pdf/0b/c4/JEM_20142358.PMC4516797.pdf
"http://dx.doi.org/10.1126/science.119549 1 McEver, R.P ., and C. Zhu.",OADS,/arxiv_data1/oa_pdf/0b/c4/JEM_20142358.PMC4516797.pdf
"http://dx.doi.org/10.1146/annurev.cellbio.042308.11323 8 Miner, J.J., L. Xia, T. Yago, J. Kappelmayer, Z. Liu, A.G. Klopocki, B.  Shao, J.M.",OADS,/arxiv_data1/oa_pdf/0b/c4/JEM_20142358.PMC4516797.pdf
"http://dx.doi.org/10.1182/blood-2008-04-14946 8 Mócsai, A., C.L.",Non-OADS,/arxiv_data1/oa_pdf/0b/c4/JEM_20142358.PMC4516797.pdf
"http://dx.doi.org/10.1038/ni140 7 Monkley, S.J., X.H.",OADS,/arxiv_data1/oa_pdf/0b/c4/JEM_20142358.PMC4516797.pdf
"http://dx.doi.org/10.1002/1097- 0177(2000)9999:9999<::AID-DVDY1079>3.0.CO;2- Y Moretti, F .A., M. Moser, R. Lyck, M. Abadier, R. Ruppert, B. Engelhardt, and  R. Fässler.",Non-OADS,/arxiv_data1/oa_pdf/0b/c4/JEM_20142358.PMC4516797.pdf
"http://dx.doi.org/10.1038/nm172 2 Moser, M., M. Bauer, S. Schmid, R. Ruppert, S. Schmidt, M. Sixt, H.-V.  Wang, M. Sperandio, and R. Fässler.",OADS,/arxiv_data1/oa_pdf/0b/c4/JEM_20142358.PMC4516797.pdf
"http://dx.doi.org/10.1038/nm.192 1 Moser, M., K.R.",OADS,/arxiv_data1/oa_pdf/0b/c4/JEM_20142358.PMC4516797.pdf
"http://dx.doi.org/10   .1126/science.116386 5 Mueller, H., A. Stadtmann, H. Van Aken, E. Hirsch, D. Wang, K. Ley, and  A. Zarbock.",OADS,/arxiv_data1/oa_pdf/0b/c4/JEM_20142358.PMC4516797.pdf
"115:3118– 3127. http://dx.doi.org/10.1182/blood-2009-11-25418 5 Nathan, C. 2006.",Non-OADS,/arxiv_data1/oa_pdf/0b/c4/JEM_20142358.PMC4516797.pdf
"http://dx.doi.org/10.1038/nri178 5 Nourshargh, S., P .L.",OADS,/arxiv_data1/oa_pdf/0b/c4/JEM_20142358.PMC4516797.pdf
"http://dx.doi.org/10.1038/nrm288 9 Petrich, B.G., P. Marchese, Z.M.",Non-OADS,/arxiv_data1/oa_pdf/0b/c4/JEM_20142358.PMC4516797.pdf
"http://dx.doi.org/   10.1084/jem.2007180 0 Phillipson, M., and P .",OADS,/arxiv_data1/oa_pdf/0b/c4/JEM_20142358.PMC4516797.pdf
"http://dx.doi.org/10.1038/nm.251 4 Phillipson, M., B. Heit, P .",OADS,/arxiv_data1/oa_pdf/0b/c4/JEM_20142358.PMC4516797.pdf
"http://dx.doi.org/10.1084/jem.2006092 5Critchley, D.R.",Non-OADS,/arxiv_data1/oa_pdf/0b/c4/JEM_20142358.PMC4516797.pdf
"http://dx.doi.org/10.1182/blood-   2010-12-32285 9 Gakidis, M.A., X. Cullere, T. Olson, J.L.",Non-OADS,/arxiv_data1/oa_pdf/0b/c4/JEM_20142358.PMC4516797.pdf
"http://dx.doi.org/10.1083/jcb.20040416 6 Grenz, A., J.H.",OADS,/arxiv_data1/oa_pdf/0b/c4/JEM_20142358.PMC4516797.pdf
"http://dx.doi.org/10.4049/jimmunol.120165 1 Griffin, G.K., G. Newton, M.L.",Non-OADS,/arxiv_data1/oa_pdf/0b/c4/JEM_20142358.PMC4516797.pdf
"http://dx.doi.org/10.4049/jimmunol.120038 5 Haling, J.R., S.J.",OADS,/arxiv_data1/oa_pdf/0b/c4/JEM_20142358.PMC4516797.pdf
"http://dx.doi.org/10.1182/   blood-2010-09-30543 3 Henderson, R.B., J.A.",Non-OADS,/arxiv_data1/oa_pdf/0b/c4/JEM_20142358.PMC4516797.pdf
"http://dx.doi.org/10.1182/blood-2002-   10-322 8 Herter, J.M., J. Rossaint, T. Spieker, and A. Zarbock.",Non-OADS,/arxiv_data1/oa_pdf/0b/c4/JEM_20142358.PMC4516797.pdf
"http://dx.doi.org/10.1159/   00035823 8 Jung, U., K.E.",Non-OADS,/arxiv_data1/oa_pdf/0b/c4/JEM_20142358.PMC4516797.pdf
"http://dx.doi.org/10.1172/JCI11989 3 Kim, C., F. Ye, and M.H.",OADS,/arxiv_data1/oa_pdf/0b/c4/JEM_20142358.PMC4516797.pdf
"http://dx.doi.org/10.1146/   annurev-cellbio-100109-10410 4 Kim, C., F. Ye, X. Hu, and M.H.",OADS,/arxiv_data1/oa_pdf/0b/c4/JEM_20142358.PMC4516797.pdf
"http://dx.doi.org/10.1083/jcb.20111214 1 Kunkel, E.J., and K. Ley.",OADS,/arxiv_data1/oa_pdf/0b/c4/JEM_20142358.PMC4516797.pdf
"http://dx.doi.org/10.1161/01.RES.79.6.119 6 Kuwano, Y., O. Spelten, H. Zhang, K. Ley, and A. Zarbock.",Non-OADS,/arxiv_data1/oa_pdf/0b/c4/JEM_20142358.PMC4516797.pdf
"http://dx.doi   .org/10.1182/blood-2010-01-26612 2 Labow, M.A., C.R.",Non-OADS,/arxiv_data1/oa_pdf/0b/c4/JEM_20142358.PMC4516797.pdf
"http://dx.doi.org/10.1016/1074-7613(94)90041- 8 Lefort, C.T., and K. Ley.",OADS,/arxiv_data1/oa_pdf/0b/c4/JEM_20142358.PMC4516797.pdf
"3:157. http://dx.doi.org/10.3389/fimmu.2012.0015 7 Lefort, C.T ., J. Rossaint, M. Moser, B.G.",Non-OADS,/arxiv_data1/oa_pdf/0b/c4/JEM_20142358.PMC4516797.pdf
"http://dx.doi.org/10.1182/blood-2011-08-37311 8 Ley, K., D.C. Bullard, M.L.",Non-OADS,/arxiv_data1/oa_pdf/0b/c4/JEM_20142358.PMC4516797.pdf
"http://dx.doi.org/10   .1084/jem.181.2.66 9 Ley, K., C. Laudanna, M.I.",Non-OADS,/arxiv_data1/oa_pdf/0b/c4/JEM_20142358.PMC4516797.pdf
http://dx.doi.org/10.1038/nri215 6,Non-OADS,/arxiv_data1/oa_pdf/0b/c4/JEM_20142358.PMC4516797.pdf
"http://dx.doi.org/10.1016/   j.cell.2006.10.04 8 Xia, L., M. Sperandio, T. Yago, J.M.",OADS,/arxiv_data1/oa_pdf/0b/c4/JEM_20142358.PMC4516797.pdf
"http://dx.doi.org/10.1172/JCI021415 1 Xia, L., J.M.",Non-OADS,/arxiv_data1/oa_pdf/0b/c4/JEM_20142358.PMC4516797.pdf
"http://dx.doi.org/10.1182/blood-2004-02-065 0 Xue, Z.H., C. Feng, W .L.",Non-OADS,/arxiv_data1/oa_pdf/0b/c4/JEM_20142358.PMC4516797.pdf
"http://dx.doi.org/10.1371/journal   .pone.005691 1 Yago, T., J. Fu, J.M.",OADS,/arxiv_data1/oa_pdf/0b/c4/JEM_20142358.PMC4516797.pdf
"http://dx.doi   .org/10.1073/pnas.100311010 7 Y ago, T ., B. Shao, J.J.",OADS,/arxiv_data1/oa_pdf/0b/c4/JEM_20142358.PMC4516797.pdf
"http://dx.doi.org/10.1182/   blood-2009-12-25955 6 Yamada, K., T. Miwa, J. Liu, M. Nangaku, and W .C.",OADS,/arxiv_data1/oa_pdf/0b/c4/JEM_20142358.PMC4516797.pdf
"http://dx.doi.org/10.4049/jimmunol.172.6.386 9 Yao, L., T. Yago, B. Shao, Z. Liu, R. Silasi-Mansat, H. Setiadi, F. Lupu, and  R.P.",Non-OADS,/arxiv_data1/oa_pdf/0b/c4/JEM_20142358.PMC4516797.pdf
"122:3832– 3842. http://dx.doi.org/10.1182/blood-2012-12-47383 5 Ye, F., B.G.",Non-OADS,/arxiv_data1/oa_pdf/0b/c4/JEM_20142358.PMC4516797.pdf
"http://dx.doi.org/10.1016/j.cub.2013.09.05 0 Ye, F., A.K.",OADS,/arxiv_data1/oa_pdf/0b/c4/JEM_20142358.PMC4516797.pdf
"http://dx.doi.org/   10.1007/s11684-014-0317- 3 Zarbock, A., C.A.",Non-OADS,/arxiv_data1/oa_pdf/0b/c4/JEM_20142358.PMC4516797.pdf
"http://dx.doi   .org/10.1016/j.immuni.2007.04.01 1 Zarbock, A., C.L.",OADS,/arxiv_data1/oa_pdf/0b/c4/JEM_20142358.PMC4516797.pdf
"http://dx.doi.org/10.1084/jem.2007266 0 Zarbock, A., K. Ley, R.P.",OADS,/arxiv_data1/oa_pdf/0b/c4/JEM_20142358.PMC4516797.pdf
"http://dx.doi.org/10   .1182/blood-2011-07-34356 6 Zhang, X., G. Jiang, Y. Cai, S.J.",Non-OADS,/arxiv_data1/oa_pdf/0b/c4/JEM_20142358.PMC4516797.pdf
"http://dx.doi   .org/10.1073/pnas.96.20.1145 2 Salas, A., M. Shimaoka, A.N.",OADS,/arxiv_data1/oa_pdf/0b/c4/JEM_20142358.PMC4516797.pdf
"http://dx.doi.org/10.1016/   S1074-7613(04)00082- 2 Saltel, F., E. Mortier, V.P.",OADS,/arxiv_data1/oa_pdf/0b/c4/JEM_20142358.PMC4516797.pdf
"http://dx.doi.org/   10.1083/jcb.20090813 4 Schürpf, T., and T.A.",OADS,/arxiv_data1/oa_pdf/0b/c4/JEM_20142358.PMC4516797.pdf
"http://dx.doi.org/10.1038/emboj   .2011.33 3 Shao, B., T. Yago, P.A.",OADS,/arxiv_data1/oa_pdf/0b/c4/JEM_20142358.PMC4516797.pdf
"http://dx.doi.org/10.1074/jbc.M112.36151 9 Sharfuddin, A.A., and B.A.",Non-OADS,/arxiv_data1/oa_pdf/0b/c4/JEM_20142358.PMC4516797.pdf
"http://dx.doi.org/   10.1038/nrneph.2011.1 6 Singbartl, K., and K. Ley.",OADS,/arxiv_data1/oa_pdf/0b/c4/JEM_20142358.PMC4516797.pdf
"28:2507– 2514. http://dx.doi.org/10.1097/00003246-200007000-0005 3 Singbartl, K., S.A. Green, and K. Ley.",OADS,/arxiv_data1/oa_pdf/0b/c4/JEM_20142358.PMC4516797.pdf
"http://dx.doi.org/10.1084/jem.2004042 4 Song, X., J. Yang, J. Hirbawi, S. Ye, H.D.",OADS,/arxiv_data1/oa_pdf/0b/c4/JEM_20142358.PMC4516797.pdf
"http://dx.doi.org/10.1038/cr.2012.9 7 Stadtmann, A., L. Brinkhaus, H. Mueller, J. Rossaint, M. Bolomini-Vittori,  W. Bergmeier, H. Van Aken, D.D.",Non-OADS,/arxiv_data1/oa_pdf/0b/c4/JEM_20142358.PMC4516797.pdf
"http://dx.doi.org/10.1002/eji.20104119 6 Stefanini, L., F .",Non-OADS,/arxiv_data1/oa_pdf/0b/c4/JEM_20142358.PMC4516797.pdf
"http://dx.doi.org/10.1182/blood-2013-12-54336 3 Sun, H., J. Liu, Y. Zheng, Y. Pan, K. Zhang, and J. Chen.",Non-OADS,/arxiv_data1/oa_pdf/0b/c4/JEM_20142358.PMC4516797.pdf
"http://dx.doi.org/   10.1016/j.devcel.2014.05.00 2 Suzuki-Inoue, K., C.E.",OADS,/arxiv_data1/oa_pdf/0b/c4/JEM_20142358.PMC4516797.pdf
"302:103– 106. http://dx.doi.org/10.1126/science.108665 2 Vinogradova, O., A. Velyvis, A. Velyviene, B. Hu, T. Haas, E. Plow, and J.  Qin.",OADS,/arxiv_data1/oa_pdf/0b/c4/JEM_20142358.PMC4516797.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the  publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/6d/a7/JEM_20150308.PMC4516798.pdf
"After six months it is available  under a Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Un - ported license, as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).T.",Non-OADS,/arxiv_data1/oa_pdf/6d/a7/JEM_20150308.PMC4516798.pdf
"http://dx.doi.org/10   .1007/s00018-007-7271- z Calegari, F ., and W .B.",Non-OADS,/arxiv_data1/oa_pdf/6d/a7/JEM_20150308.PMC4516798.pdf
"http://dx.doi.org/10   .1242/jcs.0082 5 Cheng, T., N. Rodrigues, D. Dombkowski, S. Stier, and D.T.",Non-OADS,/arxiv_data1/oa_pdf/6d/a7/JEM_20150308.PMC4516798.pdf
"http://dx.doi.org/10.1038/8133 5 Cheng, T ., N. Rodrigues, H. Shen, Y .",Non-OADS,/arxiv_data1/oa_pdf/6d/a7/JEM_20150308.PMC4516798.pdf
"http://dx.doi.org/10.1126/   science.287.5459.180 4 Cosgun, K.N., S. Rahmig, N. Mende, S. Reinke, I. Hauber, C. Schäfer,   A. Petzold, H. Weisbach, G. Heidkamp, A. Purbojo, et al.",OADS,/arxiv_data1/oa_pdf/6d/a7/JEM_20150308.PMC4516798.pdf
"http://dx.doi.org/10.1016/j.stem.2014.06.00 1 Grinenko, T., K. Arndt, M. Portz, N. Mende, M. Günther, K.N.",OADS,/arxiv_data1/oa_pdf/6d/a7/JEM_20150308.PMC4516798.pdf
"http://dx.doi.org/10.1084/jem.2013111 5 Hamann, M.V ., N. Stanke, E. Müllers, K. Stirnnagel, S. Hütter, B. Artegiani,   S. Bragado Alonso, F .",Non-OADS,/arxiv_data1/oa_pdf/6d/a7/JEM_20150308.PMC4516798.pdf
"http://dx.doi.org/10.1016/j.stemcr.2014.10.00 5 Janzen, V ., R. Forkert, H.E.",OADS,/arxiv_data1/oa_pdf/6d/a7/JEM_20150308.PMC4516798.pdf
"http://dx.doi.org/10.1038/nature0515 9 Lange, C., W .B.",OADS,/arxiv_data1/oa_pdf/6d/a7/JEM_20150308.PMC4516798.pdf
"http://dx.doi.org/10.1016/j.stem.2009.05.02 6 Laurenti, E., C. Frelin, S. Xie, R. Ferrari, C.F .",OADS,/arxiv_data1/oa_pdf/6d/a7/JEM_20150308.PMC4516798.pdf
"http://dx.doi.org/10.1038/nature0309 4 Matsumoto, A., S. Takeishi, T. Kanie, E. Susaki, I. Onoyama, Y .",OADS,/arxiv_data1/oa_pdf/6d/a7/JEM_20150308.PMC4516798.pdf
"http://dx.doi.org/10.1016/j.stem.2011.06.01 4 Mochizuki, H., J.P .",OADS,/arxiv_data1/oa_pdf/6d/a7/JEM_20150308.PMC4516798.pdf
"http://dx.doi.org/10.1016/j.immuni.2006.04.00 8 Nakamura-Ishizu, A., H. Takizawa, and T. Suda.",OADS,/arxiv_data1/oa_pdf/6d/a7/JEM_20150308.PMC4516798.pdf
"http://dx.doi.org/10.1242/dev.10657 5 Nakano, M., E.J.",OADS,/arxiv_data1/oa_pdf/6d/a7/JEM_20150308.PMC4516798.pdf
"http://dx.doi.org/10.1124/mol   .112.08008 5 Orford, K.W ., and D.T .",OADS,/arxiv_data1/oa_pdf/6d/a7/JEM_20150308.PMC4516798.pdf
http://dx.doi.org/10.1038/nrg226 9	∂ ∂=( )−( )−( )( ) ∂ ∂=− − −g ta g t a g t a g t g t brd ta gb g b g g b b g12 2 1 1 2 12 1 2 1* bb g g b b g b g bt a brd t a brdt g t g ta g t a g− − − − −( )−( )−( )( ) ∂ ∂=( )−2 2 22 22 2 tt( )2.,Non-OADS,/arxiv_data1/oa_pdf/6d/a7/JEM_20150308.PMC4516798.pdf
Online supplemental material is available at  http://www.jem.org/cgi/content/full/jem.20150308/DC1.,Non-OADS,/arxiv_data1/oa_pdf/6d/a7/JEM_20150308.PMC4516798.pdf
"http://dx.doi   .org/10.1101/gr.133744.11 1 Arndt, K., T. Grinenko, N. Mende, D. Reichert, M. Portz, T. Ripich,   P .",Non-OADS,/arxiv_data1/oa_pdf/6d/a7/JEM_20150308.PMC4516798.pdf
http://dx.doi.org/10.1084/jem.2010216 7,Non-OADS,/arxiv_data1/oa_pdf/6d/a7/JEM_20150308.PMC4516798.pdf
"http://dx.doi.org/10   .1083/jcb.20110213 1 Raue, A., C. Kreutz, T. Maiwald, J. Bachmann, M. Schilling, U. Klingmüller,  and J. Timmer.",OADS,/arxiv_data1/oa_pdf/6d/a7/JEM_20150308.PMC4516798.pdf
"http://dx.doi.org/10.1093/bioinformatics/   btp35 8 Raue, A., M. Schilling, J. Bachmann, A. Matteson, M. Schelker, D. Kaschek, S.  Hug, C. Kreutz, B.D.",OADS,/arxiv_data1/oa_pdf/6d/a7/JEM_20150308.PMC4516798.pdf
"http://dx.doi.org/10.1371/journal.pone.007433 5 Ren, S., and B.J.",OADS,/arxiv_data1/oa_pdf/6d/a7/JEM_20150308.PMC4516798.pdf
"http://dx.doi.org/10.1016/S0092-8674(04)   00300- 9 Scheicher, R., A. Hoelbl-Kovacic, F .",OADS,/arxiv_data1/oa_pdf/6d/a7/JEM_20150308.PMC4516798.pdf
"http://dx.doi.org/   10.1182/blood-2014-06-58441 7 Singh, A.M., and S. Dalton.",Non-OADS,/arxiv_data1/oa_pdf/6d/a7/JEM_20150308.PMC4516798.pdf
"http://dx.doi.org/10.1016/j.stem.2009.07.00 3 Sykes, S.M., and D.T .",OADS,/arxiv_data1/oa_pdf/6d/a7/JEM_20150308.PMC4516798.pdf
"http://dx.doi.org/   10.1053/j.seminhematol.2013.03.02 9 T oettcher, J.E., A. Loewer, G.J.",Non-OADS,/arxiv_data1/oa_pdf/6d/a7/JEM_20150308.PMC4516798.pdf
"http://dx.doi.org/   10.1038/nri272 6 van Galen, P ., A. Kreso, E. Wienholds, E. Laurenti, K. Eppert, E.R.",Non-OADS,/arxiv_data1/oa_pdf/6d/a7/JEM_20150308.PMC4516798.pdf
"http://dx.doi.org/10.1016/j.stem.2013.11.02 1 van Os, R., L.M.",OADS,/arxiv_data1/oa_pdf/6d/a7/JEM_20150308.PMC4516798.pdf
"http://dx.doi.org/10.1634/stemcells.2006-063 1 Viatour, P ., T.C.",OADS,/arxiv_data1/oa_pdf/6d/a7/JEM_20150308.PMC4516798.pdf
"http://dx.doi.org/10.1371/ journal.pone.006068 0 Y uan, Y ., H. Shen, D.S.",Non-OADS,/arxiv_data1/oa_pdf/6d/a7/JEM_20150308.PMC4516798.pdf
"6:436– 442. http://dx.doi.org/10.1038/ncb112 6 Zou, P ., H. Y oshihara, K. Hosokawa, I. Tai, K. Shinmyozu, F .",OADS,/arxiv_data1/oa_pdf/6d/a7/JEM_20150308.PMC4516798.pdf
http://dx.doi   .org/10.1016/j.stem.2011.07.00 3,OADS,/arxiv_data1/oa_pdf/6d/a7/JEM_20150308.PMC4516798.pdf
This article is distributed under the terms of an Attribution–   Noncommercial–Share Alike–No Mirror Sites license for the first six months  after the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/74/10/JEM_20150329.PMC4516799.pdf
"After six months  it is available under a Creative Commons License (Attribution–Noncommercial– Share Alike 3.0 Unported license, as described at http://creativecommons.org/   licenses/by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/74/10/JEM_20150329.PMC4516799.pdf
Online   supplemental material is available at http://www.jem.org/cgi/content/full/   jem.20150329/DC1.,Non-OADS,/arxiv_data1/oa_pdf/74/10/JEM_20150329.PMC4516799.pdf
"http://dx.doi.org/10.1172/JCI7593 5 Anderson, B.E., J.M.",OADS,/arxiv_data1/oa_pdf/74/10/JEM_20150329.PMC4516799.pdf
"http://dx.doi.org/10.1182/blood-2004-08-303 2 Auffray, C., M.H.",Non-OADS,/arxiv_data1/oa_pdf/74/10/JEM_20150329.PMC4516799.pdf
"http://dx.doi.org/10.1146/annurev.immunol   .021908.13255 7 Banovic, T., K.P.",OADS,/arxiv_data1/oa_pdf/74/10/JEM_20150329.PMC4516799.pdf
"http://dx.doi.org/10.1182/blood-2005-01-006 2 Blazar, B.R., W.J.",Non-OADS,/arxiv_data1/oa_pdf/74/10/JEM_20150329.PMC4516799.pdf
"http://dx.doi.org/10.1038/nri321 2 Bogunovic, M., F. Ginhoux, J. Helft, L. Shang, D. Hashimoto, M. Greter,  K. Liu, C. Jakubzick, M.A.",OADS,/arxiv_data1/oa_pdf/74/10/JEM_20150329.PMC4516799.pdf
"http://dx.doi.org/10.1016/j.immuni.2009.08.01 0 Bouillet, P., J.F.",OADS,/arxiv_data1/oa_pdf/74/10/JEM_20150329.PMC4516799.pdf
"http://dx.doi.org/10   .1038/415922 a Bunting, M.D., I. Comerford, N. Seach, M.V.",Non-OADS,/arxiv_data1/oa_pdf/74/10/JEM_20150329.PMC4516799.pdf
"http://dx.doi.org/10   .1182/blood-2012-06-43488 6 Chakraverty, R., and M. Sykes.",Non-OADS,/arxiv_data1/oa_pdf/74/10/JEM_20150329.PMC4516799.pdf
"http://dx.doi.org/10.1182/blood-2006-12-02203 8 Chen, X., R. Das, R. Komorowski, A. Beres, M.J. Hessner, M. Mihara, and  W .R.",Non-OADS,/arxiv_data1/oa_pdf/74/10/JEM_20150329.PMC4516799.pdf
"http://dx.doi.org/10.1182/blood-   2009-01-19717 8 Chen, Y., E.M. Akirav, W. Chen, O. Henegariu, B. Moser, D. Desai, J.M.",Non-OADS,/arxiv_data1/oa_pdf/74/10/JEM_20150329.PMC4516799.pdf
"http://dx.doi.org/10.4049/jimmunol.181.6.4272 Cochran, W.G., and G.M.",OADS,/arxiv_data1/oa_pdf/74/10/JEM_20150329.PMC4516799.pdf
"http://dx.doi.org/10.1172/JCI428 5 Cretney, E., A. Xin, W. Shi, M. Minnich, F. Masson, M. Miasari, G.T.",Non-OADS,/arxiv_data1/oa_pdf/74/10/JEM_20150329.PMC4516799.pdf
"http://dx.doi.org/10.1038/ni.200 6 Domínguez, P .M., and C. Ardavín.",Non-OADS,/arxiv_data1/oa_pdf/74/10/JEM_20150329.PMC4516799.pdf
"http://dx.doi.org/10.1111/j.0105- 2896.2009.00876. x Ferrara, J.L., J.E.",Non-OADS,/arxiv_data1/oa_pdf/74/10/JEM_20150329.PMC4516799.pdf
http://dx.doi.org/10.1016/S0140-   6736(09)60237- 3,OADS,/arxiv_data1/oa_pdf/74/10/JEM_20150329.PMC4516799.pdf
"http://dx.doi.org/10.4049/jimmunol   .100403 6 Gooley, T.A., J.W.",OADS,/arxiv_data1/oa_pdf/74/10/JEM_20150329.PMC4516799.pdf
"http://dx.doi.org/10.1056/   NEJMoa100438 3 Hashimoto, D., A. Chow, M. Greter, Y. Saenger, W.H.",OADS,/arxiv_data1/oa_pdf/74/10/JEM_20150329.PMC4516799.pdf
"http://dx.doi.org/10.1084/jem.2010170 9 Heidegger, S., M.R.",Non-OADS,/arxiv_data1/oa_pdf/74/10/JEM_20150329.PMC4516799.pdf
"5:337. http://dx.doi.org/10.3389/fimmu.2014.0033 7 Henden, A.S., and G.R.",Non-OADS,/arxiv_data1/oa_pdf/74/10/JEM_20150329.PMC4516799.pdf
"http://dx.doi.org/10.4049/jimmunol   .150011 7 Hill, G.R., J.M.",Non-OADS,/arxiv_data1/oa_pdf/74/10/JEM_20150329.PMC4516799.pdf
"http://dx.doi.org/10.3109/0883018980904299 7 Joffre, O.P., E. Segura, A. Savina, and S. Amigorena.",Non-OADS,/arxiv_data1/oa_pdf/74/10/JEM_20150329.PMC4516799.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/74/10/JEM_20150329.PMC4516799.pdf
"http://dx.doi.org/10.1084/jem.2005110 0 Kennedy, G.A., A. Varelias, S. Vuckovic, L. Le Texier, K.H.",Non-OADS,/arxiv_data1/oa_pdf/74/10/JEM_20150329.PMC4516799.pdf
"http://dx.doi.org/10   .1016/S1470-2045(14)71017- 4 Kondo, T., T. Kawai, and S. Akira.",OADS,/arxiv_data1/oa_pdf/74/10/JEM_20150329.PMC4516799.pdf
"http://dx.doi.org/10.1038/nm.259 7 Li, H., C. Matte-Martone, H.S.",OADS,/arxiv_data1/oa_pdf/74/10/JEM_20150329.PMC4516799.pdf
"http://dx.doi.org/10.4049/jimmunol.100296 5 MacDonald, K.P., R.D.",Non-OADS,/arxiv_data1/oa_pdf/74/10/JEM_20150329.PMC4516799.pdf
"http://dx.doi.org/10.1182/blood-2007-01-06724 9 MacDonald, K.P., J.S.",Non-OADS,/arxiv_data1/oa_pdf/74/10/JEM_20150329.PMC4516799.pdf
"http://dx.doi.org/10.1182/blood-2008-12-19183 3 Markey, K.A., A.C. Burman, T. Banovic, R.D.",Non-OADS,/arxiv_data1/oa_pdf/74/10/JEM_20150329.PMC4516799.pdf
"http://dx.doi.org/10.1182/blood-2009-01-19992 7 Markey, K.A., M. Koyama, R.D.",Non-OADS,/arxiv_data1/oa_pdf/74/10/JEM_20150329.PMC4516799.pdf
"http://dx.doi.org/   10.1182/blood-2011-12-39816 4 Markey, K.A., K.P .",Non-OADS,/arxiv_data1/oa_pdf/74/10/JEM_20150329.PMC4516799.pdf
"http://dx.doi.org/10.1182/blood-2014-02-51474 5 Massberg, S., P. Schaerli, I. Knezevic-Maramica, M. Köllnberger, N. Tubo,  E.A.",Non-OADS,/arxiv_data1/oa_pdf/74/10/JEM_20150329.PMC4516799.pdf
"http://dx.doi.org/10.1016/j.cell.2007.09.04 7 Matte, C.C., J. Liu, J. Cormier, B.E.",OADS,/arxiv_data1/oa_pdf/74/10/JEM_20150329.PMC4516799.pdf
"http://dx.doi.org/10.1146/annurev-immunol-020711-07495 0 Mittrücker, H.W., T. Matsuyama, A. Grossman, T.M.",OADS,/arxiv_data1/oa_pdf/74/10/JEM_20150329.PMC4516799.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/74/10/JEM_20150329.PMC4516799.pdf
"http://dx.doi.org/10.1172/JCI2524 9 Nagai, Y., K.P.",OADS,/arxiv_data1/oa_pdf/74/10/JEM_20150329.PMC4516799.pdf
"http://dx.doi.org/10.1016/j.immuni.2006.04.00 8 Nishimura, R., J. Baker, A. Beilhack, R. Zeiser, J.A.",OADS,/arxiv_data1/oa_pdf/74/10/JEM_20150329.PMC4516799.pdf
"http://dx.doi.org/10   .1182/blood-2007-06-09281 7 Ochando, J.C., C. Homma, Y. Yang, A. Hidalgo, A. Garin, F. Tacke, V.  Angeli, Y. Li, P. Boros, Y. Ding, et al.",Non-OADS,/arxiv_data1/oa_pdf/74/10/JEM_20150329.PMC4516799.pdf
"http://dx.doi.org/10.1038/ni133 3 Persson, E.K., H. Uronen-Hansson, M. Semmrich, A. Rivollier, K. Hägerbrand,  J. Marsal, S. Gudjonsson, U. Håkansson, B. Reizis, K. Kotarsky, and  W.W. Agace.",Non-OADS,/arxiv_data1/oa_pdf/74/10/JEM_20150329.PMC4516799.pdf
"http://dx.doi.org/10.1016/j.immuni.2013.03.00 9 Reddy, P., T. Teshima, M. Kukuruga, R. Ordemann, C. Liu, K. Lowler,  and J.L.",OADS,/arxiv_data1/oa_pdf/74/10/JEM_20150329.PMC4516799.pdf
"http://dx.doi.org/10.1084/jem.194.10.143 3 Saleh, M., and G. Trinchieri.",Non-OADS,/arxiv_data1/oa_pdf/74/10/JEM_20150329.PMC4516799.pdf
"http://dx.doi.org/10.1038/nri289 1 Schlitzer, A., N. McGovern, P. Teo, T. Zelante, K. Atarashi, D. Low,  A.W.",Non-OADS,/arxiv_data1/oa_pdf/74/10/JEM_20150329.PMC4516799.pdf
"http://dx.doi.org/10.1126/science.285.5426.41 2 Shortman, K., and W .R.",OADS,/arxiv_data1/oa_pdf/74/10/JEM_20150329.PMC4516799.pdf
"http://dx.doi.org/10.1111/j.0105-2896.2009   .00870. x Stagg, A.J., M.A.",OADS,/arxiv_data1/oa_pdf/74/10/JEM_20150329.PMC4516799.pdf
"32:1445– 1454. http://dx.doi.org/10.1002/1521-4141(200205)32:5<1445::AID-   IMMU1445>3.0.CO;2- E Tamoutounour, S., S. Henri, H. Lelouard, B. de Bovis, C. de Haar, C.J.",Non-OADS,/arxiv_data1/oa_pdf/74/10/JEM_20150329.PMC4516799.pdf
"http://dx.doi.org/   10.1002/eji.20124284 7 Tawara, I., M. Koyama, C. Liu, T. Toubai, D. Thomas, R. Evers, P.  Chockley, E. Nieves, Y.",OADS,/arxiv_data1/oa_pdf/74/10/JEM_20150329.PMC4516799.pdf
"http://dx.doi.org/   10.1158/1078-0432.CCR-10-119 8 Teshima, T., R. Ordemann, P. Reddy, S. Gagin, C. Liu, K.R.",Non-OADS,/arxiv_data1/oa_pdf/74/10/JEM_20150329.PMC4516799.pdf
"http://dx.doi.org/10.1038/nmeth.190 5Toubai, T., I. Tawara, Y.",OADS,/arxiv_data1/oa_pdf/74/10/JEM_20150329.PMC4516799.pdf
"119:3844– 3853. http://dx.doi.org/10.1182/blood-2011-10-38405 7 Tsou, C.L., W. Peters, Y. Si, S. Slaymaker, A.M. Aslanian, S.P.",Non-OADS,/arxiv_data1/oa_pdf/74/10/JEM_20150329.PMC4516799.pdf
"http://dx.doi.org/10.1172/   JCI2991 9 Varelias, A., K.H.",Non-OADS,/arxiv_data1/oa_pdf/74/10/JEM_20150329.PMC4516799.pdf
"http://dx.doi.org/10.1182/blood-2014-07-59023 2 Varol, C., A. Vallon-Eberhard, E. Elinav, T. Aychek, Y .",Non-OADS,/arxiv_data1/oa_pdf/74/10/JEM_20150329.PMC4516799.pdf
"http://dx.doi.org/10.1016/j.immuni.2009.06.02 5 Weisdorf, D., M.J. Zhang, M. Arora, M.M.",OADS,/arxiv_data1/oa_pdf/74/10/JEM_20150329.PMC4516799.pdf
"http://dx.doi.org/10.1016/j.bbmt.2012.06.01 4 Yamamoto, M., S. Sato, H. Hemmi, K. Hoshino, T. Kaisho, H. Sanjo,   O. Takeuchi, M. Sugiyama, M. Okabe, K. Takeda, and S. Akira.",OADS,/arxiv_data1/oa_pdf/74/10/JEM_20150329.PMC4516799.pdf
"http://dx.doi.org/10.1126/science   .108726 2 Zhang, Y., J.P. Louboutin, J. Zhu, A.J.",OADS,/arxiv_data1/oa_pdf/74/10/JEM_20150329.PMC4516799.pdf
http://dx.doi.org/10.1172/JCI021498 9,Non-OADS,/arxiv_data1/oa_pdf/74/10/JEM_20150329.PMC4516799.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months  after the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/f2/e8/JEM_20150110.PMC4516800.pdf
"After six months  it is available under a Creative Commons License (Attribution–Noncommercial–   Share Alike 3.0 Unported license, as described at http://creativecommons.org/   licenses/by-nc-sa/3.0 /).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/f2/e8/JEM_20150110.PMC4516800.pdf
Online supplemental material is available at http://www.jem   .org/cgi/content/full/jem.20150110/DC 1.,Non-OADS,/arxiv_data1/oa_pdf/f2/e8/JEM_20150110.PMC4516800.pdf
http://dx.doi.org/10.1046/ j.1440-1711.1998.00709.,Non-OADS,/arxiv_data1/oa_pdf/f2/e8/JEM_20150110.PMC4516800.pdf
"http://dx.doi.org/10.1016/S0022-1759(03)00191- 1 Dadgostar, H., S.E.",OADS,/arxiv_data1/oa_pdf/f2/e8/JEM_20150110.PMC4516800.pdf
"http://dx.doi.org/10.1038/   nature0526 9 Dillon, N., G. Kollias, F. Grosveld, and J.G.",OADS,/arxiv_data1/oa_pdf/f2/e8/JEM_20150110.PMC4516800.pdf
"http://dx.doi.org/10.1093/nar/   19.22.622 7 Dillon, T.J., M. Takahashi, Y. Li, S. Tavisala, S.E.",Non-OADS,/arxiv_data1/oa_pdf/f2/e8/JEM_20150110.PMC4516800.pdf
"http://dx.doi.org/10.1093/intimm/   dxs10 4 Fischer, A.M., C.D.",OADS,/arxiv_data1/oa_pdf/f2/e8/JEM_20150110.PMC4516800.pdf
"http://dx.doi.org/10.1016/j.immuni   .2005.08.01 3HSP60 (H1), Zap70 (1E7.2), Tubulin (TU-02), p-ERK (E-4), MEK1 (C-18),  Lck (3A5), p38 / (H-147), PLC  (1249), and Calregulin (N-19) were   from Santa Cruz Biotechnology, Inc. HRP-conjugated anti-HA antibody  (3F10) was from Roche.",OADS,/arxiv_data1/oa_pdf/f2/e8/JEM_20150110.PMC4516800.pdf
"http://dx.doi.org/10.1038/   nri79 8 Hogquist, K.A., S.C. Jameson, W.R. Heath, J.L.",OADS,/arxiv_data1/oa_pdf/f2/e8/JEM_20150110.PMC4516800.pdf
"http://dx.doi.org/10.1016/0092-   8674(94)90169- 4 Hu, Q., S.A. Nicol, A.Y.",OADS,/arxiv_data1/oa_pdf/f2/e8/JEM_20150110.PMC4516800.pdf
"http://dx.doi.org/10.1038/333742a 0 Klein, L., B. Kyewski, P.M. Allen, and K.A.",Non-OADS,/arxiv_data1/oa_pdf/f2/e8/JEM_20150110.PMC4516800.pdf
"http://dx.doi.org/10.1038/   nri366 7 Kortum, R.L., A.K.",Non-OADS,/arxiv_data1/oa_pdf/f2/e8/JEM_20150110.PMC4516800.pdf
"http://dx.doi.org/10.1016/j.it   .2013.02.00 4 Mayinger, P. 2011.",OADS,/arxiv_data1/oa_pdf/f2/e8/JEM_20150110.PMC4516800.pdf
"http://dx.doi.org/10.1101/cshperspect.a00531 4 Michie, A.M., and J.C. Zúñiga-Pflücker.",OADS,/arxiv_data1/oa_pdf/f2/e8/JEM_20150110.PMC4516800.pdf
"14:311– 323. http://dx.doi.org/10.1016/S1044-5323(02)00064- 7 Nakaya, M., Y. Xiao, X. Zhou, J.H.",OADS,/arxiv_data1/oa_pdf/f2/e8/JEM_20150110.PMC4516800.pdf
"http://dx.doi   .org/10.1016/j.immuni.2014.04.00 7 Nakayama, T., D.J.",OADS,/arxiv_data1/oa_pdf/f2/e8/JEM_20150110.PMC4516800.pdf
"http://dx.doi   .org/10.1126/science.286.5443.137 4 Reiley, W.W., W. Jin, A.J.",OADS,/arxiv_data1/oa_pdf/f2/e8/JEM_20150110.PMC4516800.pdf
"http://dx.doi.org/10.1084/jem.2006269 4 Schultz, J., F. Milpetz, P. Bork, and C.P.",OADS,/arxiv_data1/oa_pdf/f2/e8/JEM_20150110.PMC4516800.pdf
"http://dx.doi.org/10.1073/   pnas.95.11.585 7Schwenk, F., U. Baron, and K. Rajewsky.",Non-OADS,/arxiv_data1/oa_pdf/f2/e8/JEM_20150110.PMC4516800.pdf
"http://dx.doi.org/10.1016/j.cell.2009.08.04 1 Starr, T.K., S.C. Jameson, and K.A.",OADS,/arxiv_data1/oa_pdf/f2/e8/JEM_20150110.PMC4516800.pdf
"http://dx.doi   .org/10.1146/annurev.immunol.21.120601.14110 7 Sun, S.-C., P.A.",Non-OADS,/arxiv_data1/oa_pdf/f2/e8/JEM_20150110.PMC4516800.pdf
"http://dx.doi.org/10.1002/eji.183023032 6 Tsukamoto, H., A. Irie, S. Senju, A.K.",OADS,/arxiv_data1/oa_pdf/f2/e8/JEM_20150110.PMC4516800.pdf
"http://dx.doi.org/10.1002/   eji.20073743 0 Uhlik, M., L. Good, G. Xiao, E.W.",OADS,/arxiv_data1/oa_pdf/f2/e8/JEM_20150110.PMC4516800.pdf
"http://dx.doi.org/10.1074/jbc.273.33.2113 2 Vanhecke, D., B. Verhasselt, M. De Smedt, G. Leclercq, J.",OADS,/arxiv_data1/oa_pdf/f2/e8/JEM_20150110.PMC4516800.pdf
"http://dx.doi   .org/10.1016/j.smim.2010.04.01 3 Wolfer, A., A. Wilson, M. Nemir, H.R.",OADS,/arxiv_data1/oa_pdf/f2/e8/JEM_20150110.PMC4516800.pdf
"http://dx.doi.org/10.1016/S1074-7613(02)00330- 8 Xie, P., Z.J.",OADS,/arxiv_data1/oa_pdf/f2/e8/JEM_20150110.PMC4516800.pdf
"http://dx.doi.org/   10.4049/jimmunol.100029 0 Yamashita, I., T. Nagata, T. Tada, and T. Nakayama.",OADS,/arxiv_data1/oa_pdf/f2/e8/JEM_20150110.PMC4516800.pdf
"5:1139– 1150. http://dx.doi.org/10.1093/intimm/5.9.113 9 Zamoyska, R., and M. Lovatt.",OADS,/arxiv_data1/oa_pdf/f2/e8/JEM_20150110.PMC4516800.pdf
"http://dx.doi.org/10.1016/j.coi.2004.01.00 1 Zou, Q., J. Jin, H. Hu, H.S.",OADS,/arxiv_data1/oa_pdf/f2/e8/JEM_20150110.PMC4516800.pdf
http://dx.doi.org/10.1038/ni.288 5,Non-OADS,/arxiv_data1/oa_pdf/f2/e8/JEM_20150110.PMC4516800.pdf
This article is distributed under the terms of an Attribution–   Noncommercial–Share Alike–No Mirror Sites license for the first six months after  the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/94/c2/JEM_20142076.PMC4516803.pdf
"After six months it is  available under a Creative Commons License (Attribution–Noncommercial–Share  Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/   by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/94/c2/JEM_20142076.PMC4516803.pdf
"http://dx.doi.org/10.1172/JCI651 5 Bradley, P .P ., D.A.",OADS,/arxiv_data1/oa_pdf/94/c2/JEM_20142076.PMC4516803.pdf
"84:523. http://dx.doi.org/10.1002/ajh.2132 1 Faull, R.J., and M.H.",OADS,/arxiv_data1/oa_pdf/94/c2/JEM_20142076.PMC4516803.pdf
"http://dx.doi.org/10.1038/   jid.2012.13 7 Goerge, T., B. Ho­Tin­Noe, C. Carbo, C. Benarafa, E. Remold­O’Donnell,  B.Q.",Non-OADS,/arxiv_data1/oa_pdf/94/c2/JEM_20142076.PMC4516803.pdf
"http://dx.doi   .org/10.1182/blood­2007­11­12362 0 Hara, T., K. Shimizu, F .",Non-OADS,/arxiv_data1/oa_pdf/94/c2/JEM_20142076.PMC4516803.pdf
"http://dx.doi.org/10.2353/ajpath.2010.08111 7 Ho­Tin­Noé, B., T. Goerge, S.M.",OADS,/arxiv_data1/oa_pdf/94/c2/JEM_20142076.PMC4516803.pdf
"http://dx.doi.org/10.1158/0008­ 5472.CAN­08­071 8 Ho­Tin­Noé, B., C. Carbo, M. Demers, S.M.",Non-OADS,/arxiv_data1/oa_pdf/94/c2/JEM_20142076.PMC4516803.pdf
"http://dx.doi.org/10   .2353/ajpath.2009.09046 0 Ho­Tin­Noé, B., M. Demers, and D.D.",OADS,/arxiv_data1/oa_pdf/94/c2/JEM_20142076.PMC4516803.pdf
http://dx.doi.org/10   .1111/j.1538­7836.2011.04317.,Non-OADS,/arxiv_data1/oa_pdf/94/c2/JEM_20142076.PMC4516803.pdf
"F1000Prime Rep.  6:45. http://dx.doi.org/10.12703/P6­4 5 Jain, R.K., L.L.",OADS,/arxiv_data1/oa_pdf/94/c2/JEM_20142076.PMC4516803.pdf
"http://dx.doi.org/10.1038/nrc77 8 Jenne, C.N., R. Urrutia, and P .",Non-OADS,/arxiv_data1/oa_pdf/94/c2/JEM_20142076.PMC4516803.pdf
"http://dx.doi.org/10.1038/nri215 6 Matzdorff, A., W .",OADS,/arxiv_data1/oa_pdf/94/c2/JEM_20142076.PMC4516803.pdf
"http://dx.doi.org/10.1159/00035691 0 Mayadas, T.N., R.C.",Non-OADS,/arxiv_data1/oa_pdf/94/c2/JEM_20142076.PMC4516803.pdf
"http://dx.doi.org/10.1016/   0092­8674(93)80055­ Jspots and quantified leukocyte recruitment by measurement of the green  fluorescent intensity (using the Adobe Photoshop histogram function) of  equally exposed microscopic images (0, 30, 60, and 90 min after ICV induc ­ tion).",OADS,/arxiv_data1/oa_pdf/94/c2/JEM_20142076.PMC4516803.pdf
"http://dx.doi.org/10.1146/ annurev.immunol.021908.13255 4 Aledort, L.M., C.P .",OADS,/arxiv_data1/oa_pdf/94/c2/JEM_20142076.PMC4516803.pdf
"http://dx.doi.org/10   .1002/ajh.2010 4 Andreasen, C., and N.H. Carbonetti.",OADS,/arxiv_data1/oa_pdf/94/c2/JEM_20142076.PMC4516803.pdf
"http://dx.doi.org/10   .1056/NEJMra080088 7 Neunert, C., W .",OADS,/arxiv_data1/oa_pdf/94/c2/JEM_20142076.PMC4516803.pdf
"http://dx.doi.org/10.1182/   blood­2010­08­30298 4 Nieswandt, B., W. Bergmeier, K. Rackebrandt, J.E.",Non-OADS,/arxiv_data1/oa_pdf/94/c2/JEM_20142076.PMC4516803.pdf
"116:4712– 4719. http://dx.doi.org/10.1182/blood­2010­03­27631 1 Provan, D., R. Stasi, A.C. Newland, V .S.",Non-OADS,/arxiv_data1/oa_pdf/94/c2/JEM_20142076.PMC4516803.pdf
"http://dx.doi   .org/10.1182/blood­2009­06­22556 5 Psaila, B., and J.B. Bussel.",OADS,/arxiv_data1/oa_pdf/94/c2/JEM_20142076.PMC4516803.pdf
"http://dx.doi.org/10.1016/j.hoc   .2007.06.00 7 Rodeghiero, F ., M. Michel, T. Gernsheimer, M. Ruggeri, V .",OADS,/arxiv_data1/oa_pdf/94/c2/JEM_20142076.PMC4516803.pdf
"http://dx.doi.org/10.1182/blood­2012­07­44239 2 Rudolph, U., M.J. Finegold, S.S. Rich, G.R.",Non-OADS,/arxiv_data1/oa_pdf/94/c2/JEM_20142076.PMC4516803.pdf
"http://dx.doi.org/10.1038/ng0695­14 3 Schubert, C., E. Christophers, O. Swensson, and T .",Non-OADS,/arxiv_data1/oa_pdf/94/c2/JEM_20142076.PMC4516803.pdf
"http://dx.doi.org/10.1007/BF0051008 3 Schulte, D., V .",Non-OADS,/arxiv_data1/oa_pdf/94/c2/JEM_20142076.PMC4516803.pdf
"http://dx.doi   .org/10.1038/emboj.2011.30 4Sindrilaru, A., S. Seeliger, J.M.",OADS,/arxiv_data1/oa_pdf/94/c2/JEM_20142076.PMC4516803.pdf
"http://dx.doi.org/10.1038/   sj.jid.570056 3 Skokowa, J., S.R.",OADS,/arxiv_data1/oa_pdf/94/c2/JEM_20142076.PMC4516803.pdf
"http://dx.doi.org/10.4049/jimmunol.174   .5.304 1 Spangrude, G.J., F. Sacchi, H.R.",Non-OADS,/arxiv_data1/oa_pdf/94/c2/JEM_20142076.PMC4516803.pdf
"http://dx.doi.org/10.1126/science.806644 8 Thornton, P ., B.W .",OADS,/arxiv_data1/oa_pdf/94/c2/JEM_20142076.PMC4516803.pdf
"http://dx.doi.org/10.1182/blood ­2009­  11­25264 3 Vestweber, D. 2008.",Non-OADS,/arxiv_data1/oa_pdf/94/c2/JEM_20142076.PMC4516803.pdf
"http://dx.doi.org/10.1161/ATVBAHA   .107.15801 4 V estweber, D., F .",Non-OADS,/arxiv_data1/oa_pdf/94/c2/JEM_20142076.PMC4516803.pdf
"http://dx.doi.org/10.1007/s00281­   014­0419­ 7 Wessel, F ., M. Winderlich, M. Holm, M. Frye, R. Rivera­Galdos, M. Vockel,  R. Linnepe, U. Ipe, A. Stadtmann, A. Zarbock, et al.",OADS,/arxiv_data1/oa_pdf/94/c2/JEM_20142076.PMC4516803.pdf
"http://dx.doi.org/10.1038/ni.282 4 Wiege, K., S.R.",OADS,/arxiv_data1/oa_pdf/94/c2/JEM_20142076.PMC4516803.pdf
"http://dx.doi.org/10.4049/jimmunol.120139 8 Wilson, R.W ., C.M.",Non-OADS,/arxiv_data1/oa_pdf/94/c2/JEM_20142076.PMC4516803.pdf
This article is distributed under the terms of an Attribution–Noncommercial–Share  Alike–No Mirror Sites license for the first six months after the publication date  (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/cf/96/JEM_20141286.PMC4516804.pdf
"After six months it is available under a Cre - ative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported  license, as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/cf/96/JEM_20141286.PMC4516804.pdf
"http://dx.doi.org/10.1016/j.jaci.2013.04.05 5 Aloj, G., G. Giardino, L. Valentino, F. Maio, V. Gallo, T. Esposito, R.  Naddei, E. Cirillo, and C. Pignata.",OADS,/arxiv_data1/oa_pdf/cf/96/JEM_20141286.PMC4516804.pdf
"http://dx.doi.org/10.1016/   S0140-6736(03)12513- 5 Argenton, F., S. Giudici, G. Deflorian, S. Cimbro, F. Cotelli, and M.  Beltrame.",OADS,/arxiv_data1/oa_pdf/cf/96/JEM_20141286.PMC4516804.pdf
"http://dx.doi.org/10.1016/j.mod.2004.01.00 1 Bandlow, W., G. Strobel, C. Zoglowek, U. Oechsner, and V. Magdolen.",OADS,/arxiv_data1/oa_pdf/cf/96/JEM_20141286.PMC4516804.pdf
http://dx.doi.org/10.1111/j.1432-1033.1988   .tb14469.,Non-OADS,/arxiv_data1/oa_pdf/cf/96/JEM_20141286.PMC4516804.pdf
"29:759– 762. http://dx.doi.org/10.1038/sj.bmt.170353 1 Bujan, W., A. Ferster, E. Sariban, and W. Friedrich.",Non-OADS,/arxiv_data1/oa_pdf/cf/96/JEM_20141286.PMC4516804.pdf
"http://dx.doi   .org/10.1074/jbc.M110.13410 6 Castaigne, S., C. Chomienne, M.T.",Non-OADS,/arxiv_data1/oa_pdf/cf/96/JEM_20141286.PMC4516804.pdf
"13:31. http://dx.doi.org/10.1186/   1471-2199-13-3 1 Choi, Y., G.E.",Non-OADS,/arxiv_data1/oa_pdf/cf/96/JEM_20141286.PMC4516804.pdf
"http://dx.doi.org/10.1371/journal.pone.004668 8 Craven, S.E., D. French, W. Ye, F. de Sauvage, and A. Rosenthal.",Non-OADS,/arxiv_data1/oa_pdf/cf/96/JEM_20141286.PMC4516804.pdf
"http://dx.doi   .org/10.1182/blood-2004-03-108 9 Daily, M.D., G.N.",Non-OADS,/arxiv_data1/oa_pdf/cf/96/JEM_20141286.PMC4516804.pdf
"http://dx.doi.org/10.1016/j.jmb.2010.05.01 5 De Vaal, O.M., and V. Seynhaeve.",OADS,/arxiv_data1/oa_pdf/cf/96/JEM_20141286.PMC4516804.pdf
"http://dx.doi.org/10.1016/S0140-6736(59)90105- 9 Dzeja, P.P., and A. Terzic.",OADS,/arxiv_data1/oa_pdf/cf/96/JEM_20141286.PMC4516804.pdf
"http://dx.doi.org/10.1242/   jeb.0042 6 Dzeja, P ., and A. T erzic.",OADS,/arxiv_data1/oa_pdf/cf/96/JEM_20141286.PMC4516804.pdf
"http://dx.doi.org/10.3390/ijms1004172 9 Dzeja, P .P ., C. Shung, and A. T erzic.",OADS,/arxiv_data1/oa_pdf/cf/96/JEM_20141286.PMC4516804.pdf
Online supplemental material is available at http://www.jem.org/   cgi/content/full/jem.20141286/DC1.,Non-OADS,/arxiv_data1/oa_pdf/cf/96/JEM_20141286.PMC4516804.pdf
"http://dx.doi.org/10.1016/j.cmet.2013.03.00 2 Lin, H.F ., D. Traver, H. Zhu, K. Dooley , B.H.",OADS,/arxiv_data1/oa_pdf/cf/96/JEM_20141286.PMC4516804.pdf
"http://dx.doi.org/10.1182/blood-   2005-01-017 9 Liu, R., A.L.",Non-OADS,/arxiv_data1/oa_pdf/cf/96/JEM_20141286.PMC4516804.pdf
"http://dx.doi   .org/10.3791/5132 8 Pannicke, U., M. Hönig, I. Hess, C. Friesen, K. Holzmann, E.M. Rump,  T.F.",Non-OADS,/arxiv_data1/oa_pdf/cf/96/JEM_20141286.PMC4516804.pdf
"http://dx.doi   .org/10.1038/ng.26 5 Park, I.H., N. Arora, H. Huo, N. Maherali, T. Ahfeldt, A. Shimamura,   M.W .",Non-OADS,/arxiv_data1/oa_pdf/cf/96/JEM_20141286.PMC4516804.pdf
"http://dx.doi.org/10.1038/nature0653 4 Poliani, P .L., F .",Non-OADS,/arxiv_data1/oa_pdf/cf/96/JEM_20141286.PMC4516804.pdf
"http://dx.doi.org/10.1182/blood-2009-03-21102 9 Pucar, D., E. Janssen, P.P.",Non-OADS,/arxiv_data1/oa_pdf/cf/96/JEM_20141286.PMC4516804.pdf
"http://dx.doi.org/10.1074/jbc.M00790320 0 Pucar, D., P. Bast, R.J. Gumina, L. Lim, C. Drahl, N. Juranic, S. Macura, E.  Janssen, B. Wieringa, A. Terzic, and P.P.",OADS,/arxiv_data1/oa_pdf/cf/96/JEM_20141286.PMC4516804.pdf
"http://dx.doi.org/10.1152/ajpheart.00116.200 2 Renaud, O., P. Herbomel, and K. Kissa.",Non-OADS,/arxiv_data1/oa_pdf/cf/96/JEM_20141286.PMC4516804.pdf
"http://dx.doi.org/10   .1038/nprot.2011.40 8 Rissone, A., E. Foglia, L. Sangiorgio, S. Cermenati, S. Nicoli, S. Cimbro,  M. Beltrame, F. Bussolino, F. Cotelli, and M. Arese.",Non-OADS,/arxiv_data1/oa_pdf/cf/96/JEM_20141286.PMC4516804.pdf
"http://dx.doi   .org/10.1161/ATVBAHA.111.24300 6 Ryter, S.W., and A.M. Choi.",OADS,/arxiv_data1/oa_pdf/cf/96/JEM_20141286.PMC4516804.pdf
"http://dx.doi.org/10.1089/1523086026022012 0 Sauer, H., M. Wartenberg, and J. Hescheler.",Non-OADS,/arxiv_data1/oa_pdf/cf/96/JEM_20141286.PMC4516804.pdf
"http://dx.doi.org/10.1159/00004780 4 Shapiro, Y.E., M.A.",Non-OADS,/arxiv_data1/oa_pdf/cf/96/JEM_20141286.PMC4516804.pdf
"http://dx.doi.org/10.1021/bi992076 h Sheehan, H.L., and G.W.",OADS,/arxiv_data1/oa_pdf/cf/96/JEM_20141286.PMC4516804.pdf
"http://dx.doi.org/10.1002/path.170059014 2Finckbeiner, S., P.J.",Non-OADS,/arxiv_data1/oa_pdf/cf/96/JEM_20141286.PMC4516804.pdf
"1:32.  http://dx.doi.org/10.1186/2045-3701-1-3 2 Fischer, A., F. Le Deist, S. Hacein-Bey-Abina, I. André-Schmutz, G.S.",Non-OADS,/arxiv_data1/oa_pdf/cf/96/JEM_20141286.PMC4516804.pdf
http://dx.doi.org/10.1111/ j.0105-2896.2005.00223.,Non-OADS,/arxiv_data1/oa_pdf/cf/96/JEM_20141286.PMC4516804.pdf
"http://dx.doi.org/10.1093/nar/gks123 6 Fujisawa, K., R. Murakami, T. Horiguchi, and T. Noma.",OADS,/arxiv_data1/oa_pdf/cf/96/JEM_20141286.PMC4516804.pdf
"http://dx.doi.org/10.1016/j.cbpb.2009.01.00 6 Goujon, M., H. McWilliam, W. Li, F. Valentin, S. Squizzato, J. Paern,  and R. Lopez.",OADS,/arxiv_data1/oa_pdf/cf/96/JEM_20141286.PMC4516804.pdf
"http://dx.doi.org/   10.1093/nar/gkq31 3 Hatefi, Y.",Non-OADS,/arxiv_data1/oa_pdf/cf/96/JEM_20141286.PMC4516804.pdf
"http://dx.doi   .org/10.1146/annurev.bi.54.070185.00505 5 Henderson, L.A., F .",Non-OADS,/arxiv_data1/oa_pdf/cf/96/JEM_20141286.PMC4516804.pdf
"http://dx.doi   .org/10.1016/j.jaci.2012.07.04 5 Jang, Y.Y., and S.J.",OADS,/arxiv_data1/oa_pdf/cf/96/JEM_20141286.PMC4516804.pdf
"http://dx.doi.org/10.1182/   blood-2007-05-08775 9 Janssen, E., P.P.",Non-OADS,/arxiv_data1/oa_pdf/cf/96/JEM_20141286.PMC4516804.pdf
"http://dx.doi   .org/10.1093/emboj/19.23.637 1 Kimmel, C.B., W.W. Ballard, S.R.",OADS,/arxiv_data1/oa_pdf/cf/96/JEM_20141286.PMC4516804.pdf
"http://dx.doi.org/10.1002/aja.100203030 2 Kissa, K., E. Murayama, A. Zapata, A. Cortés, E. Perret, C. Machu, and P.  Herbomel.",Non-OADS,/arxiv_data1/oa_pdf/cf/96/JEM_20141286.PMC4516804.pdf
"http://dx.doi.org/   10.1182/blood-2007-07-09949 9 Köhler, C., A. Gahm, T .",Non-OADS,/arxiv_data1/oa_pdf/cf/96/JEM_20141286.PMC4516804.pdf
"http://dx.doi.org/10.1038/ng.27 8 Lagresle-Peyrou, C., B. Neven, E. Six, C. Picard, C. Demerens-de  Chappedelaine, Y .",Non-OADS,/arxiv_data1/oa_pdf/cf/96/JEM_20141286.PMC4516804.pdf
"http://dx.doi.org/10.1016/j.jaci.2011.02.00 8 Lawson, N.D., and B.M.",OADS,/arxiv_data1/oa_pdf/cf/96/JEM_20141286.PMC4516804.pdf
"248:307– 318. http://dx.doi.org/10.1006/dbio.2002.071 1 Le Guyader, D., M.J. Redd, E. Colucci-Guyon, E. Murayama, K. Kissa, V .",Non-OADS,/arxiv_data1/oa_pdf/cf/96/JEM_20141286.PMC4516804.pdf
"http://dx.doi.org/10.1182/blood-2007-06-   09539 8 Lee, H.J., J.O.",Non-OADS,/arxiv_data1/oa_pdf/cf/96/JEM_20141286.PMC4516804.pdf
http://dx.doi.org/10.1038/ncb165 0,Non-OADS,/arxiv_data1/oa_pdf/cf/96/JEM_20141286.PMC4516804.pdf
"5:1001– 1003. http://dx.doi.org/10.1038/sj.cdd.440046 2 Sood, R., M.A.",OADS,/arxiv_data1/oa_pdf/cf/96/JEM_20141286.PMC4516804.pdf
"http://dx.doi.org/10.1016/j.ymeth.2006   .04.01 2 Sood, R., B. Carrington, K. Bishop, M. Jones, A. Rissone, F. Candotti, S.C.  Chandrasekharappa, and P. Liu.",OADS,/arxiv_data1/oa_pdf/cf/96/JEM_20141286.PMC4516804.pdf
"http://dx.doi.org/10.1371/journal.pone.005723 9 Takubo, K., N. Goda, W. Yamada, H. Iriuchishima, E. Ikeda, Y. Kubota,  H. Shima, R.S.",OADS,/arxiv_data1/oa_pdf/cf/96/JEM_20141286.PMC4516804.pdf
"http://dx.doi.org/10.1016/j.stem .2010   .06.02 0Thisse, C., and B. Thisse.",OADS,/arxiv_data1/oa_pdf/cf/96/JEM_20141286.PMC4516804.pdf
"http://dx.doi   .org/10.1038/nprot.2007.51 4 Traver, D., B.H.",OADS,/arxiv_data1/oa_pdf/cf/96/JEM_20141286.PMC4516804.pdf
"http://dx.doi.org/10.1038/   mt.2010.31 4 Westerfield, M. 1995.",Non-OADS,/arxiv_data1/oa_pdf/cf/96/JEM_20141286.PMC4516804.pdf
http://dx.doi.org/10.1016/j.jmb.2006.11.08 5,OADS,/arxiv_data1/oa_pdf/cf/96/JEM_20141286.PMC4516804.pdf
"Accepted for publication: 23 June 2015 To cite this article: Agbaje JO, Heijsters G, Salem AS, Van Slycke S, Schepers S, Politis C, Vrielinck L. Coronectomy of Deeply Impacted Lower  Third Molar: Incidence of Outcomes and Complications after One Year Follow-Up J Oral Maxillofac Res 2015;6(2):e1 URL: http://www.ejomr.org/JOMR/archives/2015/2/e1/v6n2e1.pdf doi: 10.5037/jomr.2015.6201 http://www.ejomr.org/JOMR/archives/2015/2/e1/v6n2e1ht.htm J Oral Maxillofac Res 2015 (Apr-Jun) | vol.",Non-OADS,/arxiv_data1/oa_pdf/f7/c9/jomr-06-e1.PMC4516853.pdf
http://www.ejomr.org/JOMR/archives/2015/2/e1/v6n2e1ht.htm J Oral Maxillofac Res 2015 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/f7/c9/jomr-06-e1.PMC4516853.pdf
http://www.ejomr.org/JOMR/archives/2015/2/e1/v6n2e1ht.htm J Oral Maxillofac Res 2015 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/f7/c9/jomr-06-e1.PMC4516853.pdf
http://www.ejomr.org/JOMR/archives/2015/2/e1/v6n2e1ht.htm J Oral Maxillofac Res 2015 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/f7/c9/jomr-06-e1.PMC4516853.pdf
http://www.ejomr.org/JOMR/archives/2015/2/e1/v6n2e1ht.htm J Oral Maxillofac Res 2015 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/f7/c9/jomr-06-e1.PMC4516853.pdf
http://www.ejomr.org/JOMR/archives/2015/2/e1/v6n2e1ht.htm J Oral Maxillofac Res 2015 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/f7/c9/jomr-06-e1.PMC4516853.pdf
[URL: http://www.ejomr.org/JOMR/archives/2014/4/e1/v5n4e1ht.htm ]  [Medline: 25635208 ] [PMC free article: 4306319 ] [doi: 10.5037/jomr.2014.5401 ] 16.,Non-OADS,/arxiv_data1/oa_pdf/f7/c9/jomr-06-e1.PMC4516853.pdf
J Oral Maxillofac Res 2015;6(2):e1 URL: http://www.ejomr.org/JOMR/archives/2015/2/e1/v6n2e1.pdf doi: 10.5037/jomr.2015.6201,Non-OADS,/arxiv_data1/oa_pdf/f7/c9/jomr-06-e1.PMC4516853.pdf
http://www.ejomr.org/JOMR/archives/2015/2/e1/v6n2e1ht.htm J Oral Maxillofac Res 2015 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/f7/c9/jomr-06-e1.PMC4516853.pdf
"Copyright ©  Agbaje JO, Heijsters G, Salem AS, Van Slycke S, Schepers S, Politis C, Vrielinck L. Published in the JOURNAL  OF ORAL & MAXILLOFACIAL RESEARCH ( http://www.ejomr.org ), 30 June 2015.",Non-OADS,/arxiv_data1/oa_pdf/f7/c9/jomr-06-e1.PMC4516853.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org ) must be  included.",Non-OADS,/arxiv_data1/oa_pdf/f7/c9/jomr-06-e1.PMC4516853.pdf
J Oral Maxillofac Res 2015;6(2):e2 URL: http://www.ejomr.org/JOMR/archives/2015/2/e2/v6n2e2.pdf doi: 10.5037/jomr.2015.6202 http://www.ejomr.org/JOMR/archives/2015/2/e2/v6n2e2ht.htm J Oral Maxillofac Res 2015 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/16/e2/jomr-06-e2.PMC4516854.pdf
http://www.ejomr.org/JOMR/archives/2015/2/e2/v6n2e2ht.htm J Oral Maxillofac Res 2015 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/16/e2/jomr-06-e2.PMC4516854.pdf
http://www.ejomr.org/JOMR/archives/2015/2/e2/v6n2e2ht.htm J Oral Maxillofac Res 2015 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/16/e2/jomr-06-e2.PMC4516854.pdf
http://www.ejomr.org/JOMR/archives/2015/2/e2/v6n2e2ht.htm J Oral Maxillofac Res 2015 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/16/e2/jomr-06-e2.PMC4516854.pdf
http://www.ejomr.org/JOMR/archives/2015/2/e2/v6n2e2ht.htm J Oral Maxillofac Res 2015 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/16/e2/jomr-06-e2.PMC4516854.pdf
http://www.ejomr.org/JOMR/archives/2015/2/e2/v6n2e2ht.htm J Oral Maxillofac Res 2015 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/16/e2/jomr-06-e2.PMC4516854.pdf
http://www.ejomr.org/JOMR/archives/2015/2/e2/v6n2e2ht.htm J Oral Maxillofac Res 2015 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/16/e2/jomr-06-e2.PMC4516854.pdf
[URL: http://www.ejomr.org/JOMR/archives/2012/2/e3/v3n2e3ht.htm ] [Medline: 24422010 ]  [PMC free article: 3886103 ] [doi: 10.5037/jomr.2012.3203 ] 14.,Non-OADS,/arxiv_data1/oa_pdf/16/e2/jomr-06-e2.PMC4516854.pdf
"J Oral Maxillofac Res 2015;6(2):e2 URL: http://www.ejomr.org/JOMR/archives/2015/2/e2/v6n2e2.pdf doi: 10.5037/jomr.2015.6202 Copyright ©  Andersen K, Svenstrup M, Pedersen TK, Küseler A, Jensen J, Nørholt SE.",Non-OADS,/arxiv_data1/oa_pdf/16/e2/jomr-06-e2.PMC4516854.pdf
"Published in the JOURNAL OF  ORAL & MAXILLOFACIAL RESEARCH ( http://www.ejomr.org ), 30 June 2015.",Non-OADS,/arxiv_data1/oa_pdf/16/e2/jomr-06-e2.PMC4516854.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org ) must be  included.",Non-OADS,/arxiv_data1/oa_pdf/16/e2/jomr-06-e2.PMC4516854.pdf
J Oral Maxillofac Res 2015;6(2):e3 URL: http://www.ejomr.org/JOMR/archives/2015/2/e3/v6n2e3.pdf doi: 10.5037/jomr.2015.6203 http://www.ejomr.org/JOMR/archives/2015/2/e3/v6n2e3ht.htm J Oral Maxillofac Res 2015 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/ec/c6/jomr-06-e3.PMC4516855.pdf
http://www.ejomr.org/JOMR/archives/2015/2/e3/v6n2e3ht.htm J Oral Maxillofac Res 2015 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/ec/c6/jomr-06-e3.PMC4516855.pdf
http://www.ejomr.org/JOMR/archives/2015/2/e3/v6n2e3ht.htm J Oral Maxillofac Res 2015 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/ec/c6/jomr-06-e3.PMC4516855.pdf
http://www.ejomr.org/JOMR/archives/2015/2/e3/v6n2e3ht.htm J Oral Maxillofac Res 2015 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/ec/c6/jomr-06-e3.PMC4516855.pdf
http://www.ejomr.org/JOMR/archives/2015/2/e3/v6n2e3ht.htm J Oral Maxillofac Res 2015 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/ec/c6/jomr-06-e3.PMC4516855.pdf
http://www.ejomr.org/JOMR/archives/2015/2/e3/v6n2e3ht.htm J Oral Maxillofac Res 2015 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/ec/c6/jomr-06-e3.PMC4516855.pdf
http://www.ejomr.org/JOMR/archives/2015/2/e3/v6n2e3ht.htm J Oral Maxillofac Res 2015 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/ec/c6/jomr-06-e3.PMC4516855.pdf
http://www.ejomr.org/JOMR/archives/2015/2/e3/v6n2e3ht.htm J Oral Maxillofac Res 2015 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/ec/c6/jomr-06-e3.PMC4516855.pdf
"J Oral Maxillofac Res 2015;6(2):e3 URL: http://www.ejomr.org/JOMR/archives/2015/2/e3/v6n2e3.pdf doi: 10.5037/jomr.2015.6203 Copyright ©  Sinanoglu A, Soluk-Tekkesin M, Olgac V .",Non-OADS,/arxiv_data1/oa_pdf/ec/c6/jomr-06-e3.PMC4516855.pdf
"Published in the JOURNAL OF ORAL & MAXILLOFACIAL  RESEARCH ( http://www.ejomr.org ), 30 June 2015.",Non-OADS,/arxiv_data1/oa_pdf/ec/c6/jomr-06-e3.PMC4516855.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org ) must be  included.",Non-OADS,/arxiv_data1/oa_pdf/ec/c6/jomr-06-e3.PMC4516855.pdf
"Accepted for publication: 24 June 2015 To cite this article: Goel S, Khurana N, Marwah A, Gupta S. Expression of cdk4 and p16 in Oral Lichen Planus J Oral Maxillofac Res 2015;6(2):e3 URL: http://www.ejomr.org/JOMR/archives/2015/2/e4/v6n2e4.pdf doi: 10.5037/jomr.2015.6204 http://www.ejomr.org/JOMR/archives/2015/2/e4/v6n2e4ht.htm J Oral Maxillofac Res 2015 (Apr-Jun) | vol.",Non-OADS,/arxiv_data1/oa_pdf/13/de/jomr-06-e4.PMC4516856.pdf
http://www.ejomr.org/JOMR/archives/2015/2/e4/v6n2e4ht.htm J Oral Maxillofac Res 2015 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/13/de/jomr-06-e4.PMC4516856.pdf
http://www.ejomr.org/JOMR/archives/2015/2/e4/v6n2e4ht.htm J Oral Maxillofac Res 2015 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/13/de/jomr-06-e4.PMC4516856.pdf
http://www.ejomr.org/JOMR/archives/2015/2/e4/v6n2e4ht.htm J Oral Maxillofac Res 2015 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/13/de/jomr-06-e4.PMC4516856.pdf
http://www.ejomr.org/JOMR/archives/2015/2/e4/v6n2e4ht.htm J Oral Maxillofac Res 2015 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/13/de/jomr-06-e4.PMC4516856.pdf
http://www.ejomr.org/JOMR/archives/2015/2/e4/v6n2e4ht.htm J Oral Maxillofac Res 2015 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/13/de/jomr-06-e4.PMC4516856.pdf
http://www.ejomr.org/JOMR/archives/2015/2/e4/v6n2e4ht.htm J Oral Maxillofac Res 2015 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/13/de/jomr-06-e4.PMC4516856.pdf
"J Oral Maxillofac Res 2015;6(2):e4 URL: http://www.ejomr.org/JOMR/archives/2015/2/e4/v6n2e4.pdf doi: 10.5037/jomr.2015.6204 Copyright ©  Goel S, Khurana N, Marwah A, Gupta S. Published in the JOURNAL OF ORAL & MAXILLOFACIAL  RESEARCH ( http://www.ejomr.org ), 30 June 2015.",Non-OADS,/arxiv_data1/oa_pdf/13/de/jomr-06-e4.PMC4516856.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org ) must be  included.",Non-OADS,/arxiv_data1/oa_pdf/13/de/jomr-06-e4.PMC4516856.pdf
Management of Intraosseous Vascular  Malformations of the Jaws in Children and Adolescents: Report of 6 Cases and Literature Review J Oral Maxillofac Res 2015;6(2):e5 URL: http://www.ejomr.org/JOMR/archives/2015/2/e5/v6n2e5.pdf doi: 10.5037/jomr.2015.6205 http://www.ejomr.org/JOMR/archives/2015/2/e5/v6n2e5ht.htm J Oral Maxillofac Res 2015 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/7d/48/jomr-06-e5.PMC4516857.pdf
http://www.ejomr.org/JOMR/archives/2015/2/e5/v6n2e5ht.htm J Oral Maxillofac Res 2015 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/7d/48/jomr-06-e5.PMC4516857.pdf
http://www.ejomr.org/JOMR/archives/2015/2/e5/v6n2e5ht.htm J Oral Maxillofac Res 2015 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/7d/48/jomr-06-e5.PMC4516857.pdf
http://www.ejomr.org/JOMR/archives/2015/2/e5/v6n2e5ht.htm J Oral Maxillofac Res 2015 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/7d/48/jomr-06-e5.PMC4516857.pdf
http://www.ejomr.org/JOMR/archives/2015/2/e5/v6n2e5ht.htm J Oral Maxillofac Res 2015 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/7d/48/jomr-06-e5.PMC4516857.pdf
http://www.ejomr.org/JOMR/archives/2015/2/e5/v6n2e5ht.htm J Oral Maxillofac Res 2015 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/7d/48/jomr-06-e5.PMC4516857.pdf
http://www.ejomr.org/JOMR/archives/2015/2/e5/v6n2e5ht.htm J Oral Maxillofac Res 2015 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/7d/48/jomr-06-e5.PMC4516857.pdf
http://www.ejomr.org/JOMR/archives/2015/2/e5/v6n2e5ht.htm J Oral Maxillofac Res 2015 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/7d/48/jomr-06-e5.PMC4516857.pdf
http://www.ejomr.org/JOMR/archives/2015/2/e5/v6n2e5ht.htm J Oral Maxillofac Res 2015 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/7d/48/jomr-06-e5.PMC4516857.pdf
"J Oral Maxillofac Res 2015;6(2):e5 URL: http://www.ejomr.org/JOMR/archives/2015/2/e5/v6n2e5.pdf doi: 10.5037/jomr.2015.6205 Copyright ©  Theologie-Lygidakis N, Schoinohoriti O, Tzermpos F, Christopoulos P, Iatrou I.",Non-OADS,/arxiv_data1/oa_pdf/7d/48/jomr-06-e5.PMC4516857.pdf
"Published in the JOURNAL OF  ORAL & MAXILLOFACIAL RESEARCH ( http://www.ejomr.org ), 30 June 2015.",Non-OADS,/arxiv_data1/oa_pdf/7d/48/jomr-06-e5.PMC4516857.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org ) must be  included.",Non-OADS,/arxiv_data1/oa_pdf/7d/48/jomr-06-e5.PMC4516857.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/d6/ae/40266_2015_Article_272.PMC4516859.pdf
2014. http://www.ema.europa.eu/docs/ en_GB/document_library/EPAR_-_Product_Information/human/ 002499/WC500139011.pdf .,Non-OADS,/arxiv_data1/oa_pdf/d6/ae/40266_2015_Article_272.PMC4516859.pdf
June 1996.http://www.ich.org/ﬁleadmin/Public_Web_Site/.../E6_R1_Guidel ine.pdf .,Non-OADS,/arxiv_data1/oa_pdf/d6/ae/40266_2015_Article_272.PMC4516859.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s)and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/3d/4e/40272_2015_Article_136.PMC4516863.pdf
Retrieved from http://www.accessdata.fda.,OADS,/arxiv_data1/oa_pdf/3d/4e/40272_2015_Article_136.PMC4516863.pdf
http://www.cms.gov/Research-Statistics-Data-and-System s/Computer-Data-and-Systems/MedicaidDataSourcesGenInfo/MSIS-Tables-Items/CMS1254739.html .,OADS,/arxiv_data1/oa_pdf/3d/4e/40272_2015_Article_136.PMC4516863.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s)and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/b4/77/40272_2015_Article_134.PMC4516866.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s)and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/88/aa/40266_2015_Article_276.PMC4516900.pdf
http://apps.who.int/iris/bitstream/10665/42563/ 1/9241562188.pdf?ua=1.,OADS,/arxiv_data1/oa_pdf/6c/f9/kfv104.PMC4517054.pdf
"[a]Dr.T.Klingstedt, Dr.H.Shirani,Dr.S.Nystrçm, Dr.K.P.R.Nilsson Depar tment ofChem istry,Linkçpi ngUniversi ty SE-581 83Linkçping (Sweden) E-mail :petni@ifm.liu.se [b]J.Mahler ,Dr.B.M.Wegenast-Braun ,Prof.M.Jucker Depar tment ofCellular Neurology Hertie Instit uteforClinicalBrain Research Universi tyofT(o2z2bing en,T(o2z2bing en(Germany ) [c]Dr.M.Goedert MRC Labor atory ofMolec ular Biology ,Cambridg e(United Kingdo m) [d]J.Mahler ,Dr.B.M.Wegenast-Braun ,Prof.M.Jucker DZNE ,German Cente rforNeurodegener ative Diseases ,T(o2z2bing en(Germany) Supportin ginformat ionforthisarticle isavailab leontheWWW under http://dx.doi.or g/10.1002/ chem.201 500556.",Non-OADS,/arxiv_data1/oa_pdf/55/40/chem0021-9072.PMC4517144.pdf
Supportin ginformat ionforthisarticle isavailab leontheWWW under http://dx.doi.or g/10.1002/ chem.201 405994.,Non-OADS,/arxiv_data1/oa_pdf/48/7f/chem0021-8840.PMC4517157.pdf
"Keywords: cross-coupling ·hetero- geneous catalysts ·metal–organic frameworks ·nanoparticles ·palla- dium [a] V. Pascanu, Dr. Q. Yao, Dr. A. Bermejo G/C243mez, Dr. M. Gustafsson, Y. Yun, Dr. W. Wan, Prof. X. Zou, Prof. B. Mart/C237n-Matute Berzelii Center EXSELENT on Porous Materials Stockholm University, SE-10691 Stockholm (Sweden)E-mail: xzou@mmk.su.se belen@organ.su.se [b] V. Pascanu, Dr. A. Bermejo G/C243mez, Prof. B. Mart/C237n-Matute Department of Organic Chemistry, Arrhenius Laboratory Stockholm University, SE-10691 Stockholm (Sweden) [c] Dr. Q. Yao, Dr. M. Gustafsson, Y. Yun, Dr. W. Wan, Dr. L. Samain, Prof. X. ZouInorganic and Structural ChemistryDepartment of Materials and Environmental Chemistry Arrhenius Laboratory, Stockholm University SE-10691 Stockholm (Sweden) Supporting information for this article is available on the WWWunder http://dx.doi.org/10.1002/chem.201302621.",Non-OADS,/arxiv_data1/oa_pdf/1b/fc/chem0019-17483.PMC4517175.pdf
"[40] W. S. Rasband, ImageJ, US National Institute of Health, Bethesda, MD, http://imagej.nih.gov/ij/, 1997 –2012.",Non-OADS,/arxiv_data1/oa_pdf/1b/fc/chem0019-17483.PMC4517175.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/content/ full/1/3/e1500175/DC1Fig.,Non-OADS,/arxiv_data1/oa_pdf/0c/f1/1500175.PMC4517288.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bd/e8/main.PMC4517293.pdf
http://dx.doi.org/10.1016/j.pmedr.2015.06.0172211-3355/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/bd/e8/main.PMC4517293.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bd/e8/main.PMC4517293.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/bd/e8/main.PMC4517293.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ea/38/main.PMC4517435.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ea/38/main.PMC4517435.pdf
http://dx.doi.org/10.1016/j.jcte.2015.06.002Journal of Clinical & Translational Endocrinology 2 (2015) 99 e104,OADS,/arxiv_data1/oa_pdf/ea/38/main.PMC4517435.pdf
Homeostasis model assessment of insulin resistance (HOMA-IR) and beta cell function (HOMA-%B) were calculated using the web tool at http://www.dtu.ox.ac.uk/ homacalculator/index.php .,OADS,/arxiv_data1/oa_pdf/ea/38/main.PMC4517435.pdf
"© Yanely Tirado, Alina Puig, Nadine Alvarez, Reinier Borrero, Alicia Aguilar, Frank Camacho, Fatima Reyes, Sonsire Fern /C19andez, Jos /C19e Luis P /C19erez, Dulce Mata Espinoza, Jorge Alberto Barrios Pay /C19an, María Elena Sarmiento, Mohd-Nor Norazmi, Rogelio Hern /C19andez-Pando, and Armando Acosta *Correspondence to: Mohd-Nor Norazmi; Email:norazmimn@usm.mySubmitted: 08/31/2014; Revised: 10/13/2014; Accepted: 11/20/2014 http://dx.doi.org/10.1080/21645515.2015.1011566 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/54/a1/khvi-11-03-1011566.PMC4517452.pdf
ISBN 978 983 470355 4 (http://tbvaccines.usm.my/ﬁnlay/) (2014) 2.,Non-OADS,/arxiv_data1/oa_pdf/54/a1/khvi-11-03-1011566.PMC4517452.pdf
N Engl J Med 2013;368(8):745-55; PMID:23425167; http://dx.doi.org/10.1056/ NEJMra1200894 3.,Non-OADS,/arxiv_data1/oa_pdf/54/a1/khvi-11-03-1011566.PMC4517452.pdf
Lancet Respir Med 2014;2(4):301-20; PMID:24717627; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/54/a1/khvi-11-03-1011566.PMC4517452.pdf
Philos Trans R Soc Lond B Biol Sci 2011;366:2782-9; PMID:21893541; http://dx.doi.org/10.1098/rstb.2011.0097 6.,Non-OADS,/arxiv_data1/oa_pdf/54/a1/khvi-11-03-1011566.PMC4517452.pdf
J Infect Dev Ctries 2013;7(3):169-81; PMID:23492994; http://dx.doi.org/ 10.3855/jidc.3114 8.,Non-OADS,/arxiv_data1/oa_pdf/54/a1/khvi-11-03-1011566.PMC4517452.pdf
Clin Dev Immunol 2012;2012:917860; PMID:22611423;http://dx.doi.org/10.1155/2012/917860 9.,Non-OADS,/arxiv_data1/oa_pdf/54/a1/khvi-11-03-1011566.PMC4517452.pdf
ISBN 978 983 47 0355 4 (http://tbvaccines.usm.my/ ﬁnlay/) (2014) 10.,Non-OADS,/arxiv_data1/oa_pdf/54/a1/khvi-11-03-1011566.PMC4517452.pdf
Vaccine 2009;27(2):205-12; http://dx.doi.org/10.1016/j.vaccine.2008.10.052 11.,Non-OADS,/arxiv_data1/oa_pdf/54/a1/khvi-11-03-1011566.PMC4517452.pdf
"P /C19erez O, Bracho G, Lastre M, Mora N, del Campo J, Gil D, Zayas C, Acevedo R, Gonzales D, Lopez JA,et al: Novel adjuvant based on a proteoliposome- derived cochleate structure containing native lipopoly- saccharide as a pathogen-associated molecular pattern.Immunol Cell Biol 2004;82(6):603-10; http://dx.doi.",OADS,/arxiv_data1/oa_pdf/54/a1/khvi-11-03-1011566.PMC4517452.pdf
PLoS One 2013;8(8):e71243; PMID:23977002; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/54/a1/khvi-11-03-1011566.PMC4517452.pdf
Vaccine 2011; 29(37):6236-41; PMID:21736914; http://dx.doi.org/ 10.1016/j.vaccine.2011.06.077 18.,Non-OADS,/arxiv_data1/oa_pdf/54/a1/khvi-11-03-1011566.PMC4517452.pdf
Vaccine 2013; 31: 676-84; PMID:23196205; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/54/a1/khvi-11-03-1011566.PMC4517452.pdf
J Infect Dis 2005;191 (2):299-306; http://dx.doi.org/10.1086/426453 20.,OADS,/arxiv_data1/oa_pdf/54/a1/khvi-11-03-1011566.PMC4517452.pdf
Clin Microbiol Rev 2005;18(4):687-702; PMID:16223953; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/54/a1/khvi-11-03-1011566.PMC4517452.pdf
J Clin Invest 2008;118(4): 1255-65; PMID:18382738; http://dx.doi.org/10.1172/JCI34614 24.,Non-OADS,/arxiv_data1/oa_pdf/54/a1/khvi-11-03-1011566.PMC4517452.pdf
Am J Respir Crit Care Med 1995;152(5 Pt 1):1575-8;PMID:7582297; http://dx.doi.org/10.1164/ ajrccm.152.5.7582297 26.,Non-OADS,/arxiv_data1/oa_pdf/54/a1/khvi-11-03-1011566.PMC4517452.pdf
Int J Epidemiol 1995;24(5):1042-9; PMID:8557438; http://dx.doi.org/10.1093/ije/ 24.5.1042 28.,OADS,/arxiv_data1/oa_pdf/54/a1/khvi-11-03-1011566.PMC4517452.pdf
JAMA 1994;271(9):698-702; PMID:8309034; http://dx.doi.org/10.1001/ jama.1994.03510330076038 29.,Non-OADS,/arxiv_data1/oa_pdf/54/a1/khvi-11-03-1011566.PMC4517452.pdf
Lancet 1995;346 (8986):1339-45; PMID:7475776; http://dx.doi.org/10.1016/S0140-6736(95)92348-9 30.,Non-OADS,/arxiv_data1/oa_pdf/54/a1/khvi-11-03-1011566.PMC4517452.pdf
Clin Infect Dis 2000;31(Suppl 3):S64-7; PMID:11010824; http://dx.doi.org/10.1086/314072 31.,OADS,/arxiv_data1/oa_pdf/54/a1/khvi-11-03-1011566.PMC4517452.pdf
ISBN 978 983 47 0355 4 (http://tbvaccines.usm.my/ﬁnlay/) (2014) 32.,Non-OADS,/arxiv_data1/oa_pdf/54/a1/khvi-11-03-1011566.PMC4517452.pdf
ISBN 978 983 47 0355 4 (http://tbvaccines.usm.my/ﬁnlay/) (2014)33.,Non-OADS,/arxiv_data1/oa_pdf/54/a1/khvi-11-03-1011566.PMC4517452.pdf
Infect Immun 2005;73(8): 4676-83; PMID:16040980; http://dx.doi.org/10.1128/ IAI.73.8.4676-4683.2005 34.,Non-OADS,/arxiv_data1/oa_pdf/54/a1/khvi-11-03-1011566.PMC4517452.pdf
Vaccine 2006;24(16): 3353-64; PMID:16488518; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/54/a1/khvi-11-03-1011566.PMC4517452.pdf
Infect Immun 2006 ;74 (8):4634-43; PMID:16861651; http://dx.doi.org/ 10.1128/IAI.00517-06 36.,Non-OADS,/arxiv_data1/oa_pdf/54/a1/khvi-11-03-1011566.PMC4517452.pdf
PLoS ONE 2007;2(10): e1052; PMID:17957238; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/54/a1/khvi-11-03-1011566.PMC4517452.pdf
"Safety and efﬁcacy of MVA85A, a new tubercu- losis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial.Lancet 2013;381(9871):1021-8; PMID:23391465; http://dx.doi.org/10.1016/S0140-6736(13)60177-4 38.",Non-OADS,/arxiv_data1/oa_pdf/54/a1/khvi-11-03-1011566.PMC4517452.pdf
2013;7 (3):169-81; PMID:23492994; http://dx.doi.org/ 10.3855/jidc.3114 39.,Non-OADS,/arxiv_data1/oa_pdf/54/a1/khvi-11-03-1011566.PMC4517452.pdf
2012;2012:917860; PMID:22611423; http://dx.doi.org/10.1155/2012/917860 40.,Non-OADS,/arxiv_data1/oa_pdf/54/a1/khvi-11-03-1011566.PMC4517452.pdf
2003;15 (8):915-25; PMID:12882829; http://dx.doi.org/10.1093/intimm/dxg091 41.,Non-OADS,/arxiv_data1/oa_pdf/54/a1/khvi-11-03-1011566.PMC4517452.pdf
1994;8 (2):119-26; PMID:8173551; http://dx.doi.org/ 10.1111/j.1574-695X.1994.tb00433.x 43.,Non-OADS,/arxiv_data1/oa_pdf/54/a1/khvi-11-03-1011566.PMC4517452.pdf
"army.mil; malabi.m.venkatesan.civ@mail.mil Submitted: 07/25/2014; Revised: 10/27/2014; Accepted: 11/09/2014http://dx.doi.org/10.4161/21645515.2014.986984 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use,distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/72/25/khvi-11-06-986984.PMC4517455.pdf
Lancet 2012; 380:2055-8; PMID:23245598;http://dx.doi.org/10.1016/S0140-6736(12)62134-5 2.,OADS,/arxiv_data1/oa_pdf/72/25/khvi-11-06-986984.PMC4517455.pdf
PloS one 2012; 7:e29151; PMID:22235266; http://dx.doi.org/10.1371/journal.pone.0029151 3.,Non-OADS,/arxiv_data1/oa_pdf/72/25/khvi-11-06-986984.PMC4517455.pdf
Lancet 2010; 375:870-2; PMID:19833382; http://dx.doi.org/10.1016/S0140-6736(09)61798-0 5. WHO.,OADS,/arxiv_data1/oa_pdf/72/25/khvi-11-06-986984.PMC4517455.pdf
PloS one 2013; 8:e72788; PMID:24023773; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/72/25/khvi-11-06-986984.PMC4517455.pdf
Epidemiol Infect 2013; 141:115-31; PMID:22793874; http://dx.doi.org/10.1017/ S0950268812001525 8.,Non-OADS,/arxiv_data1/oa_pdf/72/25/khvi-11-06-986984.PMC4517455.pdf
Lancet 2012; 380:2095-128; PMID:23245604; http://dx.doi.org/10.1016/S0140- 6736(12)61728-0 9.,OADS,/arxiv_data1/oa_pdf/72/25/khvi-11-06-986984.PMC4517455.pdf
Lancet 2012; 380:2197-223;PMID:23245608; http://dx.doi.org/10.1016/S0140- 6736(12)61689-4 10.,OADS,/arxiv_data1/oa_pdf/72/25/khvi-11-06-986984.PMC4517455.pdf
PloS Negl Trop Dis 2010; 4:e768; PMID:20689809; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/72/25/khvi-11-06-986984.PMC4517455.pdf
Adv Exp Med Biol 2013; 764:13-26; PMID:23654054; http://dx.doi.org/10.1007/978-1-4614-4726-9_2 12.,Non-OADS,/arxiv_data1/oa_pdf/72/25/khvi-11-06-986984.PMC4517455.pdf
Clin Infect Dis 2012; 55 Suppl 4:S232-45;PMID:23169936; http://dx.doi.org/10.1093/cid/ cis753 13.,Non-OADS,/arxiv_data1/oa_pdf/72/25/khvi-11-06-986984.PMC4517455.pdf
Clin Infect Dis 2012; 55 Suppl 4:S215-24; PMID:23169934; http://dx.doi.org/ 10.1093/cid/cis761 14.,Non-OADS,/arxiv_data1/oa_pdf/72/25/khvi-11-06-986984.PMC4517455.pdf
Lancet 2013; 382:209-22; PMID:23680352; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/72/25/khvi-11-06-986984.PMC4517455.pdf
J Clin Microbiol 2013; 51:1740-6; PMID:23536399; http://dx.doi.org/10.1128/JCM.02713-1216.,Non-OADS,/arxiv_data1/oa_pdf/72/25/khvi-11-06-986984.PMC4517455.pdf
IntJ Epidemiol 2008; 37:816-30; PMID:18567626; http://dx.doi.org/10.1093/ije/ dyn099 17.,Non-OADS,/arxiv_data1/oa_pdf/72/25/khvi-11-06-986984.PMC4517455.pdf
AmJ Epidemiol2013; 178:1129-38; PMID:23966558; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/72/25/khvi-11-06-986984.PMC4517455.pdf
BMC Public Health 2012; 12:276; PMID:22480268;http://dx.doi.org/10.1186/1471-2458-12-276 20.,Non-OADS,/arxiv_data1/oa_pdf/72/25/khvi-11-06-986984.PMC4517455.pdf
Foodborne diseases active surveillance network (FoodNet): foodnet surveillance report for 2011.2012. http://www.cdc.gov/foodnet/PDFs/2011_annual_ report_508c.pdf 21.,OADS,/arxiv_data1/oa_pdf/72/25/khvi-11-06-986984.PMC4517455.pdf
The Journal of infec- tious diseases 1999; 180:2053-5; PMID:10558969;http://dx.doi.org/10.1086/315121 22.,Non-OADS,/arxiv_data1/oa_pdf/72/25/khvi-11-06-986984.PMC4517455.pdf
Journal ofapplied microbiology 2008; 104:1128-36; PMID:17976169; http://dx.doi.org/10.1111/ j.1365-2672.2007.03628.x 23.,Non-OADS,/arxiv_data1/oa_pdf/72/25/khvi-11-06-986984.PMC4517455.pdf
Journal of travel medi- cine 2006; 13:92-9; PMID:16553595; http://dx.doi.org/10.1111/j.1708-8305.2006.00020.x 25.,Non-OADS,/arxiv_data1/oa_pdf/72/25/khvi-11-06-986984.PMC4517455.pdf
BMC gastroenterology 2013; 13:46; PMID:23510245; http://dx.doi.org/10.1186/ 1471-230X-13-46 26.,Non-OADS,/arxiv_data1/oa_pdf/72/25/khvi-11-06-986984.PMC4517455.pdf
Digestive diseases and sciences 2011;56:3262-9; PMID:21643738; http://dx.doi.org/ 10.1007/s10620-011-1762-3 27.,Non-OADS,/arxiv_data1/oa_pdf/72/25/khvi-11-06-986984.PMC4517455.pdf
Military medicine 2013; 178:452-69; PMID:23707833; http://dx.doi.org/10.7205/ MILMED-D-12-00510 28.,Non-OADS,/arxiv_data1/oa_pdf/72/25/khvi-11-06-986984.PMC4517455.pdf
Current opinion in infectious diseases 2012; 25:546-54; PMID:22907281; http://dx.doi.org/10.1097/QCO.,Non-OADS,/arxiv_data1/oa_pdf/72/25/khvi-11-06-986984.PMC4517455.pdf
Journal of travel medi- cine 2008; 15:221-8; PMID:18666921; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/72/25/khvi-11-06-986984.PMC4517455.pdf
The Journal of infection 2009; 59:19-27; PMID:19552961; http://dx.doi.org/10.1016/j.jinf.2009.05.008 32.,Non-OADS,/arxiv_data1/oa_pdf/72/25/khvi-11-06-986984.PMC4517455.pdf
Diagnostic microbiology and infectious disease 2014; 78:149-52; PMID:24286625; http://dx.doi.org/10.1016/j.diagmicrobio.2013.10.013 35.,Non-OADS,/arxiv_data1/oa_pdf/72/25/khvi-11-06-986984.PMC4517455.pdf
The American journal oftropical medicine and hygiene 2014; 90:351-3; PMID:24379243; http://dx.doi.org/10.4269/ ajtmh.12-0782 36.,Non-OADS,/arxiv_data1/oa_pdf/72/25/khvi-11-06-986984.PMC4517455.pdf
TheLancet infectious diseases 2014; 14:725-30; PMID:24981041; http://dx.doi.org/10.1016/S1473- 3099(14)70767-4 37.,Non-OADS,/arxiv_data1/oa_pdf/72/25/khvi-11-06-986984.PMC4517455.pdf
Clinical infectious diseases : an ofﬁcial publication of the Infectious Diseases Societyof America 2001; 32:1706-9; PMID:11360211; http://dx.doi.org/10.1086/320756 38.,Non-OADS,/arxiv_data1/oa_pdf/72/25/khvi-11-06-986984.PMC4517455.pdf
"APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2007; 115:218-24; PMID:17367467; http://dx.doi.org/ 10.1111/j.1600-0463.2007.apm_567.x 39.",Non-OADS,/arxiv_data1/oa_pdf/72/25/khvi-11-06-986984.PMC4517455.pdf
Diagnostic microbi- ology and infectious disease 2004; 48:175-9; PMID:15023426; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/72/25/khvi-11-06-986984.PMC4517455.pdf
Travelmedicine and infectious disease 2011; 9:263-77; PMID:22118951; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/72/25/khvi-11-06-986984.PMC4517455.pdf
Antimicrobial agents and chemotherapy 2006; 50:1612-3; PMID:16569899; http://dx.doi.org/ 10.1128/AAC.50.4.1612-1613.2006 43.,Non-OADS,/arxiv_data1/oa_pdf/72/25/khvi-11-06-986984.PMC4517455.pdf
Infection and immunity 2007; 75:3961-8; PMID:17548483;http://dx.doi.org/10.1128/IAI.00459-07 44.,Non-OADS,/arxiv_data1/oa_pdf/72/25/khvi-11-06-986984.PMC4517455.pdf
Clinical microbi- ology reviews 2005; 18:465-83; PMID:16020685;http://dx.doi.org/10.1128/CMR.18.3.465- 483.2005 45.,Non-OADS,/arxiv_data1/oa_pdf/72/25/khvi-11-06-986984.PMC4517455.pdf
PloS one 2013; 8: e62029; PMID:23658619; http://dx.doi.org/10.1371/journal.pone.0062029 46.,Non-OADS,/arxiv_data1/oa_pdf/72/25/khvi-11-06-986984.PMC4517455.pdf
Clinical infectious diseases : an ofﬁcial publication of the Infec- tious Diseases Society of America 2005; 41 Suppl 8:S577-86; PMID:16267722; http://dx.doi.org/ 10.1086/432956 47.,Non-OADS,/arxiv_data1/oa_pdf/72/25/khvi-11-06-986984.PMC4517455.pdf
The Journal of hygiene 1963; 61:365-72; PMID:14066593; http://dx.doi.org/10.1017/ S0022172400039656 48.,Non-OADS,/arxiv_data1/oa_pdf/72/25/khvi-11-06-986984.PMC4517455.pdf
Postgraduate medical journal 1972; 48:98-106; PMID:4622606; http://dx.doi.org/10.1136/pgmj.48.556.98 53.,Non-OADS,/arxiv_data1/oa_pdf/72/25/khvi-11-06-986984.PMC4517455.pdf
